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The choroid contributes blood supply to the outer retina including 
photoreceptors and is therefore associated with the pathogenesis of a number of major 
retinal diseases, such as high myopia, age-related macular degeneration (AMD), and 
diabetic retinopathy (DR). To elucidate the mechanisms how the choroid may affect 
chorioretinal diseases, an easy, objective and quantitative analysis of the choroid is 
required. The field of choroidal imaging has been greatly transformed with the 
introduction of enhanced depth imaging (EDI) technique of spectral domain optical 
coherence tomography (SD-OCT). However, despite these new techniques, it has not 
been easy to characterize and image the choroid. Among various reasons, one was 
that the junction between the choroid and sclera called “choroid-scleral interface” 
(CSI) was still not adequately visible. Anatomically, CSI forms the posterior 
boundary of the choroid; a well-defined CSI is therefore a critical landmark for 
accurate quantification of the choroid such as choroidal thickness (CT), the distance 
between the retinal pigmented epithelium (RPE) and CSI.  
We hypothesize that poor visibility of CSI will lead increased variability in CT 
measurements (Chapter 4). To test this hypothesis we conducted a pilot study in 179 
healthy eyes from a population-based study with the aim to assess (i) percentage 
visibility of CSI in EDI OCT images and (ii) variability in CT measurement in images 
with differently visible CSI. We found that only 60% of EDI images had well-defined 
CSI and that the variability in CT measurement was higher in the images with poorly 
defined CSI (ICC: 0.97 for images with well-defined CSI vs. ICC: 0.51 for images 
with poorly defined CSI). Thereby confirming that visibility of CSI was critical for 
accurate determination of CT.  
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The measurement of CT was performed manually at few points around foveal 
centre, therefore subject to intra- and inter-operator biases and this does not 
adequately reflect the profile of entire choroid. Thus, there was a need for novel 
image processing techniques which can enhance the CSI, objectively and accurately 
define the CSI as well as measure CT and choroidal volume. In Aim 1 of this 
dissertation we first overcame the primary challenge of poor CSI visibility by 
enhancing the visualization of CSI by a novel technique of “adaptive compensation” 
(Chapter 5). In our enhanced images the contrast between choroid and sclera was 
significantly increased and CT measurements were more reliable (ICC: 0.93 to 0.97) 
than the non-enhanced images (ICC: 0.90 to 0.93). However, our technique was semi-
automated as it required manual input to mark the CSI and measure CT, thus subject 
to measurement errors. To overcome this problem we used a fully automated 
choroidal segmentation technique which can objectively and accurately define CSI 
and measure CT and volume (Chapters 6 and 7). We compared our automated 
technique with the reference standard manual technique and found good agreement 
(ICC: 0.90 to 0.96) between the 2 techniques. Thus, our automated choroidal image 
processing technique was valid and comparable to existing manual CT measurement 
technique (Chapter 6). 
There is currently limited population-based data on CT in Asians. It is 
unknown whether there exists any ethnic variation in CT among Asians; neither is it 
known if there are differences in systemic and ocular risk factors of CT among the 
different ethnic groups (e.g., Malays versus Indians) in Asians. We addressed these 
gaps in knowledge through a multi-ethnic population-based study in Singapore. In 
Aim 2 of this project, we performed a population-based evaluation of the distribution 
and determinants of most commonly used macular and peripapillary choroidal traits 
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such as CT and volume using our novel fully automated choroidal segmentation 
technique (Chapter 7). After adjusting for the differences in population specific 
characteristics, we found slight difference in macular CT (mean difference [MD] 12 
µm), macular choroidal volume (MD 0.02 mm
3
) and peripapillary CT (MD ~32 µm, p 
<0.001) among ethnic Malays and Indians. Both macular and peripapillary choroid 
was asymmetrically distributed (macular: thickest subfoveally and thinnest nasally; 
peripapillary: thickest superiorly and thinnest inferiorly) in the 2 ethnic groups, but, 
there was no difference in topographical profile of either macular and peripapillary 
choroid. Factors such as age, gender and axial length were the major determinants of 
CT and volume among both ethnic groups and should be taken into account when 
interpreting EDI OCT based CT measurements in clinical settings. Furthermore, two-
third (~66%) of the subfoveal choroid was found to be vascular in healthy eyes 
(Chapter 8). 
Lastly, detailed morphological and vascular analyses of the choroid would 
further help to better understand the role of choroid in eye diseases such as high 
myopia, DR and AMD. We found significant alterations in choroidal attributes such 
as CT, volume, morphology and vasculature in the above diseases (Chapters 9, 10 
and 11). In high myopia there was marked reduction in CT, volume and vasculature 
but no change in morphological features such as curvature of CSI and inflection 
points compared to emmetropes (Chapter 9). Conversely, persons with diabetes with 
DR showed significant increase in thickness, volume and vasculature, and decrease in 
inflection points compared to no DR (Chapter 10). Nevertheless, in AMD there was 
no significant difference in any of the above choroidal traits compared to PCV 
(Chapter 11).  
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In summary, in this Thesis, I developed and utilized novel image techniques 
(semi- and fully-automated) to perform detailed characterization of the morphological 
and vascular attributes of the choroid in normal and diseased eyes in Asians. Results 
will be useful in further understanding the role and contribution of choroidal measures 




LIST OF TABLES 
Chapter 4  
Table 4.1  A summary of subjects’ demographics, ocular parameters and systemic 
factors 
Table 4.2  Intra- and interobserver reliability assessment of CSI visibility 
Table 4.3  Univariate analysis between ocular and systemic factors with visibility 
of choroidal scleral interface 
Table 4.4  Multivariate analysis of ocular and systemic factors with visibility of 




Table 5.1  Baseline characteristics of study subjects 
Table 5.2  Summary of choroidal thickness measurements at various locations 
Table 5.3  Intra- and inter-grader agreements for the choroidal thickness 
measurement at 5 horizontal locations using adaptive compensation 
Table 5.4  Intra- and inter-grader agreements for the choroidal thickness 
measurement at 5 horizontal locations using Spectralis SD-OCT with 
conventional manual technique 




Table 6.1  Agreement between automated versus manual macular choroidal 
thickness measurement at 5 horizontal locations (n = 45 eyes) 
Table 6.2  Assessment of intra-session repeatability of macular choroidal 
thickness (at various horizontal locations) and macular choroidal 
volume using automated segmentation software (n = 20) 
Table 6.3  Agreement between automated versus manual peripapillary choroidal 
thickness at four optic disc quadrants (n = 45 eyes) 
Table 6.4  Intra-session repeatability of peripapillary choroidal thickness 
measurement at four quadrants obtained using automated choroidal 




Table 7.1  Demographic, ocular and systemic characteristics of ethnic Malays (n 
= 540) for evaluation of choroidal thickness and volume using fully 
automated choroidal segmentation technique 
Table 7.2  Distribution of mean macular choroidal thickness (at various points on 
the horizontal axis) and volume measurements in ethnic Malays (n = 
540) using fully automated choroidal segmentation technique 
Table 7.3  Univariate and multivariate analysis of the association of ocular and 
systemic factors with sub-foveal choroidal thickness in ethnic Malays 
(n = 540) measured using fully automated choroidal segmentation 
technique 
Table 7.4  Univariate and multivariate analysis of the association of ocular and 
systemic factors with choroidal volume at central macula in ethnic 
 xvii 
 
Malays (n = 540) measured using fully automated choroidal 
segmentation technique 
Table 7.5  Distribution of peripapillary choroidal thickness at clock-hour sectors 
(30° apart) and four quadrants in ethnic Malays (n = 904 eyes) 
Table 7.6  Associations of average peripapillary choroidal thickness with ocular 
and systemic factors using generalized estimating equation in Malays 
(n = 904 eyes) 
Table 7.7  Multivariate analysis of the associations of regional (inferior, superior, 
nasal and temporal) peripapillary choroidal thickness (PPCT) with 
ocular and systemic factors using generalized estimating equation in 
Malays (n = 904 eyes) 
Table 7.8  Baseline characteristics of study subjects of Indian ethnicity 
Table 7.9  Mean macular choroidal thickness (at various points on the horizontal 
axis) and volume measurements in subjects of Indian origin (n = 439) 
measured using fully automated choroidal segmentation technique 
Table 7.10  Univariate and multivariate analysis of the association of ocular and 
systemic factors with sub-foveal choroidal thickness in Singapore 
Indians (n = 439) 
Table 7.11  Univariate and multivariate analysis of the association of ocular and 
systemic factors with choroidal volume at central macula in Singapore 
Indians (n = 437) 
Table 7.12  Distribution of peripapillary choroidal thickness at clock-hour sectors 
(30° apart) and four quadrants in Singapore Indians (n = 650 eyes) 
measured using fully automated choroidal segmentation technique 
Table 7.13  Associations of average peripapillary choroidal thickness with ocular 
and systemic factors using generalized estimating equation in 
Singaporean Indians (n = 650 eyes) 
Table 7.14  Multivariate analysis of the associations of regional (inferior, superior, 
nasal and temporal) peripapillary choroidal thickness with ocular and 
systemic factors using generalized estimating equation in Indians (n = 
650 eyes) 
Table 7.15  Comparison of the baseline characteristics of ethnic Malays (n = 540)  
and Indians (n = 439) 
Table 7.16  Comparison of the distribution of mean unadjusted macular choroidal 
thickness and volume in ethnic Malays and Indians using fully 
automated choroidal segmentation technique 
Table 7.17  Comparison of the distribution of mean adjusted macular choroidal 
thickness and volume in ethnic Malays and Indians using fully 
automated choroidal segmentation technique 
Table 7.18  Comparison of the distribution of mean unadjusted peripapillary 
choroidal thickness in ethnic Malays and Indians using fully automated 
choroidal segmentation technique 
Table 7.19  Comparison of the distribution of mean adjusted peripapillary 
choroidal thickness in ethnic Malays and Indians using fully automated 




Table 8.1  Demographics, clinical and choroidal characteristics of study subjects 
(n = 345) 
 xviii 
 
Table 8.2  Intra- and inter-grader reliability assessment of choroidal parameters in 
35 subjects 
Table 8.3  Linear regression analyses of ocular and systemic factors associated 
with sub-foveal choroidal thickness  
Table 8.4  Linear regression analyses of ocular and systemic factors associated 
with choroidal vascularity index  




Table 9.1  Baseline characteristics of study subjects for macular choroidal 
thickness 
Table 9.2  Intra-grader reliability of macular choroidal thickness measurements at 
different locations in myopic and emmetropic group 
Table 9.3  Distribution of mean adjusted macular choroidal thickness (CT) at 
different locations across the myopic and control groups using 
generalized linear model 
Table 9.4  Association of ocular factors with sub-foveal choroidal thickness in all 
myopes (n = 520) 
Table 9.5  Clinical characteristics of the study subjects for peripapillary choroidal 
thickness 
Table 9.6  Intra-grader reliability of peripapillary choroidal thickness 
measurements at different locations in myopic and emmetropic group 
Table 9.7  Distribution of mean peripapillary choroidal thickness at different 
locations across the three myopic and control groups 
Table 9.8  Association of ocular factors with average peripapillary choroidal 
thickness in all myopes (n = 448) 
Table 9.9  Clinical characteristics of study subjects with high myopia (n=515 
eyes) and controls with emmetropia (n=88 eyes). 
Table 9.10  Choroidal morphologic and vascular characteristics in high myopic and 
control eyes. 
Table 9.11  Multiple regression analysis of choroidal attributes such as vascular 
area, stromal area and vascularity (dependent variables) in high myopic 
eyes (n=515) with reference to control eyes (n=88). 
Table 9.12  Association of axial length with choroidal traits such as vascular area, 
stromal area and vascularity (dependent variables) in high myopic eyes 
(n=515). 
Table 9.13  Baseline characteristics of extremely high (<-10 D) myopic subjects 
Table 9.14  Distribution of choroidal and retinal thicknesses at different locations 
across the extremely high myopic (<-10D) and control groups  
Table 9.15  Association of subfoveal choroidal thickness with best corrected visual 
acuity in young, extremely high myopic eyes (SE<-10D, n = 105) 
Table 9.16  Summary of macular choroidal thickness and other variables in various 
studies in high myopia  
Table 9.17  Summary of peripapillary choroidal thickness and other variables in 








Table 10.1  Clinical and choroidal characteristics of study subjects in the non-
diabetic and diabetic groups  
Table 10.2  Difference in choroidal characteristics in subjects with diabetes (n = 
189), compared to those without diabetes (n = 274) 
Table 10.3  Clinical and choroidal characteristics of study diabetic subjects without 
and with DR  
Table 10.4  Difference in choroidal characteristics in diabetic subjects with DR (n 
= 89), compared to those without DR (n = 100) 
Table 10.5  Choroidal characteristics of study subjects in the diabetic group with 
stages of diabetic retinopathy (minimal-mild DR, moderate NPDR and 
PDR). 
Table 10.6  Choroidal characteristics of subjects with DR who had laser treatment 




Table 11.1  Clinical characteristics of study subjects between AMD and PCV  
Table 11.2  Choroidal characteristics of study subjects between AMD and PCV 
Table 11.3  Choroidal characteristics of study subjects between AMD and thick 
PCV (>250 µm) 





LIST OF FIGURES 
Chapter 1 
Figure 1.1  Illustration of the typical features observed in histological images of 
the choroid (Adapted from Nickla DL, Wallman J. The multifunctional 
choroid. Prog Retin Eye Res. 2010; 29:144-168). 
Figure 1.2  Illustration of zero delay line in conventional Spectral domain optical 
coherence tomography (SD-OCT) vs. enhanced depth imaging (EDI) 
SD-OCT.  (A) In a conventionally acquired OCT image the peak 
sensitivity is located at the posterior vitreous and the sensitivity curve 
is flipped on its side and overlaid on the SD-OCT. (B) In EDI-OCT, 
when instrument is pushed closer to the eye to invert the image, the 
peak sensitivity curve is moved to the inner sclera (Adapted from 
Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging 
spectral-domain optical coherence tomography. Am J Ophthalmol. 
2008;146:496-500). 
Figure 1.3  Optical coherence tomography image demonstrating enhanced depth 
imaging on Spectralis (Heidelberg Engineering). (A) Image was 
acquired with the inner retina adjacent to the zero delay. Note that the 
choroid–sclera junction is not distinct (white arrowheads) and there is 
low signal from the choroid but high signal from the inner retina. (B) 
Image was acquired with the choroid adjacent to the zero delay by 
advancing the instrument toward the patient. Note that the choroid–
sclera junction is distinct and that there is reduced signal from the inner 
retina but increased signal from the choroid (Adapted from Regatieri 
CV, Branchini L, Fujimoto JG, Duker JS. Choroidal imaging using 





Figure 3.1  Study sampling areas in Singapore. 
Figure 3.2  An illustration of macular choroid imaged using EDI mode of 
Spectralis SD-OCT. Each set of images comprised of 7 serial 
horizontal B-scans (each composed of 1536 A-scans) covering a 
rectangular region of 30° X 5°centered on the fovea. Distance between 
consecutive B-scans was 240 µm and each B-scan was averaged 100 
times during acquisition. 
Figure 3.3  An illustration of peripapillary choroid imaged using EDI mode of 
Spectralis SD-OCT. The peripapillary region was scanned using a 
360°, 3.4 mm diameter circle that was centered on the optic disc, each 
comprising 100 averaged scans.  
 
Chapter 4 
Figure 4.1  The choroidal-scleral interface (CSI) is indicated by hyper-reflective 
line shown by arrowheads. Panel (A) demonstrates an example of a 
well-defined CSI,  Panel (B) shows a moderately defined CSI and 
 xxi 
 
Panel (C) a poorly defined CSI in EDI-OCT image in the SiMES-2 
cohort.  
Figure 4.2  Comparison of CSI visibility between EDI-OCT scans in two subjects 
of different ages. (A) A 46-year-old male with poorly demarcated CSI 
(subfoveal choroidal thickness of 326 µm). (B) An 83-year-old man 
with CSI distinctly visible (subfoveal choroidal thickness of 163 µm). 
Figure 4.3  Comparison of CSI visibility between EDI-OCT scans in two subjects 
according to refractive status. (A) A 46-year-old male with no 
refractive error (AL=23.41) and a poorly demarcated CSI (subfoveal 
choroidal thickness of 275 µm). (B) A 46-year-old male with myopia 




Figure 5.1  Illustration of the raw versus the compensated image. (A) Raw OCT 
image of a healthy subject. The choroid-scleral interface is only 
partially visible. Note the presence of blood vessels shadows as 
indicated by red asterisks. (B) Adaptive compensation was applied to 
the raw image in order to remove blood vessels shadows, enhance 
contrast and improve visibility of the choroid-scleral interface (more 
uniform). 
Figure 5.2  Flow diagram of the measurement protocol. 
Figure 5.3  Setting of the foveal reference line. Open the image from the file 
menu, go the view menu and click on new guides options (A). Change 
the guide orientation to vertical (B). A foveal reference line is 
generated (C). 
Figure 5.4  Placement of measurement such that the central point on the grid 
coincides with the foveal reference line. 
Figure 5.5  Setting of the measurement scale. Select Analysis > Set Measurement 
Scale > Custom to open the measurement scale dialog box (A). 
Convert the values to desired units (B). 
Figure 5.6  Performing measurements using the ruler tool from the analysis tab. 
Figure 5.7  Displays recording of the measurements (A) and exporting of the 
measurement log data (B). 
Figure 5.8  Bland Altman plot of intra-grader reliability of sub-foveal choroidal 
thickness (CT) measurement. The difference was calculated by the 1st 
measurement minus the 2nd measurement. Pink dashed line represents 
regression line of difference between 1st and 2nd measurements. 
Figure 5.9  Bland Altman plots of inter-grader reliability of sub-foveal choroidal 
thickness (CT) measurement. The difference was calculated by the 
grader A measurement minus the grader B measurement. Pink dashed 











Figure 6.1 Automated detection of choroid scleral interface. 
Figure 6.2  EDI-OCT image of the macular region demonstrating automated 
segmentation of the Bruch’s membrane and the choroidal-scleral 
interface. Choroidal thickness at each measurement points (shown by 
the numbered grid) was defined as CT (x,y), where x and y are the 
transversal (from nasal to temporal) and inter-frame (from superior to 
inferior) direction respectively. The separation between frames is 246 
µm. 
Figure 6.3  EDI-OCT image of the macular region demonstrating automated 
segmentation of the Bruch’s membrane and the choroidal-scleral 
interface. The horizontal choroidal thickness profile was generated at 
the fovea (detected as the lowest points of internal limiting membrane 
automatically) and at 500-µm intervals up to 3 mm temporal and nasal 
to the fovea. 
Figure 6.4  An illustration of the color-coded choroidal volume map obtained from 
the 7 serial horizontal B-scans covering an area of 8.9 x 1.5 mm 
centered on the fovea. The choroidal volume is expressed in millimeter 
cube (mm
3
) with the warm and the cool colors representing thicker and 
thinner choroidal volume respectively. X and Y presents the transverse 
(from nasal to temporal) and inter frame (from superior to inferior) 
directions respectively.  
Figure 6.5  EDI-OCT image in the peripapillary region demonstrating automated 
segmentation of the Bruch’s membrane (BM) and the choroidal–scleral 
interface (CSI).  
Figure 6.6  Illustration of automated peripapillary choroidal thickness (CHT) 
measured in the optic disc region. The numbers on the x-axis are 
locations in clock hour sectors (30° apart). The location of the zero 
degree is always on the left- most point of the disc circle and the value 
of degree increases in the clockwise direction. T, temporal; S, superior; 
N, nasal; I, inferior quadrants.          
 
Chapter 8 
Figure 8.1  Image binarization for choroid with normal choroidal thickness. (A) 
Original SD OCT image. (B) 1.5 mm segmentation block of the 
subfoveal choroidal area. (C) Segmented OCT image using modified 
image binarization approach. (D) Overlay of region of interest created 
after image binarization was performed on the SD OCT image. 
Figure 8.2  To set the scale, the option Analyse > Set Scale was selected, and the 
known distance was set to 2 mm.  
Figure 8.3  Auto local threshold was applied. Image > Type > 8 bit was first 
applied (A), followed by Image > Adjust > Auto Local Threshold (B). 
Niblack was selected as the method (C). 
Figure 8.4  The polygon tool was used to draw a polygon under the lines drawn, to 
select the subfoveal choroid (A). The area of the choroid under the 
retinal pigment epithlium was selected. The upper border was marked 
at the retinal pigment epithelium and the lower border area was below 
the line of light pixels at the choroid scleral junction. The area was 
 xxiii 
 
saved in the ROI manager by selecting the option Analyse > Tools > 
ROI manager, and Add [t] (B). 
Figure 8.5  Fifthly, the area of vascularity was highlighted by selecting Image > 
Type > RGB colour, and Image > Adjust > Colour Threshold. The first 
bar under Brightness was adjusted to 0, and the second bar was 
adjusted to 254 (A). After clicking Select (B), the area was added to 
the ROI manager. 
Figure 8.6  After clicking Select in the above figure, the area was added to the ROI 
manager by selecting Add [t]. to determine the area of vascularity 
within the initially selected polygon, both areas in the ROI manager 
were selected (A) and merged by selecting More > AND (B). The 
composite third area was added to the ROI manager by selecting Add 
[t] (C). Lastly, the first and third areas were selected and measured 
using the ROI manager. The first area represents the total area of 
choroid selected, and the third composite area is the vascular area. 
Figure 8.7  Distribution of subfoveal choroidal thickness (A) and choroidal 
vascularity index (B) across the population. 
Figure 8.8  Bland Altman plots of total choroidal area and luminal area. (A) and 
(B) shows intra- and inter- rater reliability for total choroidal area 
respectively. (C) and (D) shows intra- and inter- rater reliability for 
luminal area respectively. For intra-rater reliability, the difference was 
calculated by the 1st measurement minus the 2nd measurement. Pink 
dashed line represents regression line of difference between 1st and 
2nd measurements. For inter-rater reliability, the difference was 
calculated by the grader 1 measurement minus the grader 2 
measurement. Pink dashed line represents regression line of difference 
between the two graders measurements. 
 
Chapter 9 
Figure 9.1  Enhanced depth imaging optical coherence tomography image 
demonstrating peripapillary region scanned using a 360°, 3.5 mm 
diameter circle centered on the optic disc. The peripapillary choroidal 
thickness was measured as the perpendicular distance between Bruch’s 
membrane and the choroid-scleral interface at the following locations: 
T = temporal; ST = superotemporal; S = superior; SN = superonasal; N 
= nasal; IN = inferonasal; I = inferior; IT = inferotemporal.  
Figure 9.2  Comparison of EDI-OCT scans of choroidal thickness between 
emmetrope and myope. (A) A 22-year-old male with no refractive 
error (AL = 23.61 mm) and an average choroidal thickness of 325 µm. 
(B) A 23-year-old male with SE of -12.25D (AL = 29.35 mm) and an 
average choroidal thickness of 117 µm. 
Figure 9.3  shows the presence of posterior staphyloma on horizontal scan of the 
macular central on the fovea (20°) obtained using SD-OCT. 
Figure 9.4  Visualization of choroid morphological and vascular parameters 
obtained by our custom-written application on MATLAB on choroidal 
images acquired by EDI, SD-OCT. 
Figure 9.5  Validation of Niblack binarization against manual delineation of 
stromal areas; (A) Original choroid cross-sectional scans with RPE 
choroid-scleral boundaries; (B) Identification of choroid vasculature by 
 xxiv 
 
automated binarization with overlayed manual delineation of four 
blood vessels. 
Figure 9.6  Graph showing the differences in macular choroidal thickness in the 
high myopic groups and emmetropic group along the horizontal axis 
(A) and vertical axis (B). Mean thickness at each of the nasal, 
temporal, superior, and inferior locations measured at 1.5 mm and 3 
mm intervals eccentric to the sub-foveal area. Error bars indicate 
standard error. SFCT is sub-foveal choroidal thickness. 
Figure 9.7  (A) Scatterplot showing negative correlation between subfoveal 
choroidal thickness and axial length in all myopes. (B). Scatterplot 
showing positive correlation between subfoveal choroidal thickness 
and spherical equivalent in all myopes. (C). Scatterplot showing 
negative correlation between subfoveal choroidal thickness and corneal 
curvature in all myopes. 
Figure 9.8  (A) Scatterplot showing negative correlation between LogMAR visual 
acuity and subfoveal choroidal thickness in all myopes. (B). Scatterplot 
showing negative correlation between Log contrast sensitivity and 
subfoveal choroidal thickness in all myopes. 
Figure 9.9  Graph showing the distribution of mean peripapillary choroidal 
thickness (micrometer, µm) in high myopic and emmetropic groups at 
different locations around the optic disc. The x-axis represents the 
locations of the measurements of peripapillary choroidal thickness 
around the optic disc. T = temporal, ST = superiotemporal, S = 
superior, SN = superionasal, N = nasal, IN = inferonasal, I = inferior, 
IT = inferotemporal. Error bars indicate standard error.  
Figure 9.10  Distribution profiles of choroidal and retinal thicknesses at different 
locations in high myopic and emmetropic groups. Mean thickness at 
each of the nasal, temporal, superior, and inferior locations was measured at 
1.5 mm and 3 mm intervals eccentric to the sub-foveal area. Error bars 
indicate standard error. SFCT=sub-foveal choroidal thickness; SFRT=sub-
foveal retinal thickness; N=nasal; T=temporal; S=superior; I=inferior. 
 
Chapter 11 
Figure 11.1  Comparison of FFA, ICG, choroidal thickness and vascular area across 






LIST OF ABBREVIATIONS 
EDI…………………………… Enhanced depth imaging 
SD-OCT……………………… Spectral domain optical coherence tomography 
CSI…………………………… Choroidal scleral interface 
RPE…………………………... Retinal pigmented epithelium 
CT……………………………. Choroidal thickness 
ICC…………………………... Intra-class correlation coefficient 
MD………………………….... Mean deviation 
DR……………………………. Diabetic retinopathy 
AMD…………………………. Age-related macular degeneration 
FAZ…………………………... Foveal avascular zone 
ONH…………………………. Optic nerve head 
ICGA……………………….. .. Indocyanine green angiography 
PCV………………………….. Polypoidal choroidal vasculopathy 
CSCR………………………… Central serous chorio-retinopathy 
FFA…………………………... Fundus fluorescein angiography 
TD-OCT……………………… Time domain optical coherence tomography 
SEED………………………… Singapore Epidemiology of Eye Disease 
SiMES………………………... Singapore Malay Eye Study 
SINDI………………………… Singapore Indian Eye Study 
SCES…………………………. Singapore Chinese Eye Study 
SAF…………………………… Singapore Armed Forces 
SERI………………………….. Singapore Eye Research Institute 
SNEC…………………………. Singapore National Eye Center 
RNFL…………………………. Retinal nerve fiber layer thickness 
LSO…………………………… Line scanning ophthalmoscope 
Log MAR……………………... Log of minimum angle of resolution 
SE……………………………... Spherical equivalent 
D………………………………. Diopters 
ETDRS………………………… Early Treatment Diabetic Retinopathy Study 
VA……………………………... Visual acuity 
AL……………………………… Axial length 
ACD…………………………… Anterior chamber depth 
CCT……………………………. Central corneal thickness 
IOP…………………………….. Intraocular pressure 
BMI……………………………. Body Mass Index 
BP……………………………… Blood pressure 
OPP……………………………. Ocular perfusion pressure 
MAP…………………………… Mean arterial pressure 
HDL…………………………… High-density lipoprotein  
LDL……………………………. Low-density lipoprotein 
HbA1c …………………………. Haemoglobin 
NPDR…………………………... Non proliferative diabetic retinopathy 
PDR…………………………….. Proliferative diabetic retinopathy 
CSME…………………………... Clinically significant macular edema 
VTDR………………………… Vision threatening diabetic retinopathy 
ISGEO………………………... International Society of Geography and 
Epidemiology of Ophthalmology 
 xxvi 
 
PACG…………………………  Primary angle closure glaucoma 
POAG………………………...  Primary open angle glaucoma 
LOCS…………………………  Lens Opacity Classification System 
Kw……………………………  Weighted Kappa 
SD……………………………  Standard deviation 
CI…………………………….  Confidence interval 
LOA………………………….  Limits of agreement 
PPCT…………………………  Peripapillary choroidal thickness 
CVI…………………………..  Choroidal vascularity index 
TCA………………………….  Total choroidal area 
LA……………………………  Luminal area 
SA……………………………  Stromal area 
SFCT…………………………  Sub foveal choroidal thickness 
COV………………………….  Coefficient of variation 
CS…………………………….  Contrast sensitivity 
NVG…………………………. Night vision goggles 
PPA………………………….. Peripapillary atrophy 
ANOVA……………………... Analysis of variance 
BCVA………………………... Best corrected visual acuity 




LIST OF PUBLICATIONS 
Publications directly related to the thesis 
1. Gupta P, Sidhartha E, Girard MJ, et al. A simplified method to measure 
choroidal thickness using adaptive compensation in enhanced depth imaging 
optical coherence tomography. PLoS One. 2014;9(5):e96661. 
  
2. Gupta P, Saw S, Cheung CY, et al. Choroidal thickness and high myopia: a 
case-control study of young Chinese men in Singapore. Acta Ophthalmol. 
2015;93(7):585-592. 
 
3. Gupta P, Jing T, Marziliano P, et al. Peripapillary choroidal thickness 
assessed using automated choroidal segmentation software in an Asian 
population. Br J Ophthalmol. 2015;99(7):920-926. 
 
4. Gupta P, Cheung CY, Saw SM, et al. Peripapillary Choroidal Thickness in 
Young Asians with High Myopia. Invest Ophthalmol Vis Sci. 
2015;56(3):1475-1481.  
 
5. Gupta P, Jing T, Marziliano P, et al. Distribution and determinants of 
choroidal thickness and volume using automated segmentation software in a 
population-based study. Am J Ophthalmol. 2015;159(2):293-301.  
 
6. Gupta P, Cheung CY, Baskaran M, et al. Relationship between Peripapillary 
Choroid and Retinal Nerve Fiber Layer Thickness in a Population-based 
Sample of Non-Glaucomatous Eyes. Am J Ophthalmol.  2016 Jan;161:4-11.e1-
2. doi: 10.1016/j.ajo.2015.09.018. Epub 2015 Sep 24. 
 
7. Gupta P, Cheng CY, Cheung CM, et al. Relationship of ocular and systemic 
factors to the visibility of Choroid-scleral interface using Spectral domain 
optical coherence tomography. Acta Ophthalmol. 2016;94(2):e142-149. 
 
8. Gupta P, Cheung CY, Saw SM, et al.Choroidal thickness does not predict 
visual acuity in young, high myopes. Acta Ophthalmol. 2016 May 19. doi: 
10.1111/aos.13084. [Epub ahead of print] 
 
9. Agrawal R,* Gupta P,* Tan KA, et al. Choroidal vascularity index as a 
measure of vascular status of the choroid: Measurements in healthy eyes from 
a population-based study. Scientific Reports. 2016 Feb 12;6:21090. doi: 
10.1038/srep21090. 
*Joint first author 
10. Tan KA,* Gupta P,*Chhablani J, et al. State of Science: Choroidal thickness 
and systemic health. Survey of Ophthalmol. 2016 Mar 12. pii: S0039-
6257(15)30010-2. doi: 10.1016/j.survophthal.2016.02.007. [Epub ahead of 
print] 






11. Gupta P, Cheung CY. Refining the Definition of the Choroidal-Scleral 
Interface. Acta Ophthalmol. 2016 May 27. doi: 10.1111/aos.13101. [Epub 
ahead of print] 
 
12. Gupta P, Ting, DW, Thakku SG, et al. "Detailed Characterization of 
Choroidal Morphological and Vascular Features in Age-Related Macular 
Degeneration and Polypoidal Choroidal Vasculopathy." Retina 2016 
 
13. Gupta P, Thakku SG, Sabanayagam C, et al. "Characterization of Choroidal 
Morphology and Vasculature in Diabetes and Diabetic Retinopathy." British 
Journal of Ophthalmology 2016 
 
14. Gupta, P, Thakku SG, Saw SM, et al. “Detailed Phenotyping and 
Characterization of Choroidal Morphological and Vascular Features in Young 
Men with High Myopia using Spectral Domain Optical Coherence 








REVIEW OF LITERATURE 
 
1.1 THE CHOROID AND ITS COMPOSITION 
1.1.1 Anatomical Location 
The choroid is the posterior part of the eyeball, which is sandwiched between 
the retina and the sclera. Anatomically, the choroid extends from the margins of the 
optic nerve to the pars plana, where it continues anteriorly, becoming the ciliary 
body.
1
 Histologic investigations demonstrate that it is 0.22 mm thick posteriorly and 




The choroid is predominantly composed of blood vessels surrounded by 
stromal tissue comprising of connective tissue, melanocytes, nerves and extracellular 
fluid.
3 Being a highly vascularized tissue accounting for ~ 85% of the ocular blood 
flow,
4
 most of the choroidal space is taken by vessels differentiated in three vascular 
layers. From internal to external, with increasing vessel luminal diameter, the 
innermost layer is the choriocapillaris, the middle is Sattler’s layer with medium 
vessels, and the outer is Haller’s layer, with large vessels1,3, 5 (Figure 1.1). 
Choriocapillaris: The choriocapillaris is a highly anastomosed network of capillaries, 
forming a thin sheet opposed to Bruch’s membrane (Figure 1.1).6 It is 10 µm thick at 
the fovea, thinning to ~ 7 µm in the periphery. The capillaries arise from the arterioles 
in the Sattler’s layer, each of which give rise to a hexagonal-shaped domain of a 
single layer of capillaries, giving a patch-like structure of the choriocapillaris.
7
 The 
fenestrated choriocapillaris are highly permeable to proteins, contributing to the high 
oncotic pressure in the extravascular stroma, which fosters the movement of fluids 
 2 
 
from the retina to the choroid.
8
 On the other hand, in the retina, the capillaries are 
continuous type (the walls have no fenestrations), constituting the blood-ocular 
barrier, and are impermeable to even small molecules such as glucose and amino acid 
which require a special transport system to move them across the endothelium. The 
choroidal circulation is crucial in supplying nutrients as well as oxygen because 
choriocapillaris are fenestrated (with large pores) and have high permeability. The 
molecules pass through the fenestrations into extracellular matrix, creating a high 
glucose concentration there, thereby facilitating transport across the RPE to the 
retina.
3
 The choriocapillaris supplies oxygen and nutrients to Bruch's membrane and 
the outer third of the retina, except in the macula, where it supplies the entire retina. It 
is slightly flattened under Bruch's membrane, providing a large surface area for 
metabolic exchange, whereas the external floor (scleral surface) of the capillaries is 
gently undulating. 
Choroidal Vascular Layers: The vascular region of the choroid consists of the outer 
Haller’s layer of large blood vessels and the inner Sattler’s layers of medium and 
small arteries and arterioles that feed the capillary network, and veins.
6, 7
 The stroma 
(extravascular tissue) contains collagen and elastic fibers, fibroblasts, non-vascular 
smooth muscle cells and numerous very large melanocytes that are closely opposed to 
the blood vessels.  
The blood supply to the choroid comes from the short posterior ciliary arteries 
which are branches of ophthalmic artery.
3
 Blood from the choroid drains into the 4-6 
vortex veins which drain into the ophthalmic veins and eventually exit the eye via the 
cavernous sinus. 
Supra-choroid: The interface between choroid and sclera is called the suprachoroid. 
This transition zone composed of thin interconnected lamellar fibers that bind the 
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choroid and sclera together,
9
 is a potential space and measures 30 μm in thickness. 
Anteriorly, the suprachoroid is continuous with the supraciliary space and posteriorly, 
it extends to the optic nerve. Externally, it is limited by the lamina fusca, the 
melanocytic layer lining the inner sclera.  
 
1.2 FUNCTIONS OF THE CHOROID 
1.2.1 Primary Function: Vascular Support 
Being one of the most vascular tissue of the human body, such that about 85% 
of the blood flow in the eye circulates through the choroidal vessels, its principal 
function is to provide the metabolic support. Choroid nourishes the following 
structures/regions in the eye: 
Outer Retina: Choroid plays a vital role in nourishing outer third of the retina.
3, 10
 In 
the retina, the capillaries are the continuous type (the walls have no fenestrations), 
constituting the blood-ocular barrier, and are impermeable to even glucose and amino 
acids, therefore they require special transport system to move them across the 
endothelium. Given the fenestrated nature of capillaries of the choroid, the choroidal 
circulation is crucial in supplying nutrients as well as oxygen, creating a very high 
glucose concentration, thereby facilitating transport across the retinal pigmented 
epithelium (RPE) to the retina.
11
 Thus, while retinal vasculature nourishes the inner 
retinal layers, choroid is responsible for the vascular support of outer third of the 
retina including RPE and photoreceptors.
3, 10
 
Foveal Avascular Zone: In particular, in foveal avascular zone (FAZ), which 
contains metabolically active photoreceptors and is responsible for central vision, 
there is no retinal vascular supply and the choroid is the only source of metabolic 
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exchange for the avascular fovea. This area is therefore most vulnerable to changes in 
the normal structure or physiology of the choroid.  
Optic Nerve Head: In addition to RPE and photoreceptors, choroid also supplies 
blood to optic nerve, including the optic disc.
12, 13
 Although the circulation of the 
posterior ciliary artery is the main source of blood supply to the optic nerve head 
(ONH), the choroid as an important vascular bed affect the peripapillary region as the 
pre-laminar portion of the ONH is primarily nourished by the peripapillary choroid.
12-
14
 According to the vascular theory of glaucoma, ischaemia occurs in the prelaminar 
area of the ONH
15, 16
 and given that the blood supply of this region is derived from the 
branches within the peripapillary choroid,
14
 peripapillary choroid might therefore play 
a significant role in the pathogenesis of glaucoma. 
1.2.2 Other Functions  
Apart from the traditional function of providing vascular support, other 
functions of the choroid include:  
Thermoregulation of the Retina via Heat Dissipation
17
: The high metabolism of 
the outer retina generates heat and the choroidal blood flow acts as a heat sink.
18, 19
 
Emmetropization: Choroid participates in refractive adjustment by changes in its 
thickness which moves the retina forward and back, bringing the photoreceptors into 
the plane of focus.
20
 The choroid increases its thickness in response to myopic 
defocus (where image is formed in front of the retina) pushing the retina towards the 
image plane and thus compensating for the imposed refractive error whereas choroid 
thins in response to hyperopic defocus (where image is focused behind the retina) 
pushing the retina backwards.
21, 22 
1 mm change in the thickness of the choroid can 
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account for +15 D to -15D of defocus which could possibly be due to expansion of the 
lacunae. 
Modulation of Intra-ocular Pressure: The choroid also plays an important role in 
the drainage of the aqueous humour from the anterior chamber, via the uveo-scleral 
pathway which is responsible for 35% of the drainage in humans.
23 
 
1.3 CHOROIDAL BLOOD FLOW
 
Since choroid is an important vascular bed with metabolic support as its prime 
function, knowledge of choroidal blood flow/circulation is essential. The choroid is 
supplied by the posterior ciliary arteries, branching from the ophthalmic artery
24, 25
 
whereas the drainage of choroidal circulation is mainly through vortex veins.
24
  
1.3.1 Choroidal Circulation is NOT Autoregulated 
An important feature of choroidal circulation which makes it substantially 
different from retinal circulation is “autoregulation”. Autoregulation is an adaptive 
compensatory mechanism to adjust blood flow according to the local needs of the 
tissue supplied. Almost every tissue in the body including retina has some form of 
autoregulation i.e. fluctuations in perfusion pressure do not cause proportional 
changes in blood flow because of compensatory dilation or constriction of the vessels 
locally. In contrast, the choroid does not exhibit any autoregulation,
26-28
 as choroidal 
circulation is characterized by high choroidal blood flow (higher than any other 
tissues) and low oxygen extraction ratio which precludes the need for it.  
1.3.2 Choroidal Blood Flow and Eye Diseases 
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Because the choroidal blood flow constitutes 85% of the ocular blood flow
4
 
and is the major source of oxygen and nutrients for not only the choroid but also the 
outer retina, including RPE and metabolically active photoreceptors,
3, 8, 10
 impaired 
choroidal circulation would cause functional damage to the retina specifically in the 
avascular foveal zone eventually leading to vision loss. Therefore normal choroidal 
circulation is critical for not only the normal function of the choroid but also the 
retina.  
Reduced choroidal blood flow is shown to be associated with photoreceptors 
dysfunction and death eventually causing vision loss.
29
 Impaired choroidal blood flow 
has also been found to be associated with pathogenesis of various ocular diseases such 
as diabetic retinopathy,
30-32
 age related macular degeneration
33
 and high myopia.
34, 35
 
In addition, since the peripapillary choroid supplies blood to the ONH,
10, 14, 24, 27
 
altered choroidal circulation is hypothesised to be related to pathogenesis of 
conditions like glaucoma.
14, 36, 37
 Therefore, determination of the choroidal blood flow 
is crucial for understanding the pathogenesis and progression of many vision 
threatening eye diseases. 
1.3.3 Limitations of Current Blood Flow Assessment Methods 
Various choroidal blood flow evaluation techniques such as pulsatile choroidal 
blood flow,
38  





and laser Doppler flowmetry
41  
have been used to evaluate choroidal 
blood flow in-vivo. But all these techniques provide an indirect estimation of the 
choroidal blood flow. With the limitation of none of the existing techniques capable 
of measuring absolute blood flow rate, and therefore unable to reliably quantifying 
choroidal hemodynamics, necessitate the need for a reliable alternative to examine 
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changes in the choroid, which may help clinicians assisting in risk-profiling for 
various diseases where choroid is implicated in the pathophysiology. 
 
1.4 CHOROIDAL THICKNESS AS AN INDEX TO EVALUATE CHOROIDAL 
HEALTH 
The choroid because of its vital roles plays an integral part in the functioning 
of the eye.
29
 However, in order to sustain proper functioning of the choroid, its normal 
structure has to be maintained. We speculate that any changes in the structure of the 
choroid such as its thickness, volume or any alterations in its other morphological and 
vascular characteristics would lead to disturbances in the normal physiological 
functions of the choroid which in turn would reduce perfusion to the outer retina, 
which may have impact on visual function. For example, studies have shown that 
abnormality in the choroid such as its thinning can lead to compromised circulation, 
which can lead to photoreceptor dysfunction and death with resultant vision loss.
29, 42
 
A structurally and functionally normal choroid is therefore essential for functioning of 
the retina as a whole. However, this doctoral thesis concentrates on the structural 
aspect of the choroid. 
The emergence of new imaging technology, in particular optical coherence 
tomography (OCT)
43
 has now made it possible to visualize not only the cross-
sectional images of the choroid with substantially enhanced imaging sensitivity
44
 but 
also can perform quantitative measurements of parameters such as its thickness.
44, 45
 It 
was not until relatively recently (2008) that OCT has been employed to characterize 
the choroid by quantifying its thickness, which is measured as a perpendicular 
distance between the RPE and the choroid scleral interface (CSI). Since then 
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“choroidal thickness” (CT) is emerging as a new index to quantitatively characterize 
the choroid in-vivo.  
1.4.1 Choroidal Thickness and Eye Diseases 
Numerous studies have now measured CT in normal
46-50
 and different disease 
states.
51-56
  These studies have reported variations in the thickness of the choroid in 
different diseases, with choroidal thinning in age related macular degeneration 
(AMD),
33, 57
 diabetic retinopathy (DR),
58-61
 and high myopia related chorio-retinal 
atrophy,
52, 54, 62-64
 whereas thickening in polypoidal choroidal vasculopathy (PCV)
53, 65
 
and central serous chorioretinopathy (CSCR).
55, 66
 Given the role of choroidal 
vasculature in the blood supply of anterior optic nerve head,
13, 24
 CT is also associated 
with pathologies like glaucoma. Glaucoma eyes were found to have thinner 
peripapillary choroid.
36, 67, 68
 These observations of variations in the thickness of the 
choroid suggest that CT could be a potential marker in the evaluation of ocular 
diseases as well as signal their progression and provide insights into their prognosis. 
Studies have suggested CT could be an important surrogate marker for the 
differential diagnosis of diseases with similar presentation. For example, AMD and 
PCV are often difficult to differentiate since they share many clinical features. 
Measuring the thickness of choroid may help to differentiate between these two 
conditions as studies have revealed significant thinning of the choroid in AMD
33, 57
 
and marked thickening in PCV.
53, 65
 However recent studies have demonstrated 
significant overlap in CT between PCV and exudative AMD, indicating that CT alone 
is not sufficient to differentiate between the two conditions and a more detailed 
investigation of the choroid in terms of its morphometric and vascular features is 
essential to better understand the role of choroid in typical AMD and PCV. 
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1.4.2 Choroidal Thickness and Systemic Diseases 
Due to vascular nature of the choroid, potentially any disease affecting 
vasculature or blood supply could also affect the choroidal health. CT is altered in 







 There are reports on significant increase in CT in subjects 
with hypertension.
69
 Likewise choroid is considered as a potential site for the 
occurrence of atherosclerotic changes
71
 which occur in presence of 
hypercholesterolemia. Thickness of the choroid is shown to be significantly higher in 
subjects with hypercholesterolemia.
70
 Interestingly, although various studies have 
reported CT in patients with diabetes mellitus, the results have been equally 
contrasting, with some suggesting CT is increased,
59
 and some decreased
58
 and other 
no difference.
72  Even though, the general consensus is that diabetes mellitus as a 
systemic disease causes a decrease in CT, further investigations are warranted to 
confirm these findings. 
In summary, CT could be considered as a significant marker to assess both 
ocular and systemic health status. Measurements of CT would enable new directions 
to study normal and pathological processes within the choroid. 
 
1.5 CHOROIDAL IMAGING METHODS 
Imaging of the choroid along with quantitative assessment of its thickness is 
gaining increasing importance for the diagnosis, management and follow-up of 
diseases where choroid is implicated in the pathophysiology. The current choroidal 
imaging methods include the following: 
Histological Analysis: Most anatomical information regarding the choroid has been 
gained through histological analysis.
73, 74
 However, in the fixation of the tissues 
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during the histological process, there is shrinkage of the choroid, making it difficult to 
study the changes in vascular tone of the choroid. Therefore, the validity of in-vitro 
studies is compromised.  
Angiography: Presently, angiographies, in particular ICGA
75
 and to a lesser extent 
fundus fluorescein angiography (FFA) are the current standards in clinical settings to 
evaluate the functional aspects such as detecting vascular abnormalities of the 
choroid.
76, 77
  FFA (absorption peak between 465 and 490 nm) is limited by light 
absorption and scattering by the pigment in the RPE and the choroid as well as the 
blood vessels in the choroid (up to 5% of light is absorbed), decreasing the light 
transmittance and hence visualization of the choroid. Furthermore, fluorescein 
extravasates rapidly from choriocapillaris preventing delineation of the choroidal 
anatomy.  
On the other hand, ICGA with absorption peak between 790 and 805 nm 
penetrates the pigmentation of the eye better (only 38% is absorbed by the RPE and 
the choroid) and is less likely to leak from the normal choroidal vessels.
78
 
Nevertheless, both FFA and ICGA do not provide cross-sectional anatomical 
information of the choroid and poorly identify the depth of vascular pathology. In 
addition, these imaging techniques are invasive, time-consuming and have limitations 
of low resolution and inability for reliable quantitative assessment.
79, 80
  
B-scan Ultrasonography: B-scan ultrasonography is another imaging modality 
which is used especially in the presence of opaque media. However, a problem with 
ultrasonography is that the exact location of the image obtained is not known, thereby 
providing limited repeatability. In addition its low image resolution makes the 





Laser Doppler Flowmetry: Laser Doppler flowmetry
41
 is a non-invasive technique 
for the measurement of local choroidal blood flow and its regulation. However, the 
assessment of blood flow in this technique is limited to the foveal region (because it is 
free of retinal vessels), resulting in the Doppler signal arising predominantly from the 
choriocapillaris.
41
 Therefore this technique evaluates only a limited area of the 
posterior pole that may or may not be representative of the flow in other regions of the 
choroid. It is further constrained by its inability to provide reliable quantitative 
assessment.   
Although, the above techniques are useful for determining vessel 
abnormalities or changes in the choroidal blood flow, quantitative assessment of the 
choroid such as its thickness measurement has been very challenging with these 
techniques as they do not provide three-dimensional anatomical information about the 
RPE or the choroidal layers.  
 
1.6 OPTICAL COHERENCE TOMOGRAPHY FOR CHOROIDAL IMAGING 
It was the introduction of OCT, an optical imaging technique based upon 
interferometry,
43, 82
 that has revolutionized the imaging of the posterior segment of the 
eye including the choroid.
44
 OCT enables visualization of detailed in-vivo structures 
non-invasively and provides high-quality, cross-sectional images with greater 
resolution and reliability.
83
 Furthermore, it can perform quantitative measurements of 
different structures in the eye.
84
 However, not all OCT devices are adequate to 
visualize the choroid. 
The first commercially available OCT devices used time domain modality 
(TD-OCT) and were designed to visualize retina at 10 µm resolution. The more recent 
commercial OCT’s, which are based on the spectral domain detection (SD-OCT) 
 12 
 
technology allow for even higher scanning speeds (~ 20,000 to 40,000 A-scans/sec), 
higher scan density and image resolution (axial resolution 5 μm and transverse 
resolution 15 µm) further improving visualization of the deeper structures in the eye.
83
 
The current commercially available SD-OCT devices uses light wavelengths in the 
800-870 nm range, which is appropriate for achieving highly detailed images of the 
retina. However, due to scattering and absorption of the melanin in this range,
85
 it is 
difficult to visualize structures that lay beneath this layer, such as the choroid and 
choriocapillaris.  
1.6.1 Limitations of Conventional OCT in Imaging the Choroid  
Even though, the above features make conventional OCT an important 
diagnostic tool for disease documentation, disease progression and therapeutic 
outcomes, imaging of the choroid with SD-OCT is not adequate to visualize the entire 
choroidal structures. Mainly, because of difficulty in signal penetration beyond the 
heavily pigmented RPE, decreased maximal dynamic range inherent in SD-OCT, 
wavelength dependent light scattering, and signal loss in image path.
44
 More 
importantly, it is decreasing sensitivity and resolution with increasing displacement 
from the zero-delay line or the line of peak sensitivity.
86
 Zero-delay line is a reference 
point set by the software where the image captured is optimal and theoretically, 
structures that are closer to the zero delay line have higher signals than structures that 
are farther from zero delay line (Figure 1.2).  
However, in conventional SD-OCT, the zero-delay line is placed at posterior 
vitreous,
44, 45
 maximizing the sensitivity from the retina and vitreoretinal interface. In 
this way, the retinal image is improved but it leaves the outer choroid farther from the 
zero delay line with subsequent diminished signal and therefore a poor quality of 





1.6.2 Technological Advances in OCT Technique of Choroidal Imaging 
Research to improve understanding of functional aspects of the choroid, and 
identification of choroidal changes as potential markers for the onset and progression 
of many ocular diseases has provided the catalyst to develop improved imaging 
techniques to allow better visualization of the choroidal structures. One such 
successful attempt is a novel modification to the standard technique of SD-OCT, 
termed “enhanced depth imaging” (EDI) which allows cross-sectional imaging of 
the choroid
44
 including the sclera, with substantially enhanced imaging sensitivity.  
Principle of Enhanced Depth Imaging: In EDI technique the instrument is moved 
closer to the eye to image deeper layers, the inverted image is displaced such that the 
choroid is shown facing up (i.e. closer to zero-delay) while the inner retina is facing 
down.
44
 Since the zero-delay line is placed further posteriorly, usually at CSI instead 
of vitreoretinal interface, it maximize the sensitivity on the outer limit of the choroid 
thereby giving better visualization of the choroid than retina (Figure 1.3, panel B). 
EDI-OCT has revolutionized choroid studies as it was not until relatively recently 
(2008) that the measurement of CT became possible through EDI technique of SD-
OCT.   
Other advantages of SD-OCT: Apart from providing enhanced visualization of the 
choroid, by setting it adjacent to the zero delay line, SD-OCT also have other 
additional advantages such as:  
1) Multiple Image Averaging (an average of maximum 100 B-Scans): is another 
important technique to visualize the choroid by using multiple scans obtained from 
the same retinal locations that are subsequently averaged together by the OCT 
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software. This reduces the speckle and increases signal-to-noise ratio, thereby 
enhancing the continuity and sharpness of the underlying structures.  
2) Eye Tracking: minimizes artefacts caused by eye drift and micro-saccades to 
ensure that all the images to be averaged are taken from the same retinal location, 
thereby increasing signal by reducing the motion artefact. Given the topographical 
variation in the thickness of the choroid this feature is of great importance.  
3) High-speed Scanning and Low Speckle Noise: can further produce high-quality 
choroidal images with the EDI mode in Spectralis SD-OCT.  
Thus, because of the above technological amelioration, it is conceived that 
SD-OCT (Spectralis) with EDI mode can provide more reliable and accurate 
assessment of CT compared to conventional OCT. 
 
1.7 CHALLENGES IN CHOROIDAL IMAGING DESPITE EDI TECHNIQUE 
 
The field of choroidal imaging is greatly transformed with the advent of the 
technique of EDI-OCT and since then numerous studies have measured CT in 
normal
45, 47, 48, 50
 and different disease states.
33, 52, 54-56
 However, despite this technique 
it is not a trivial task to image the choroid as it is still not adequately visible for 
reliable determination of CT. The EDI technique of SD-OCT and current CT 
assessment technique lacks some of the critical aspects which are discussed in next 
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CHAPTER I FIGURES 
Figure 1.1 Illustration of the typical features observed in histological images of the 
choroid (Adapted from: Nickla DL, Wallman J. The multifunctional choroid. Prog 







Figure 1.2 Illustration of zero delay line in conventional spectral domain optical 
coherence tomography (SD-OCT) vs. enhanced depth imaging (EDI) SD-OCT.  (A) 
In a conventionally acquired OCT image the peak sensitivity is located at the 
posterior vitreous and the sensitivity curve is flipped on its side and overlaid on the 
SD-OCT. (B) In EDI-OCT, when instrument is pushed closer to the eye to invert the 
image, the peak sensitivity curve is moved to the inner sclera (Adapted from Spaide 
RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical 








Figure 1.3 Optical coherence tomography image demonstrating enhanced depth 
imaging on Spectralis (Heidelberg Engineering). (A) Image was acquired with the 
inner retina adjacent to the zero delay. Note that the choroid–sclera junction is not 
distinct (white arrowheads) and there is low signal from the choroid but high signal 
from the inner retina. (B) Image was acquired with the choroid adjacent to the zero 
delay by advancing the instrument toward the patient. Note that the choroid–sclera 
junction is distinct and that there is reduced signal from the inner retina but increased 
signal from the choroid (Adapted from Regatieri CV, Branchini L, Fujimoto JG, 














RATIONALE AND THESIS OVERVIEW 
 
2.1 STATEMENT OF THE PROBLEM AND RATIONALE 
The emergence of EDI technique of SD-OCT has made it possible to visualize 
cross-sectional images of the choroid with enhanced sensitivity and also to perform 
quantitative measurements of choroidal parameters such as CT.
1
 However, current CT 
assessment technique lacks objectivity or the resolution/information needed to 
accurately measure CT. Hence, there is a need for development of novel choroidal 
image processing techniques to objectively and accurately quantify various choroidal 
parameters including CT which is essential in distinguishing clinically significant 
change of CT and assisting in risk-profiling for various posterior segment diseases.  
 
2.2 UNMET CLINICAL NEEDS IN CHOROIDAL THICKNESS 
MEASUREMENT 
The currently available techniques to measure CT and other choroidal features 
using SD-OCT with EDI techniques lack the following aspects: 
2.2.1 There is Inadequate Visualization of CSI  
Despite the technique of EDI, the choroid is still difficult to image thoroughly: 
first because of its posterior location. Choroid lies behind the pigmented RPE
2
 and 
within the shell of the opaque and rigid sclera, therefore it is less accessible than the 
retina and thus difficult to visualize. Second, the pigmentation in the RPE and the 
choroid itself which leads to light scattering and signal attenuation thereby further 
compromising the visibility of the choroid. Third, the choroid is a vascular layer, 
presence of blood vessels further impede choroidal imaging by shadowing effects of 
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the vasculature, thereby decreasing the contrast between the choroid and the sclera. 
Last, but most important is that unlike retinal layers, wherein the RPE and internal 
limiting membrane are thin and clearly identifiable,
3
 the transition zone between the 
choroid and  sclera called “CSI” has blurred border and is broader making it further 
difficult to visualize the choroid. Because CSI forms the posterior boundary of the 
choroid, it is a principal landmark in quantification of CT which is measured as a 
perpendicular distance between the RPE and CSI. The visibility of CSI is therefore 
crucial for precise measurement of CT.   
However, despite the current technique of EDI, the contrast between the 
choroid and the sclera is still weak,
4-7
 giving CSI a poor visibility. We postulate that 
poor visibility of CSI will result in increased variability in CT measurements. 
Therefore, to test our hypothesis we aim to conduct a pilot study to assess the 
percentage visibility of CSI in EDI-OCT images and the variability in CT 
measurements in images with differently visible CSI.  
2.2.2 There is no Robust Automated Choroidal Segmentation Software 
The poor visualization of the CSI is also a hindrance to the development of 
automated choroidal segmentation software. Presently, none of the commercially 
available SD-OCT can either define the CSI or measure CT objectively. As a result, 
current studies segment the CSI and measure the CT manually by using the in-built 
caliper system provided by the machine.
8-11
 Manual measurements are subject to both 
intra- and inter-operator biases which might lead to large variations and inaccuracies 
in the measurement of CT. In addition, manual method is also time-and effort-
consuming. Thus the above limitations of manual CSI marking and CT measurements 
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make it impractical for both clinical use and epidemiological research involving large 
samples.  
2.2.3 A Comprehensive Evaluation of the Choroid beyond the Foveal Center is  
Lacking 
Owing to unavailability of automated choroidal segmentation software, 
current measurements of choroid are not comprehensive enough as the assessment of 
CT in most of the studies is usually limited to a few points around the foveal centre. 
However, measurements of a few sampling points are influenced by focal thickening 
or thinning of the choroid,
12, 13
 or by irregularity of the inner chorioscleral border,
14, 15
 
and thus highly dependent on location of measurements. Since choroid is a complex 
three-dimensional vascular structure, consisting of a highly anastomosed network of 
blood vessels,
16
 measurement of point thicknesses therefore provides limited 
information on the actual topographical variation of the choroid at the macula. 
Because point measurements do not adequately reflect the profile of entire choroid, 
measuring the choroidal volume may be a better way to study its anatomy. Thus, an 
objective and comprehensive assessment of choroid, such as CT maps and volumetric 
analysis, is required but is still unavailable. 
We aim to address the above gaps in knowledge in Aims 1a and 1b, wherein, 
we first addressed the primary challenge of poor CSI visibility by enhancing the 
visualization of CSI by a novel technique of “adaptive compensation” (Aim 1a). 
However, our technique of adaptive compensation to enhance the CSI is still a semi-
automated technique as it requires manual input to mark the CSI and measure CT, 
thus subject to measurement errors. We overcome this problem in Aim 1b, wherein 
we used a fully automated choroidal segmentation technique which can objectively 
and accurately define the CSI and measure CT as well as addresses the present 
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concern of non-comprehensive choroidal assessment by computing choroidal volume. 
However, apart from the above technological challenges in CT measurement, there 
are other issues (discussed below) which need to be addressed. 
2.2.4 Choroidal Thickness, Distribution and Determinants in Asians has not been 
well studied 
There are limited population-based data on CT in Asians.
17
 The Beijing Eye 
Study is the only population-based study on CT. However, their measurement of CT 
was performed manually and at sub-foveal location only, thus limited by 
measurement error and non-comprehensive assessment of the choroid. None of the 
studies so far have performed a comprehensive assessment of the ocular and systemic 
factors that might influence CT. To date, it is not known whether there exists any 
ethnic variation in CT among Asians. Neither is it known if there are differences in 
systemic and ocular risk factors of CT in different ethnic groups in Asians.  
2.2.5 There are few studies on the Distribution and Determinants of the 
Peripapillary Choroid  
Furthermore, because peripapillary choroid supplies blood to the anterior optic 
nerve head,
18, 19
 it might be associated with conditions like glaucoma
20-22
 and high 
myopia. Knowledge of the distribution of peripapillary CT in the population may 
therefore be useful in facilitating the detection of abnormal changes in peripapillary 
CT and thus help in elucidating the pathophysiology of such eye diseases. Despite this 
present focus of the current SD-OCT studies is macular CT. 
We propose to address these gaps in knowledge in our project through 
population-based study to evaluate CT and volume among ethnic groups in Singapore. 
Singapore has three major racial/ethnic groups, Malay, Indian and Chinese, which 
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provides a unique opportunity to study the effect of ethnic differences on CT in a 
relatively common geographic and socio-economic environment. In Aim 2 of this 
project, we propose to perform a population-based evaluation of the distribution and 
determinants of macular and peripapillary choroidal characteristics such as CT and 
volume using our novel fully automated choroidal segmentation technique.  
2.2.6 The Relationship of Choroidal Features in Major Retinal Diseases require 
Further Investigations  
The choroid has been implicated in the pathogenesis of many sight threatening 






 Given that the choroid is a 
three dimensional vascular structure predominantly composed of blood vessels, a 
detailed morphological and vascular analysis of the choroid would provide clearer 
understanding of the role of choroid in these diseases. However, attempts to quantify 
and define choroidal structural and vascular characteristics in-vivo have been limited. 
With the rising trend in the prevalence and severity of these diseases in particular in 
Asia, it is imperative to have baseline measures of various choroidal morphological 
and vascular features in diseases where choroid is implicated in the pathophysiology. 
In Aim 3 of this doctoral work, in addition to CT and volume measurements 
(which alone may not always reflect specific changes in the choroid), we propose to 
perform a more detailed analysis of various morphological features like curvature of 
the CSI, inflection points and distance of the thickest point from the fovea as well as 
additional architectural features of the stromal and vascular parameters in the choroid 
of the above eye diseases and their comparison with healthy eyes. 
 
2.3 AIMS AND OBJECTIVES OF THESIS 
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The overall objective of this thesis is to develop and utilize novel image 
processing techniques (semi- and fully-automated) to characterize the macular and 
peripapillary choroid in Asians and to determine the relationship of choroidal features 
with major retinal diseases including high myopia, DR and AMD. Our novel 
choroidal imaging techniques will provide the platform for filling the above gaps to 
fulfil all of the unmet needs. The specific aims are as follows: 
Aim 1: To develop and evaluate novel image processing techniques to quantify  
choroidal characteristics such as CT and choroidal volume using EDI SD-
OCT          
a. Development and evaluation of novel semi-automated image processing 
technique to quantify macular choroidal thickness; and its comparison with 
reference standard manual method               
b. Development and evaluation of novel fully automated macular and 
peripapillary choroidal segmentation technique; and its comparison with 
reference standard manual method  
Hypothesis: New choroidal imaging techniques will provide comparable but 
more reliable choroidal measurements than existing manual methods. 
 
Aim 2: To determine the distribution and determinants of choroidal  
 characteristics such as thickness, volume and vasculature in a multi-
ethnic Asian population 
a. Multi-ethnic population-based evaluation of the distribution and determinants  
            of macular and peripapillary CT and macular choroidal volume using  
            the fully automated choroidal segmentation method 
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b. Evaluation of choroidal vasculature and its determinants in healthy eyes from 
a population-based study 
            Hypothesis: There are differences in the distribution and determinants of  
  choroidal characteristics (thickness, volume and vasculature) among 
  two major Asian ethnic groups.  
 
Aim 3: To characterize choroidal morphological and vascular features in eyes 
with major retinal diseases 
a. Evaluation of choroidal morphological and vascular features in high myopia 
b. Evaluation of choroidal morphological and vascular features in diabetic 
retinopathy 
c. Evaluation of choroidal morphological and vascular features in age related 
macular degeneration 
 Hypothesis: Choroidal morphological traits such as curvature of the CSI,  
 inflection points, distance of the thickest point from the fovea and vascular 
 features like luminal area are different in eyes with different retinal diseases.     
 
2.4 THESIS STRUCTURE 
This thesis consists of nine chapters: Chapter 1 reviews the published 
literature on various choroidal imaging methods and highlight the limitations of 
current techniques; Chapter 2 presents statement of the problem and study rationale; 
Chapter 3 presents measurement methods, disease definitions and baseline 
characteristics of the study participants from a multi-ethnic population; Chapter 4 
evaluates the visibility of CSI in EDI-OCT images as well as the variability in CT 
measurements in images with differently visible CSI; Chapter 5 describes our 
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attempts to enhance the visibility of CSI by novel semi-automated technique of 
“adaptive compensation” to quantify macular CT and its comparison with reference 
standard manual method; Chapter 6 describes development and evaluation of novel 
fully automated macular and peripapillary choroidal segmentation techniques to 
quantify macular and peripapillary CT and macular choroidal volume and their 
comparison with reference standard manual method; Chapter 7 presents multi-ethnic 
population-based evaluation of the distribution and determinants of macular and 
peripapillary choroidal characteristics using the fully automated choroidal 
segmentation technique; Chapter 8 describes the distribution and determinants of 
choroidal vasculature in healthy eyes from a population-based study; Chapter 9 
describes characterization of morphological and vascular traits of the choroid in high 
myopia; Chapter 10 presents characterization of morphological and vascular features 
of the choroid in DR; Chapter 11 describes characterization of morphological and 
vascular traits of the choroid in AMD; and Chapter 12 summarizes the key findings, 
and also discusses the strengths and limitations of this doctoral work. In addition, the 
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SUBJECTS AND METHODS 
 
3.1 STUDY POPULATIONS 
To achieve the 3 Specific Aims proposed, data from the following studies were used: 
 Singapore Epidemiology of Eye Disease (SEED) Study  
 Aetiology of Pathological Myopia in NSF Study 
 Asian Age-related Macular Degeneration Phenotyping Study  
3.1.1 Singapore Epidemiology of Eye Disease (SEED) Study 
The analyses of this dissertation included data from the Singapore 
Epidemiology of Eye Disease (SEED) Study, a population-based, cohort study of eye 
diseases in three major ethnic groups in Singapore: Malays, Indians, and Chinese 
adults aged 40 and older residing in south-western Singapore (Figure 3.1). The 
baseline examination
1, 2
 was conducted between 2004 and 2011 and a follow-up 
examination
3
 of the participants has been conducted since January 2011, 6 years after 
the baseline examination and is on-going. Using an age-stratified random sampling 
strategy, 5,600 Malay names, 6,350 Indian names, and 6,752 Chinese names were 
selected from the Ministry of Home Affairs. A total of 4,168 Malays, 4,497 Indians, 
and 4,605 Chinese were deemed eligible to participate. The “ineligible” persons were 
those who had moved from the residential address, had not lived there in the past six 
months, or were deceased or terminally ill. A total of 3,280 Malays, 3,400 Indians and 
3,353 Chinese participated in the baseline SEED study, giving a response rate of 
78.7%, 75.6%, and 72.8% respectively (Figure 3.1). In the follow up examination, a 
total of 1,901 Malays and 2,200 Indians participated, giving a response rate of 72.2% 
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and 75.6% respectively. The follow up of Chinese participants is on-going and 
therefore we could not include them in this dissertation. The study adhered to the 
Declaration of Helsinki, and ethics approval was obtained from the Singapore Eye 
Research Institute (SERI) Institutional Review Board. All examinations were carried 
out at SERI. A detailed interviewer-administered questionnaire was used to collect 
information regarding socioeconomic status (e.g., education, income and housing 
type) and medical history of eye diseases. 
Participants were invited to attend a comprehensive eye and physical exam at 
the SERI via telephone, by mail, and/or by home visit. A booklet outlining the overall 
eye study findings and an invitation letter (reply-paid postage) were sent to all 
baseline participants to elicit a strong spirit of cooperation.  
3.1.2 Aetiology of Pathological Myopia in NSF Study 
This is a case control study of 718 Singapore Armed Forces (SAF) conscripts 
with high myopia measurements (defined as spherical equivalent [SE] of more than -
6.00 diopter [D]) and a control group of up to 200 emmetropes who were invited to 
participate in this study at SERI. All participants underwent detailed clinical and 
ocular examination including retina, optic disc and choroidal architectural parameters, 
using Heidelberg Spectralis OCT. SAF conscripts were eligible to participate in the 
study if they do not have any history of anterior ocular diseases, trauma or conditions 
that affects visual performance i.e. visual acuity (VA) and contrast sensitivity and no 
refractive surgery done to any of their eyes. 
3.1.3 Asian Age-related Macular Degeneration Phenotyping Study 
The Asian AMD Phenotyping Study is a prospective, observational clinical 
study which recruited  consecutive AMD patients from the Singapore National Eye 
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Centre (SNEC) who provided a complete set of data during the baseline visit to 
phenotype this condition. Each patient was examined according to a standardized 
protocol.
4
 Data collected and risk factors examined were compared against age-
matched Asian controls from population studies under the SEED programme, which 
has a clinical database of persons of Chinese, Malays and Indian ethnicity. 
 
3.2 CHOROIDAL IMAGING  
3.2.1 Macular Choroidal Imaging 
The choroidal architectural parameters were determined using SD-OCT 
(Spectralis, Wavelength: 870 nm; Heidelberg Engineering, Heidelberg, Germany) 
with EDI modality after pupil dilation. OCT raster scans with EDI were acquired in 
macular region of each subject. Each set of images comprised 7 serial horizontal B-
scans (each composed of 1536 A-scans) covering a rectangular region of 30° X 
5°centered on the fovea. Distance between consecutive scans was 240 µm. To reduce 
speckle noise, each B-scan was averaged 100 times during acquisition (Figure 3.2). 
The CT at each location was defined as the distance between the Bruch’s membrane 
(lower boundary of RPE) and the CSI.  
3.2.2 Peripapillary Choroidal Imaging 
Peripapillary choroid was imaged using EDI mode of Spectralis SD-OCT. The 
peripapillary region was scanned using a 360°, 3.4 mm diameter circle that was 
centered on the optic disc (Figure 3.3), each comprising 100 averaged scans (using 
the proprietary automatic averaging and eye tracking features of the device). Scans 
were centered using an internal fixation and centering was confirmed by a scanning 
laser ophthalmoscope integrated in the instrument.  
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For both macular and peripapillary choroidal scans, following Spectralis user 
manual guidelines subjects’ keratometry readings and the most recent refraction were 
entered into the Software Program to estimate optical magnification and, therefore, to 
allow for more accurate comparisons across individuals. 
 
3.3 RETINAL IMAGING  
3.3.1 Macular Scan 
The retinal architectural parameters were determined using SD-OCT (Cirrus, 
Wavelength: 870 nm; Carl Zeiss Meditec, Inc, Dublin, CA) after pupil dilation. Cirrus 
SD-OCT has a scan speed of 27,000 axial scans per second and an axial resolution of 
5 µm.
5
 It was used to acquire 1 macular scan in an area of 6 X 6 mm
2
 using the 
macular cube 200 X 200 scan protocol in each eye after pupil dilation. The built-in 
software was used to produce retinal thickness maps, which then were averaged over 
nine retinal subfields in a 6-mm diameter circle centered at the true fovea location, as 
defined by the Early Treatment Diabetic Retinopathy Study (ETDRS).  
3.3.2 Optic Nerve Head Scan 
Cirrus SD-OCT also images the ONH and peripapillary retinal nerve fiber 
layer (RNFL) in an area of 6 X 6 mm
2
, and samples 200 X 200 data points in <1.5 
seconds. After pupil dilation, ONH and RNFL scan acquisitions were performed for 
each participant using an optic disc cube 200 X 200 scan protocol, which generates a 
cube of data in a 6 X 6 mm
2
 grid with 200 X 200 axial measurements, following the 
recommended procedure (Cirrus HD-OCT manual).  
3.3.3 Cirrus Image Acquisition Protocol 
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In brief, the subject’s pupil was first centered and focused in an iris viewing 
camera on acquire screen, and the line scanning ophthalmoscope (LSO) with “auto 
focus” mode was then used to optimize the view of the retina. The “center” and 
“enhance” modes were used to optimize the Z-offset and scan polarization 
respectively for the OCT scan to maximize the OCT signal. After each capture, 
motion artifact was checked with the LSO image with the OCT en face overlaid. 
Rescanning was performed if a motion artefact (indicated by discontinuity of blood 
vessels) or saccades were detected. Centration was checked to confirm whether the 
central subfield aligned to center of fovea correspondingly. In addition, each of the B-
scans were scrutinized manually in each eye by trained technicians and checked for 
segmentation boundaries displayed. Images with motion artefact, centration error, or 
macular and RNFL or ONH algorithm segmentation failure were excluded from the 
analysis. All the OCT scans included in the study had signal strength of at least 6, 
which is considered as acceptable quality. Macular and RNFL thicknesses (average, 
clock hours, and quadrants), were derived automatically from a single scan using the 
in-built automated software for segmentation and parameter measurements without 
manual operator adjustment. 
 
3.4 CLINIC INTERVIEW 
A face-to-face detailed interviewer-administered questionnaire was used to 
collect information on socioeconomic characteristics (e.g. education, occupation, 
income level and housing type), lifestyle factors such as smoking and alcohol use, 





3.5 OTHER OCULAR EXAMINATION 
Visual Acuity: Distance presenting VA was measured using a logarithm of the 
minimum angle of resolution (Log MAR) number chart (Lighthouse International, 
New York, USA) at a distance of 4 meters, with the participant wearing their current 
optical correction (spectacles or contact lenses), if any. A number chart was used for 
participants who were unable to identify the Latin alphabets. If no number could be 
read at 4 meters, the participant was moved to 3, 2 or 1 meters consecutively and 
finally VA was assessed as counting fingers, hand movements, perception of light, or 
no perception of light. Subjective refraction and distance best-corrected VA in Log 
MAR scores were measured by trained and certified study optometrists. Near vision 
acuity test was done using the Log MAR near vision chart.  
Refraction: The refraction (sphere, cylinder and axis) was measured using an 
autorefractor machine (Canon RK 5 Auto Ref-Keratometer, Canon Inc. Ltd., 
Tochigiken, Japan) operated by optometrists or trained technicians. The first five 
valid readings were used and averaged using vector methods to give a single estimate 
of refractive error. All five readings should be at most 0.50 D apart in both the 
spherical and cylinder components.  
Ocular Biometry: Ocular biometry was performed using an optical biometry 
machine (Zeiss IOL Master, version: 3.01.0294). This device is a non-contact optical 
biometry machine that is non-invasive as opposed to the ultrasound A-scan biometry 
machine. The axial length (AL), anterior chamber depth (ACD) and corneal curvature 
radii in the horizontal and vertical meridian will be measured in the right and left eye.  
Visual Field Testing: Standardized visual field testing was performed with static 
automated white-on-white threshold perimetry (SITA Fast 24-2, Humphrey Field 
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Analyzer II; Carl Zeiss Meditec, Inc., Oberkochen, Germany). A visual field was 
defined as reliable when fixation losses were less than 20%, and false-positive, false-
negative rates were less than 33%. Visual field test was repeated if the test result was 
unreliable. A glaucomatous visual field defect was defined as the presence of three or 
more significant (p<0.05) non-edge contiguous points with at least one at the p<0.01 
level on the same side of the horizontal meridian in the pattern deviation plot, and 
classified as “outside normal limits” on the Glaucoma Hemifield Test, confirmed on 2 
consecutive visual field examinations. 
Fundus Photography: Fundus photography was performed using a digital non-
mydriatic retinal camera (Canon CRDGi with a 20Diopter SLR backing, Canon, 
Japan). Retinal photographs centered on the optic disc and the macula was taken from 
both eyes after pupil dilation using eye drops containing 1% tropicamide according to 
a standardized protocol adapted by all studies affiliated to the SERI.
1, 2 
Slit Lamp Examination: Anterior and posterior segment examinations were 
performed at the slit-lamp (Haag-Streit model BQ-900; Haag-Streit, Switzerland) 
using a 78 D lens, which included measurements of vertical dimensions of the optic 
disc and cup with an eyepiece graticule, etched in 0.1 mm units.  
Central Corneal Thickness and Intraocular Pressure: Central corneal thickness 
(CCT) was measured in each eye with an ultrasound pachymeter (Advent; Mentor O 
& O Inc, Norwell, Massachusetts). Goldmann applanation tonometry (AT900, Haag-
Streit AG International, Switzerland) was used to measure intraocular pressure (IOP) 
before pupil dilation. One reading was taken from each eye. If the IOP reading was 





3.6 SYSTEMIC EVALUATION 
Anthropometry: Height was measured in centimeters using a wall-mounted 
measuring tape. Weight was measured in kilograms using a digital scale (SECA, 
model 782 2321009; Vogel & Halke, Germany). Body mass index (BMI) was 
calculated as body weight (in kilograms) divided by body height (in meters) squared. 
Blood Pressure and Pulse Rate: Blood pressure was taken with the participant 
seated and after 5 minutes of rest. Systolic and diastolic blood pressure (BP) and pulse 
rate were measured with a digital automatic blood pressure monitor (Dinamap model 
Pro Series DP110X-RW, 100V2; GE Medical Systems Information Technologies, 
Inc., USA). Blood pressure was measured on two occasions 5 minutes apart. If the 
blood pressures differed by more than 10 mmHg systolic and 5 mmHg diastolic, a 
third measurement was made. The blood pressure of the individual was then taken as 
the mean between the two closest readings.  
Mean Ocular Perfusion Pressure: Mean ocular perfusion pressure (OPP) was 
calculated using the following equation: mean OPP = (2/3 x mean arterial pressure 
[MAP] – IOP), where MAP = diastolic BP + (1/3 x [systolic BP – diastolic BP]).  
Systolic and diastolic OPP were calculated using the following equations: systolic 
OPP = systolic BP – IOP and diastolic OPP = diastolic BP – IOP, respectively. 
Biochemistry Tests: Non-fasting venous blood samples were drawn and sent for 
biochemistry tests, including analysis of total cholesterol, high density lipoprotein 
cholesterol (HDL), low density lipoprotein cholesterol (LDL), triglycerides, 




3.7 DEFINITION OF EYE AND SYSTEMIC DISEASES 
The clinical definitions of various ocular and systemic conditions are 
summarized below: 
Refractive Error: SE was defined as sphere plus half cylinder. Myopia was defined 
as a SE of -0.5 D or less, hyperopia as a SE of 0.5D or more, and emmetropia as a SE 
of between -0.5 and 0.5D. Moderate myopia was defined as a SE of -3.0 D or less. 
High myopia was defined as SE less than -6.0 D.  
Age-Related Macular Degeneration: A digital retinal camera (Canon CR-DGi with 
a 10-D SLR back; Canon, Tokyo, Japan) was used to obtain color photographs 
centered at the optic disc and macula of each eye. The photographs were graded for 
AMD signs based on the Wisconsin Age-Related Maculopathy Grading System.
6
  
Diabetic Retinopathy: Signs of DR were graded from fundus photographs using the 
modified Airlie House classification system and a modification of the ETDRS 
severity system for DR.
7, 8
 Graders assessed the presence/severity of diabetic macular 
edema, and sign of laser treatment scar. Retinopathy severity was categorized into 
minimal non-proliferative diabetic retinopathy (NPDR; level 15 through 20), mild 
NPDR (level 35), moderate NPDR (level 43 through 47), severe NPDR (level 53), 
and proliferative diabetic retinopathy (PDR, level more than 60). Macular edema was 
defined by hard exudates in the presence of microaneurysms and blot hemorrhage 
with one disc diameter from the foveal center or presence of focal photocoagulation 
scars in the macular areas. Those with macular edema were further divided into cases 
with clinically significant macular edema (CSME) and without CSME. CSME was 
defined by macular edema within 550 μm of the foveal center or if focal 
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photocoagulation scars were present in the macular area. Vision-threatening diabetic 
retinopathy (VTDR) was defined as the presence of severe NPDR, PDR, or CSME.  
Glaucoma Suspect: was defined as having any of the following criteria: (1) IOP>21 
mm Hg, (2) vertical cup-to-disc ratio (VCDR) > 0.6 or VCDR asymmetry > 0.2 (3) 
signs consistent with pseudoexfoliation or pigment dispersion syndrome, (4) narrow 
angles (posterior trabecular meshwork visible for <180 degrees during static 
gonioscopy), and (5) peripheral anterior synechiae, (6) other findings consistent with 
secondary glaucoma, and (7) known history of glaucoma. 
Glaucoma: was defined according to the International Society of Geographical and 
Epidemiological Ophthalmology (ISGEO) criteria based on three categories.
9
 In brief, 
category 1 cases were defined as optic disc abnormality (VCDR/VCDR asymmetry ≥ 
97.5 percentile with a corresponding glaucomatous visual field defect. Category 2 
cases were defined as having a severely damaged optic disc (VCDR or VCDR 
asymmetry ≥ 99.5th percentile) in the absence of reliable visual field test results. 
Category 3 cases were defined for subjects who were blind (corrected visual acuity of 
<3/60), without visual field or optic disc data and had previous glaucoma surgery or 
IOP >99.5 percentile. 
 A narrow anterior chamber angle was diagnosed if the posterior trabecular 
meshwork was seen for 180° or less of the angle circumference during static 
gonioscopy. Primary angle-closure glaucoma (PACG) was defined as glaucoma case 
presented with narrow anterior chamber angles and trabecular obstruction by 
peripheral iris (such as peripheral anterior synechiae, elevated IOP, iris whirling, 
“glaukomflecken” lens opacities, or excessive pigment deposition on the trabecular 
surface). Subjects with glaucoma and an open, normal drainage angle with no 
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identifiable secondary pathologic processes were defined as primary open angle 
glaucoma (POAG).  
Hypertension: was defined as systolic BP of ≥140 mmHg or diastolic BP≥90 mm Hg 
at the time of the examination, or a reported history of physician diagnosed 
hypertension or self-reported history of antihypertensive medication use, or both.  
Hyperlipidaemia: was defined as total cholesterol of 6.2 mmol/l or more or use of 
lipid-lowering drugs. 
Diabetes Mellitus: was defined as random glucose ≥11.1 mmol/L or HbA1c≥6.5 
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CHAPETR III FIGURES 
 












Figure 3.2 An illustration of macular choroid imaged using EDI mode of Spectralis 
SD-OCT. Each set of images comprised of 7 serial horizontal B-scans (each 
composed of 1536 A-scans) covering a rectangular region of 30° X 5°centered on the 
fovea. Distance between consecutive B-scans was 240 µm and each B-scan was 







Figure 3.3 An illustration of peripapillary choroid imaged using EDI mode of 
Spectralis SD-OCT. The peripapillary region was scanned using a 360°, 3.4 mm 











THE VISIBILITY OF CHOROIDAL-SCLERAL INTERFACE  
 
Since CSI forms the posterior boundary of the choroid, it is a principal 
landmark for quantification of CT which is measured as a perpendicular distance 
between the RPE and CSI.  The visibility of CSI is therefore essential for accurate 
thickness and volumetric analysis of the choroid. However, despite the current 
technique of EDI, the contrast between the choroid and the sclera is still weak, giving 
CSI a poor visibility. We believe/ hypothesize that poor visibility of CSI is the main 
obstacle to accurate measurement of CT and will result in increased variability in CT 
measurements. Therefore, to test this hypothesis we conducted a pilot study to assess 
the percentage visibility of CSI in images obtained by EDI technique of SD-OCT in 
healthy eyes as well as the variability in CT measurement in images with differently 
visible CSI. Furthermore we also investigated the effects of a range of ocular and 
systemic factors on CSI visibility in the population-based sample. Knowledge of the 
factors influencing the visibility of CSI is crucial for accurate analysis of the thickness 
and volume of the choroid.  
 
The manuscript relevant to the contents of this chapter has been published in the 
journal: Acta Ophthalmologica 
Gupta, P., C. Y. Cheng, C. M. Cheung, H. M. Htoon, Y. Zheng, E. L. Lamoureux, T. 
Aung, T. Y. Wong and C. Y. Cheung. "Relationship of Ocular and Systemic 
Factors to the Visibility of Choroidal-Scleral Interface Using Spectral Domain 




Gupta P., C. Y. Cheung. Refining the Definition of the Choroidal-Scleral Interface.  






The choroid is a major vascular layer of the eye which provides oxygen and 
nourishment to the outer layers of the retina including the photoreceptors.
1
 
Abnormalities in choroidal vasculature (e.g. vascular hyper-permeability, vascular 
changes and loss, and thinning) are of importance in the pathophysiology of a number 






 and high myopia-related 
chorioretinal atrophies.
8-10
 To elucidate the mechanisms how the choroid may affect 
chorioretinal diseases, an easy, objective and quantitative analysis of the choroid is 
required. ICG, and to a lesser extent FA are the current standard to evaluate the 
choroidal circulation in clinic; however they are invasive and can only provide 
qualitative assessment of choroid. 
Since the introduction of optical coherence tomography based EDI-OCT by 
Spaide and colleagues,
11
 this technique has been used to study changes in CT in many 
conditions 
2, 4, 5, 7-9
 as well as other ocular abnormalities.
12
 Nonetheless, an accurate 
estimation of CT with EDI-OCT relies mainly on the visibility of CSI, which 
anatomically represents the junction between the choroid and the sclera and is a 
principal landmark for quantitative measurements of choroid. However, unlike retinal 
layers, the contrast between the choroid and scleral border is weak,
13-16
 giving CSI a 
variable visibility leading to variations and inaccuracy in CT measurements across the 
clinical studies. There have been no studies which investigate factors which may 
determine the visibility of the CSI. 
The aim of this study was to assess the visibility of CSI in EDI-OCT images in 
healthy eyes and to determine the effects of a range of ocular and systemic factors on 





4.2.1 Study Population  
Data for this analysis were derived from the SiMES-2, a population-based 
cohort study of eye diseases in Malay adults aged 46-86 years living in Singapore. 
Details of the baseline study design, sampling plan, and methodology (SiMES-1), 
conducted in 2004-6, have been have been described in Chapter III and previously 
reported elsewhere.
17
 For this analysis, we enrolled 176 consecutive participants of 
the SiMES-2
18
 from June 2012 to January 2013. Participants recruited in this phase 
underwent standardized and detailed ophthalmic examination, including Spectralis 
EDI SD-OCT.   
Normal participants had no history of ocular disease except cataract. 
Participants were excluded based on the following characteristics: best corrected 
LogMAR VA >0.3, evidence of macular or vitroretinal diseases, DR, previous retinal 
or refractive surgery, past history of intraocular surgery, or clinical features 
compatible with a diagnosis of glaucoma suspect or glaucoma.  
A glaucoma suspect
19
 was defined as described in Chapter III. Glaucoma was 
diagnosed and classified using the ISGEO scheme,
20
 based on findings from 
gonioscopy, optic disc characteristics, and visual fields results (see details in Chapter 
III). The study was approved by the Institutional Review Board of SERI. It followed 
the tenants of the Declaration of Helsinki and written informed consent was obtained 
from the subjects. 
4.2.2 EDI-OCT Imaging  
CT was obtained using a SD-OCT (Spectralis, Heidelberg Engineering, 
Heidelberg, Germany) with EDI modality as specified in details in Chapter III.  All 
the scans included in the study had signal strength of at least 18, which is considered 
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as acceptable quality. One of the authors (PG) who was masked to subject 
characteristics and clinical diagnosis performed the EDI-OCT examination. Only the 
horizontal section passing through the center of the fovea was selected for analysis. 
4.2.3 Image Analysis 
Choroidal Thickness Measurement: Using the Spectralis linear measurement tool, a 
single observer (PG) measured CT perpendicularly from the outer portions of the 
hyperreflective line, corresponding to the RPE (automatically detected by the 
instrument), to the hyporeflective line or margin corresponding to the sclerochoroidal 
interface (drawn manually) at sub-foveal location. 
CSI Visibility Grading System: We developed a new grading system to assess 
visibility of CSI for EDI-OCT images. 2 masked observers evaluated all the OCT 
scans to locate the CSI on each EDI-OCT image. The CSI was defined as a hypo-
reflective line between the large vessel layer of the choroid and the sclera (Figure 
4.1). For the grading of CSI visibility, the EDI-OCT images were given a score 
between 0 and 2. A score of “2” was assigned if the image contained a well-defined 
CSI. A score of “1” was assigned if the visibility of CSI was between well-defined 
and poorly defined CSI and a score of “0” was given if the image had poorly defined 
CSI visibility i.e.  no clearly identifiable border between the choroid and sclera was 
seen. Figure 4.1 demonstrates examples of well-defined, moderately defined and 
poorly defined CSI in EDI-OCT images in the SiMES-2 cohort.  
Reliability Assessment: We evaluated both the intra and inter-observer reliability in 
assessing CSI visibility. For intra-observer reliability, 176 Spectralis images were 
assessed again by the same grader (grader 1 vs. grader 1) after an interval of one 
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week. Two independent graders (grader 1 vs. grader 2) assessed the inter-observer 
reliability of CSI visibility in 176 Spectralis images.  
In addition, sub-foveal CT at the foveal center was measured twice by the 
same grader to assess the reliability of CT measurement in each score of CSI visibility 
(15 images for each score).  
4.2.4 Measurement of Ocular Factors 
All participants underwent an extensive and standardized examination 
procedure, which included measurement of VA monocularly using LogMAR number 
chart (Lighthouse International, New York, USA) at a distance of 4 m. IOP was 
measured with a Goldmann applanation tonometer (Haag-Streit, Bern, Switzerland) 
before pupil dilation. The static refraction of each eye was measured using an 
autorefractor (Canon RK 5 Auto Ref-Keratometer, Canon Inc. Ltd., Tochigiken, 
Japan). SE refraction was calculated as the sum of the value of the spherical value and 
half of the cylindrical value. CCT was measured with an ultrasound pachymeter 
(Advent, Mentor O & O, Norwell, MA) and the mean of five measurements was used 
in the analysis. AL, corneal curvature and ACD were measured with a non-contact 
partial coherence laser interferometry (IOLMaster V3.01, Carl Zeiss Meditec AG, 
Jena, Germany) and the mean of five measurements was used in the analysis. Lens 
opacity was assessed by trained ophthalmologists using Lens Opacities Classification 
System (LOCS) III 
21
 with a Haag-Streit slit-lamp microscope (model BQ-900) in 
comparison to standard photographic slides for nuclear opalescence, nuclear color, 
cortical and posterior subcapsular cataract. Retinal thickness of central 1 mm region 
was obtained from Spectralis OCT after pupil dilation. 
4.2.5 Assessment of Demographic, Lifestyle and Systemic Factors 
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All participants underwent a detailed interview using standardized 
questionnaires. Information on socio-demographic status, lifestyle risk factors (e.g. 
smoking, alcohol consumption), medication use and self-reported history of systemic 
disease were collected. Systolic and diastolic BP were measured using a digital 
automatic blood pressure monitor (Dinamap model Pro Series DP110X-RW, 100V2; 
GE Medical Systems Information Technologies, Inc., Milwaukee, WI), after subjects 
were seated for at least five minutes. BMI was calculated as body weight (in 
kilograms) divided by body height (in meters) squared. Smoking status was defined as 
those currently smoking, ex-smokers and non-smokers. The number of packs smoked 
per week was recorded. Nonfasting venous blood samples were analyzed at the 
National University Hospital Reference Laboratory for biochemical testing of serum 
total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, glycosylated 
haemoglobin (HbA1c), glucose and creatinine. 
4.2.6 Statistical Analyses 
Statistical analyses was performed using MedCalc version 12.3 (Medcalc 
Software, Ostend, Belgium) and SPSS version 20.0 (SPSS, Inc., Chicago, IL, USA).  
Intra-inter Grader Reliability Assessment: The intra-inter grader reliability in 
assessing CSI visibility was measured by weighted Kappa Statistics (Kw).
22
 Κw values 
of 0.81 – 1.00 indicate almost perfect agreement, values of 0.61 – 0.80 indicate good 
agreement and values of 0.41 to 0.60 indicate moderate agreement. Values of less 
than 0.40 indicate poor to fair agreement. The reliability of CT measurement in each 
score of CSI visibility was measured by the absolute agreement model of the intra-
class correlation coefficient (ICC).  ICC value of 0.81 – 1.00 indicates almost perfect 
agreement. Values of less than 0.40 indicate poor to fair agreement. 
 60 
 
Relationship of Ocular and Systemic Factors with CSI Visibility: Since the 
dependent variable (CSI visibility scores 0, 1 & 2) is ordinal in nature, we used 
ordinal regression for our analysis. Univariate and multiple ordinal regression analysis 
were performed to assess the ocular and systemic factors (independent variables) 
related to the CSI visibility (dependent variable). For multiple regression analysis, 
gender and factors which showed significant association in univariate analysis were 
included. The three groups (CSI visibility score 0, 1 & 2) were not evenly distributed. 
Thus, the Logit link function could not be used and instead complementary log-log 
(higher scores more probable) was used. However, this function could only determine 
the direction of the relationship between each predictor and the ordinal nature of 
categorical outcome. A p-value of < 0.05 was considered statistically significant. 
Right eye (n= 161) of each subject was selected for the analysis. However, when 
images of right eye was not available then left eye (n= 15) was used. 
 
4.3 RESULTS 
4.3.1 Participants’ Characteristics and Distribution of CSI Visibility Grades 
Table 4.1 shows the baseline characteristics and the distribution of CSI 
visibility grade of the study subjects. A total of 176 eyes from 176 subjects (85 men 
and 91 women) with a mean±SD (standard deviation) age of 60.44±8.19 years (range, 
48-86 years) were included in the study. The CSI was clearly identifiable (score 2) in 
59.1% (104/176 eyes), poorly defined (score 0) in 8.5 % (15/176 eyes) and was 
between clearly and poorly defined (score 1) in 32.4% (57/176 eyes) of our subjects.  
4.3.2 Intra- and Inter-grader Reliability Assessment 
Table 4.2 shows the intra and inter grader reliability assessment of CSI 
visibility. Both the intra and inter-observer reliability was moderate to good (Kw = 
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0.78, 95% CI: 0.70-0.85 and Kw = 0.74, 95% CI: 0.64-0.83 for intra and inter-
observer reliability respectively). 
The reliability of sub-foveal CT measurement was highest for CSI visibility 
score 2 (ICC = 0.977, 95% CI, 0.935 to 0.992) followed by score 1 (ICC = 0.734, 
95% CI, 0.585 to 0.940) and score 0 (ICC = 0.514, 95% CI, 0.058 to 0.853) 
respectively.  In addition, in our previously published paper,
23
 we have reported that 
both the intra-grader reliability (ICC: 0.87 to 0.94) and inter-grader reliability (ICC: 
0.90 to 0.93) for the CT measurement using Spectralis SD-OCT were excellent. 
4.3.3 Association of Ocular and Systemic Factors with Visibility of CSI 
Among the ocular factors, decreased AL (p = 0.006), thicker retinal (p<0.001) 
and choroidal (p=0.012) thicknesses were more likely to have lower CSI visibility 
score. Among other factors, young individuals (p = 0.003) and those with diabetes (p 
= 0.033) were associated with lower CSI visibility score. We did not observe any 
associations between CSI visibility with other factors for example gender, BMI, 
systolic and diastolic blood pressure, HDL and LDL cholesterol, blood creatinine, 
triglycerides, serum blood glucose level, HbA1c, smoking status, and hypertension ( 
all p>0.10) (Table 4.3). Factors with p<0.10 in the univariate analysis were further 
included into the multivariate analysis. However, because of collinearity between AL 
and spherical equivalent, only AL was selected and retained in the multivariate 
analysis. 
In the multivariate adjusted model, decreased AL (estimate of ordinal 
regression = 0.465, p = 0.003), thicker retinal thickness (estimate of ordinal regression 
= -0.030, p = 0.004), younger age (estimate of ordinal regression = 0.045, p = 0.030) 
and diabetes (estimate of ordinal regression = -0.746, p = 0.004) were significantly 
and independently associated with lower CSI visibility score (Table 4.4). In this 
 62 
 
sample, we found that 10.9% of younger people (age less than 60 years), 12.5% of 
those with thicker retinal thickness (≥ 280 µm), 11.8% of those with shorter AL (≤ 23 





In this study, we found that only 60% of subjects had well delineated CSI that 
allowed good visualization of the choroid, and the CT measurements had higher 
variability in the images with poor visualization of CSI. Moreover, we demonstrated 
that the visualization of CSI was poorer in eyes with shorter eye ball, thicker retinal 
thickness, and in younger persons and persons with diabetes. 
Correct identification and knowledge of factors determining CSI visibility is 
essential for the accuracy and performance of imaging programs that aim to 
automatically detect this anatomical structure. We found that younger age was 
associated with poorer identification of choroid scleral junction (Figure 4.2). Previous 
histologic studies have shown a decrease in vascular density, overall luminal area and 
diameter of chorio-capillary vessels with increase in age.
24-26 
This leads to a decrease 
in physiological functions of the choroid i.e. the ability of the choroid to provide 
sufficient levels of oxygen and other metabolites to the RPE and outer retina may 
decrease
11 
contributing to the onset of many diseases in elderly people. There is an 
increasing trend of data from other older adult studies which states that CT decreases 
with age.
27,28
 Thicker choroid in younger age would undergo more attenuation of 
incident light resulting in poor visualization of the CSI. Nevertheless, we did not find 
any significant association between CSI visibility score and CT in the multiple 
regression model (Table 4.4). Another possible explanation of poorer CSI visibility at 
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younger age is higher concentration of choroidal melanin pigments in young 
individuals, which tend to progressively decrease with advancing age.
29
 
In addition to age, persons with diabetes had poorer visibility of choroid-
scleral junction. There is inconsistency in literature in terms of choroidal blood flow, 
which is reported to decrease, increase and remain unchanged in patients with 
diabetes.
30-32
 However, many studies have demonstrated significant decrease in 
choroidal blood flow in diabetic patients, especially those with macular edema.
30, 33
 
However, in our cohort, none of the diabetic subjects had diabetic macular edema or 
intraretinal cystic changes. While comparing the retinal thickness in diabetics (259.15 
µm) and non-diabetics (262.12 µm), we found no significant difference (p = 0.402) in 
thickness. Thus, the reasons for diabetic people having poor CSI visibility are still 
unclear. We can only speculate that poor CSI visibility in diabetics might be 
associated with blood flow changes in choroid, but unfortunately, in our study we did 
not obtain any information pertaining to blood flow. An alternative explanation could 
be the hypereflectivity of incident light from the intraretinal fluid which can lead to a 
shadowing effect of the deeper layers resulting in poorer CSI visibility.
34
  
Another reason for diabetic subjects having poor CSI visibility could be the 
fact that diabetes leads to a faster development of cataract which in turn might be 
associated with poorer visibility of CSI. However, in a subgroup analysis in diabetic 
subjects with cataracts, we found no significant association between the presence of 
cataract and CSI visibility score (p = 0.074, chi-square test), indicating that the 
presence of cataract in diabetic subjects does not affect the visibility of CSI. In our 
study, we also found that thicker retinal thickness was associated with poorer CSI 
visibility. It is noted that there were no relationships between CSI visibility with most 
systemic factors such as BMI, blood pressure, cholesterol, glucose, and smoking. 
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Among the ocular factors, the visibility of CSI was influenced by AL. CSI was 
poorly distinct in eyes with shorter AL. Our results are compatible with histologic 
findings that in eyes with greater AL, the elongation of the eyeball leads to 
mechanical stretching and thinning of retina.
35, 36
 The excessive elongation affects not 
only the retina but also the choroid and Bruch membrane. There is found to be 
choroidal thinning in eyes with high myopia
8, 9, 27, 37
 due to significant thinning of the 
choriocapillaris and focal lack of vessels.
38-40
 The sclera is also weaker in myopes 
with a correlation between high myopes and scleral thinning found in human eyes.
41
 
The choroid adheres to the sclera because of the fixed position of the blood vessels 
passing through the sclera, and it is likely that the choroid is stretched in myopic 
eyes.
42
 This allows more penetration of light into the deep choroid giving greater 
resolution and potentially better specification of the posterior choroidal border. In 
addition, myopic subjects usually have less pigmented RPE which facilitates detection 
of the scleral interface.  
An important factor in standardizing CT measurements is the definition of the 
choroid-scleral junction. While most EDI-OCT studies, including the landmark 
Spaide et al. study, define the choroidal-scleral junction as the inner border of the 
sclera, a recent study by Yiu et al.
43
 reported the presence of a hyporeflective band 
likely corresponding to the suprachoroidal layer (SCL). However, it is often difficult 
to visualize SCL and in Yiu et al. study, SCL was visible in only 45% of their healthy 
Caucasian subjects. In contrast, in our cohort of healthy Asian subjects, we could not 
appreciate the presence of SCL and therefore, like majority of other EDI-OCT studies 
on CT assessment, we considered inner border of the sclera as posterior boundary of 
the choroid. A probable reason for invisible SCL in our subjects of Asian descent is 
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the presence of greater pigmentation in Asian eyes compared to Caucasians, thereby 
affecting the visibility of SCL. 
The strengths of this study include its unselected population based sample, 
standardized assessment of systemic and ocular factors, and laboratory investigations. 
Our study had some limitations. Although the location of the CSI on Spectralis 
images was determined qualitatively as the junction between posterior choroid and 
sclera, there was no reference standard to confirm where this structure is actually 
located in the eye. The study population only consisted of subjects of Malay ethnicity 
and the findings may vary in other racial groups. Further studies in other ethnic 
populations are thus warranted. Although we performed a 7 line scan but only the 
horizontal section passing through the center of the fovea was used to evaluate the 
CSI. It is ideal to assess intra-session repeatability. However, in this study we did not 
assess intra-session repeatability of the CSI visibility. Knowing that subject 
pigmentation might influence signal penetration thus affecting the visibility of CSI, it 
was not considered in our study. However, all our subjects were of Malay ethnicity 
having more or less similar pigmentation, therefore, there should be no impact of 
pigmentation on our results. Visualization of the choroidal scleral boundary may vary 
across different OCT modalities. However, this study only described the visibility of 
CSI using the Spectralis OCT. Lastly, even though we have explored series of ocular 
and systemic factors affecting CSI, reflectivity of the choroid might have influenced 
the visibility of CSI. 
 
4.5 CONCLUSIONS 
In summary, we found that only 60% of our images had well delineated CSI 
and the variability in the measurement of CT was higher in the images with poorly 
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defined CSI. The factors associated with poorer CSI visibility are younger age, shorter 
AL, thicker retinal thickness and diabetes. The CSI visibility is critical for accurate 
determination of CT which can help clinicians evaluate choroioretinal disorders such 
as age related macular degeneration, central serous chorioretinopathy as well as 
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CHAPTER IV TABLES 
 
Table 4.1 A summary of subjects’ demographics, ocular parameters and systemic 
factors 
 
 Included (n =176) 
Age, yrs 60.44 (8.19) 
Gender, % male 48.3 
Spherical equivalent, D 0.03 (2.03) 
Best corrected visual acuity, logMAR 0.13 (0.10) 
Axial length, mm 23.62 (1.07) 
Anterior chamber depth, mm 3.22 (.35) 
Corneal curvature, mm 7.45 (1.19) 
Intraocular pressure, mmHg 14.90 (2.94) 
Central corneal thickness, μm 541.15 (35.68) 
LOCS III nuclear cataract, % 35 (19.9) 
LOCS III cortical, % 56 (38.8) 
LOCS III PSC, % 8 (4.5) 
Retinal thickness, μm 261.25 (21.17) 
Subfoveal choroidal thickness, μm 244.36 (95.31) 
OCT signal strength  30.56 (5.08) 
Systolic blood pressure, mmHg 137.23 (19.50) 
Body mass index, kg/m
2
 77.52 (9.84) 
Current smoking, % 36 (20.05) 
Diabetes Mellitus, % 51 (29.0) 
Hypertension, % 74 (42.0) 
Visibility Grade  
Grade 0 15 (8.5) 
Grade 1 57 (32.4) 
Grade 2 104 (59.1) 
Data are means (SD), except for gender, cataracts, HbA1c, current smoking, diabetes 
hypertension and visibility grades which are expressed as number (%).
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Inter-grader  Intra-grader  
Score 0 Score  1 Score  2 Total Score 0 Score  1 Score  2 Total 
Score 0 12 4 1 17 8 10 0 18 
Score 1 5 35 12 52 3 39 13 55 
Score 2 1 10 96 107 0 10 93 103 
Total 18 49 109 176 11 59 106 176 

















Table 4.3 Univariate analysis between ocular and systemic factors (independent 
variables) with visibility of choroidal scleral interface (dependent variable) 
 
                         Choroid Scleral Interface Visibility 








Ocular factors     
Axial length (mm) 0.375 0.006 0.106 0.645 
Spherical equivalent (D) -0.143 0.054 -2.88 0.003 
Anterior chamber depth (mm) -0.290 0.383 -0.942 0.362 
Central corneal thickness (μm) 0.004 0.229 -0.003 0.011 
Corneal curvature (mm) 0.104 0.197 -0.054 0.262 
Intraocular pressure (mmHg) 0.021 0.605 -0.059 0.101 
LOCS III nuclear cataract (no vs. yes) -0.683 0.056 -1.382 0.017 
LOCS III cortical (no vs. yes) 0.011 0.966 -0.487 0.509 
LOCS III PSC (no vs. yes) 0.546 0.261 -0.406 1.498 
Retinal thickness (μm) -0.034 <0.001 -0.052 -0.016 
Subfoveal choroidal thickness (μm) -0.003 0.012 -0.006 -0.001 
OCT signal strength  0.022 0.352 -0.024 0.068 
Systemic factors     
Age (yrs) 0.048 0.003 0.016 0.080 
Diabetes Mellitus (yes vs. no) -0.524 0.033 -1.006 -0.042 
 Bolded font indicates statistical significance. 
*Given the ordinal nature of dependent variable (visibility of CSI), p-values are based on 




Table 4.4 Multivariate analysis of ocular and systemic factors (independent variables) 
with visibility of choroidal scleral interface (dependent variable) 
 
              Choroid Scleral Interface Visibility 
  95% Confidence 
Interval 






Axial length (mm) 0.465 0.003 0.160 0.771 
LOCS III nuclear cataract (no vs. yes) -0.104 0.795 -0.891 0.683 
Age (yrs) 0.045 0.030 0.004 0.086 
Retinal thickness (μm) -0.030 0.004 -0.050 -0.009 
Subfoveal choroidal thickness (μm) -0.002 0.278 -0.005 0.001 
Gender (male vs. female) 0.218 0.413 -0.304 0.740 
Diabetes Mellitus (yes vs. no) -0.746 0.004 -1.256 -0.236 
Bolded font indicates statistical significance. 
*Given the ordinal nature of dependent variable (visibility of CSI), p-values are based on 
















CHAPTER IV FIGURES 
 
Figure 4.1 The choroidal-scleral interface (CSI) is indicated by hyper-reflective line 
shown by arrowheads. Panel (A) demonstrates an example of a well-defined CSI, 
Panel (B) shows a moderately defined CSI and Panel (C) a poorly defined CSI in 







Figure 4.2 Comparison of CSI visibility between EDI-OCT scans in two subjects of 
different ages. (A) A 46-year-old male with poorly demarcated CSI (subfoveal 
choroidal thickness of 326 µm). (B) An 83-year-old man with CSI distinctly visible 






Figure 4.3 Comparison of CSI visibility between EDI-OCT scans in two subjects 
according to refractive status. (A) A 46-year-old male with no refractive error 
(AL=23.41) and a poorly demarcated CSI (subfoveal choroidal thickness of 275 µm). 
(B) A 46-year-old male with myopia (AL=29.57) with a well-defined CSI (subfoveal 





















ENHANCEMENT OF CHOROID-SCLERAL INTERFACE VISIBILITY 
USING THE SEMI-AUTOMATED TECHNIQUE OF ADAPTIVE 
COMPENSATION  
 
In chapter IV we found that 40% of our EDI-OCT macular images had poorly 
defined CSI and the variability in the measurement of CT was higher in the images 
with poorly defined CSI. The results from Chapter IV confirms that clearly visible 
CSI leads to better delineation of choroidal boundaries in turn leading to accurate 
measurement of CT. Therefore, in this Chapter we made an attempt to enhance the 
visibility of macular CSI by employing a novel semi-automated technique of 
“adaptive compensation”.  
We observed that compared to macular scans, the visibility of CSI in 
peripapillary scans were generally very good. In a sample of 100 randomly selected 
peripapillary scans, nearly all the images had CSI visibility of grade 1 and above. 
Therefore, we did not proceed further to categorize our peripapillary images into 3 
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The choroid is important to support retinal and visual function as it supplies 
nutrients and oxygen to RPE cells and photoreceptors.
1
 Therefore, the choroid may 









 disease and myopic macular 
degeneration.
9-12
 To elucidate the mechanisms through which the choroid affects these 
retinal diseases, quantitative assessment of choroidal characteristics such as CT is 
required. 
However, it was not trivial to image CT because of its posterior location and 
pigments in the RPE layer,
13
 until the advent of SD-OCT with EDI. EDI SD-OCT has 
provided many new insights into choroidal qualitative morphology. However, to date 
a notable disparity exists between the CT measurements obtained in different studies. 
Such variations could be due to unavailability of a standardized and simple to use 
measurement method and absence of built-in automated software to measure CT in 
most of the commercially available OCT machines.
14
 At present, most of the studies 
perform the measurements manually by using the in-built caliper system provided by 
the machine, which is prone to measurement errors. The manual method is also time- 
and effort-consuming, making it unfeasible especially when dealing with large 
population data. 
As a result, while many studies have published the distribution of CT in 
patients with retinal diseases and normal controls,
15-19
 none of these studies have 
clearly described the method used in detailed to measure CT. Therefore, the reliability 
of the CT measurement methods in most of the papers is unknown. In this paper, we 
describe a simple, semi-automated, time-efficient method to measure CT using 
images acquired by EDI SD-OCT and available compensation algorithms. We aimed 
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to assess the reliability of this new CT measurement technique in a sample of healthy 
eyes.  
 
5.2 MATERIALS AND METHODS 
5.2.1 Study Subjects and Design 
Data for this analysis were derived from the SiMES, a population-based cross-
sectional study of eye diseases in Malay adults, age ranged from 40-80 years living in 
Singapore. Details of the study design, sampling plan, and methodology have been 
described in Chapter III and previously elsewhere.
20
 In brief, participants recruited in 
the current study underwent standardized and detailed ophthalmic examination, 
including Spectralis EDI SD-OCT imaging (see next section). The study was 
approved by the Institutional Review Board of SERI. It followed the tenants of the 
Declaration of Helsinki and written informed consent was obtained from the subjects 
after explanation of the nature and possible consequences of the study. 
5.2.2 Inclusion and Exclusion Criteria 
Spectralis images of 31 subjects were randomly selected using a random 
number generated in Stata (College par, Texas, USA). Choroidal images were only 
selected from right eye of each subject as our measurement technique can be applied 
uniformly between right and left eyes. Therefore only the right eyes of the subjects 
were evaluated. In addition, selecting only one eye from individuals would help to 
avoid inter-eye correlation issue in statistical analysis. “Normal fundus” was defined 
as free of any macular or vitroretinal diseases on the basis of clinical fundus 
examination by experienced Ophthalmologist and the results of OCT imaging.  
Exclusion criteria for the normal participants included: best corrected 
LogMAR VA >0.3, evidence of macular or vitroretinal diseases, previous retinal or 
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refractive surgery, past history of intraocular surgery, or clinical features compatible 
with a diagnosis of glaucoma suspect or glaucoma. 
 
5.2.3 Intra-grader and Inter-grader Reliability Assessment 
To evaluate the intra-grader and inter-grader reliability, 31 Spectralis images 
were randomly selected for the initial grading phase. Grader A and grader B, masked 
to subject characteristics and clinical diagnosis, independently graded these images to 
assess inter-grader reliability of CT measurements. In addition, grader A repeated the 
measurements after 2 weeks to assess intra-grader reliability. Both graders assessed 
the same sets of training images before commencing the grading task. 
5.2.4 EDI SD-OCT Imaging  
CT was obtained using Spectralis SD-OCT (Wavelength: 870 nm; Heidelberg 
Engineering, Heidelberg, Germany) with EDI modality as specified in details in 
Chapter III.  A single experienced examiner masked to the clinical diagnosis of the 
subject performed the EDI-OCT examination. Only the horizontal section passing 
through the center of the fovea was selected for analysis and for each subject their 
right eye was chosen for subsequent analysis. 
5.2.5 Measurement of Choroidal Thickness 
The two major steps in our CT semi-automatic measurement protocol are: (A) 
post processing of images by adaptive compensation technique and (B) quantitative 
measurement of CT using Photoshop software. On average, measurement of CT at 
multiple locations (1.5 and 3 mm nasal and temporal to the fovea) requires 
approximately 1 minute per image. 
(A) Adaptive Compensation Technique 
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An accurate evaluation of the CT with EDI-OCT mainly relies on how well 
one can delineate the CSI, which anatomically represents the junction between the 
choroid and the sclera, and is a principal landmark for quantitative measurements of 
choroid. However, at present identification of CSI is highly variable as there is no 
algorithm available in Spectralis for its automatic detection. Therefore, in order to 
accurately determine CT, once the EDI-OCT image was obtained, the CSI was 
enhanced using a novel post-processing adaptive compensation algorithm
21
 which 
greatly improved the detection of CSI by correcting the deleterious effects of light 
attenuation.  
An adaptive compensation algorithm was developed to over a limitation of 
standard compensation algorithm that is the overamplification of noise at high depth. 
Such limitation currently hampers the ability to distinguish the posterior CSI 
boundary. In adaptive compensation, standard compensation operations are performed 
until an energy threshold is reached, at which stage the compensation process is 
stopped to limit noise overamplification in the deeper portion of OCT image.
21
 With 
the above modification adaptive compensation provided significant improvement in 
visibility of posterior boundary compared to standard compensation. In brief, this 
novel adaptive compensation algorithm improved the ability to detect and visualize 
the CSI. First, it removes noise over-amplification at high depth and shadow artifacts 
casted by blood vessels (thus decreasing the intra-layer contrast of the choroid). 
Second, it improves the visibility of posterior choroid boundary, by significantly 
increasing the inter-layer contrast across the CSI (Figure 5.1). 
(B) Measurement of CT using Photoshop Software  
The enhanced images were measured in Photoshop CS6 extended (Adobe 
Systems Incorporated, San Jose, California). CT at sub-foveal, 1.5 mm and 3 mm 
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nasal and temporal from the fovea were measured. Figure 5.2 shows a flow diagram 
summarizing the CT measurement protocol. The detailed explanation of the steps 
involved in quantification of CT measurement using Photoshop is as below: 
Set the Foveal Reference Line: firstly we opened the image from the file menu, then 
go the View menu and click on new guides options (Figure 5.3 A). In the following 
window, change the guide orientation to vertical and set the position of the guide and 
click ok (Figure 5.3 B), a reference line is generated (C). 
Place the Measurement Grid: we used a grid to indicate accurately our measurement 
points (sub-fovea, 1.5 and 3 mm nasal and temporal to the fovea) and placed it such 
that the central point on the grid coincides with the reference line (Figure 5.4). 
Set the Measurement Scale: select Analysis > Set Measurement Scale > Custom to 
open the Measurement Scale dialog box (Figure 5.5 A). Enter the Logical Length and 
Logical Units that one want to set equal to the Pixel Length. For example, in our case 
the Pixel Length is 1, and we want to set a scale of 0.0039 mm per pixel, enter 0.0039 
for Logical Length, and millimeter for the Logical Units. Click OK in the 
Measurement Scale dialog box to set the measurement scale on the document (Figure 
5.5 B). Choose File > Save to save the current measurement scale setting with the 
document. 
Perform Measurement: choose Analysis> Ruler Tool, or Click the Ruler tool in the 
toolbox (left hand corner), then use the tool to measure the length of the image. Click 
at the starting location for the measuring line and drag to the end location. Release the 
mouse button to create the measurement line (Figure 5.6).  
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Display and Export the Measurement Log Data: choose Analysis> Record 
Measurements, or Click Record Measurements in the Measurement Log panel. Each 
row in the log represents a measurement set; columns represent the data points in a 
measurement set (Figure 5.7A). One can reorder columns in the log, sort data in the 
columns, delete rows or columns, or export data from the log to a comma delimited 
text file. Export data from the Measurement Log into a comma-delimited text file 
(Figure 5.7 B). One can open the text file in a spreadsheet application and perform 
statistical or analytical calculations from the measurement data.  
a. Select one or more rows of data in the log. 
b. Choose Export from the Measurement Log options menu or click the Export 
icon at the top of the panel or right-click in a row, then select Export from the 
pop-up menu. 
c. Enter a filename and location, and click Save.  
The measurements are exported to a comma-delimited, UTF‑8 text file. 
5.2.6 Statistical Analyses 
Statistical analysis was performed using MedCalc Version 12.6 (MedCalc 
Software, Ostend, Belgium) and SPSS Version 20.0 (SPSS, Inc., Chicago, IL, USA). 
Shapiro-Wilk tests were used to check the normality of CT data at various locations.  
Reliability Assessment of CT: The reliability of the CT measurement was assessed 
using intra- and inter-grader agreements between two independent graders, measured 
by the absolute agreement model of the intra-class correlation coefficient (ICC).
22
 
ICC value of 0.81 – 1.00 indicates almost perfect agreement. Values of less than 0.40 
indicate poor to fair agreement. Bland Altman plot analyses
23, 24
 were performed to 
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see if there is any proportional bias between measurements. A two-tailed paired 
sample t-test was used to analyze differences between means in CT by location. 
 
5.3 RESULTS 
5.3.1 Baseline Characteristics and CT Measurements 
Images from 31 eyes of 31 participants (aged 64.4 ± 7.4 years) were included 
in the analysis (Table 5.1). The mean (standard deviation) sub-foveal CT in this study 




 measurements of grader A). CT 
measured by the two graders is summarized in Table 5.2. The mean sub-foveal CT 
measured by grader A for the 1st and 2
nd
 measurements was 229.74 (65.12) µm and 
231 (69.14) µm, respectively, and was 232.19 (67.89) µm by grader B.  
 
5.3.2 Intra- and Inter-grader Agreements using Adaptive and Conventional 
Techniques 
Using adaptive compensation both the intra-grader reliability (ICC: 0.95 to 
0.97) and inter-grader reliability (ICC: 0.93 to 0.97) were perfect for all five locations 
of CT (Table 5.3). However, with the conventional technique of manual CT 
measurements using built-in callipers provided with the Heidelberg explorer software, 
the intra- (ICC: 0.87 to 0.94) and inter-grader reliability (ICC: 0.90 to 0.93) for all the 
measured locations is lower (Table 5.4). Using adaptive compensation, the Bland 
Altman analysis of intra-grader reliability for sub-foveal CT measurement showed 
95% LOA of -33.3 to 30.8 with a mean difference of -1.3 µm (Figure 5.8). No 
significant systemic (except at nasal 3 mm, p = 0.003) and proportional bias was 
detected in intra-grader CT measurements at all locations. The Bland Altman analysis 
of inter-grader reliability for sub-foveal CT measurement showed 95% LOA of -36.6 
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to 34.2 with a mean difference of -1.2 µm (Figure 5.9). No significant proportional 
bias was observed in the inter-grader CT measurements at all locations. Nonetheless, 
a significant systemic bias at both 1.5 and 3 mm nasal locations was found in the 
inter-grader CT measurement comparison (p = 0.001). However, this could be due to 
thinnest CT at nasal locations, making it more prone to systemic bias in CT 
measurements.  
 
5.3.3 Intra- and Inter-layer Contrast Measurement 
In addition, the choroid intra-layer contrast (a measure of shadow presence 
when high) and the CSI inter-layer contrast (a measure of boundary visibility when 
high) were computed for all images (n = 31) before and after applying adaptive 
compensation (as in 
25
). We found that the intra-layer contrast significantly decreased 
from 0.84 ± 0.07 to 0.60 ± 0.07 (p < 0.001; t-test), whereas the inter-layer contrast 
significantly increased from 0.50 ± 0.14 to 0.90 ± 0.10 (p < 0.001; paired t-test) after 
applying adaptive compensation (Table 5). 
 
5.4 DISCUSSION 
Despite significant advances in imaging technology there are considerable 
variations in CT measurements across clinical studies. In this report, we described a 
simple, semi-automated method using adaptive compensation to measure CT from 
images acquired by EDI SD-OCT. The results showed that the method permits a 
highly reproducible tool for assessing CT from EDI SD-OCT images. Our 
measurement method is also simple and requires little time to perform (on average ~ 1 
minute per image). With these features, our method may have great potential for use 
in both clinical and population-based studies which involve large number of images. 
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There are considerable differences in CT measurements across studies. Even 
though advances in OCT technology have reduced acquisition time, adequate 
visualization of choroid is still lacking. There are several challenges in imaging the 
choroid. First, the choroid is located behind the RPE and Bruch’s membrane, making 
it less accessible than the retina and more difficult to be visualized. Second, the 
pigmentation in the RPE and the choroid itself decreases the signal intensity. Lastly, 
unlike retinal imaging,
26
 wherein the RPE and internal limiting membrane are thin 
and clearly identifiable, the transition zone between the choroid and sclera (i.e. CSI) 
has blurred border and is broader, making CSI difficult to identify. 
However, it is not always easy to distinguish CSI on acquired images, which 
may be related to scan quality or anatomic variation. Some choroidal scans have a 
distinct hypo-reflective line corresponding to the supra-choroidal space, but often this 
line can be indistinct leading to measurement error.
27
 At present, identification of CSI 
is highly variable. To overcome these challenges, in this study we enhanced 
choroidal-scleral junction using a post-processing adaptive compensation algorithm.
21 
Measurement of CT was performed in the post-processed images using Photoshop 
(Adobe Systems Incorporated, San Jose, California), a readily available and easy-to-
use program.  
Adaptive compensation provides two major improvements. First, the intra-
layer contrast (of the choroid) significantly decreased after applying adaptive 
compensation, indicating successful shadow correction within the choroid. Second, 
the inter-layer contrast (across the CSI) significantly increased after applying adaptive 
compensation, indicating better visualization of CSI and therefore allowing for 
precise measurement of CT. These results are consistent with a previous study on 
standard compensation
25
 and indicate significant improvements in image quality. 
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Also, a study by Lin et al. established outer choroidal contrast as a valid quantifiable 
measure of choroidal image quality and demonstrated that inverted SD-OCT imaging 




With improved intra- and inter-layer contrast, the compensated images are 
likely more accurate than the non-compensated images as the deleterious effects of 
OCT light attenuation have been corrected, thus making the CSI more visible. The 
post-compensation images are more representative of the eye tissue architecture, since 
better estimates of the ocular tissues optical properties (e.g. reflectivity) are provided. 
This has been formally demonstrated in the original article by Girard et al.,
25
 and in 
the following studies.
21, 29, 30
 Lastly, although adaptive compensation is useful in all 
images, it is likely to be more useful when the CSI is poorly visible, e.g. in images 
where light attenuation is strong (Figure 5.1), emphasizing further the need for 
compensation for more accurate thickness measurement of the choroid. 
Adaptive compensation achieves high intra-grader (ICC: 0.95 to 0.97) and 
inter-grader (ICC: 0.93 to 0.97) repeatability in CT measurements compared to 
conventional method (intra-grader ICC: 0.87 to 0.94, inter-grader ICC: 0.90 to 0.93), 
suggesting the use of adaptive compensation to improve the visualization of CSI and 
to obtain more reliable CT measurements. However, the high repeatability can be 
explained by the standardization and strict adherence to a rigorous grading protocol in 
the present study. In addition, both graders underwent the same training set for 
standardization purpose before embarking on the actual grading task. The present 
results are in line in the studies by Ikuno et al.
31
 and Yamashita et al.
32
 who reported 
an inter-grader ICC of 0.97 and 0.94, respectively, for sub-foveal CT measurements. 
However, in these two previous studies the intra-grader repeatability was not 
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evaluated, and it is not clear how the choroid images, where CSI could not be clearly 
visualized, were processed. 
But the present study has its own limitations, as the measurement of CT was 
subjective in nature, and was therefore subject to measurement bias. However, our 
method may be less prone to observer error because the CSI was enhanced by 
adaptive compensation to give better visibility. An automated, and thus may be more 
objective, method of measuring CT would be of potential interest to facilitate, speed-
up such analyses. 
There are few recent studies on automatic choroidal segmentation in OCT 
images. Zhang et al. proposed an automatic segmentation algorithm for the choroidal 
vessels using Cirrus OCT in 24 normal subjects. But their aim was to quantify 
choroidal vasculature thickness and choroicapillaries equivalent thickness rather than 
the CT 
33
. Likewise, Torzicky et al.
34
 and Duan et al.
35
 developed the automatic 
algorithms to detect the boundary between the choroid and sclera based on 
polarization sensitive OCT which are not commercially available. Although, Tian et 
al.
36
 in 2013 proposed an automatic algorithm that could segment choroid in 
commercially available Spectralis OCT, but their algorithm was tested only on 20 
EDI OCT images and need to be validated on more images to prove the robustness of 
algorithm before its application in clinical studies. While we are preparing the 
manuscript, a commercially available CT measurement algorithm in swept-source 
OCT (Topcon Corp., Tokyo, Japan) is being made available. However, in view of 
lack of supporting agreement studies on the algorithm and manual choroidal 
segmentation (in both normal and diseased eyes), the accuracy and reliability of 
automated CT analysis by using swept-source OCT is yet to be established for use in 





In conclusion, we described a simplified, semi-automated and practical 
method “adaptive compensation followed by using Photoshop” that gives excellent 
intra- and inter-grader reliability (ICC>0.93) to quantify CT in the EDI SD-OCT 
images. This method has great potential usage in both clinical and population based 
studies, as reliable and accurate measurements of CT from EDI-OCT images are 
essential in distinguishing clinically significant change of CT and assisting in risk-
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CHAPTER V TABLES 
 
 
Table 5.1 Baseline characteristics of study subjects 
 
Characteristics Mean (SD) 
Age, years 64.35 (7.42) 
Gender, male 11 (35.48) 
Axial length, mm 23.33 (0.88) 
Average choroidal thickness,* µm  
Sub-foveal  230.37 (66.66) 
Nasal, 1.5 mm  214.33 (74.34) 
Nasal, 3 mm  185.77 (69.96) 
Temporal, 1.5 mm 224.53 (57.27) 
Temporal, 3 mm 229.74 (52.03) 
 Data are expressed as mean (SD) except for gender, which is expressed as number (%).  
 *The average of 1st and 2nd measurement of Grader A.  
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Table 5.2 Summary of choroidal thickness measurements at various locations 
 










Sub-foveal  229.74 (65.12) 231.00(69.14) 232.19 (67.89) 
Nasal, 1.5 mm  213.84 (75.12) 214.84(75.49) 221.52(76.08) 
Nasal, 3 mm   191.13 (72.79) 180.42(68.25) 187.55(71.06) 
Temporal, 1.5 mm 223.94 (56.33) 225.13(59.24) 231.65 (60.82) 
Temporal, 3 mm 228.68 (50.64) 230.81(54.57) 230.71 (53.80) 
  Data are mean (SD).  
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Table 5.3 Intra- and inter-grader agreements for the choroidal thickness measurement at 5 horizontal locations using adaptive 
compensation 
 
     Assessment of proportional bias
d
 
 Locations, CT 
measurement 













Sub-foveal  0.97 (0.94 to 0.98) -1.3 (-33.3 to 30.8) 0.672 0.248 0.179 
Nasal, 1.5 mm  0.95 (0.90 to 0.97) -1.0 (-48.0 to 46.0) 0.818 -0.160 0.933 
Nasal, 3 mm   0.95 (0.87 to 0.98) 10.7 (-25.3 to 46.7) 0.003 0.249 0.176 
Temporal, 1.5 mm 0.96 (0.92 to 0.98) -1.2 (-31.9 to 29.5) 0.674 -0.187 0.313 





Sub-foveal  0.96 (0.93 to 0.98) -1.2 (-36.6 to 34.2) 0.715 0.070 0.708 
Nasal, 1.5 mm  0.97 (0.92 to 0.99) -9.0 (-34.4 to 16.4) 0.001 -0.127 0.495 
Nasal, 3 mm   0.97 (0.89 to 0.98) -9.8 (-37.4 to 17.8) 0.001 -0.230 0.212 
Temporal, 1.5 mm 0.93 (0.86 to 0.96) -6.5 (-48.3 to 35.3) 0.099 -0.075 0.687 
Temporal, 3 mm 0.94 (0.88 to 0.97) 0.1 (-35.5 to 35.7) 0.977 0.043 0.818 
LOA, Limits of Agreement; ICC, Intraclass Correlation Coefficient; CI, Confidence Interval. 
a
Mean difference was determined from the1
st
time measurement minus the 2
nd
time measurement.  
b
Mean difference was determined from Grader A measurement minus Grader B measurement. 
c
P value of one sample t-tests (comparing between mean difference and zero value) to indicate presence of systemic bias 
dUsing Pearson’s correlation coefficients of regression line  
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Table 5.4 Intra- and inter-grader agreements for the choroidal thickness measurement 












Sub-foveal  0.94 (0.87 to 0.97) 9.7 (-30.3 to 49.7) 
Nasal, 1.5 mm  0.92 (0.85 to 0.96) 2.9 (-41.1 to 54.9) 
Nasal, 3 mm   0.92 (0.85 to 0.96) 4.1 (-36.1 to 44.3) 
Temporal, 1.5 mm 0.87 (0.75 to 0.93) -7.0 (-52.1 to 38.1) 





Sub-foveal  0.90 (0.60 to 0.96) -19.1 (-63.7 to 25.6) 
Nasal, 1.5 mm  0.93 (0.68 to 0.97) 18.3 (-59.7 to 23.2) 
Nasal, 3 mm   0.91 (0.67 to 0.96) -15 (-54.3 to 24.3) 
Temporal, 1.5 mm 0.91 (0.72 to 0.96) -12.7 (-49.8 to 24.4) 
Temporal, 3 mm 0.90 (0.58 to 0.96) -15.7 (-51.3 to 19.9) 
CT, Choroidal Thickness; LOA, Limits of Agreement; ICC, Intraclass Correlation 
Coefficient; CI, Confidence Interval. 
a
Mean difference was determined from the1
st









Table 5.5 Intra- and inter-layer contrast (n = 31 subjects) 
 
 Mean (SD) P-Value 
Intra-layer Contrast Standard (without compensation) 0.84 (0.07)  
<0.001 
Adaptive Compensation 0.60 (0.07) 
Inter-layer Contrast Standard (without compensation) 0.50 (0.14)  
<0.001 
Adaptive Compensation 0.90 (0.10) 
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CHAPTER V FIGURES 
Figure 5.1 Illustration of the raw versus the compensated image. (A) Raw OCT 
image of a healthy subject. The choroid-scleral interface is only partially visible. Note 
the presence of blood vessels shadows as indicated by red asterisks. (B) Adaptive 
compensation was applied to the raw image in order to remove blood vessels 












Post-processing of images by 
Adaptive Compensation 
Technique 
Processed images quantified 
for CT measurement using 
Photoshop 
Set the measurement scale: 
1. The raw measured values 
from Photoshop are 
expressed in pixels  
2. Absolute values conversion 
(to mm) done by taking into 
account the scale factors 
(mm/pixel) 
Spectralis EDI OCT images Set the foveal reference Line 
Place the measurement grid 
with measurement locations 
marked 
Select Ruler Tool in tool box 
and measure length of the 
image  
Record the measurement and 




Detailed steps to quantify choroidal thickness using Photoshop 
 
Figure 5.3 Setting of the foveal reference line. Open the image from the file menu, go 
the view menu and click on new guides options (A). Change the guide orientation to 












Figure 5.4 Placement of measurement such that the central point on the grid coincides 





Figure 5.5 Setting of the measurement scale. Select Analysis > Set Measurement Scale 
> Custom to open the measurement scale dialog box (A). Convert the values to 



















Figure 5.7 Displays recording of the measurements (A) and exporting of the 














Figure 5.8 Bland Altman plot of intra-grader reliability of sub-foveal choroidal 
thickness (CT) measurement. The difference was calculated by the 1st measurement 
minus the 2nd measurement. Pink dashed line represents regression line of difference 





Intra-Grader Reliability for Sub-foveal CT Measurement




















































Figure 5.9 Bland Altman plots of inter-grader reliability of sub-foveal choroidal 
thickness (CT) measurement. The difference was calculated by the grader A 
measurement minus the grader B measurement. Pink dashed line represents regression 











Inter-Grader Reliability for Sub-foveal CT Measurement


















































FULLY AUTOMATED CHOROIDAL IMAGE PROCESSING TECHNIQUE 
TO OVERCOME THE LIMITATIONS OF SEMI-AUTOMATED 
TECHNIQUE 
 
In chapter V, although we have successfully enhanced the visibility of macular 
CSI by using novel semi-automated technique of adaptive compensation and our 
technique was less prone to observer error because the CSI was augmented to give 
better visibility. But the marking of CSI and measurements of CT were performed 
manually and thus our semi-automated technique is still subject to measurement 
errors, limiting its clinical utility. In addition, manual method is also time- and effort-
consuming, making it unfeasible especially when dealing with large population data.  
Therefore, in order to overcome the limitations of semi-automated technique, 
in this Chapter, we developed and evaluated novel fully automated choroidal image 
processing technique which can objectively and accurately define the CSI and 
objectively measure CT as well as choroidal volume at both macular and peripapillary 
regions. The measurements obtained by our fully automated choroidal image 






Although the use of EDI in SD-OCT has now allowed better visualization of 
the choroidal structures,
1
 the quantification of CT for evaluating chorioretinal diseases 
is mostly performed manually and often restricted to one or few points around the 
foveal center.
2-9 
This is due to unavailability of automated choroidal segmentation 
software, because of which previous investigators have used manual (mostly single 
point) measurement technique using in-built calipers to evaluate CT.
7, 10-12
 However, 
measurements of a few sampling points are influenced by focal thickening or thinning 
of the choroid,
13, 14
 or by irregularity of the inner chorio-scleral border,
2, 5
 and thus 
highly dependent on location of measurements. In addition, manual methods are 
further subject to intra- and inter-observer variation. Given the high anatomic 
variability of choroid, these are impractical for clinical use and epidemiological 
research involving large samples, which makes the measurements tedious and time- 
consuming. Thus, an objective and comprehensive assessment of the choroid, such as 
CT maps and volumetric analysis, is required but is still unavailable.  
A few studies
 
have calculated choroidal volume using the built-in software. 
However, the segmentation of the CSI is still done manually. For EDI SD-OCT to 
become a clinically practical tool to determine CT, an automatic and accurate 
measurement algorithm must be developed.  
In this study we developed and evaluated novel fully automated choroidal 
image processing technique which can objectively and accurately define the CSI and 
objectively measure CT as well as choroidal volume at both macular and peripapillary 
regions. The measurements obtained by our fully automated choroidal image 





6.2.1 Study Subjects 
For this analysis we randomly selected (using Strata random number 
generator) 45 subjects from SiMES-2 (2011 – 2013), a comprehensive detailed 
population-based cohort study of the Singaporean Malay adults aged 45-85 years.
15
 
Each subject underwent standardized and detailed ophthalmic examination, including 
choroidal imaging at macular and optic nerve head region. 
 
6.2.2 Choroidal Image Acquisition Protocol at Macular and Peripapillary 
Regions 
Choroid was imaged using SD-OCT (Spectralis, Heidelberg Engineering, 
Heidelberg, Germany) with EDI modality after pupil dilation. The detailed choroidal 
image acquisition protocol for both macular and peripapillary regions have been 
described in Chapter III of the thesis and elsewhere.
16, 17
 
 All OCT scans were acquired by a single examiner (PG), who is experienced 
at performing scans using EDI-Spectralis. After each capture, each of the B-scans was 
scrutinized manually in each eye by the same examiner, and images of insufficient 
quality (quality index of < 18 decibels for Spectralis OCT as suggested by the 
manufacturer for the image quality assurance) were excluded.  
6.2.3 Automated Detection of CSI 
The changes between choroidal tissue structures create distinct valleys in the 
OCT A-scans and hence we can delineate CSI as the smooth curve formed by “valley 
pixels”. In our method, valley pixels are defined as the local minima of A-scans and 
are used as the feature to detect the CSI. However, the valley pixels are also caused by 
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the speckle noise and the blood vessels in the choroid as shown in Figure 6.1. So in 
order to distinguish the valley pixels caused by CSI from the ones caused by speckle 
noise and blood vessels, we assume that the CSI is a continuous and smooth curve, 
the valley pixels caused by it are close to one another and can be connected to form a 
smooth path between valley pixels on both ends of the image. On the other hand, the 
valley pixels caused by the speckle noise appears randomly located and the ones 
caused by blood vessels in the choroid region form short layer segments, which means 
that the smooth path cannot be formed by these valley pixels as illustrated in Figure 
6.1. 
6.2.4 Automated Measurements of Choroidal Thickness and Volume  
The CT at each location was defined as the distance between the Bruch’s 
membrane (lower boundary of RPE) and the CSI. In this study, Bruch’s membrane 
and CSI were delineated with our newly developed automated choroidal image 
processing technique.  
For macular CT, from the 7 serial horizontal B-scans, the scan passing through 
the fovea was selected by an experienced examiner (PG) and the center of fovea was 
detected as the lowest points of internal limiting membrane automatically. The CT 
profile at the fovea and at 500-µm intervals up to 3 mm temporal and nasal to the 
fovea in horizontal section (Figure 6.2), was then automatically measured and 
created. Figure 6.3 shows an example of EDI SD-OCT scan of the macula with the 
automated segmentation lines. Furthermore, the choroidal volume of 7 horizontal B-
scans (covering a rectangular region of 8.9 mm x 1.5 mm centered on the fovea) of 
the region {(x,y)| −3mm < x < 3mm, 720𝜇𝑚<y< 720𝜇𝑚} was calculated with the 
automatically detected fovea as the center of origin, (0,0) and the measurement points 
between lines were measured with linear interpolation as illustrated in Figure 6.4. In 
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addition, choroidal volume of 1mm diameter circle at fovea and thickness maps were 
obtained for each subject. 
Likewise, CT (as defined above) in the optic disk region was objectively 
measured by the automated segmentation software at 12 discrete locations (30
o
 apart) 
and at 4 quadrants: superior, nasal, inferior and temporal (Figure 6.5). Figure 6.6 
demonstrates automated peripapillary CT profile measured in the optic disc region.  
6.2.5 Agreement and Repeatability of Automated Choroidal Measurements 
We evaluated the agreement of automated CT measurements against the 
manual measurements of CT (ground truth) obtained using in-built calipers of 
Spectralis OCT in 45 randomly selected subjects at both macular and peripapillary 
regions.  
In addition, we also assessed the intra-session repeatability using EDI SD-
OCT and automated choroidal image processing technique. For this images from the 
same eye of 20 subjects were obtained twice at an interval of 10 minutes. Two images 
from the same eyes were each measured by automated image processing technique to 
assess the repeatability of CT and choroidal volume measurements.  
6.2.6 Statistical Analyses 
Statistical analysis was performed using MedCalc version 12.3 (Medcalc 
Software, Ostend, Belgium) and SPSS version 20.0 (SPSS, Inc., Chicago, IL, USA). 
Eyes with other ocular diseases, such as refractive errors, cataract, glaucoma, and 
retinopathy were not excluded if the quality of OCT image was sufficient to be 
evaluated.  
The agreement and intra-session repeatability of the CT and macular choroidal 
volume were measured by the absolute agreement model of the intra-class correlation 
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coefficient (ICC). ICC value of 0.81 – 1.00 indicates good agreement. Values of less 
than 0.40 indicate poor to fair agreement. We also performed Bland Altman plot 
analyses to see the mean difference between the repeated measurements. All p values 
were 2-sided and considered statistically significant when the values were less than 
0.05; 95% confidence intervals (CIs) were presented.  
 
6.3 RESULTS 
A total of 45 eyes from 45 subjects were included in the study. In none of the 
images did the automated software fail to detect the RPE and choroidal borders and 
therefore no eyes were excluded from the analysis. 
Table 6.1 shows the agreement between automated and manual CT 
measurements at 5 horizontal locations. Agreement of CT at 5 measured horizontal 
locations was excellent (ICC ranging from 0.90 to 0.96). The mean difference (95% 
limits of agreement) for sub-foveal CT was 2.2 (-61 to 65.5) µm. 
Table 6.2 shows the intra-session repeatability of CT and choroidal volume 
using automated choroidal segmentation software. Repeatability of CT at 5 measured 
horizontal locations and macular choroidal volume was excellent (ICC ranging from 
0.97 to 0.99).  
Table 6.3 shows the agreement between automated CT and manual CT at 
various locations in the optic disc region. The agreement of peripapillary CT was 
excellent (ICC ranging from 0.95 to 0.99). 
Table 6.4 shows the intra-session repeatability of peripapillary CT using 
automated choroidal segmentation software. Repeatability of peripapillary CT at 4 
quadrants was excellent (ICC ranging from 0.9998 to 0.9999). The mean difference 





In this study, we have successfully designed fully automated choroidal image 
processing technique that can enhance the visualization of CSI, objectively and 
accurately define the CSI and consistently measure CT (at macular and peripapillary 
regions) as well as choroidal volume (at macula). Our automated choroidal image 
processing technique is valid and comparable to existing manual method as our 
objectively measured macular and peripapillary CT showed good agreement with 
reference standard manually assessed CT. In addition, the intra-session repeatability 
of macular and peripapillary CT and macular choroidal volume using automated 
choroidal image processing technique was excellent. 
Although Spectralis OCT with EDI allows visualization of the choroidal 
structure in detail, the measurement of CT is still performed manually. To date, none 
of the previous clinical studies used automated measurements of thickness or volume 
of the choroid because in each of these studies demarcation of CSI, a principal 
landmark for accurate measurement of the choroid was performed manually.
18-21
 This 
makes the existing measurements not only time and effort consuming but also prone 
to measurement errors, thereby compromising their validity. 
To our best knowledge, this is the first time to use Spectralis OCT with EDI 
with a fully automated choroidal image processing technique to measure thickness 
and volume of the choroid. Our fast (processing time ~1.25 seconds per image which 
comprised of 7 radial scans vs. ~ 2.8 minutes per image comprised of 7 radial scans 
measured manually), objective and accurate technique has great potential usage in 
both clinical and population based studies and may improve the diagnosis and 
management of patients with eye diseases in which the choroid is affected. However, 
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our study also had limitations. Although the location of the CSI on Spectralis images 
was determined qualitatively as the junction between posterior choroid and sclera, 
there was no reference standard to confirm where this structure is actually located in 
the eye.  
 
6.5 CONCLUSION 
In summary, our fully automated choroidal image processing technique 
allowed fast, reliable and accurate measurements of CT and choroidal volume which 
are essential in distinguishing clinically significant change in choroid and assisting in 
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CHAPTER VI TABLES 
 
Table 6.1 Agreement between automated versus manual macular choroidal thickness 








Choroidal thickness   
Sub-foveal 0.96 (0.94 to 0.98) 2.2 (-61 to 65.5) 
Nasal, 1.5 mm 0.95 (0.92 to 0.97) -4.3 (-74 to 65.4) 
Nasal, 3 mm 0.90 (0.82 to 0.94) 3.9 (-83.6 to 91.4) 
Temporal, 1.5 mm 0.94 (0.89 to 0.96) 9 (-59.4 to 77.4) 
Temporal, 3 mm 0.93 (0.87 to 0.96) 3 (-62.3 to 68.4) 
 *Mean difference was determined from the automated measurement minus manual   
  measurement.  
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Table 6.2 Assessment of intra-session repeatability of macular choroidal thickness (at 
various horizontal locations) and macular choroidal volume using automated 
segmentation software (n = 20) 
 
Locations of measurement 
Intraclass correlation 





Choroidal thickness    
  Sub-foveal  0.996 (0.992 to 0.998) -0.4 (-21.5 to 20.7) 
  Nasal, 1.5 mm  0.992 (0.981 to 0.997) -2.1 (-29.1 to 24.9) 
  Nasal, 3 mm   0.996 (0.991 to 0.998) 1.6 (-15.6 to 18.8) 
  Temporal, 1.5 mm 0.995 (0.989 to 0.998) 0.1 (-26.2 to 26.4) 
  Temporal, 3 mm 0.979 (0.949 to 0.992) 0.5 (-38.2 to 39.2) 
Choroidal volume of 7 line 
scan (8.9 mm x 1.5 mm)   
0.999 (0.997 to 0.999) 0.0 (-0.08 to 0.09) 
 a
Mean difference was determined from the 1
st






Table 6.3 Agreement between automated versus manual peripapillary choroidal 










Peripapillary CT   
Inferior Quadrant 0.96 (0.92 to 0.98) -3.68 (-33.45 to 26.08) 
Superior Quadrant 0.99 (0.98 to 0.99) 2.04 (-12.60 to 16.70) 
Nasal Quadrant 0.95 (0.91 to 0.97) -1.94 (-35.62 to 31.72) 
Temporal Quadrant 0.97 (0.94 to 0.98) -3.97 (-37.35 to 29.40) 
Average 0.98 (0.96 to 0.99) -4.05 (-24.36 to 16.25) 
 a






Table 6.4 Intra-session repeatability of peripapillary choroidal thickness measurement 
at four quadrants obtained using automated choroidal segmentation software (n = 30) 
 
Locations of measurement 
Intraclass correlation  
(95% CI) 
Mean difference (µm)*  
(95% LOA) 
Peripapillary CT   
Inferior Quadrant  0.99 (0.99 to 0.99) 0.2 (-2.7 to 2.2) 
Superior Quadrant  0.99 (0.99 to 1.00) -0.2 (-2.9 to 2.6) 
Nasal Quadrant  0.99 (0.99 to 0.99) 0.3 (-2.9 to 3.4) 
Temporal Quadrant  0.99 (0.99 to 0.99) -0.5 (-3.8 to 2.7) 
Average  1.00 (0.99 to 1.00) -0.1 (-1.5 to 1.2) 
 *Mean difference was determined from the 1
st







CHAPTER VI FIGURES 
Figure 6.1 illustrating automated detection of the choroid-scleral interface (CSI). The 
valleys (local minimums) of the OCT A-scans are used as the feature to detect the 
CSI. However, there are also valleys caused by the speckle noise and the blood 





Figure 6.2 EDI-OCT image of the macular region demonstrating automated 
segmentation of the Bruch’s membrane and the choroidal-scleral interface. Choroidal 
thickness at each measurement points (shown by the numbered grid) was defined as 
CT (x,y), where x and y are the transversal (from nasal to temporal) and inter-frame 








 Figure 6.3 EDI-OCT image of the macular region demonstrating automated 
segmentation of the Bruch’s membrane and the choroidal-scleral interface. The 
horizontal choroidal thickness profile was generated at the fovea (detected as the 
lowest points of internal limiting membrane automatically) and at 500-µm intervals 









Figure 6.4 An illustration of the color-coded choroidal volume map obtained from the 
7 serial horizontal B-scans covering an area of 8.9 x 1.5 mm centered on the fovea. 
The choroidal volume is expressed in millimeter cube (mm
3
) with the warm and the 
cool colors representing thicker and thinner choroidal volume respectively. X and Y 
presents the transverse (from nasal to temporal) and inter frame (from superior to 






Figure 6.5 EDI-OCT image in the peripapillary region demonstrating automated segmentation of the Bruch’s membrane (BM) and the 
choroidal–scleral interface (CSI).  
 
                              





























Figure 6.6 Illustration of automated peripapillary choroidal thickness (CHT) 
measured in the optic disc region. The numbers on the x-axis are locations in clock 
hour sectors (30° apart). The location of the zero degree is always on the left- most 
point of the disc circle and the value of degree increases in the clockwise direction. T, 














DISTRIBUTION AND DETERMINANTS OF CHOROIDAL THICKNESS 
AND VOLUME USING AUTOMATED CHOROIDAL IMAGE PROCESSING 
TECHNIQUE IN A MULTI-ETHNIC POPULATION IN SINGAPORE 
 
In chapter VI, we established that our novel automated choroidal image 
processing technique which can objectively and accurately define CSI and assess CT 
is valid and comparable to existing manual CT measurements in both macular and 
peripapillary regions. In this Chapter, we adapted our validated technique to obtain 
choroidal measures such as thickness and volume in macular and peripapillary regions 
in our large population sample in Singapore. 
 
 
The manuscripts relevant to the contents of previous (Chapter 6) and this chapter have 
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Currently there is limited population-based data on CT and volume in Asians. 
To the best of our knowledge, Beijing eye study is the only population-based study 
but their measurement of CT was performed manually and was restricted to sub-
foveal location only. There is lack of population-based data reporting a series of 
comprehensive ocular and systemic factors that may influence CT and volume 
measurements using SD-OCT. To date, it is unknown whether there exists any ethnic 
variation in CT and volume among Asians. Neither is it known if there are differences 
in systemic and ocular risk factors of CT and volume in different ethnic groups in 
Asians. Knowledge of such factors is crucial before drawing inferences on CT and 
volume by SD-OCT. 
Singapore has major racial/ethnic groups, Malay, Indian and Chinese, which 
provides a unique opportunity to study the effect of ethnic differences on CT and 
volume in a relatively common geographic and socio-economic environment. The aim 
was to evaluate the distribution and determinants of macular and peripapillary CT and 
macular choroidal volume in a multi-ethnic population in Singapore using our novel 
fully automated choroidal segmentation technique.  
 
7.2 METHODS 
7.2.1 Study Subjects 
A total of 980 participants were consecutively recruited from the SEED Study, 
a population-based cohort study, comprising of major ethnic groups in Singapore: 
Malays (n= 540, from the SiMES, year 2011-2013) and Indians (n= 440 from the 
SINDI, year 2012-2015). Details of the study design and 3 methodology of the SEED 





Subjects were excluded if their choroidal images could not be successfully 
attained due to unstable fixation, opacities of the optic media, such as significant 
cataract or the available images were not of sufficient quality (quality index below 18 
dB), and subjects whose peripapillary atrophy involved the OCT scanning ring. As 
our aim was to determine the distribution of CT in a general population sample, 
therefore, any ocular diseases, such as presence of refractive errors, cataract, 
glaucoma, retinopathy and disorders of the optic nerve or macula, were no reason to 
exclude a subject if the quality of OCT image was sufficient to be evaluated.  
7.2.2 Choroidal Imaging and Measurements 
The choroidal image acquisition protocol for both macular and peripapillary 
regions as well as automated measurements of CT (macular and peripapillary) and 




7.2.3 Assessment of Ocular and Systemic Factors 
Each subject underwent an interview and a detailed systemic and ocular 
examination including, choroidal imaging at macular and optic nerve head regions 
using Spectralis SD-OCT. 
Detailed descriptions of comprehensive systemic and ocular examinations are 
described in Chapter III of the thesis.  
7.2.4 Statistical Analyses 
Statistical analysis was performed using SPSS version 20.0 (SPSS, Inc., 
Chicago, IL, USA). Demographic, ocular and systemic characteristics of the study 
participants are presented as means (SD) or number (%) as appropriate. CT at various 
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locations is expressed as means (SD). Univariate and multiple linear regression 
analyses were performed to determine the associations of sub-foveal CT, peripapillary 
CT and macular choroidal volume (dependent variables) with ocular and systemic 
factors (independent variables). For multiple linear regression, age, gender and factors 
showing suggestively significant association in univariate analysis (p<0.10) were 
included. In the assessment of associations with ocular and systemic factors, we 
included glaucoma status, diabetic retinopathy and age related macular degeneration 
in the regression models to adjust for potential confounding. Generalized estimating 
equation, exchangeable correlation matrix, was used to account for inter-eye 
correlations when both eyes of the study subjects were used for analysis. 
 
7.3 RESULTS 
We first describe the results of the distribution and determinants of macular 
CT and volume in ethnic Malays. This was followed by the evaluation of the 
distribution and determinants of peripapillary CT in ethnic Malays. Next, we 
performed the above analyses (evaluation of the distribution and determinants of 
macular and peripapillary CT) in subjects of Indian ethnicity. Furthermore, to 
elucidate whether the observed differences in CT and volume across ethnic groups are 
attributable to ethnicity, we compared these choroidal parameters across ethnic groups 
after adjusting for the population-specific factors. 
 
7.3.1 Distribution and Determinants of Macular CT and Volume in Ethnic 
Malays 
          
 
Study Subjects’ Characteristics: A total of 540 eyes from 540 consecutive subjects 
of Malay ethnicity (251 men and 289 women) with a mean (SD) age of 62.70 (8.91) 
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years were included in the analysis. In none of the images did the automated software 
fail to detect the RPE and choroidal borders and therefore no eyes were excluded from 
the analysis. The demographics, ocular and systemic characteristics of the study 
population are shown in Table 7.1. 
Distribution of Macular CT and Volume: Table 7.2 shows the mean CT and 
choroidal volume. CT was measured at 13 different locations on the horizontal axis. 
Choroid was thickest at the sub-fovea (242.28±97.58 µm), followed by temporal and 
thinnest at 3 mm nasal (142.44±79.19 µm) location (which is the last point measured 
using the software). The mean macular (1 mm diameter) and 7 line scan choroidal 




 respectively.  
Determinants of Macular CT and Volume: In the univariate analysis (Table 7.3), 
among the ocular factors only SE and AL showed significant association with sub-
foveal CT (both p<0.001). For each mm increase in AL, sub-foveal CT on average 
decreased by 19.63 µm (p<0.001). A decrease in mean CT by 10.77 µm was observed 
for each myopic dioptre increase (p<0.001). Among the systemic factors, younger 
age, male gender, higher serum cholesterol or triglycerides levels, current smoking 
and free of  arterial hypertension were found to be significantly associated with 
thicker sub-foveal CT (all p<0.05). 
Because of collinearity between AL and SE (correlation coefficient = -0.584), 
only AL was selected and retained in the multivariate analysis as it had a greater 
explanatory power on sub-foveal CT change than did SE (standardized β, -0.197 vs. 
0.192). In the multiple linear regression model (Table 7.3) including all significant 
factors, only shorter AL (p<0.001), younger age (p<0.001) and male gender (p=0.001) 
remained significantly associated with thicker sub-foveal CT. 
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Similarly, in the analysis of the association of choroidal volume at central 
macular (1 mm diameter) with ocular and systemic factors (Table 7.4), only shorter 
AL, younger age and male gender showed significant association with larger central 
choroidal volume (all p<0.001).  Similar factors were associated with greater 
choroidal volume of 7 line scan (data not shown). 
 
7.3.2 Distribution and Determinants of Peripapillary CT in Ethnic Malays 
          
Of the 540 consecutive subjects (1080 eyes) whose optic disc scans were 
available, we further excluded 88 subjects because either their choroidal images were 
not successfully attained (n=47) or the available images were of insufficient quality 
(n=28) for a reliable determination of the peripapillary choroidal thickness (PPCT) or 
subjects whose peripapillary atrophy involved the OCT scanning ring (n=13), leaving 
452 subjects (904 eyes) with complete data on PPCT for analysis. In none of the 
images did the automated software fail to detect the Bruch’s membrane and choroidal 
borders and therefore no eyes were excluded from the analysis because of software 
demarcation error.  
Distribution of Peripapillary CT: Table 7.5 shows the mean PPCT measured at 12 
clock hours and four quadrants (superior, nasal, inferior and temporal). The overall 
mean PPCT in our study subjects was 136.2 ± 56.8 µm. There are regional differences 
in PPCT among clock hours and different quadrants. Peripapillary choroid was 
thickest (150.5 ± 59.6 µm) at the superior and thinnest (102.6 ± 51.1 µm) at the 
inferior quadrant. 
Determinants of Peripapillary CT: In the univariate linear regression analysis 
(Table 7.6), AL, IOP, triglycerides levels and diabetes showed significant association 
with average PPCT (all p<0.10). In the multiple linear regression model (Table 7.6) 
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including age, gender and all suggestively significant factors (p<0.10) from the 
univariate analysis, shorter AL (p=0.002), younger age (p<0.018), lower triglycerides 
levels (p=0.015) and presence of diabetes (p=0.036) remained significantly associated 
with thicker PPCT. The association with IOP was no longer significant (p=0.407). For 
each mm increase in AL and per year increase in age, PPCT on average decreased by 
6.59 µm (p=0.002) and 0.56 µm (p=0.018) respectively. A decrease in mean PPCT by 
4.88 µm was observed for each mmol/L increase in triglycerides level (p=0.015). 
Presence of diabetes increased the mean PPCT by 13.73 µm (p=0.036). However, if 
gender and IOP were removed from our multivariate model, presence of diabetes still 
remained significantly associated with PPCT (regression coefficient = 13.22; 95% CI 
= 0.42 to 26.02; p=0.043).  
Table 7.7 presents the multivariate analysis results of the associations of 
PPCT with ocular and systemic factors by quadrant. In the multivariate models, only 
younger age and shorter AL was associated with thicker inferior peripapillary 
choroid; and shorter AL, lower triglycerides level and presence of diabetes were 
associated with thicker superior peripapillary choroid. IOP was the only significant 
factor associated with thicker nasal peripapillary choroid. For temporal PPCT, 
associated factors were similar to those identified from overall PPCT. 
7.3.3 Distribution and Determinants of Macular CT and Volume in Ethnic 
Indians 
          
Study Subjects’ Characteristics: A total of 440 eyes from 440 consecutive subjects 
of Indian ethnicity (231 men and 209 women) with a mean (SD) age of 58.56 (8.18) 
years were included in the analysis. The demographics, ocular and systemic 
characteristics of the study population are shown in Table 7.8.  
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Distribution of Macular CT and Volume: Table 7.9 shows the mean CT and 
choroidal volume. CT was measured at 13 different locations on the horizontal axis. 
Choroid was thickest at the sub-fovea 267.23 ±100.99 µm, followed by temporal and 
thinnest at 3 mm nasal (170.09±88.79 µm) location (which is the last point measured 
using the software). The mean macular (1 mm diameter) and 7 line scan choroidal 
volume were 0.209±0.071 mm
3
 and 2.167±0.689 mm
3
 respectively.  
Determinants of Macular CT and Volume: In the univariate analysis (Table 7.10), 
among the ocular factors only AL showed significant association with sub-foveal CT 
(p=0.001). For each mm increase in AL, sub-foveal CT on average decreased by 
15.77 µm (p=0.001). Among the systemic factors, younger age, male gender, higher 
triglycerides levels, current smoking and free of  diabetes mellitus were found to be 
significantly associated with thicker sub-foveal CT (all p<0.10). In the multiple linear 
regression model (Table 7.10) including all significant factors, only shorter AL 
(p<0.001), more curved cornea (p<0.001), younger age (p=0.010), male gender 
(p<0.001) and absence of diabetes (p=0.015) remained significantly associated with 
thicker sub-foveal CT. 
Similarly, in the analysis of the association of choroidal volume at central 
macular (1 mm diameter) with ocular and systemic factors (Table 7.11), only shorter 
AL, younger age, male gender and higher levels of triglycerides showed significant 
association with larger central choroidal volume (all p<0.05).  Similar factors were 
associated with greater choroidal volume of 7 line scan (data not shown). 
 
7.3.4 Distribution and Determinants of Peripapillary CT in Ethnic Indians 
         
To assess the distribution and determinants of PPCT in ethnic Indians we 
analysed 650 Indian eyes. 
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Distribution of Peripapillary CT: Table 7.12 shows the mean PPCT measured at 12 
clock hours and four quadrants (superior, nasal, inferior and temporal). The overall 
mean PPCT in our study subjects was 181.74±67.51 µm. There are regional 
differences in PPCT among clock hours and different quadrants. Peripapillary choroid 
was thickest (197.50±73.13 µm) at the superior and thinnest (151.09±61.07 µm) at the 
inferior quadrant. 
Determinants of Peripapillary CT: In the univariate linear regression analysis 
(Table 7.13), AL, corneal curvature, age, gender, diastolic BP, HbA1c, triglycerides 
levels and smokers showed significant association with average PPCT (all p<0.10). In 
the multiple linear regression model (Table 7.13) including age, gender and all 
suggestively significant factors (p<0.10) from the univariate analysis, shorter AL 
(p<0.001), younger age (p<0.001), male gender (p<0.001) and higher HbA1c levels 
(p=0.021) remained significantly associated with thicker PPCT. For each mm increase 
in AL and per year increase in age, PPCT on average decreased by 18.46 µm 
(p<0.001) and 2.23 µm (p<0.001) respectively. Males have 40.08 µm thicker 
peripapillary choroid than females (p<0.001). A decrease in mean PPCT by 5.19 µm 
was observed for each unit increase in HbA1c level (p=0.021).  
Table 7.14 presents the multivariate analysis results of the associations of 
PPCT with ocular and systemic factors by quadrant. In the multivariate models, 
shorter AL, younger age, male gender and lower HbA1c levels were associated with 
thicker superior, nasal and temporal peripapillary choroid. For inferior PPCT, except 
HbA1c, all other factors remained the same.  
 
7.3.5 Comparison of Macular CT and Volume among Ethnic Malays and Indians 
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To elucidate whether the observed differences in CT and volume across ethnic 
Malays and Indians are attributable to ethnicity, we compared the above choroidal 
parameters (CT and volume) between ethnic groups after adjusting for the differences 
in population-specific factors and other relevant confounders. 
Table 7.15 shows the comparison of the baseline characteristics of ethnic 
Malays and Indians. Indians are significantly younger with more number of male 
participants of shorter AL, more hyperopic refractive error, lower OPP, SBP, 
cholesterol and creatinine levels. Compared to Malays, less number of Indians had 
hypertension. 
Table 7.16 shows the unadjusted distribution of macular choroidal volume 
and CT at various locations in the posterior pole among ethnic Malays and Indians. In 
general, Indians had significantly thicker choroid at all the measured locations (all 
p<0.001). Likewise they had greater choroidal volume at both 7 line scan region (8.9 
x 1.5 mm) and central macular (1mm) region (both p<0.001). However after adjusting 
for population-specific factors which were significantly different between the ethnic 
groups such as age, gender, AL, corneal curvature, OPP, current smoking, creatinine 
and cholesterol as well as other potential confounders like presence of AMD, DR and 
glaucoma, we found that although Indians demonstrated a trend towards thicker 
choroid at all the locations but it was not statistically significant at most of the 
locations including sub-foveal. On average, the choroid in Indians is thicker by 12 µm 
which is statistically significant but this difference is unlikely to be clinically 
meaningful (Table 7.17). 
 
7.3.6 Comparison of Peripapillary CT among Ethnic Malays and Indians 
Table 7.18 shows the unadjusted distribution of peripapillary CT at four 
quadrants among ethnic Malays and Indians. In general, Indians had significantly 
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thicker peripapillary choroid at all 4 quadrants (all p<0.001). However after adjusting 
for population-specific factors which were significantly different between the ethnic 
groups such as age, gender, AL, corneal curvature, OPP, current smoking, alcohol 
consumption, creatinine, cholesterol and triglycerides as well as other potential 
confounders like presence of AMD, DR and glaucoma, we found that Indians showed 
thicker peripapillary choroid at all 4 quadrants. On average, the peripapillary choroid 




7.4.1 Macular CT and Volume in Ethnic Malays and Indians 
Using the fully automated choroidal image processing technique and after 
adjusting for the differences in population-specific factors and all other relevant 
confounders, our results demonstrate the mean macular CT to be 223.44±3.86 µm and 
236.13±4.43 µm in ethnic Malays and Indians respectively. Indians had a trend 
towards thicker choroid at all measured locations but it was not statistically significant 
at most of the locations including sub-foveal. Although, the difference in mean 
macular CT of 12 µm between the ethnic groups is statistically significant, it seems to 
be driven by nasal location. Likewise Indians had greater choroidal volume than 
ethnic Malays with a mean difference of 0.01 mm
3 
(at central 1 mm macular region). 
In terms of topographical distribution of macular CT, our results indicate its 
asymmetric distribution in ethnic Malays and Indians. In both the ethnic groups, the 
mean CT measurements showed regional differences, being thickest subfoveally, 
followed by temporal and thinnest at the nasal location. 
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In both the ethnic groups, male gender, younger age, and shorter axial length 
are the factors independently associated with thicker choroid and larger choroidal 
volume. Additionally, higher triglycerides levels and absence of diabetes are 
associated with thicker choroid in Indians. These factors should be taken into 
consideration when interpreting EDI SD-OCT based CT and volume measurements in 
clinics.  
7.4.2 Peripapillary CT in Ethnic Malays and Indians 
Using our fully automated choroidal image processing technique and after 
adjusting for the differences in population-specific factors and other likely 
confounders, our study showed the mean peripapillary CT of 142.56±3.01 µm and 
174.49±3.30 µm in ethnic Malays and Indians respectively. The mean difference of 
32 µm between the two ethnic groups is both statistically and clinically meaningful. 
In relation to the topographical profile of peripapillary choroid, our results 
exhibit asymmetric distribution of peripapillary CT in ethnic Malays and Indians. In 
both the ethnic groups, the mean peripapillary CT measurements showed regional 
differences, being thickest in the superior region and thinnest in the inferior region. 
However, in ethnic Malays nasal quadrant was thicker than temporal but in Indians 
temporal region was thicker than nasal. 
In both the ethnic groups, younger age and shorter axial length are the factors 
independently associated with thicker peripapillary choroid. Additionally, male 
gender and lower HbA1c levels in Malays and lower triglycerides and absence of 
diabetes in Indians are associated with thicker peripapillary choroid. These factors 
should be taken into account when interpreting EDI OCT based peripapillary CT 





Our results demonstrate that there exist slight difference in macular CT (mean 
difference 12 µm), macular choroidal volume (mean difference 0.02 mm
3
) and 
peripapillary CT (mean difference ~32 µm) among ethnic Malays and Indians. Indians 
tend to have slightly thicker choroid than Malays. With regards to topographical 
distribution, both macular and peripapillary choroid is asymmetrically distributed 
(macular: thickest subfoveally and thinnest nasally; peripapillary: thickest superiorly 
and thinnest inferiorly). However, there is no difference in topographical profile of 
macular and peripapillary choroid among ethnic Malays and Indians. Factors such as 
age, gender and axial length are the major determinants of CT and volume among 
both ethnic groups and should be taken into account when interpreting EDI OCT 
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CHAPTER VII TABLES 
Table 7.1 Demographic, ocular and systemic characteristics of ethnic Malays (n = 
540) for evaluation of choroidal thickness and volume using fully automated 
choroidal segmentation technique 
 
Characteristics Included (n = 540) 
Age, years 62.70 (8.91) 
Gender, % male 251 (46.5) 
Axial length, mm 23.59 (0.96) 
Anterior chamber depth, mm 3.17 (0.34) 
Corneal curvature, mm 7.66 (0.24) 
Spherical equivalent, D 0.11 (1.74) 
Best corrected visual acuity, Log MAR 0.16 (0.20) 
Central corneal thickness, μm 541.76 (35.15) 
Intraocular pressure, mmHg 14.49 (3.10) 
Ocular perfusion pressure, mmHg 55.55 (8.19) 
Systolic blood pressure, mmHg 139.56 (19.68) 
Diastolic blood pressure mmHg 76.90 (10.66) 
Mean arterial pressure, mmHg 97.78 (12.37) 
Body mass index, kg/m
2
 26.87 (5.07) 
Serum glucose, mmol/L 7.22 (3.52) 
HbA1c, % 6.35 (1.43) 
Total cholesterol, mmol/L 5.36 (1.29) 
Triglycerides, mmol/L 1.92 (1.30) 
Blood creatinine, mmol/L 83.23 (41.23) 
Current smoking, % 98 (18.1) 
Diabetes mellitus, % 143 (26.5) 
Arterial hypertension, % 323 (59.8) 
Alcohol consumption, % 7 (1.3) 
Data are means (standard deviations), except for gender, HbA1c, current smoking, diabetes, 







Table 7.2 Distribution of mean macular choroidal thickness (at various points on the 
horizontal axis) and volume measurements in ethnic Malays (n = 540) using fully 
automated choroidal segmentation technique 
 
Location of measurements Mean (SD) 
CHOROIDAL THICKNESS (um)  
Sub-foveal 242.28 (97.58) 
Nasal, 0.5 mm 237.11 (97.72) 
Nasal, 1 mm  226.68 (98.10) 
Nasal, 1.5 mm 208.35 (98.20) 
Nasal, 2 mm 187.29 (94.21) 
Nasal, 2.5 mm 166.02 (89.72) 
Nasal, 3 mm 142.44 (79.19) 
Temporal, 0.5 mm 241.93 (96.58) 
Temporal, 1 mm  239.39 (92.83) 
Temporal, 1.5 mm 232.17 (89.42) 
Temporal, 2 mm 221.31 (84.12) 
Temporal, 2.5 mm  216.19 (81.93) 




Choroidal volume of 7 line scan (8.9 x 1.5 mm) 1.889 (0.693) 
Choroidal volume at central macula (1mm diameter circle) 0.185 (0.071) 




Table 7.3 Univariate and multivariate analysis of the association of ocular and systemic factors with sub-foveal choroidal thickness in 
ethnic Malays (n = 540) measured using fully automated choroidal segmentation technique 
 












Ocular factors       
Spherical equivalent, D 10.773 0.192 <0.001 - - - 
Axial length, mm  -19.638 -0.197 <0.001 -32.111 -0.317 <0.001 
Corneal curvature, mm -33.037 -0.084 0.063 20.160 0.051 0.303 
Anterior chamber depth, mm 0.870 0.003 0.944 - - - 
Central corneal thickness, μm 0.164 0.059 0.170 - - - 
Intraocular pressure, mmHg 0.473 0.015 0.727 - - - 
Ocular perfusion pressure, mmHg 0.269 0.023 0.600 - - - 
Systemic factors       
Age, years -3.104 -0.284 <0.001 -4.139 -0.366 <0.001 
Gender, (female) -19.432 -0.099 0.021 -30.869 -0.158 0.001 
Mean arterial pressure,  mmHg 0.172 0.022 0.612 - - - 
Body mass index, kg/m
2
 -1.233 -0.064 0.137 - - - 
Serum glucose, mmol/L 0.556 0.020 0.651 - - - 
HbA1c, % 3.230 0.047 0.279 - - - 
Total cholesterol, mmol/L 9.110 0.121 0.005 4.495 0.060 0.163 
Triglycerides, mmol/L 7.209 0.096 0.027 4.180 0.057 0.185 
Blood creatinine, mmol/L -0.035 -0.015 0.734 - - - 
Current smoking, Yes 36.601 0.145 0.001 -1.028 -0.004 0.930 
Diabetes mellitus, Yes 1.472 0.007 0.878 - - - 
Arterial hypertension, Yes -21.077 -0.106 0.014 -3.723 -0.019 0.678 
Alcohol consumption, Yes 34.549 0.040 0.353 - - - 
   a





Table 7.4 Univariate and multivariate analysis of the association of ocular and systemic factors with choroidal volume at central macula 
in ethnic Malays (n = 540) measured using fully automated choroidal segmentation technique 












Ocular factors        
Spherical equivalent, D 0.009 0.207 <0.001 - - - 
Axial length, mm  -0.014 -0.189 <0.001 -0.021 -0.280 <0.001 
Corneal curvature, mm -0.014 -0.049 0.274 - - - 
Anterior chamber depth, mm 0.003 0.013 0.777 - - - 
Central corneal thickness, per 10 μm 0.000 0.065 0.135 - - - 
Intraocular pressure, per 10 mmHg -0.0007 0.003 0.942 - - - 
Ocular perfusion pressure, per 10 mmHg 0.001  0.011 0.795 - - - 
Systemic factors       
Age, years -0.003 -0.320 <0.001 -0.003 -0.396 <0.001 
Gender, (female vs male) -0.016 -0.109 0.011 -0.023 -0.159 <0.001 
Mean arterial pressure, per 10 mmHg 0.0004 0.006 0.886 - - - 
Body mass index, kg/m
2
 -0.001 -0.058 0.177 - - - 
Serum glucose, mmol/L 0.000 0.007 0.880 - - - 
HbA1c, % 0.003 0.053 0.227 - - - 
Total cholesterol, mmol/L 0.007 0.131 0.002 0.003 0.057 0.175 
Triglycerides, mmol/L 0.006 0.115 0.008 0.003 0.065 0.122 
Blood creatinine, mmol/L -0.000 0.035 0.420 - - - 
Current smoking, Yes 0.033 0.175 <0.001 0.006 0.032 0.475 
Diabetes mellitus, Yes -0.000 0.000 0.996 - - - 
Arterial hypertension, Yes -0.017 -0.116 0.007 -0.001 -0.007 0.874 
Alcohol consumption, Yes 0.018 0.029 0.508 - - - 
    a






Table 7.5 Distribution of peripapillary choroidal thickness at clock-hour sectors (30° 
apart) and four quadrants in ethnic Malays (n = 904 eyes) 
 
  Data presented are means (standard deviations). 
1 o’clock corresponded to the temporal region, 4 o’clock to the superior, 7 o’clock to the 





Clock hour  
  1 139.5 (77.0) 
  2 147.8 (71.0) 
  3 148.9 (64.9) 
  4  150.8 (61.9) 
  5 151.4 (59.3) 
  6 152.1 (60.8) 
  7  145.4 (61.7) 
  8 134.0 (58.6) 
  9 115.8 (53.5) 
  10  102.6 (51.1) 
  11 113.9 (57.3) 
  12 130.3 (68.6) 
Quadrants  
 Inferior   111.3 (51.7) 
 Superior  150.5 (59.6) 
 Nasal   143.5 (58.4) 
 Temporal   139.4 (68.9) 
 Average quadrant thickness 136.2 (56.8) 
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Table 7.6 Associations of average peripapillary choroidal thickness with ocular and systemic factors using generalized estimating 
equation in Malays (n = 904 eyes) 
 
 Univariate analysis Multivariate analysis* 
 Beta (95% CI) P-value Beta (95% CI) P-value 
Ocular factors     
  Spherical equivalent, D -0.22 (-0.23, 1.88) 0.833 - - 
  Axial length, mm  -4.23 (-8.88, 0.40) 0.074 -6.59 (-10.86, -2.33) 0.002 
  Corneal curvature, mm -13.14 (-30.39, 4.10) 0.135 - - 
  Central corneal thickness, μm -0.01 (-0.14, 0.12) 0.841 - - 
 Intraocular pressure, mmHg 1.30 (0.20, 2.40) 0.020 0.60 (-0.82, 2.02) 0.407 
 Ocular perfusion pressure, mmHg -0.18 (-0.64, 0.27) 0.436 - - 
Systemic factors     
  Age, years -0.20 (-0.61, 0.19) 0.319 -0.56 (-1.03, -0.09) 0.018 
  Gender, male -5.63 (-14.53, 3.27) 0.215 5.60 (-5.08, 16.29) 0.304 
  Systolic blood pressure, mmHg -0.06 (-0.25, 0.13) 0.538 - - 
  Diastolic blood pressure, mmHg -0.00 (-0.36, 0.34) 0.959 - - 
  Mean arterial pressure, mmHg -0.05 (-0.36, 0.25) 0.718 - - 
  Body mass index, kg/m
2
 0.18 (-0.55, 0.91) 0.631 - - 
  Serum glucose, mmol/L 0.53 (-0.69, 1.76) 0.392 - - 
  HbA1c, % 1.13 (-1.83, 4.09) 0.455 - - 
  Total cholesterol, mmol/L 0.25 (-3.10, 3.60) 0.883 - - 
  Triglycerides, mmol/L -2.42 (-5.13, 0.29) 0.080 -4.88 (-8.80, -0.95) 0.015 
  Blood creatinine, mmol/L 0.00 (-0.07, 0.08) 0.818 - - 
  Current smoking  -2.79 (-13.74, 8.14) 0.616 - - 
  Diabetes mellitus  9.39 (-0.73, 19.52) 0.069 13.73 (0.90, 26.34) 0.036 
  Arterial hypertension  3.16 (-5.88, 12.20) 0.493 - - 
  Alcohol consumption  -7.99 (-38.18, 22.19) 0.604 - - 
  *Adjusted for glaucoma status, diabetic retinopathy and age related macular degeneration; CI = confidence interval. 
    Beta represents the change in peripapillary choroidal thickness for per unit change in continuous variables and the difference in peripapillary 
   choroidal thickness between groups for categorical variables.    
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Table 7.7 Multivariate analysis of the associations of regional (inferior, superior, nasal and temporal) peripapillary choroidal thickness 
(PPCT) with ocular and systemic factors using generalized estimating equation in Malays (n = 904 eyes) 
 
 
Inferior PPCT Superior PPCT Nasal PPCT  Temporal PPCT 
 
 Beta (95% CI) P-
value 
Beta (95% CI) P-
value 
Beta (95% CI) P-
value 
Beta (95% CI) P-
value 
AL, mm -5.59 (-9.53, -1.65) 0.005 -6.03 (-10.56, -1.49) 0.009 - - -7.96 (-13.34, -2.58) 0.004 
CC, mm - - - - - - -3.01 (-28.32, 22.29) 0.815 
IOP, mmHg 0.64 (-0.53, 1.83) 0.284 0.51 (-1.04, 2.07) 0.518 1.37 (0.04, 2.70) 0.044 0.56 (-1.24, 2.36) 0.543 
Age, years -0.54 (-0.96, -0.11) 0.012 -0.44 (-0.94, 0.04) 0.074 -0.28 (-0.71, 0.13) 0.184 -0.68 (-1.27, -0.09) 0.023 
TG, mmol/L - - -5.15 (-9.26, -1.05) 0.014 - - -5.96 (-10.51, 1.41) 0.010 
DM  9.36 (-2.26, 20.99) 0.115 15.15 (2.26, 28.04) 0.021 - - 17.07 (1.82, 32.32) 0.028 
For inferior, superior, nasal and temporal PPCT age, gender, glaucoma status, diabetic retinopathy, age related macular degeneration and variables   
with p<0.10 in univariate models were included in multivariate models. 
CI=confidence interval; PPCT=peripapillary choroidal thickness; AL=axial length; CC=corneal curvature; IOP=intra ocular pressure;   




Table 7.8 Baseline characteristics of study subjects of Indian ethnicity 
Characteristics Included (n = 439) 
Age, years 58.56 (8.18) 
Gender, % male 231 (52.6) 
Axial length, mm 23.42 (1.00) 
Anterior chamber depth, mm 3.23 (0.39) 
Corneal curvature, mm 7.61 (0.26) 
Spherical equivalent, D 0.33 (1.57) 
Best corrected visual acuity Log MAR 0.10 (0.11) 
Central corneal thickness, μm 541.99 (33.82) 
Intraocular pressure, mmHg 15.12 (2.85) 
Ocular perfusion pressure, mmHg 53.87 (7.69) 
Systolic blood pressure, mmHg 132.50 (18.43) 
Diastolic blood pressure mmHg 77.54 (10.44) 
Mean arterial pressure, mmHg 95.86 (11.87) 
Body mass index, kg/m
2 26.41 (4.42) 
Serum glucose, mmol/L 7.24 (3.76) 
HbA1c, % 6.31 (1.37) 
Total cholesterol, mmol/L 5.07 (1.25) 
Triglycerides, mmol/L 1.99 (1.10) 
Blood creatinine, mmol/L 76.13 (43.75) 
Current smoking, % 58 (13.2) 
Diabetes mellitus, % 158 (36) 
Arterial hypertension, % 255 (58.1) 
Alcohol consumption, % 55 (12.5) 
Data are mean (standard deviations), except for gender, HbA1c, current smoking, diabetes, 




Table 7.9 Mean macular choroidal thickness (at various points on the horizontal axis) 
and volume measurements in subjects of Indian origin (n = 439) measured using fully 
automated choroidal segmentation technique 
 
Location of measurements Mean (SD) 
CHOROIDAL THICKNESS (um)  
Sub-foveal 267.23 (100.99) 
Nasal, 0.5 mm 270.00 (104.54) 
Nasal, 1 mm  269.85 (106.46) 
Nasal, 1.5 mm 254.59 (107.70) 
Nasal, 2 mm 237.70 (107.49) 
Nasal, 2.5 mm 209.92 (101.59) 
Nasal, 3 mm 170.09 (88.79) 
Temporal, 0.5 mm 264.16 (96.28) 
Temporal, 1 mm  257.76 (91.19) 
Temporal, 1.5 mm 249.23 (91.06) 
Temporal, 2 mm 241.05 (86.47) 
Temporal, 2.5 mm  234.65 (84.30) 




Choroidal volume of 7 line scan (8.9 x 1.5 mm) 2.167 (0.689) 





Table 7.10 Univariate and multivariate analysis of the association of ocular and systemic factors with sub-foveal choroidal thickness in 
Singapore Indians (n = 439) 






Ocular factors     
Spherical equivalent, D -2.957 0.335 - - 
Axial length, mm  -15.772 0.001 -31.154 <0.001 
Corneal curvature, mm -32.039 0.075 53.150 0.010 
Anterior chamber depth, mm 8.480 0.486 - - 
Central corneal thickness, μm 0.017 0.908 - - 
Intraocular pressure, mmHg 0.974 0.566 - - 
Ocular perfusion pressure, mmHg 0.591 0.347 - - 
Systemic factors     
Age, years -2.479 <0.001 -2.457 <0.001 
Gender, (female vs male) -36.205 <0.001 -41.717 <0.001 
Mean arterial pressure,  mmHg 0.446 0.273 - - 
Body mass index, kg/m
2
 -1.515 0.167 - - 
Serum glucose, mmol/L -1.209 0.357 - - 
HbA1c, % -5.243 0.138 - - 
Total cholesterol, mmol/L 2.632 0.498 - - 
Triglycerides, mmol/L 12.406 0.005 7.617 0.074 
Blood creatinine, mmol/L 0.182 0.102 - - 
Current smoking, Yes 27.665 0.052 10.345 0.481 
Diabetes mellitus, Yes -26.430 0.008 -25.033 0.015 
Arterial hypertension, Yes -1.745 0.858 - - 
Alcohol consumption, Yes 1.613 0.912 - - 
  *Adjusted for glaucoma status, diabetic retinopathy and age-related macular degeneration. 
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Table 7.11 Univariate and multivariate analysis of the association of ocular and systemic factors with choroidal volume at central macula 
in Singapore Indians (n = 437) 






Ocular factors      
Spherical equivalent, D -0.002 0.362 - - 
Axial length, mm  -0.013 <0.001 -0.019 <0.001 
Corneal curvature, mm -0.019 0.147 - - 
Anterior chamber depth, mm 0.003 0.757 - - 
Central corneal thickness, per 10 μm 9.113E-5 0.371 - - 
Intraocular pressure, per 10 mmHg 0.001 0.526 - - 
Ocular perfusion pressure, per 10 mmHg 0.000 0.355 - - 
Systemic factors     
Age, years -0.002 <0.001 -0.002 <0.001 
Gender, (female vs male) -0.028 <0.001 -0.035 <0.001 
Mean arterial pressure, per 10 mmHg 0.000 0.300 - - 
Body mass index, kg/m
2
 -0.001 0.092 0.000 0.550 
Serum glucose, mmol/L -0.001 0.266 - - 
HbA1c, % -0.005 0.066 -0.004 0.287 
Total cholesterol, mmol/L 0.002 0.532 - - 
Triglycerides, mmol/L 0.008 0.007 0.006 0.038 
Blood creatinine, mmol/L 0.000 0.124 - - 
Current smoking, Yes 0.020 0.051 0.004 0.705 
Diabetes mellitus, Yes -0.021 0.004 -0.011 0.239 
Arterial hypertension, Yes -0.001 0.888 - - 
Alcohol consumption, Yes 0.003 0.764 - - 
  *Adjusted for glaucoma status, diabetic retinopathy and age-related macular degeneration. 
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Table 7.12 Distribution of peripapillary choroidal thickness at clock-hour sectors (30° 
apart) and four quadrants in Singapore Indians (n = 650 eyes) measured using fully 
automated choroidal segmentation technique 
 
 
 Data presented are means (standard deviations). 
 1 o’clock corresponded to the temporal region, 4 o’clock to the superior, 7 o’clock to the   
 nasal, and 10 o’clock to the inferior. 
  
Measurement Location Peripapillary Choroidal 
Thickness, µm 
Clock hour  
  1 193.80 (89.72) 
  2 204.32 (82.64) 
  3 199.64 (78.15) 
  4  197.29 (75.12) 
  5 195.44 (74.47) 
  6 193.54 (76.70) 
  7  186.20 (76.54) 
  8 172.47 (71.87) 
  9 152.14 (63.11) 
  10  141.23 (60.26) 
  11 157.36 (67.32) 
  12 182.64 (80.48) 
Quadrants  
  Inferior   151.09 (61.07) 
  Superior  197.50 (73.13) 
  Nasal   184.03 (72.69) 
  Temporal   194.33 (78.78) 
  Average quadrant thickness 181.74 (67.51) 
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Table 7.13 Associations of average peripapillary choroidal thickness with ocular and systemic factors using generalized estimating 
equation in Singaporean Indians (n = 650 eyes) 
 
 Univariate analysis Multivariate analysis* 
Beta (95% CI) P-value Beta (95% CI) P-value 
Ocular factors     
  Axial length, mm  -15.56 (-23.17, -7.96) <0.001 -18.46 (-26.47, -10.46) <0.001 
  Corneal curvature, mm -26.90 (-51.90, -1.90) 0.035 -13 (-41.03, 15.02) 0.363- 
  Central corneal thickness, μm -0.05 (-0.24, 0.13) 0.574 - - 
 Intraocular pressure, mmHg 0.93 (-0.88, 2.75) 0.314 - - 
 Ocular perfusion pressure, mmHg -0.07 (-0.85, 0.70) 0.851 - - 
Systemic factors     
  Age, years -1.94 (-2.97, -0.90) <0.001 -2.23 (-3.37, -1.09) <0.001 
  Gender, male 29.25 (15.70, 42.81) <0.001 40.08 (25.60, 54.55) <0.001 
  Systolic blood pressure, mmHg -0.30 (-0.67, 0.07) 0.117 - - 
  Diastolic blood pressure, mmHg 0.61 (-0.11, 1.34) 0.099 -0.11 (-0.76, 0.53) 0.721 
  Mean arterial pressure, mmHg 0.05 (-0.45, 0.56) 0.831 - - 
  Body mass index, kg/m
2
 -0.87 (-2.35, 0.60) 0.246 - - 
  Serum glucose, mmol/L -0.99 (-3.02, 1.03) 0.335 - - 
  HbA1c, % -4.53 (-9.38, 0.31) 0.067 -5.19 (-9.59, -0.78) 0.021 
  Total cholesterol, mmol/L 0.27 (-5.79, 6.35) 0.929 - - 
  Triglycerides, mmol/L 4.86 (-0.57, 10.30) 0.080 3.04 (-2.47, 8.55) 0.280 
  Blood creatinine, mmol/L 0.03 (-0.05, 0.13) 0.445 - - 
  Current smoking  25.49 (4.59, 46.39) 0.017 3.37 (-17.67, 24.41) 0.754 
  Diabetes mellitus  -11.55 (-26.06, 2.95) 0.119 - - 
  Arterial hypertension  2.63 (-11.26, 16.54) 0.710 - - 
  Alcohol consumption  11.73 (-12.81, 36.27) 0.349 - - 
 *Adjusted for glaucoma status, diabetic retinopathy and age related macular degeneration; CI = confidence interval. 
 Beta represents the change in peripapillary choroidal thickness for per unit change in continuous variables and the difference in peripapillary  




Table 7.14 Multivariate analysis of the associations of regional (inferior, superior, nasal and temporal) peripapillary choroidal thickness 
with ocular and systemic factors using generalized estimating equation in Indians (n = 650 eyes) 
 
 
Inferior PPCT Superior PPCT Nasal PPCT  Temporal PPCT 
 
 Beta (95% CI) P-
value 
Beta (95% CI) P-
value 
Beta (95% CI) P-
value 
Beta (95% CI) P-
value 
AL, mm -14.08 (-20.61, -7.55) <0.001 -19.111 (-27.36, -10.86) <0.001 -16.26 (-23.27, -9.25) <0.001 -21.83 (-30.19, -13.47) <0.001 
CC, mm -10.08 (-35.97, 15.81) 0.445 -12.92 (-44.20, 18.35) 0.481 - - -9.28 (-42.87, 24.30) 0.588 
Age, years -1.83 (-2.85, -0.81) <0.001 -2.43 (-3.57, -1.29) <0.001 -2.19 (-3.25, -1.13) <0.001 -2.31 (-3.55, -1.06) <0.001 
Gender (male) 28.18 (16.44, 39.92) <0.001 39.97 (25.39, 54.54) <0.001 42.54 (28.57, 56.13) <0.001 49.89 (34.95, 64.82) <0.001 
SBP, mmHg - - - - - - -2.72 (-0.68, 0.13) 0.193 
DBP, mmHg - - 0.02 (-0.67, 0.71) 0.954 - -   
HbA1c, % -3.72 (-7.72, 0.27) 0.068 -5.22 (-10.06, -0.37) 0.035 -5.29 (-10.24, -0.35) 0.036 -5.44 (-10.35, -0.52) 0.030 
TG, mmol/L - - - - 2.27 (-3.35, 8.79) 0.380 2.79 (-3.28, 8.88) 0.367 
For inferior, superior, nasal and temporal PPCT age, gender, glaucoma status, diabetic retinopathy, age related macular degeneration and variables with p<0.10 in  
univariate models were included in multivariate models. 
CI=confidence interval; PPCT=peripapillary choroidal thickness, AL=axial length; CC=corneal curvature; SBP=systolic blood pressure; DBP=diastolic blood 




Table 7.15 Comparison of the baseline characteristics of ethnic Malays (n = 540) and 




 (n = 540) 
Indians  
(n = 439) 
P-value* 
Age, years 62.70 (8.91) 58.56 (8.18)  <0.001 
Gender, % male 251 (46.5) 231 (52.6)  0.046 
Axial length, mm 23.59 (0.96) 23.42 (1.00)  0.012 
Corneal curvature, mm 7.66 (0.24) 7.61 (0.26)  0.003 
Spherical equivalent, D 0.11 (1.74) 0.33 (1.57)  0.039 
OPP, mmHg 55.55 (8.19) 53.29 (7.12)  0.001 
SBP, mmHg 139.56 (19.68) 132.80 (17.32)  <0.001 
DBP, mmHg 76.90 (10.66) 77.72 (9.77)  0.209 
BMI, kg/m
2
 26.87 (5.07) 26.41 (4.42)  0.133 
HbA1c, % 6.35 (1.43) 6.31 (1.37)  0.678 
Total cholesterol, mmol/L 5.36 (1.29) 5.07 (1.25)  0.001 
Triglycerides, mmol/L 1.92 (1.30) 1.99 (1.10)  0.410 
Blood creatinine, mmol/L 83.23 (41.23) 76.13 (43.75)  0.010 
Diabetes mellitus, % 220 (42.1) 199 (45.3)  0.328 
Hypertension, % 385 (71.3) 255 (58.2) <0.001 
Diabetic retinopathy, % 30 (5.6) 26 (5.9) 0.890 
AMD, % 1 (0.2) 1 (0.2) 0.887 
Glaucoma, % 5 (5.3) 6 (9.2) 0.359 
Current smoking, % 98 (18.1) 59 (13.4)  0.054 
Data presented are means (standard deviations) or number (%). 
*Based on independent sample t-test for continuous variables or Chi-square/Fisher’s exact 
test for categorical variables. 
OPP=ocular perfusion pressure; SBP=systolic blood pressure; DBP=diastolic blood pressure; 




Table 7.16 Comparison of the distribution of mean unadjusted macular choroidal 
thickness and volume in ethnic Malays and Indians using fully automated choroidal 
segmentation technique. 
  Data are means (standard devaitions). 
 *Based on independent sample t-test  
  
Macular Choroidal Thickness 
(µm) 
Malays  
(n = 540) 
Indians  
(n = 439) 
P-
value* 
Average  212.99 (79.72)  242.83 (81.73)  <0.001 
Sub-foveal 242.28 (97.58) 267.23 (100.99) <0.001 
Nasal, 1.5 mm 142.44 (79.19) 170.09 (88.79) <0.001 
Nasal, 3 mm 208.35 (98.20) 254.59 (107.70) <0.001 
Temporal, 1.5 mm 232.17 (89.42) 249.23 (91.06) <0.001 
Temporal, 3 mm 207.65 (80.98) 230.59 (84.13) <0.001 
Choroidal Volume (mm3) 
   
Choroidal volume of 7 line scan 
(8.9 x 1.5 mm) 
1.88 (0.69) 2.16 (0.68) <0.001 
Choroidal volume at central macula 
(1mm) 
 0.185 (0.072) 0.209 (0.071)  <0.001 
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Table 7.17 Comparison of the distribution of mean adjusted macular choroidal 
thickness and volume in ethnic Malays and Indians using fully automated choroidal 
segmentation technique. 
  Data are mean (standard error). 
  *Adjusted for age, gender, AL, corneal curvature, OPP, current smoking, creatinine,    
  cholesterol, AMD, DR and glaucoma status. 
 
  
Macular Choroidal Thickness 
(µm) 
Malays  
(n = 540) 
Indians  
(n = 439) 
P-
value* 
Average  223.44 (3.86) 236.13 (4.43) 0.011 
Sub-foveal 253.40 (4.95) 261.72 (5.69) 0.195 
Nasal, 1.5 mm 224.44 (4.92) 250.19 (5.56) <0.001 
Nasal, 3 mm 151.75 (4.11) 163.16 (4.72) 0.032 
Temporal, 1.5 mm 240.21 (4.54) 241.80 (5.21) 0.787 
Temporal, 3 mm 212.18 (4.21) 222.12 (4.84) 0.069 
Choroidal Volume (mm3)    
Choroidal volume of 7 line scan  
(8.9 x 1.5 mm) 
1.99 (0.032) 2.12 (0.037) 0.002 
Choroidal volume at central macula 
(1mm) 
0.195 (0.003) 0.205 (0.004) 0.023 
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Table 7.18 Comparison of the distribution of mean unadjusted peripapillary choroidal 






(n = 904 eyes) 
Indians 
(n = 650 eyes) 
P-value* 
Superior 150.53 (2.31) 196.87 (3.80) <0.001 
Nasal 143.53 (2.26) 183.63 (3.79) <0.001 
Inferior 111.34 (2.01) 150.63 (3.15) <0.001 
Temporal 139.47 (2.71) 193.86 (4.07) <0.001 
Average   136.22 (2.23) 181.09 (3.55)  <0.001  
  Data are mean (standard error). 





Table 7.19 Comparison of the distribution of mean adjusted peripapillary choroidal 





(n = 904 eyes) 
Indians* 
(n = 650 eyes) 
P-value* 
Superior 156.51 (3.19) 190.93 (3.50) <0.001 
Nasal 150.06 (3.17) 175.79 (3.48) <0.001 
Inferior 116.71 (2.71) 144.94 (2.98) <0.001 
Temporal 146.75 (3.51) 186.67 (3.85) <0.001 
Average   142.56 (3.01) 174.49 (3.30)  <0.001  
  Data are mean (standard error). 
  * Adjusted for age, gender, AL, corneal curvature, OPP, creatinine, cholesterol,  





DISTRIBUTION AND DETERMINATS OF CHOROIDAL VASCULATURE 
IN POPULATION-BASED STUDY  
In Chapter VII, we have evaluated choroidal parameters such as CT and 
volume in our multi-ethnic population. However, given that the choroid is 
predominantly composed of blood vessels (~85%) surrounded by stromal tissues, a 
detailed analysis of the choroid in terms of its vasculature may be a more suitable way 
to assess choroidal health and to better understand its role in diseases where choroid is 
implicated in the pathophysiology. 
Therefore, in this Chapter, we assessed vascular status of the choroid through 
image binarization of EDI SD-OCT images in healthy eyes from a population-based 
study. To represent vascular status of the choroid we computed OCT derived 
quantitative parameter called “choroidal vascularity index (CVI)”. We also evaluated 
the ocular and systemic determinants of CVI in our population-based sample. 
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The choroid is the vascular layer of eye, with one of the highest blood flow of 
any tissue in the body.
1
 The choroid is predominantly composed of blood vessels 
surrounded by stromal tissue comprising of connective tissue, melanocytes, nerves 
and extracellular fluid.
2
 The vascular layer of the choroid may be differentiated into 3 
layers from internal to external, with increasing luminal diameter. The innermost 
layer is the choriocapillaris, the middle is Sattler’s layer with medium vessels, and the 
outer is Haller’s layer, with large vessels.1 
Being a major vascular layer of the eye the choroid plays an important role in 
ocular health, and is involved in the pathogenesis of many intraocular diseases such as 
AMD, PCV, CSCR and myopic macular degeneration.
3-9
 There is evidence from 
histological studies that the disease processes affect the stroma and vasculature of the 
choroid.
10-12
 However, shrinkage occurs during the fixation of the tissues during the 




CT has been reported as an indicator of ocular
14-17
 and systemic health.
18-22
 
Although, many studies have now reported changes in the thickness of the choroid in 
various ocular and systemic diseases
8-12
 and proposed CT as a marker to assess these 
disease conditions, there exists a notable disparity in CT in various clinical studies. 
One such example is diabetes mellitus,
23-27
 where there has been no consensus as to 
whether it causes an increase or decrease in CT. This raises the question of what 
structures in the choroid changes with increasing or decreasing CT and if there is a 
more robust marker to assess choroid health.  
To answer this question, morphological and vascular analyses of the choroid 
may provide some clues and lead to the development of a more stable marker. The 
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advent of EDI OCT has allowed more precise non-invasive quantitative assessment of 
the choroid.
28
 Using EDI OCT, there have been attempts to assess the choroidal 
stromal and vascular structures.
13,29-32
 Recently Sonoda et al. described a method for 
computing luminal and interstitial areas in the choroid as a means to quantify vascular 
status of the choroid.
30,31
  
Adapting the image segmentation technique proposed by Sonoda et al.,
30,31
 we 
further propose a new quantitative parameter called choroidal vascularity index (CVI) 
to assess vascular status of the choroid through image binarization of EDI SD-OCT 
images in healthy eyes. Furthermore, we aimed to determine the ocular and systemic 
factors affecting the CVI as well as CT in subjects enrolled from a population-based 
study in Singapore. This index may provide additional information on the morphology 
and physiology of the choroid and may be a more robust marker compared to CT. 
 
8.2 METHODS 
8.2.1 Study Population 
The data for this study was derived from SiMES-2, a population based cohort 
study of 45 – 85 years old Malay adults living in Singapore.  This study was 
conducted as per the tenets set forth in the Declaration of Helsinki, and ethics 
committee approval was obtained from the Institutional Review Board of SERI. 
Written informed consent was obtained from the subjects after explanation about the 
details of the study and any potential risks involved with the study and consequences 
of the study.  
8.2.2 Study Subjects 
Details of the study design, and methodology have been reported in detail in 
Chapter III and elsewhere.
33
 In this study, we enrolled 400 consecutive participants 
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from February 2012 to April 2013. Exclusion criteria included: logMAR visual acuity 
>0.30, SE <-6 D, evidence of vitreo-retinal diseases such as AMD and DR, previous 
ocular surgery or clinical features compatible with a diagnosis of glaucoma and 
Spectralis OCT imaging with a quality index <18 decibels. Glaucoma was defined as 
described in Chapter III and elsewhere.
34
 
8.2.3 Choroidal Thickness Assessment 
The choroid was imaged using the EDI mode of SD-OCT (Spectralis, 
Heidelberg Engineering, Heidelberg, Germany) explained in detail in Chapter III. In 
our study, Bruch’s membrane and the CSI were delineated with our automatic 
segmentation algorithm
35
 which demonstrated excellent repeatability in our 
previously reported population-based study.
36
 Although measurements of both eyes of 
each study participant were obtained, due to inter eye correlation only the right eye 
was used for further analysis. 
8.2.4 Image Binarization Details 
The same raster scan passing through the fovea was selected for binarization. 
It was segmented using the protocol described by Sonoda et al.
30-31
 with minor 
modifications. The image binarization was done using public domain software, Image 
J (version 1.47; http://imagej.nih.gov/ij/). The subfoveal choroidal area with a width 
of 1.5 mm, centred at the fovea, was selected (Figure 8.1A) and this constituted the 
region of interest. Only 1.5 mm of the macular area on the single line scan was 
selected as a representative segment of the macular region due to segmental nature of 
the choroidal blood supply as described by Hayreh.
37
 The posterior ciliary arteries and 
their branches along with terminal choroidal arterioles, the choriocapillaris, and the 




Image binarization techniques can be used to convert grey scale images into 
binarized images. This facilitates tasks such as image layout analysis and image skew 
estimation. An appropriate image binarization technique, taking into account the 
uneven illumination, image contrast variation and poor image resolution, is essential 
to accurately apply a threshold to an image.  Different image binarization or 
thresholding techniques like Otsu’s, Bernsen’s and Niblack’s autolocal thresholding 
techniques were hence attempted.
38,39
 Otsu’s is a global thresholding technique while 
Bernsen’s is local thresholding technique. After comparing the different image 
segmentation techniques, we adopted Niblack’s autolocal threshold technique in our 
current study. This is because it takes into consideration the mean and standard 
deviation of all the pixels in the region of interest. In addition, given that binarization 
could be influenced by the variation in the amount of melanin in RPE in different 
eyes, and also affected by the direction of light and focusing issues, these were taken 
into account by using a distinct binarization threshold for individual subject. 
 
Using Niblack’s autolocal threshold tool, the image was first binarized to get a 
clear view of the choroid-scleral interface (Figure 8.1B). This was to allow more 
precise selection of the subfoveal choroid area. This is in contrast to Sonoda’s et 
al
30,31
 protocol in which the polygonal area was selected prior to image binarization. 
In addition, we did not preselect vessels of size more than 100 um. 
With the upper border marked at the RPE and the lower border the line of light 
pixels at the choroid scleral junction, the choroidal area was selected using polygon 
tool and added to the region of interest manager (Figure 8.1B). The image was then 
converted to RGB (red, green, blue) colour to allow the colour threshold tool to select 
the dark pixels (Figure 8.1C). The total subfoveal circumscribed choroidal area 
(TCA) and the area of dark pixels were calculated. The luminal area (LA) was defined 
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as the area of dark pixels. Stromal area (SA) was further calculated by subtracting LA 
from TCA. To determine the vascularity status of the choroid, CVI was computed by 
dividing LA by TCA. In addition, the proportion of dark (LA) to light areas (SA) was 
also computed. Figure 8.1D represents the overlay image of the region on interest on 
the original EDI OCT scan.  
The detailed step by step process of image binarization technique using Image 
J is as explained below: 
Firstly, the 1x1 pixel image of the OCT was opened in Image J, and the scale 
was set. The line tool was used to measure the pixel length of 200 um as given in the 
scale at the bottom of the OCT scan image (Figure 8.2). To set the scale, the option 
Analyse > Set Scale was selected, and the known distance was set to 2 mm. For future 
images, the “Disable Global Calibration” was unchecked when the images were 
opened.   
Secondly, a 1.5mm line was drawn above the fovea, with the center of the 
fovea. The lines were drawn by first using the Colour Picker tool to select white, then, 
using the line tool, 1.5mm was measured parallel to the retinal pigment epithelium 
and drawn with the centre of the line just above the of the fovea, above the retina. 
“Command-D” was keyed in to leave a mark where the line was initially drawn. 
Thirdly, auto local threshold was applied. Image > Type > 8 bit was first applied 
(Figure 8.3A), followed by Image > Adjust > Auto Local Threshold (Figure 8.3B). 
Niblack was selected as the method (Figure 8.3C). 
Next, the polygon tool was used to draw a polygon under the lines drawn, to 
select the subfoveal choroid (Figure 8.4A). The area of the choroid under the retinal 
pigment epithlium was selected. The upper border was marked at the retinal pigment 
epithelium and the lower border area was below the line of light pixels at the choroid 
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scleral junction. The area was saved in the ROI manager by selecting the option 
Analyse > Tools > ROI manager, and Add [t] (Figure 8.4B). Fifthly, the area of 
vascularity was highlighted by selecting Image > Type > RGB colour, and Image > 
Adjust > Colour Threshold. The first bar under Brightness was adjusted to 0, and the 
second bar was adjusted to 254 (Figure 8.5A). After clicking Select (Figure 8.5B), 
the area was added to the ROI manager. 
After clicking Select in the above figure, the area was added to the ROI 
manager by selecting Add [t] to determine the area of vascularity within the initially 
selected polygon, both areas in the ROI manager were selected (Figure 8.6A) and 
merged by selecting More > AND (Figure 8.6B). The composite third area was added 
to the ROI manager by selecting Add [t] (Figure 8.6C). Lastly, the first and third 
areas were selected and measured using the ROI manager. The first area represents 
the total area of choroid selected, and the third composite area is the vascular area. 
8.2.5 Inter-rater and Intra-rater Agreement 
10% of the total images (35 images), were initially segmented by two graders 
(KAT and RA) to determine inter-rater agreement. The same set of images was 
segmented by one grader (KAT) after an interval of one week to compute intra-rater 
reliability. The intra- and inter-rater reliability for the image binarization was 
measured by the absolute agreement model of the intra-class correlation coefficient 
(ICC).
40
 ICC value of 0.81 – 1.00 indicates good agreement. Values of less than 0.40 
indicate poor to fair agreement. We also performed Bland-Altman plot analyses
41,42 
to 
determine the mean difference between the measurements. The Bland-Altman plots 
were constructed using MedCalc version 12.3 (Medcalc Software, Ostend, Belgium) 
software. Moreover, random scans, including those with thick and thin choroid, were 
further reviewed by both graders to ensure good inter-rater agreement. After obtaining 
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good inter-rater and intra-rater agreement, all the scans were binarized by single 
author (KAT). 
8.2.6 Measurement of Ocular and Systemic Factors 
Each participant underwent a detailed interview and a standardized 
examination for comprehensive assessment of various ocular and systemic factors. 
Measurement of ocular and systemic factors has been explained in detail in Chapter 
III of this thesis.   
8.2.7 Statistical Methods 
Statistical analysis was performed using SPSS version 20.0 (SPSS, Inc., 
Chicago, IL, USA). Since CVI and subfoveal choroidal thickness (SFCT) have 
different measurement units, we used the coefficient of variation (COV) to compare 
the variability between CVI and SFCT. Univariate and multiple linear regression 
analyses were performed to determine the associations of SFCT and CVI (dependent 
variables) with ocular and systemic factors (independent variables). For multiple 
linear regression, factors showing significant association in univariate analysis 
(p<0.10) were included. All p values were 2-sided and considered statistically 
significant when the values were less than 0.05.  
 
8.3 RESULTS 
A total of 400 subjects were recruited for this study. We excluded 55 subjects 
for the following reasons: visual acuity worse than 0.30 (n=9), SE < -6 D (n=7), 
glaucoma (n=6), presence of macular or vitreo-retinal diseases (n=18) and poor OCT 
image quality (n=15). A total of 345 eyes from 345 subjects were included in the final 
analysis; 190 (55%) subjects were female. The demographics, ocular, systemic and 
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choroidal characteristics of the study subjects are shown in Table 8.1. In terms of 
choroidal characteristics, mean TCA was 0.74±0.21mm
2
 and mean LA was 
0.49±0.15mm
2. Mean SFCT was 241.34±97.11μm (range, 40.24 - 519.48μm) and 
mean CVI was 65.61±2.33% (range, 60.07 - 71.27%).  
CVI was found to have lower COV (3.55) than SFCT (COV = 40.30), 
indicating CVI to be less variable than SFCT. The histogram plots (Figure 8.7A and 
Figure 8.7B) represent the distribution of SFCT and CVI in relation to normal density 
plot.  
Using image binarization, the intra- (ICC: 0.97 to 0.99 for TCA and ICC: 0.91 
to 0.98 for LA) and inter-grader reliability (ICC: 0.90 to 0.97 for TCA and ICC: 0.89 
to 0.97 for LA) were excellent for both TCA and LA (Table 8.2). Bland Altman plot 
analysis of intra- and inter-rater reliability for TCA (Figures 8.8A and 8.8B) and LA 
(Figures 8.8C and 8.8D) at sub-foveal location was excellent.  
In Table 8.3, the multiple regression model shows younger age, shorter AL, 
higher IOP, higher LA and lower systolic blood pressure to be significantly (p<0.05) 
associated with thicker sub-foveal choroid. However, among factors associated with 
CVI (Table 8.4), in the multiple regression model, SFCT was the only factor 
associated with CVI. A thicker sub-foveal choroid was significantly (p<0.001) 
associated with higher CVI. There were no other statistically significant association 
between CVI and any other factors (Table 8.4).  
 
8.4 DISCUSSION 
In this population-based study, using the modified Sonoda’s image 
binarization technique for EDI SD-OCT scans, we propose an OCT based metric 
termed “CVI” to assess vascularity of the choroid. Our results validated the findings 
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obtained by Sonoda et al. and found that on a single cross sectional scan, nearly two 
third (~66%) of the subfoveal choroid is vascular in healthy eyes. Importantly, CVI 
showed lesser variability and was influenced by fewer physiologic factors as opposed 
to CT, indicating CVI to be a relatively stable index for studying the changes in the 
choroid. As the choroid is primarily a vascular structure, understanding of this new 
vascular index may help to further elucidate the role of vascular processes within the 
choroid in disease development and progression. We hence propose CVI as an 
independent surrogate marker to assess choroidal health in future studies. 
Several studies have assessed the vascular structures of the choroid by 
OCT,
13,29
 but they required customized software that limited their widespread use. 
There are reports
30,31
on the differentiation and quantification of the structural 
components of the choroid (luminal and interstitial areas), using freely and easily 
accessible software, Image J, these studies were performed in clinic-based settings 
with a potential selection and sampling biases. We have highlighted the significant 
differences in our protocol with that proposed by Sonoda et al.
30,31
 in Table 8.5. Our 
modification of applying auto local threshold prior to image binarization enabled us to 
accurately localise choroid scleral interface giving more precise selection of the 
choroid. In addition, the simple binarization technique without pre-selection of larger 
choroidal vessels allowed nearly accurate estimation of vascularity of the choroid 
even with a very simple algorithm, which can be reproduced by the wider research 
community.  
Although there is no concrete evidence that the dark areas represented the 
vascular areas and the light areas the stromal areas, the findings of earlier studies and 
that of numerous empirical observations suggest that the dark areas were the vascular 
components in the binarized images.
13,29
 In addition, a comparison of the original 
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EDI-OCT images to the binary images (Figure 8.1) revealed that the dark areas 
corresponded with vascular components of the choroid, including both the larger and 
smaller choroidal vessels. Therefore, the binarization technique developed by Sonoda 
et al.,
30,31
 which was further simplified by us, is valid and offers precise segmentation 
of choroidal vasculature from stroma. 
Interestingly, when comparing the factors affecting SFCT to those that affect 
CVI, we found SFCT to be associated with many physiological factors such as age, 
AL, IOP and, most significantly, the vascular area in the choroid (LA), whereas 
stromal area did not have a significant association with SFCT. On the other hand, CVI 
was only affected by SFCT, but was not affected by most of the physiological 
variables. Moreover, SFCT demonstrated relatively greater variability (mean SFCT 
was 241.34±97.11µm, COV=40.30) compared to CVI (mean CVI was 65.61±2.33%, 
COV=3.55). Thus our results suggest CVI to be a better and relatively more stable 
marker to monitor choroid compared to CT, which is affected by more variables and 
demonstrated greater variability. Clinically, measuring the proportion of vascularity 
of the eye would provide us with a deeper understanding of how disease processes 
affect different structures in the eye, and therefore may be more informative 
compared to CT measurements alone. 
We have demonstrated a significant association of SFCT with vascular area of 
the choroid. This signifies the fact that the vascular area is the predominant segment 
influencing the CT in normal population. An increase in CVI reflects either an 
increase in the number of blood vessels or in the diameter of the choroidal blood 
vessels within a designated area. Hayreh 
37
 demonstrated the vulnerability of 
submacular choroidal supply to generalised chronic ischaemic disorders (age related 
macular degeneration), due to numerous watershed zones of the short posterior ciliary 
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arteries in the choroid. There can be potential clinical implications of the CVI, which 
can be explored in further studies. A decrease in CVI on EDI OCT scans at baseline 
may be an indicator of choroidal ischemia in patients with macular disorders like age 
related macular degeneration or diabetes. On the other hand, we may use CVI to 
determine increase in vascularity of the choroid in posterior uveitis or central serous 
chorioretinopathy. CVI can also be used as a follow up tool for treatment response 
and resolution of diseases.  
The strengths of our study include a large sample size with a single common 
ethnicity. Hence, our findings were unlikely to be confounded by ethnic 
heterogeneity. Standardized clinical examination protocols, as well as reliable 
differentiation and quantifications of choroidal morphometric parameters and OCT 
parameters were used in our study. Nevertheless, this study has few limitations. First, 
binarization of choroidal images was performed only in the right eye of each study 
subject. There may exist inter-eye differences, yet such differences should be small. 
Second, the CT measurements in our study were not performed at the same time of 
the day; each participant underwent the OCT examination in a randomized manner 
with respect to when the readings were obtained. It seems unlikely that circadian 
changes may have influenced the results of our investigation. Third, although our 
images were binarized at standard threshold, there is a possibility of over or 
underestimation of both SA and LA.  
 
8.5 CONCLUSIONS 
In conclusion, in this population-based study, we introduced a novel OCT 
based marker termed “CVI” to assess vascularity of the subfoveal choroid. Our result 
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showed that on a single cross sectional EDI-OCT image, two-third (~66%) of the 
subfoveal choroid is vascular in healthy eyes. This index should provide a new means 
of studying the pathophysiology of human choroid in greater detail. However, larger 
studies for different disease models are warranted to further validate the application of 
this index in clinical practice. Whether CVI is a complimentary or substitute tool to 
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CHAPTER VIII TABLES 
Table 8.1 Demographics, clinical and choroidal characteristics of study subjects (n = 
345) 
Characteristics Mean  ± SD Range 
Age, yrs 61.53 ± 8.77 47.19 to 86.72 
Gender, male (%) 155 (44.9%) 
Axial length, mm 23.58 ± 0.96 21.60 to 27.89 
IOP, mm Hg  14.41 ± 2.84 6 to 20 
Ocular perfusion pressure, mmHg 55.68 ± 8.39 37.44 to 96.11 
Systolic blood pressure, mmHg 139.21 ±20.63 95 to 226.50 
Diastolic blood pressure mmHg 77.27±10.85 54.50 to 133 
Body mass index, kg/m
2
 26.75 ±5.13 12.15 to 52.95 
Serum glucose, mmol/L 6.98 ± 3.35 2.8 to 22.9 
HbA1c, % 6.26 ± 1.27 4.3 to 11.7 
Total cholesterol, mmol/L 5.43 ± 1.26 2.49 to 10.40 
Triglycerides, mmol/L 1.95 ± 1.38 0.42 to 14.95 
Blood creatinine, mmol/L 78.92 ± 33.11 30 to 412 
Current smoking, % 68 (19.8%) 
Alcohol consumption, % 5 (1.5%) 
Choroidal Parameters   
TCA, mm
2
 0.74±0.21 0.198 to 1.237 
LA, mm
2
 0.49± 0.15 0.122 to 0.817 
SA, mm
2
 0.25±0.06 0.076 to 0.441 
CVI (LA/TCA) 65.61±2.33 60.07 to 71.27 
LA/SA 1.92±0.20 1.50, 2.48 
SFCT, μm 241.34±97.11 40.24, 519.48 
Data presented are means ± standard deviations (SD), except for gender, HbA1c, current 
smoking and alcohol consumption which are number (%). 
TCA, total sub-foveal choroidal area; LA, luminal area; SA, stromal area; CVI, choroidal 
vascularity index; LA/SA, luminal area/ stromal area; SFCT, sub-foveal choroidal thickness. 
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Table 8.2  Intra- and inter-grader reliability assessment of choroidal parameters in 35 subjects 
 
 Intra Rater Inter Rater 
ICC 
(95% CI) 






TCA 0.99 (0.97 to 0.99) -0.01 (-0.16 to 0.13) 0.94 (0.90 to 0.97) 0 (-0.06 to 0.07) 
LA 0.96 (0.91 to 0.98) -0.01 (-0.11 to 0.09) 0.94 (0.89 to 0.97) 0.01 (-0.07 to 0.10) 
 




Table 8.3 Linear regression analyses of ocular and systemic factors associated with sub-foveal choroidal thickness  
 Univariate Multivariate* 
 Unstandardized β Standardized β P-value Unstandardized β Standardized β P-value 
Ocular factors       
Axial length, mm -15.348 -0.155 0.005 -10.508 -0.105 0.002 
IOP, mmHg 3.160 0.092 0.087 3.619 0.105 0.002 
OPP, mm Hg -0.354 -0.031 0.572 - - - 
LA, mm
2
 523.214 0.814 <0.001 459.729 0.714 <0.001 
SA, mm
2
 1132.841 0.787 <0.001 68.271 0.047 0.669 
Systemic factors       
Age, yrs -3.986 -0.360 <0.001 -0.856 -0.077 0.041 
Gender, female -22.274 -0.114 0.034 -13.171 -0.068 0.068 
Body mass index, kg/m
2
 -1.173 -0.062 0.252 - - - 
Systolic blood pressure, mmHg -0.499 -0106 0.050 -0.328 -0.071 0.043 
Diastolic blood pressure mmHg 0.749 0.084 0.122 - - - 
Serum glucose, mmol/L 0.102 0.004 0.949 - - - 
HbA1c, % 5.913 0.077 0.157 - - - 
Total cholesterol, mmol/L 8.092 0.106 0.052 -0.525 -0.007 0.836 
Triglycerides, mmol/L 3.456 0.049 0.366 - - - 
Blood creatinine, mmol/L -0.050 -0.017 0.754 - - - 
Current smoking, Yes 28.392 0.116 0.031 -11.737 -0.049 0.187 
Alcohol consumption, Yes -19.833 0.024 0.651 - - - 
  *Adjusted for variables with a p-value<0.10 in the univariate analysis. 










Table 8.4 Linear regression analyses of ocular and systemic factors associated with choroidal vascularity index  
 Univariate Multivariate* 
 Unstandardized β Standardized β P-value Unstandardized β Standardized β P-value 
Ocular factors       
Axial length, mm -0.274 -0.113 0.039 -0.106 -0.004 0.375 
IOP, mmHg -0.014 -0.018 0.745 - - - 
OPP, mmHg 0.022 0.080 0.136 - - - 
SFCT, µm 0.012 0.519 <0.001 0.012 0.484 <0.001 
Systemic factors       
Age, yrs -0.057 -0.215 <0.001 -0.001 -0.003 0.950 
Gender, female -0.706 -0.151 0.005 -0.183 -0.039 0.482 
Body mass index, kg/m
2
 -0.026 -0.058 0.283 - - - 
Systolic blood pressure, mmHg -0.001 -0.012 0.818 - - - 
Diastolic blood pressure mmHg 0.031 0.145 0.007 0.019 0.089 0.072 
Serum glucose, mmol/L 0.025 0.036 0.511 - - - 
HbA1c, % 0.034 0.018 0.736 - - - 
Total cholesterol, mmol/L 0.115 0.062 0.256 - - - 
Triglycerides, mmol/L 0.130 0.077 0.158 - - - 
Blood creatinine, mmol/L 0.003 0.035 0.516 - - - 
Current smoking, Yes 1.098 0.187 <0.001 0.535 0.092 0.088 
Alcohol consumption, Yes 1.004 0.051 0.341 - - - 
  *Adjusted for variables with a p-value<0.10 in the univariate analysis. 




Table 8.5 Image binarization protocol in Sonoda et al. vs. current study 
 
 
 Sonoda et al (2014)
30
 Sonoda et al (2015)
31
 Current study 
Study sample size 15 eyes of 15 subjects 180 eyes of 180 subjects 345 eyes of 345 subjects 
 
Choroidal area measured 1.5 mm 7.5 mm 1.5 mm 
 
Location of measurement Centered on fovea , 1500 um Entire raster scan, 7500 um Centered on fovea (1500 um) due to the segmental nature 
of choroidal blood supply as described by Hayreh et al.
37
 
Pre-selection of vessels 3 choroidal vessels with lumens > 100 mm were randomly 
selected and the average reflectivity of these areas was 
determined by the software 
Used autolocal threshold techniques to allow binarization 
of smaller choroidal vessels or choriocapillaris. 
Brightness adjustment Average brightness was set as the minimum value 
 
Brightness was not adjusted as it would reduce the 
contrast between luminal and stromal areas and possibly 
affect the autolocal threshold. 
Order of binarization Region of interest selected prior to image binarization To get a clear view of the choroid-scleral interface, 
image binarization was performed prior to area selection. 






CHAPTER VIII FIGURES 
Figure 8.1 Image binarization for choroid with normal choroidal thickness. (A) 
Original SD OCT image. (B) 1.5 mm segmentation block of the subfoveal choroidal 
area. (C) Segmented OCT image using modified image binarization approach. (D) 
Overlay of region of interest created after image binarization was performed on the 







Step by step process for binarizing the image using image J software 
Figure 8.2 To set the scale, the option Analyse > Set Scale was selected, and the 












Figure 8.3 Auto local threshold was applied. Image > Type > 8 bit was first applied 
(A), followed by Image > Adjust > Auto Local Threshold (B). Niblack was selected 
as the method (C). 
 
   










Figure 8.4 The polygon tool was used to draw a polygon under the lines drawn, to 
select the subfoveal choroid (A). The area of the choroid under the retinal pigment 
epithlium was selected. The upper border was marked at the retinal pigment 
epithelium and the lower border area was below the line of light pixels at the choroid 
scleral junction. The area was saved in the ROI manager by selecting the option 
Analyse > Tools > ROI manager, and Add [t] (B). 
 
 
    








Figure 8.5 Fifthly, the area of vascularity was highlighted by selecting Image > Type 
> RGB colour, and Image > Adjust > Colour Threshold. The first bar under 
Brightness was adjusted to 0, and the second bar was adjusted to 254 (A). After 









Figure 8.6 After clicking Select in the above figure, the area was added to the ROI 
manager by selecting Add [t]. to determine the area of vascularity within the initially 
selected polygon, both areas in the ROI manager were selected (A) and merged by 
selecting More > AND (B). The composite third area was added to the ROI manager 
by selecting Add [t] (C). Lastly, the first and third areas were selected and measured 
using the ROI manager. The first area represents the total area of choroid selected, 
and the third composite area is the vascular area. 
 
   
















Figure 8.8 Bland Altman plots of total choroidal area and luminal area. (A) and (B) shows intra- and inter- rater reliability for total 
choroidal area respectively. (C) and (D) shows intra- and inter- rater reliability for luminal area respectively. 
For intra-rater reliability, the difference was calculated by the 1st measurement minus the 2nd measurement. Pink dashed line represents regression 
line of difference between 1st and 2nd measurements. For inter-rater reliability, the difference was calculated by the grader 1 measurement minus the 
grader 2 measurement. Pink dashed line represents regression line of difference between the two graders measurements. 
  













































































































(A). Intra-Grader Reliability for Total Choroidal Area (B). Inter-Grader Reliability for Total Choroidal Area 
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CHARACTERIZATION OF CHOROID IN HIGH MYOPES 
Until now we have addressed the technological challenges in the field of 
choroidal imaging by our novel semi- and fully-automated choroidal image 
processing techniques as well as objectively and reliably quantified choroidal 
parameters such as thickness, volume and vasculature in our multi-ethnic populations 
in Singapore.  
However, we postulate that due to axial elongation of the globe in eyes with 
high myopia, the above choroidal traits and in particular other morphological and 
vascular attributes of the choroid such as CSI curvature, inflection point, and vascular 
area might be altered in eyes with high myopia. Therefore, in this Chapter we 
characterized the choroid including its detailed morphological and vascular analysis in 
young high myopes. 
The manuscripts relevant to the contents of this chapter have been published in the 
following journals: 
Gupta, P., S. Saw, C. Y. Cheung, M. J. Girard, J. M. Mari, M. Bhargava, C. Tan, M. Tan, A. 
Yang, F. Tey, G. Nah, P. Zhao, T. Y. Wong and C. Y. Cheng. "Choroidal Thickness 
and High Myopia: A Case-Control Study of Young Chinese Men in Singapore." Acta 
Ophthalmologica 2015;93(7):585-592. 
Gupta, P., C. Y. Cheung, S. M. Saw, M. Bhargava, C. S. Tan, M. Tan, A. Yang, F. Tey, G. 
Nah, P. Zhao, T. Y. Wong and C. Y. Cheng. "Peripapillary Choroidal Thickness in 
Young Asians with High Myopia." Investigative Ophthalmology and Vision Science  
2015;56(3):1475-1481. 
Gupta, P., S. Saw, C. Y. Cheung, M. J. Girard, J. M. Mari, M. Bhargava, C. Tan, M.  
Tan, A. Yang, F. Tey, G. Nah, P. Zhao, T. Y. Wong and C. Y. Cheng. "Choroidal 
Thickness is not a Predictor of Visual Acuity in Young High Myopes." Acta 
Ophthalmologica May 2016; 94(8) [Epub ahead of print]. 
 
Gupta, P., S. G. Thakku, S. Saw, M. Tan, E. Lim,
 
M. Tan, C. M. G. Cheung, T. Y. Wong      
and C. Y. Cheng. “Detailed Phenotyping and Characterization of Choroidal 
Morphological and Vascular Features in Young Men with High Myopia using 
Spectral Domain Optical Coherence Tomography.” American Journal of 







High myopia (defined as -6 D or more) is a major cause of visual impairment 
in the world
1-3
 and the prevalence is especially high in East Asia.
4-7
 In particular, in 
Singapore, the prevalence of pathological myopia or high myopia in young adults is 
high ~14.7%.
8
 In high myopia, excessive axial elongation of globe can cause 
biomechanical stretching and thinning of not only the RPE layers
9, 10
 but also the 
choroid,
11-13
 leading to increased risk of various chorioretinal complications
14-17
 which 
may lead to vision loss. Thus, the changes in the choroid are significant but they are 
not well studied. 
Because, the choroid contributes blood supply not only to the outer retina
18 
 
but also to the prelaminar portion of the optic nerve,
19
 a variety of ocular pathologies 
including glaucoma
20, 21
 and high myopia
11
 occur in the peripapillary choroidal 
region. Given that high myopia is associated with a high prevalence of retinal 





atrophy as well as optic disc changes, such as oval configuration, larger area of 
peripapillary atrophy, disc tilt and rotation,
24
 these may potentially affect the 
characteristics of both macular and peripapillary choroid such as its thickness and 
distribution profile. As some of the earliest changes in high myopia begin in the 
choroid, characterization of the choroid may help elucidate the mechanisms through 
which the choroid affects these diseases.  
Since choroid supports the metabolic demands of the RPE and 
photoreceptors,
25
 disturbances in choroidal morphology and circulation may account, 
in part, for outer retinal dysfunction and vision loss in high myopia. Thus, we 





With the advancement in imaging technology, OCT based EDI 
26
 provides an 
easy and non-invasive way to quantify CT. Although, using EDI, SD-OCT various 
investigators have measured CT in the macular area in high myopes but these studies 
were either conducted on small sample populations
11, 12
 or were mainly limited in 
their assessment of CT to horizontal locations only.
27, 28
 To the best of our knowledge, 
there are no studies which investigated CT by severity of myopia, the distribution of 
CT, and assessed ocular factors associated with CT in Asian eyes. Knowledge of such 
factors is crucial before drawing inferences on how CT influences the development of 
pathological myopia. In addition, none of the studies have explored the distribution of 
CT around the optic disc in high myopes.  
There is now evidence from recent studies that suggest CT to be a predictor of 
VA and thinner choroid to be associated with poorer VA.
27, 29-31
 However, these 
studies included only older participants mostly above 40 years, and their results may 
be confounded by other ocular comorbidities due to aging. In addition, in some 
studies
27, 30
 the association was tested using univariate analysis only, thus it remained 
unclear whether the observed association between VA and CT was a primary 
relationship or was due to confounding effects from other myopia-related changes, 
such as elongated AL. Finally, these studies were performed in myopic eyes free of 
myopic macular degeneration. It is unclear whether CT influences VA in the presence 
of myopic macular degeneration. 
Therefore, in this Chapter we evaluated various choroidal characteristics 
including, thickness (at both macular and peripapillary regions), morphology and 
vasculature in young, high myopes and compared them with emmetropes. We first 
quantified and compared the distribution of macular CT in myopes with varying 





evaluation of ocular determinants of sub-foveal CT in high myopes. We then 
performed the distribution and determinants of peripapillary CT in this cohort. This 
was followed by the detailed morphological and vascular analyses of the choroid in 
the sub-foveal (1.5 mm) and macular (6 mm) regions. And finally, we examined the 
potential influence of sub-foveal CT on VA in young, extremely high myopic persons 
(more than -10 D) with and without myopic macular degeneration changes. We used a 
case-control study approach of young, highly myopic and emmetropic healthy male 
adults in Singapore. 
 
9.2 MATERIALS AND METHODS 
9.2.1 Study Population  
A total of 28,908 male adults were screened for myopia (mean age ± SD: 19.8 
± 1.2 years; range: 17-29 years) from 2009 to 2010 as part of a mandatory medical 
eye review for employment purposes. Measured using non-cycloplegic autorefraction 
(Huvitz MRK-3100P), 2,584 persons were identified to have myopia with SE of -6.0 
D or worse. Of these 2,584 persons, 719 were selected on the basis of a refractive 
error-stratified random sampling strategy and underwent a further comprehensive 
ophthalmologic examination at SERI from December 2011 to June 2012. Their SE 
was further confirmed by subjective refraction, and those with SE >-6.0 D (n =96) 
were excluded, leaving 623 subjects with high myopia (251 with SE between -6.0 D 
and -8.0 D; 207 with SE between -8.0 D and -10.0 D; 165 with SE -10.0 D or worse). 
In addition, 151 emmetropes who had SE less than 0.5 D in both eyes measured using 
autorefraction were recruited as controls and went through a similar ophthalmologic 





this medical review, had any previous ocular trauma or surgery, and those with other 
clinically significant ocular co-morbidity.  
Written informed consent was obtained from the subjects and their 
parents/guardians (if they were 21 years old and below). Ethics approval was obtained 
from the Institutional Review Board of DSO National Laboratories, Singapore. The 
study was conducted in accordance with the tenets of the World Medical 
Association’s Declaration of Helsinki.  
 
9.2.2 Clinical Examination  
The detailed ophthalmic examination and the methods involved are explained 
in Chapter III of the thesis. In brief, before dilation following ocular examinations 
were performed: objective and subjective refraction, ocular biometry, IOP and 
contrast sensitivity (CS) evaluation. 
 CS was measured using the Rabin super vision test (Rabin et al. 2004), with 
and without a night vision goggle filter (SVT-NVG) and low and high luminance log 
CS were taken for this test. The NVG filter used was a dark green, low-luminance 
filter which slides in place in front of the illuminated chart, reducing chart luminance 
(from 100 to 4 cd/m
2
) to simulate the low-luminance (i.e., wearing NVG). In order to 
minimize memorization of optotypes, two different sequences were displayed for 
right and left eyes and measurement of CS were recorded by counting the number of 
letters correctly read by the subjects using the Conversion Table. 
Subjects underwent slit lamp examination. Binocular indirect ophthalmoscopy 
was performed approximately 30 minutes after topical instillation of 3 drops of 
tropicamide and 2.5% phenylephrine, given 5 minutes apart. Dilated fundus 





retinal degenerations and vitreous degenerations were systematically documented. 
Fundus photography was performed using non-mydriatic retinal camera (Canon CR-
DGi with a 10-DSLR back, Japan). 
9.2.3 OCT Imaging  
The retinal and choroidal (macular and peripapillary) architectural parameters 
were determined using SD-OCT (Spectralis, Wavelength: 870 nm; Heidelberg 
Engineering, Heidelberg, Germany) after pupil dilation. Choroid was imaged with 
EDI modality whereas retina was imaged without EDI. Please see Chapter III for 
imaging details. Since Spectralis OCT does not allow AL to be input, our methods 
may still have residual errors (2% to 7%)
32
 due to ocular magnification from methods 
that additionally uses AL. Although, imaging of both eyes of each subject was 
performed, only right eye was chosen for subsequent analysis. 
Macular Choroidal Scan: Radial scan consisting of six sections, each comprising 
100 averaged scans (using the automatic averaging and eye tracking features of the 
proprietary device), were obtained in an angle of 30° centered onto the fovea (30° 
angles between the lines). Only the horizontal and vertical section passing through the 
center of the fovea was selected for analysis.  
Peripapillary Choroidal Scan: The peripapillary region was scanned using a 360°, 
3.5 mm diameter circle centered on the optic disc (Figure 9.1), each comprising 100 
averaged scans (using the proprietary automatic averaging and eye tracking features 
of the SD-OCT device). 





Both macular and peripapillary CT was measured manually using the 
Heidelberg Eye Explorer software (version 1.5.12.0; Heidelberg Engineering) as the 
perpendicular distance between the outer portion of the hyperreflective line 
corresponding to the RPE (automatically detected by the instrument) to the 
hyporeflective line or margin corresponding to the sclerochoroidal interface 
(manually drawn by an experienced grader, who was masked to subject characteristics 
and clinical diagnosis). 
Macular Choroidal Thickness: An accurate evaluation of the CT with EDI-OCT 
relies mainly on the visibility of CSI, which anatomically represents the junction 
between the choroid and the sclera and is a principal landmark for quantitative 
measurements of choroid. Therefore, in our study, in order to accurately determine 
CT, CSI was enhanced using our novel technique of adaptive compensation described 
in detail in Chapter V and elsewhere.
33-35
 Our method has shown higher intra- and 
inter-grader reliability of CT measurements compared to conventional method.
33
 
The CT in the enhanced images was measured at the following locations: sub-
fovea and 1.5 and 3 mm nasal, temporal, superior and inferior to fovea. As there was 
no significant difference between the horizontal and vertical sub-foveal CT (mean 
horizontal SFCT=225.87 µm, mean vertical SFCT=232.09 µm, p=0.399), only 
horizontal SFCT was used for analysis. Figure 9.2 shows an EDI-OCT scan 
comparing CT between a young emmetrope and a young myope.  In addition, we 
evaluated the intra-observer reliability of CT measurements in both the myopic and 
emmetropic group. 40 randomly selected Spectralis images (20 from each group) 






Peripapillary Choroidal Thickness: The PPCT was measured at the following 
locations around the optic disc: temporal, superotemporal, superior, superonasal, 
nasal, inferonasal, inferior and inferotemporal. Furthermore, the intra-observer 
reliability of PPCT measurements was assessed in 40 randomly selected Spectralis 
images (20 from each myopic and emmetropic group) after an interval of one week.  
9.2.5 Assessment of Myopic Macular Degeneration  
The colour fundus photos were graded similar to previously established 
grading techniques by a single trained grader masked to the participant 
characteristics.
36
 Adjudication was performed by an experienced medical retina 
specialist from an accredited fundus photo grading centre. The main findings which 
were graded included myopia-related macular pathology, including staphyloma, 
lacquer crack and peripapillary atrophy (PPA). Presence of lacquer crack, its location, 
and number were evaluated. Curtin and Karlin classification was used to determine 
the subtype and position of PPA.
37
 Staphyloma was determined by visualizing the 




Inter-grader reliability in grading for the aforementioned features was assessed 
with additional grading of 100 randomly selected eyes by trained graders, and 
reliability was found to be good (all intra-class correlation coefficient above 0.75). To 
confirm the presence of posterior staphyloma, the cross-sectional images from SD-
OCT was graded by a medical retinal specialist. Figure 9.3 shows the presence of 
posterior staphyloma on horizontal scan of the macular central on the fovea (20°) 
obtained using SD-OCT. The presence of posterior staphyloma was defined as 





periphery of the OCT B-scan. This allows posterior staphyloma with more gentle and 
subtle sloping edges to be detected. 
9.2.6 Measurement of Choroidal Morphological and Vascular Parameters 
For each eye, the horizontal cross-sectional scan passing through the fovea 
was identified. Based on this cross-sectional scan, we defined and calculated (in 
MATLAB) the following choroidal morphological and vascular parameters (Figure 
9.4). 
CSI Curvature: When compared to a healthy choroid, myopic eyes may have 
irregularities in the choroidal boundary, including thinning underneath the macula. In 
order to quantify these irregularities, we used parameters such as curvature and 
number of inflection points at the CSI. Curvature of the CSI gives an overall measure 
of the CSI shape (flat, 'U' shaped, inverted 'U' shape). In order to measure overall 
curvature, the best-fitting circular arc to the marked CSI points was identified. The 
reciprocal of the radius of this best-fitting circular arc was reported as CSI curvature. 
The sign of the curvature indicated the direction of the arc (positive denotes an 
anteriorly curved, and negative a posteriorly curved arc). 
Number of Inflection Points: The number of inflection point measures the extent of 
local irregularities. A more irregular CSI would have greater local variations and 
hence more inflection points. Mathematically an inflection point is a point on a curve 
at which the curve changes from being concave to convex, or vice versa. An inflection 
point represents the contour of the CSI, with >1 point signaling irregular shape. 
Thickest Point Distance from the Fovea: CT varies within the macular region. In 
order to quantify the position of the region with the thickest choroid, the distance of 





Choroidal Thickness and Volume: CT was defined as the distance between the RPE 
layer and the CSI. The average thickness within the macular (6mm centered on fovea) 
and foveal (1.5mm centered on fovea) regions were reported as mean CT. Choroidal 
volume was measured by the summation the area enclosed between the RPE layer and 
the CSI for each of the radial scans multiplied by the distance between consecutive 
scans. 
Choroidal Vascular Area within Foveal and Macular Regions: Based on the 
marking of the choroidal region in the horizontal scan passing through the fovea, 
image binarization was used to distinguish between the vascular and stromal areas of 
the choroid. The Niblack local thresholding technique was used, similar to that 
described in previous papers.
39
 Black spaces within the choroid after binarization 
were assumed to represent vascular regions. The area of this region was measured 
within the sub-fovea as well as the macula, and defined as vascular area. 
Validation of Image Binarization: The Niblack local thresholding technique
39
 used 
to identify stromal and luminal areas within the choroid was validated against manual 
delineations. On a set of 8 randomly chosen cross-sectional scans of the choroid, the 3 
or 4 best visible blood vessels were delineated. 4 similarly sized regions 
corresponding to the stroma were also marked. The automatically binarized images 
were compared to these manual markings. In the binarized image, black regions 
correspond to the lumen and white regions to the stroma. Overlaying the manually 
marked luminal and stromal regions, we compared the extent to which the two 
methods agreed (Figure 9.5). We found that 2.5% of the luminal area and 4.1% of the 







9.2.7 Statistical Analyses 
Subjects were excluded from analysis if they had any history of anterior ocular 
diseases, previous ocular trauma, evidence of macular or vitreoretinal diseases or any 
form of refractive surgery done in their eyes. However, conditions such as, 
peripapillary atrophy, lacquer crack, posterior staphyloma or chorio-retinal atrophy 
were not excluded, as they are commonly seen in high myopic eyes. Statistical 
analysis was performed using SPSS version 17.0 (SPSS, Inc., Chicago, IL, USA) and 
MedCalc version 12.3 (Medcalc Software, Ostend, Belgium). A p-value of <0.05 was 
considered statistically significant. For the purpose of analyses, myopic eyes were 
divided into three groups based on SE: <-6 to -8D, <-8 to -10D, and <-10D. 
I. The demographics and ocular parameters between myopic and control eyes 
were compared using independent samples Student t-tests.  
II. The intra-session repeatability of the CT was measured by the absolute 
agreement model of the intra-class correlation coefficient (ICC).
40
  
III. Generalized linear model was used to assess the mean CT across different 
locations in eyes with varying degree of myopia and conditions such as posterior 
staphyloma and chorio-retinal atrophy were included to adjust for potential residual 
confounding.  
IV. Repeated measures analysis of variance (ANOVA) with Bonferroni post-
test was used to compare mean thickness at various locations within each group.  
V. Univariate and multiple linear regression analyses were performed to 
determine the association of ocular factors (independent variables) with CT 
measurements (dependent variables). For multiple linear regression, age and factors 







We first describe the results of the distribution and determinants of macular 
CT in a larger sample of highly myopic Asian eyes and its comparison with control 
eyes. This is followed by the topographical distribution and predictors of peripapillary 
CT in high myopic eyes. We then we performed the morphological and vascular 
analysis of the choroid. Lastly we describe the impact of subfoveal CT on BCVA in a 
group of extremely high (SE<-10D) myopic eyes.  
 
9.3.1 Macular Choroidal Thickness in High Myopes 
 
Of the 623 eligible high myopes (SE ≤-6.0 D), we further excluded 103 
subjects because either their choroidal images were not successfully attained (n=69) 
or the available images were not of optimal quality to perform accurate measurements 
(n=31) or they did not meet the inclusion criteria (n=3), leaving 648 subjects (520 
high myopes and 128 emmetropes) with complete data on CT for analysis.  
Subject Demographics: The mean age of included myopic and emmetropic subjects 
was 21.59 ± 1.15 years and 22.06 ±0.97 years respectively. The mean SE was -
8.68±2.05 diopters (range, -6 to -23 D) for myopic group, and 0.12±0.24 diopters for 
emmetropic group. Among the myopic group, all our subjects had peri-papillary 
atrophy, 35.6% had posterior staphyloma, 6.5% had chorio-retinal atrophy and 2% 
had lacquer cracks. The demographics and ocular characteristics of the study 
population are shown in Table 9.1.  
Reliability Assessment of Macular Choroidal Thickness: In terms of reliability of 





emmetropic group (ICC: 0.95 to 0.97) was excellent for all locations of CT (Table 
9.2).  
Distribution Profile of Macular Choroidal Thickness: CT varied significantly 
across the myopic sub-groups and the emmetropic control group at all the locations (p 
for trend <0.001 for all locations, Table 9.3). It was significantly thinner in the more 
myopic eyes over a range of eccentricities and the pattern of distribution was different 
from emmetropes (Figure 9.6A and 9.6B). Across the three myopic sub-groups, CT 
was found to be thickest at the superior location, followed by the temporal, sub-
foveal, inferior and the nasal locations (p<0.001 by repeated measures ANOVA). In 
comparison, the choroid in emmetropic eyes was thickest at the fovea, followed by 
the superior, inferior, temporal and the nasal locations (p<0.001 by repeated measures 
ANOVA). However in both the myopia and emmetropic groups, choroid was thinnest 
at the nasal location being 108.85 µm and 238.25 µm in myopic and emmetropic 
group respectively (Figure 9.6A and 9.6B).  
Determinants of Macular Choroidal Thickness: In the univariate analysis, SE, AL, 
corneal curvature, presence of posterior staphyloma and chorio-retinal atrophy were 
significantly associated with SFCT (all p<0.05, Table 9.4 and Figure 9.7). For each 
mm increase in AL and corneal curvature, SFCT on average decreased by 32.31 µm 
(p<0.001) and 84.31 µm (p<0.001) respectively. A decrease in mean SFCT by 13.10 
µm was observed for each myopic diopter increase (p<0.001). Presence of posterior 
staphyloma and chorio-retinal atrophy decreased the mean SFCT by 22.69 µm and 
26.91 µm respectively. Both AL and SE influenced CT but a larger extent from AL. 
The results remained similar after adjusting for age (data not shown).  
Because of collinearity between AL and SE (correlation coefficient = -0.65), 





explanatory power on CT change than did SE (standardized β, -0.489 vs.0.348). In the 
multiple linear regression analysis, AL, presence of posterior staphyloma and chorio-
retinal atrophy remained significantly associated with CT (all p<0.05), whereas the 
association with corneal curvature was abolished (p=0.975). However, there was no 
change in results after adjusting for age.  
In addition, SFCT correlated negatively with the logMAR visual acuity (r=-
0.085, p=0.054) and log low luminance contrast sensitivity (r=-0.115, p=0.009) 
although the association was not statistically significant in multivariate analysis 
(Figure 9.8). 
 
9.3.2 Peripapillary Choroidal Thickness in High Myopes 
Of the 623 eligible high myopes (SE ≤-6.0 D), we further excluded 175 
subjects because their choroidal images were not successfully attained due to unstable 
fixation (n = 62), the available images were not of optimal quality (a quality index of 
< 25 decibels as suggested by the manufacturer for the image quality assurance, n = 
39), those where the choroid-scleral interface was not clearly delineated (n = 21) to 
perform accurate measurements, subjects whose peripapillary atrophy involved the 
OCT scanning ring (n=30) or they did not meet the inclusion criteria (n = 23), leaving 
448 high myopes with complete data on PPCT for analysis. Of the 151 emmetropes 
recruited, 35 were found to have SE greater than ±0.5 D on subjective refraction and 
were excluded, leaving 116 emmetropes for analysis. 
Subject Demographics: The mean age of included myopic and emmetropic subjects 
was 21.63 ± 1.15 years and 22.03 ± 0.96 years (p<0.001), respectively. The mean SE 
was -8.52 ± 1.80 D (range, -6 to -18.25 D) for myopic group, and 0.11 ± 0.24 D for 





peri-papillary atrophy, 41.3% had posterior staphyloma, 6.3% had chorio-retinal 
atrophy, 0.4% had lacquer cracks and 22.5% had tilted disc.  The demographics and 
ocular characteristics of the study population are shown in Table 9.5.  
Reliability Assessment of Peripapillary Choroidal Thickness: In terms of 
reliability of PPCT measurements, the intra-observer reliability for myopic (ICC: 0.96 
to 0.98) and emmetropic (ICC: 0.95 to 0.98) group was excellent for all locations of 
PPCT (Table 9.6).  
Topographical Distribution of Peripapillary Choroidal Thickness: PPCT varied 
significantly across the myopic sub-groups and the emmetropic group at all the 
locations (p for trend <0.001 for all locations, Table 9.7). PPCT was significantly 
thinner in the more myopic eyes over a range of eccentricities and their pattern of 
distribution was different from emmetropes (Figure 9.9). Across the three myopic 
sub-groups, peripapillary choroid was thickest (163.41 ± 50.43 µm) at the superior 
location whereas in emmetropes it was thickest (207 ± 58.01 µm) at the temporal 
location. Peripapillary choroid was thinnest in both myopes (109.98 ± 37.30 µm) and 
control eyes (137.90 ± 44.53 µm) at the inferior location. 
Predictors of Peripapillary Choroidal Thickness: In the univariate analysis, SE, 
AL, corneal curvature, IOP, average RNFL thickness and presence of posterior 
staphyloma and chorio-retinal atrophy were significantly associated with PPCT (all 
p<0.05, Table 9.8). For each mm increase in AL and corneal curvature, PPCT on 
average decreased by 13.02 µm (p<0.001) and 36.72 µm (p<0.001) respectively. A 
decrease in mean PPCT by 5.39 µm was observed for each myopic dioptre increase 
(p<0.001). Each mm Hg increase in IOP increased the PPCT by 1.40 µm whereas for 





of posterior staphyloma and chorio-retinal atrophy decreased the PPCT by 15.29 µm 
and 14.76 µm respectively (both p<0.001). The results remained similar after 
adjusting for age (data not shown).  
Because of collinearity between AL and SE (correlation coefficient = -0.574), 
only AL was selected and retained in the multivariate analysis as it had a greater 
explanatory power on PPCT change than did SE (standardized β, -0.319 vs. 0.222). 
There was no collinearity between posterior staphyloma and chorio-retinal atrophy as 
variance inflation factor (VIF) was close to 1. In the multiple linear regression 
analysis, AL (p=0.001), IOP (p=0.006), presence of posterior staphyloma (p=<0.001) 
and chorio-retinal atrophy (p=0.032), remained significantly associated with PPCT, 
whereas the association with corneal curvature (p=0.062) and RNFL thickness was 
abolished (p=0.156). The results remained similar after adjusting for age. However, 
on performing a linear regression analysis between IOP and average PPCT in the 
emmetropic group we found no significant association (p = 0.964; regression 
coefficient = -0.075; 95% CI, -3.334 to 3.183). 
9.3.3 Morphological and Vascular Analyses of Choroid in High Myopes 
Table 9.9 shows the comparison of clinical characteristics in myopes vs. 
emmetropes. The mean age of included myopic and emmetropic subjects was 
21.61±1.14 years and 21.59±1.15 years respectively. The mean SE was -8.66±2.00 D 
(range, -6 to -23 D) for the high myopic group, and 0.13±0.24 D for the emmetropic 
control group. Among the high myopic group, nearly all the subjects (99%) had PPA, 
55.2% had posterior staphyloma, 9.2% had chorio-retinal atrophy and 1.2% had 
lacquer cracks.  
Table 9.10 shows choroidal morphological and vascular characteristics of 





significantly thinner in high myopic eyes compared to control eyes (mean CT: 
257.19±68.23 µm vs. 371.33±63.35 µm, p<0.001). In myopes, choroid was thickest 
temporally compared to sub-foveal location in emmetropes (thickest point distance 
from fovea -1.51±1.42 mm vs. -0.53±1.06 mm, p<0.001).  
There was significant reduction in total choroidal, vascular and stromal areas 
respectively in high myopic eyes compared to control eyes (Table 2; all p<0.001). 
Choroidal vascularity was greater in the high myopic eyes, compared to the control 
eyes (55.4±0.40 vs. 52.2±3.30, p<0.001). 
In the multiple regression analysis after adjusting for age, both vascular and 
stromal areas were significantly lower (vascular area: β=-0.306, stromal area: β=-
0.377, both p<0.001; Model 1, Table 3) at macular region in high myopic eyes, 
compared to control eyes. Further adjusting vascular and stromal areas for choroidal 
thickness, the vascular area increased (β=0.027, p<0.001) and the stromal area showed 
a decrease (β=-0.027, p<0.001) in myopic eyes (Model 2); suggesting that thinning in 
myopes was actually due to reduction in stromal component. Compared to control 
eyes, choroidal vascularity was greater in myopic eyes (β=0.032, p<0.001). Similar 
findings were observed for sub-foveal region (Table 9.11). 
 
9.3.4 Impact of Choroidal Thickness on Visual Acuity 
The purpose of this study was to examine the potential influence of CT on VA 
in young, extremely high myopic persons (SE ≤ -10 D) with and without myopic 
macular degeneration changes. Extremely high myopic subjects were chosen as we 
conceived that if there exists an association between CT and VA, it would be more 





Of the 520 myopic (SE ≤ -6 D) subjects, we therefore selected 118 subjects 
with SE -10.0 D or worse in both eyes (mean SE in the right and left eyes was -11.56 
± 2.04 D and -11.26 ±2.30 D respectively) as cases for the current analysis. We also 
selected 55 emmetropic male subjects with SE less than ± 0.5 D in both eyes (mean 
SE in the right and left eyes was 0.14 ± 0.25 D and 0.16 ± 0.26 D respectively) as 
controls. Of the 118 subjects who had SE -10.0 D or worse, 13 subjects were excluded 
as their choroidal images were not successfully attained (n= 8) due to unstable 
fixation, those where the CSI was not clearly delineated (n= 4) to perform accurate 
measurements or they did not meet the study inclusion criteria (n=1), leaving 105 
highly myopic subjects with complete data on CT for analysis.  
 
Subject Demographics: The mean age of included myopic and emmetropic subjects 
was 21.51 ± 1.22 years and 21.96 ± 0.89 years respectively. The mean SE was -11.56 
± 2.04 D (range, -10 to -23 D) for myopic group, and 0.14 ± 0.25 D for emmetropic 
group (Table 9.13). Among the high myopic group, nearly all the subjects (99%) had 
PPA, 66.7% had posterior staphyloma, 22.9% had chorio-retinal atrophy and 4.8% 
had lacquer cracks.  
Distribution Profile of Choroidal and Retinal Thicknesses: Table 9.14 shows the 
distribution profile of choroidal and retinal thicknesses at different locations in both 
high myopic and emmetropic groups. In the highly myopic group, the mean CT was 
194.81 ± 57.78 µm and the mean retinal thickness was 287.39 ± 31.75 µm. Choroid 
was significantly thinner in the highly myopic eyes over a range of eccentricities and 
the pattern of distribution was different from emmetropes (Figure 9.10A). Among the 
high myopes, choroid was found to be thickest at the superior location, followed by 





measures ANOVA). In comparison, the choroid in emmetropic eyes was thickest at 
the fovea, followed by the superior, inferior, temporal and the nasal locations 
(p<0.001 by repeated measures ANOVA). However in both the highly myopic and 
emmetropic groups, choroid was thinnest at the 3 mm nasal location being 87.34 µm 
and 237.10 µm respectively (Figure 9.10A). Retinal thickness in both myopes and 
emmetropes showed similar distribution pattern, being thickest in the nasal location 
and thinnest subfoveally (Figure 9.10B). 
Both AL and SE influenced BCVA but a larger extent from SE (standardized 
β, -0.505 vs. 0.214), thus only SE was selected and retained in the multivariate 
analysis due to collinearity between AL and SE (correlation coefficient = -0.638).  
Association of Sub-foveal Choroidal Thickness with BCVA: Table 9.15 shows the 
linear regression analyses of the associations of sub-foveal CT (exposure variable of 
interest) evaluated against BCVA (dependent variable) to calculate regression 
coefficients (β). In model 1, (univariate analysis) sub-foveal CT was significantly 
associated with BCVA (β = -0.039, p = 0.015). However, after adjusting for SE 
(model 2), sub-foveal CT was no more significantly associated with BCVA (p = 
0.761). In model 3, including both SE and presence of any pathological myopia 
lesions such as posterior staphyloma, lacquer cracks or chorio-retinal atrophy, we 
found that sub-foveal CT was not independently associated with BCVA (p = 0.937). 
There was no significant interactions between sub-foveal CT and SE or sub-foveal CT 
and pathological myopia lesions on BCVA (both p interaction >0.05). Furthermore, 
the association between BCVA and sub-foveal CT in a group of 33 highly myopic 
subjects without any pathological myopic lesions (except PPA) was found to be 





It is speculated that if there exist any association between CT and VA, it 
would most likely concern the subfoveal CT due to maximum number of 
photoreceptors at sub-fovea. To confirm whether the distribution pattern of CT has 
influence on BCVA, we analyzed the association of CT at different locations (nasal, 
temporal, superior and inferior) with BCVA. However, we found no significant 




Although the understanding of the characteristics of the in-vivo choroid has 
increased substantially in recent years, to date, only a few studies have examined 
macular CT in high myopia. None of previous studies so far have explored the profile 
of peripapillary choroid in high myopia and only a limited number of studies have 
reported the distribution of peripapillary choroid in emmetropic eyes. To our best 
knowledge, this study measured CT directly with EDI SD-OCT in the largest group of 
young, high myopic Asian subjects at both macular and peripapillary regions. Our 
study provided new data on CT and severity of myopia. In addition we performed a 
detailed morphological and vascular analysis of the choroid. Lastly, we examined the 
impact of CT on BCVA in a group of extremely high myopes (SE<-10D). 
9.4.1 Macular Choroidal Thickness in Myopes vs. Emmetropes 
Macular CT in the myopic group was significantly lower than that of the 
emmetropic control group at all eccentricities and there was a further decrease in CT 
with increase in degree of myopic refractive error. The mean sub-foveal CT in myopic 









 µm (Table 9.5). The mean SFCT 
in emmetropes was 375.15 µm which is also thicker than previous studies that 
reported a mean thickness of 272 to 354 µm.
26, 41-43
  
The differences in CT in our study compared to other studies could be because 
of differences in participants’ characteristics, such as age, refractive error, and 
ethnicity. Our study participants are twice as young, mean age 21.63 years compared 
to other studies.
11, 12, 28, 41-43
 In addition, there were variations in OCT device 
characteristics such as wavelength, eye tracking method, and averaging software 
among studies. In our results, CT decreased with increase in severity of myopic 
refractive error. The findings suggest that thinning or abnormalities of choroid plays a 
role in the pathogenesis of myopic degeneration and thus visual impairment. 
Distribution Profile of Macular Choroidal Thickness: We found that CT in highly 
myopic eyes was thickest superiorly and thinnest nasally. In comparison, the choroid 
in normal eyes was thickest at the fovea and thinnest nasally. The observed pattern of 





 Two possible reasons for the relative choroidal thinning nasally and 
inferiorly in normal eyes are the choroidal watershed and the fetal choroidal fissure, 
which closes inferiorly at 7 weeks.
45
 
Determinants of Macular Choroidal Thickness: Among the range of ocular factors 
studied, AL, presence of posterior staphyloma and chorio-retinal atrophy were the 
significant predictors of CT. In Table 9.16, on performing a meta-regression on 
various studies to quantify the change in mean CT with SE adjusting for age we found 
no significant association between SE and mean CT (β=0.429, p=0.952) indicating 





Longer Axial Length is associated with Choroidal Thinning: We found a significant 
negative association of SFCT with AL. In high myopia because of axial elongation, 
both the retina and choroid are stretched 
9, 10, 46
 leading to thinning.
11, 12, 41
 However, 
thinner choroid is still adequate to nourish proportionally thin retina which is 
consistent with fairly normal visual functions in adolescents and young adults with 
high myopia than their aged counterparts which undergoes further age-related 
reduction in choroid.
11
 In contrast, in non-myopic elderly eyes thinner choroid may 
not be adequate to supply the relatively thick retina which might in turn influence 
visual function. We therefore speculate that the relatively thin choroid in young 
myopes may be physiologically sufficient, although the same CT may be considered 
pathologic in older eyes without myopia. 
Presence of Posterior Staphyloma is associated with Choroidal Thinning: Presence 
of posterior staphyloma, a hallmark of high myopia was significantly associated with 
choroidal thinning. Similar results were reported in the previous studies which 
demonstrated posterior staphyloma formation as a key factor in choroidal thinning in 
highly myopic eyes.
11, 12
 This association is probably because in myopic eyes with 
posterior staphyloma, choroidal circulation is altered with marked attenuation and 
reduction in number of large choroidal vessels.
47
 In addition, there is a shift in the 
entry site of the posterior ciliary arteries towards the staphyloma’s border leading to 
scarce choroidal arterial network in the area occupied by staphyloma.
48
 Thus, all these 
changes lead to choroidal thinning in eyes with staphyloma.  
9.4.2 Peripapillary Choroidal Thickness in Myopes vs. Emmetropes 
Peripapillary choroid in myopic group was significantly thinner than 
emmetropic control group at any locations. The mean PPCT in myopes and 





demonstrated further decrease in PPCT with increase in degree of myopic refractive 
error. The mean PPCT in emmetropes of 181.90 ± 46.43 µm is in concurrence with 







Distribution Profile of Peripapillary Choroidal Thickness: In terms of distribution 
of PPCT, in both myopic and emmetropic eyes, peripapillary choroid was thinnest 
inferiorly. Studies done so far have consistently shown inferior region to be the 
thinnest among other regions of the posterior pole.
49-52
 As optic fissure is located in 
the inferior aspect of the optic cup and is the last part of the globe to close,
53
 this 
regional difference in ocular development may contribute to the thinner choroid found 
in inferior region. Thinner choroid would lead to decreased blood flow in 
choriocapillaris which nourishes the prelaminar portion of the optic disk, making it 
more susceptible to hypoxia or to elevated IOP. This is supported by a very common 
observation that glaucoma typically affects the inferior optic disc region first.
51, 54 
The 
possible role of thinner choroid in glaucoma development is further supported by the 
findings of Usui et al.
55
 and Hirooka et al.
54
 who reported significant choroidal 
thinning in myopic normal tension glaucoma damage eyes as compared to myopic 
controls. Likewise, a substantial reduction in PPCT in patients with glaucoma who 
have sclerotic optic disc was demonstrated by Robert et al.
21
  
We found peripapillary choroid in highly myopic eyes was thickest superiorly 
whereas in emmetropic eyes was thickest temporally. This variation in the refractive 
error differences in CT profile could be attributed to the presence of posterior 
staphyloma in highly myopic eyes. Although staphylomas may have various 
morphologic features, the most common types involve the macular and optic nerve 
regions.
56
 Similar to our observation in emmetropes, Oh et al.
50 
also reported 





PPCT distribution in emmetropes in our study differs from most of the previous 
studies in healthy eyes which reported choroid to be thickest superiorly.
21, 49, 51, 52, 54, 
57
Although, the magnitude of the difference in thickness of the thickest point is not 
clinically significant (ranges between 15 to 20 µm). The differences in PPCT profile 
in our study compared to other studies could be because of the differences in age of 
our study participants. Our study participants are twice as young, mean age 22 years 
compared to other studies.
21, 49, 51, 52, 54, 57
 Thus, the exact reason for the variations in 
topographic profile of PPCT  is not clear and further studies on a wide range of age 
group are needed.  
Determinants of Peripapillary Choroidal Thickness: Among the range of ocular 
factors studied, AL, IOP and presence of posterior staphyloma and chorio-retinal 
atrophy were the significant factors associated with PPCT 
Longer Axial Length is associated with Thinner Peripapillary Choroid: PPCT was 
significantly thinner in eyes with longer AL. The possible reason might be the 
anatomic differences in eyes of different refractive status with more stretched and 
therefore thinner peripapillary choroid in longer eyes. Therefore, AL deserves 
consideration in a normative database of PPCT measurement and should be taken into 
account while interpreting the results. 
Greater IOP is associated with Thicker Peripapillary Choroid: Interestingly, we 
found a positive association between PPCT and IOP in high myopes. Our results are 
in concordance with previous studies,
58
 which using the pressure-volume relationship 
of the eye,
59
 estimated that to produce an IOP increase of 5 mm Hg from the average 
IOP of 15 mm Hg, the choroid would need to expand uniformly by approximately 10 





Hg increase in IOP supporting the conclusion that the IOP increase resulted from 
choroidal thickness increase.  
Posterior Staphyloma is associated with Thinner Peripapillary Choroid: Similar to 
macular CT, we found presence of posterior staphyloma was significantly associated 
with choroidal thinning in high myopes in the peripapillary region as well.  
9.4.3 Morphological and Vascular Analyses of the Choroid in High Myopes 
Our study provides detailed phenotyping and characterization of the 
morphology and vasculature of the choroid in eyes with high myopia measured using 
image binarization from choroidal scans obtained using EDI-OCT. Our results 
indicate that while the choroidal thinning in high myopic eyes was associated with a 
reduction in both choroidal vascular and stromal areas, the primary component that 
was reduced was its stromal component. This was further supported by higher 
choroidal vascularity in myopic eyes compared to control eyes.  
9.4.4 Visual Acuity is Independent of Choroidal Thickness 
Our results suggest that CT alone is not an independent indicator of VA in 
these young, highly myopic eyes, and factors such as SE still remains to be more 
important predictors of BCVA. 
Our finding of no independent association between sub-foveal CT and VA is 
in contrast to most of the previous hospital-based investigations.
27, 29, 30
 Nishida and 
colleagues in 145 myopic eyes (≥ -6 D) with no other retinal or optic nerve pathology 
demonstrated CT to be an important predictor of VA.  The discrepancy may be due to 
differences in age groups between our study and Nishida’s study. Our study 
participants are much younger with mean age of 22 years compared to Nishida’s 
study (mean age 57 years). With the advancing age, the choroid may undergo further 
age-related attenuation.
11, 13





attributed to dual factors: myopic refractive error and older age. In addition, with 
advancing age other myopic maculopathy and severity develop progressively,
60
 which 
may lead to reduced VA. In contrast, our young subjects with relatively thicker 
choroid retained their visual function and therefore enjoyed better vision. 
In the Beijing Eye Study,
31
 better BCVA was found to be associated with 
thicker sub-foveal CT after adjusting for age, AL and other parameters. However, 
Beijing Eye Study is a population-based study with a mean age of participant’s being 
64.3 years and a mean refractive error (SE) of -0.18 D. The observed association 
between sub-foveal CT and VA could be due to residual confounding effects of AL 
which was taken as a binary variable (> 26 mm vs. <=26 mm).  
Flores-Moreno and colleagues examined 60 eyes of 46 highly myopic subjects 
(SE ≥ -6 D; mean age 45.9 years) without macular diseases and found that in 
univariate analysis, BCVA (logMAR) was significantly correlated with thinner sub-
foveal CT (correlation coefficient r = -0.36; p = 0.004). Similarly, Ho and coworkers 
evaluated 56 myopic subjects (SE ≥ -6 D; mean age 50.4 years) and found that in 
univariate analysis sub-foveal CT was correlated with logMAR VA (r
2
 = 0.295, p = 
0.008). In both studies the association between BCVA and sub-foveal CT was tested 
in univariate analysis only, without taking into account other potential confounders, 
such as SE, AL and other ocular comorbidities due to ageing. By contrast, our study 
involved younger subjects with little ocular comorbidity, and thus, the results are less 
complicated by confounding factors. 
The results of our study are in concordance with the results of a recent study 
by Pang et al.
61
 who reported no significant reduction in VA (mean VA = 20/30) in 
highly myopic eyes (mean AL = 30.7 mm) with extreme choroidal thinning (mean 





function. However, their study involved relatively small sample size (36 eyes of 20 
myopic subjects) and older subjects (mean age of 71 years) with ocular comorbidities, 
and thus, their results may be complicated by confounding factors. In addition, use of 
manual calipers to measure very small CT might have introduced some measurement 
errors. 
It is interesting that although previous studies
27, 29-31
 have concluded sub-
foveal CT to be inversely correlated to VA, this study has shown that there are clear 
exceptions to these observations. We did not find any significant association between 
decreased VA and thinner choroid in our young, extremely high myopic subjects with 
or without myopic maculopathy. Although retinal thickness was reduced in myopic 
eyes (average thickness 287 µm) than in a comparable group of control eyes (average 
thickness 307 µm), thinning of 20 µm may not be clinically meaningful and 
photoreceptor layer might not have been disrupted maintaining a fairly normal visual 
functions in adolescents and young adults with high myopia than their aged 
counterparts in which both severity of myopia and other myopic maculopathy 
increases with advancing age leading to reduced VA.  
In myopic eyes with choroidal thinning, the good VA in face of thinner 
choroid may be explained by intact choroidal perfusion from larger patent choroidal 
vessels, which are typically in Haller’s layer and located eccentric to the subfoveal 
area.
25
 However, this study lacks choroidal blood flow measurements, and future 
studies of choroidal circulation will be useful to correlate CT with perfusion in normal 
eyes and in high myopes with choroidal thinning. 
 





In summary, we found that macular and peripapillary CT is significantly lower 
in high myopic eyes over a range of eccentricities. Mean sub-foveal CT in myopes 
was 225.87 ± 5.51 µm as compared to 375.15 ± 6.58 µm in emmetropes. Mean PPCT 
in myopes was 142.62 ± 43.84 µm vs. 181.90 ± 46.43 µm in emmetropes. We 
demonstrated further decrease in macular and peripapillary CT with increase in 
severity of myopia.  
Macular and peripapillary CT distribution follows a different profile in high 
myopia compared to emmetropes. Macular CT in myopic eyes was thickest superiorly 
whereas in emmetropes it was thickest at the fovea. However, in both the groups 
macular choroid was thinnest nasally. Peripapillary choroid was thickest at the 
superior location in myopic eyes, whereas in emmetropes it was thickest at the 
temporal location. However, in both the groups peripapillary choroid was thinnest 
inferiorly. 
 AL, presence of posterior staphyloma and chorio-retinal atrophy are the 
significant predictors of macular CT in high myopia. For PPCT; AL, IOP and 
presence of posterior staphyloma are independent determinants. These factors must be 
taken into account when interpreting the data on CT. Given the large number of 
people with myopia in the world, these findings seem to have widespread 
implications. 
Our result demonstrates significant alterations in choroidal morphological and 
vascular features in high myopes. Choroidal thinning in high myopic eyes was 
associated with a reduction in both choroidal vascular and stromal areas, the primary 
component that was reduced was its stromal component. This was further supported 





We further report that high myopic eyes had thinner choroid but CT is not an 
independent predictor of VA. Other factors related to myopia are likely responsible 
for the diminished VA in young highly myopic eyes. 
 
9.6 STRENGTHS  
The study has several strengths. Our EDI SD-OCT images were enhanced 
using adaptive compensation
33
 to improve CSI visibility. Therefore, the CT 
measurements obtained in our study are likely more reliable and accurate. Our study 
is one of the most large-scale, prospective studies conducted to investigate the 
topography and predictors of macular and peripapillary CT in myopic subjects. Unlike 
other studies, our study included an emmetropic group and therefore we could 
examine the differences between highly myopic eyes and non-myopic eyes in our 
case-control study. Furthermore, we involved a group of young, healthy, male, Asian 
subjects of uniform age and were thus free of confounding factors. 
 
9.7 LIMITATIONS 
The study also has some limitations. Inclusion of only male Asian subjects 
may limit the application of our data to females and subjects of other groups or 
ethnicities. Further studies in other ethnic populations are warranted to confirm the 
results. Choroidal characteristics were assessed only in the right eye of each study 
subject. There may exist inter-eye differences, yet such differences should be small. 
Although our images were binarized at standard threshold, there is a possibility of 
over or under estimation of both vascular and avascular areas. Recently, diurnal 
fluctuation of choroidal thickness was reported
62
 and this could have impacted our 





myopic and emmetropic eyes. Another limitation is that the cause-effect relationship 
cannot be ascertained due to the cross-sectional nature of our study.  
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CHAPTER IX TABLES 
 
Table 9.1 Baseline characteristics of study subjects for macular choroidal thickness 
 
 Myopes (n=520) Emmetropes (n=128) P value 
Age, years 21.59 (1.15) 22.06 (0.97) <0.001 
Axial length, mm 27.32 (1.16) 23.69 (0.62) <0.001 
Anterior chamber depth, mm 3.74 (0.25) 3.46 (0.27) <0.001 
Corneal curvature, mm 7.76 (0.25) 7.85 (0.41)  0.137 
Spherical equivalent, D -8.68 (2.05) 0.12 (0.24) <0.001 
Best corrected visual acuity Log MAR 0.01 (0.08) -0.09 (0.06) <0.001 
Log low luminance contrast sensitivity 0.36 (0.28) 0.50 (0.20) <0.001 
Log high luminance contrast sensitivity 0.66 (0.33) 0.88 (0.21) <0.001 
Intraocular pressure, mmHg 16.12 (2.94) 15.26 (2.74) 0.002 













ICC (95% CI)  Mean difference (µm)*  
              (SD) 
ICC (95% CI) Mean difference (µm)*  
              (SD) 
Choroidal thickness     
  Sub-foveal  0.98 (0.96 to 0.99) 9.9 (11.3) 0.97 (0.95 to 0.99) 11.5 (17.7) 
  Nasal, 1.5 mm  0.96 (0.93 to 0.98) 9.6 (14.8) 0.96 (0.93 to 0.98) 10.1 (20.6) 
  Nasal, 3 mm   0.94 (0.87 to 0.97) 8.0 (14.4) 0.96 (0.93 to 0.98) -15.0 (20.8) 
  Temporal, 1.5 mm 0.97 (0.93 to 0.98) 9.1 (14.8) 0.97 (0.94 to 0.98) 14.3 (19.4) 
  Temporal, 3 mm 0.97 (0.94 to 0.98) 10.8 (13.0) 0.96 (0.91 to 0.98) 11.1 (18.5) 
  Superior, 1.5 mm  0.96 (0.93 to 0.98) -7.5 (16.2) 0.95 (0.90 to 0.98) 13.2 (20.4) 
  Superior, 3 mm   0.95 (0.90 to 0.98) 9.2 (17.8) 0.97 (0.94 to 0.99) -14.9 (17.2) 
  Inferior, 1.5 mm  0.97 (0.95 to 0.99) 11.0 (13.5) 0.96 (0.92 to 0.98) 14.7 (18.0) 
  Inferior, 3 mm   0.96 (0.93 to 0.98) -8.6 (17.0) 0.97 (0.94 to 0.99) 13.1 (18.5) 
   ICC= intra-class correlation coefficient; CI= confidence interval; SD = standard deviation. 
  *Mean difference was determined from the 1
st








Table 9.3 Distribution of mean adjusted macular choroidal thickness (CT) at different locations across the myopic and control groups 




Myopia, -6 to -8(D) 
(n=233) 







Changes in CT 





Subfoveal 375.15 (6.58) 241.54 (6.63) 223.90 (7.14) 210.60 (7.13) 225.87 (5.51) -15.74 <0.001 
Nasal, 1.5 mm  324.01 (6.59) 187.01 (6.17) 165.27 (6.66) 150.70 (6.64) 168.35 (5.18) -18.60 <0.001 
Nasal,  3 mm   238.25 (6.72) 121.19 (4.76) 106.90 (5.13) 97.13 (5.12) 108.85 (3.97) -12.30 <0.001 
Temporal, 1.5 mm 359.27 (6.51) 249.52 (6.38) 235.82 (6.87) 223.47 (6.85) 236.64 (5.27) -13.10 <0.001 
Temporal, 3 mm 328.41 (6.04) 251.51 (6.02) 243.83 (6.49) 235.77 (6.47) 243.88 (4.94) -07.84 <0.001 
Superior, 1.5 mm 365.01 (5.66) 263.84 (7.05) 250.70 (7.59) 238.81 (7.57) 251.47 (5.81) -12.59 <0.001 
Superior, 3 mm  358.03 (5.74) 278.23 (7.25) 263.61 (7.81) 254.64 (7.79) 265.97 (5.97) -12.14 <0.001 
Inferior, 1.5 mm 358.93 (6.14) 243.27 (6.32) 219.94 (6.81) 202.87 (6.79) 222.74 (5.32) -20.59 <0.001 
Inferior, 3 mm   339.41 (6.30) 232.76 (6.25) 214.86 (6.74) 199.84 (6.72) 216.32 (5.21) -16.63 <0.001 
 P<0.001* P<0.001* P<0.001* P<0.001* P<0.001*   
 Data are mean (standard error) in µm, adjusted for presence of posterior staphyloma and chorio-retinal atrophy. 
 † Adjusted for presence of posterior staphyloma and chorio-retinal atrophy. 
 *Repeated measures ANOVA, comparing the distribution of choroidal thickness across fovea, nasal (3 mm), temporal (3 mm), superior (3 mm), and   
  inferior (3 mm) locations. 





Table 9.4 Association of ocular factors with sub-foveal choroidal thickness in all myopes (n =520) 
 











Ocular factors       
Spherical equivalent, D 13.109 0.348 <0.001 - - - 
Axial length, mm  -32.319 -0.489 <0.001 -24.232 -0.370 <0.001 
Corneal curvature, mm -84.318 -0.279 <0.001 0.397 0.001 0.975 
Anterior chamber depth, mm -8.200 -0.027 0.541 - - - 
Intraocular pressure, mmHg 0.714 0.027 0.535 - - - 
Posterior Staphyloma -22.698 -0.443 <0.001 -15.642 -0.306 <0.001 





Table 9.5 Clinical characteristics of the study subjects for peripapillary choroidal thickness 
 
 Myopes (n=448) Emmetropes (n=116) P value* 
Age, years 21.63 (1.15) 22.03 (0.96) <0.001 
Axial length, mm 27.23 (1.07) 23.70 (0.61) <0.001 
Anterior chamber depth, mm 3.74 (0.25) 3.46 (0.27) <0.001 
Corneal curvature, mm 7.76 (0.25) 7.81 (0.41) 0.123 
Spherical equivalent, D -8.52 (1.80) 0.11 (0.24) <0.001 
Best corrected visual acuity, logMAR 0.01 (0.07) -0.09 (0.06) <0.001 
Intraocular pressure, mmHg 16.11 (2.95) 15.22 (2.64) 0.003 
RNFL thickness, µm 87.21 (8.94) 103.76 (9.99) <0.001 
 Data presented are means (standard deviations). 
 D = dioptre; logMAR = logarithm of the minimum angle of resolution; RNFL = retinal nerve fiber layer thickness. 







Table 9.6 Intra-grader reliability of peripapillary choroidal thickness measurements at 
different locations in myopic and emmetropic group 
Locations of measurement 
Myopes  
ICC (95% CI) 
Emmetropes  




Temporal, 360° 0.97 (0.92 to 0.98) 0.96 (0.90 to 0.98) 
Superotemporal, 45° 0.97 (0.94 to 0.99) 0.98 (0.95 to 0.99) 
Superior, 90° 0.98 (0.96 to 0.99) 0.96 (0.90 to 0.98) 
Superionasal, 135° 0.98 (0.96 to 0.99) 0.97 (0.92 to 0.98) 
Nasal, 180° 0.97 (0.93 to 0.99) 0.96 (0.90 to 0.98) 
Inferonasal, 225° 0.96 (0.92 to 0.98) 0.96 (0.91 to 0.98) 
Inferior, 270° 0.96 (0.91 to 0.98) 0.95 (0.88 to 0.98) 
Inferotemporal, 315° 0.96 (0.90 to 0.98) 0.96 (0.90 to 0.98) 









(n = 116) 
High Myopia 
All  
(n = 448) 
SE <-6 to -8 D  
(n = 211) 
SE <-8 to -10 D  
(n = 143) 
SE <-10 D 
(n = 94) 
P for 
trend† 
Temporal, 360° 207.00 (58.01) 138.47 (58.57) 151.30 (62.21) 132.45 (51.00) 118.85 (54.41) <0.001 
Superotemporal, 45° 201.89 (53.13) 150.32 (54.10) 160.10 (57.14) 144.51 (49.02) 137.23 (50.82) <0.001 
Superior, 90° 188.18 (50.17) 163.41 (50.43) 170.60 (52.08) 160.88 (47.30) 151.14 (49.03) <0.001 
Superionasal, 135° 189.15 (52.85) 162.21 (50.50) 169.58 (52.26) 159.19 (47.63) 150.24 (48.45) <0.001 
Nasal, 180° 189.24 (53.17) 161.97 (51.82) 170.66 (55.30) 157.36 (47.22) 149.51 (47.30) <0.001 
Inferonasal, 225° 168.68 (50.38) 137.82 (46.16) 146.83 (50.15) 132.62 (41.11) 125.53 (40.04) <0.001 
Inferior, 270° 137.90 (44.53) 109.98 (37.30) 117.01 (39.41) 106.91 (33.54) 98.88 (34.80) <0.001 
Inferotemporal, 315° 173.17 (52.10) 116.81 (49.12) 128.19 (54.12) 110.73 (41.25) 100.52 (42.05) <0.001 
Average 181.90 (46.43) 142.62 (43.84) 151.78 (46.79) 138.08 (38.53) 128.99 (40.20) <0.001 
 P<0.001* P<0.001* P<0.001* P<0.001* P<0.001*  
 Data presented are mean (standard deviations) in µm. 
 * Repeated Measures ANOVA, comparing the distribution of peripapillary choroidal thickness at various locations within each group. 
 † Peripapillary choroidal thickness varied significantly across the myopic sub-groups and the emmetropic group at all the locations (p for trend   






Table 9.8 Association of ocular factors with average peripapillary choroidal thickness in all myopes (n = 448) 
 










Ocular factors       
Age, years -0.412 -0.011 0.818 - - - 
Spherical equivalent, D 5.396 0.222 <0.001 - - - 
Axial length, mm -13.029 -0.319 <0.001 -7.090 -0.175 0.001 
Corneal curvature, mm -36.720 -0.216 <0.001 -4.456 -0.026 0.602 
Anterior chamber depth, mm -3.989 -0.023 0.631 - - - 
Intraocular pressure, mmHg 1.407 0.095 0.045 1.628 0.111 0.006 
Average RNFL thickness, µm 0.745 0.152 0.001 0.287 0.059 0.156 
Posterior staphyloma -15.296 -0.519 <0.001 -12.160 -0.433 <0.001 
Chorio-retinal atrophy -14.768 -0.247 <0.001 -0.533 -0.089 0.032 
Tilted disc -2.814 -0.081 0.088 - - - 
  D = dioptre; RNFL = retinal nerve fiber layer thickness. 





Table 9.9 Clinical characteristic of study subjects with high myopia (n=515 eyes) and 











Age, years 21.59 (1.15) 22.02 (1.05) 0.001 
Axial length, mm 27.31 (1.14) 23.70 (0.63) <0.001 
Corneal curvature, mm 7.76 (0.25) 7.85 (0.41) <0.001 
Spherical equivalent, Diopter -8.66 (2.00) 0.13 (0.24)  <0.001 
BCVA, LogMAR 0.01 (0.08) -0.10 (0.06) <0.001 
Intraocular pressure, mmHg 16.12 (2.90) 15.19 (2.74) 0.005 
Data presented are means (standard deviations). 
BCVA=best corrected visual acuity; LogMAR = logarithm of the minimum angle of 
resolution. 
a

















Mean choroidal thickness, µm 257.19 (68.23) 371.33 (63.35) <0.001 
Choroidal volume, mm
3
 7.27 (1.92) 10.49 (1.79) <0.001 
Thickest point distance from fovea, mm -1.51 (1.42) -0.53 (1.06) <0.001 
VASCULAR  
Sub Foveal (1.5 mm region) 
Total choroidal area, mm
2
 0.416 (0.114) 0.608 (0.102) <0.001 
Vascular area, mm
2
 0.236 (0.059) 0.314 (0.044) <0.001 
Stromal area, mm
2
 0.179 (0.062) 0.293 (0.066) <0.001 
Choroidal vascularity 0.575 (0.057) 0.520 (0.040) <0.001 
Macular (6 mm region) 
Total choroidal area, mm
2
 1.543 (0.409) 2.228 (0.380) <0.001 
Vascular area, mm
2
 0.851 (0.211) 1.156 (0.167) <0.001 
Stromal area, mm
2
 0.692 (0.212) 1.071 (0.233) <0.001 
Choroidal vascularity  0.554 (0.040) 0.522 (0.033) <0.001 
Data presented are means (standard deviations) or number (%). 
a






Table 9.11 Multiple regression analysis of choroidal attributes such as vascular area, stromal area and vascularity (dependent variables) 
in high myopic eyes (n=515) with reference to control eyes (n=88). 
 
Beta represents differences in choroidal vascular area, stromal area and vascularity in high myopic eyes with reference to control eyes. 
Model 1: adjusted for age. 
Model 2: adjusted for age and choroidal thickness. However, choroidal vascularity was only adjusted for age. 
CI: confidence interval. 
  
 Vascular Area, mm
2
 Stromal Area, mm
2
 Choroidal Vascularity 
Sub Foveal 
(1.5 mm region) 
Beta (95% CI) P-value Beta (95% CI) P-value Beta (95% CI) P-value 
Model 1 -0.078 (-0.091, -0.065) <0.001 -0.114 (-0.129, -0.100) <0.001 0.054 (0.042, 0.067) <0.001 
Model 2 0.013 (0.007, 0.018) <0.001 -0.013 (-0.018, -0.007) <0.001 -- -- 
Macular  
(6 mm region) 
      
Model 1 -0.306 (-0.353, -0.259) <0.001 -0.377 (-0.426, -0.328) <0.001 0.032 (0.023, 0.041) <0.001 





Table 9.12 Association of axial length with choroidal traits such as vascular area, stromal area and vascularity (dependent variables) in 
high myopic eyes (n=515). 
 
 
Beta represents change in choroidal traits (vascular area, stromal area and vascularity) per mm change in axial length in high myopic eyes. 
CI: confidence interval. 
 Vascular Area, mm
2
 Stromal Area, mm
2
 Choroidal vascularity 

















-0.020 (-0.025, -0.016) -0.396 <0.001 -0.023 (-0.027, -0.019) -0.421 <0.001 0.011 (0.007, 0.016) 0.229 <0.001 
Macular  
(6 mm) 












Age, years 21.51 (1.22) 21.96 (0.89) 0.033 
Axial length, mm 28.46 (1.23) 23.65 (0.58) <0.001 
Anterior chamber depth, mm 3.74 (0.22) 3.47 (0.29) <0.001 
Corneal curvature, mm 7.76 (0.24) 7.79 (0.44) 0.686 
Spherical equivalent, Diopter -11.56 (2.04) 0.14 (0.25) <0.001 
BCVA, LogMAR 0.07 (0.09) -0.10 (0.05) <0.001 
Intraocular pressure, mmHg 16.42 (3.04) 15.28 (2.78) 0.035 
  Data presented are means (standard deviations). 
  BCVA=best corrected visual acuity; LogMAR = logarithm of the minimum angle of   
  resolution. 





Table 9.14 Distribution of choroidal and retinal thicknesses at different locations across the extremely high myopic (<-10D) and control 
groups  
 Choroidal Thickness Retinal Thickness 









Subfoveal 194.81 (57.78) 377.98 (77.61) <0.001 237.19 (22.24) 224.36 (19.31) <0.001 
Nasal, 1.5 mm  136.69 (54.650 325.67 (71.93) <0.001 338.51 (24.22) 361.70 (21.19) <0.001 
Nasal,  3 mm   87.34 (39.39) 237.10 (69.49) <0.001 291.00 (31.56) 312.90 (22.05) <0.001 
Temporal, 1.5 mm 210.48 (60.17) 358.60 (73.62) <0.001 315.84 (19.11) 337.94 (13.72) <0.001 
Temporal, 3 mm 225.30 (62.57) 316.69 (68.28) <0.001 250.47 (27.89) 273.67 (14.73) <0.001 
Superior, 1.5 mm 225.67 (76.06) 370.58 (67.58) <0.001 327.36 (19.89) 349.70 (23.92) <0.001 
Superior, 3 mm  242.82 (84.77) 355.63 (72.81) <0.001 273.15 (20.14) 288.10 (13.14) <0.001 
Inferior, 1.5 mm 188.21 (60.68) 362.23 (67.49) <0.001 316.29 (19.13) 344.52 (16.90) <0.001 
Inferior, 3 mm   188.50 (69.05) 338.50 (81.60) <0.001 259.16 (18.46) 274.43 (13.99) <0.001 
Average 188.85 (55.78) 338.11 (59.69) <0.001 287.39 (31.75) 307.48 (18.87) <0.001 
  Data presented are means (standard deviations) in µm. 
 *P-value was obtained from independent sample T-test. 
 †For both choroidal and retinal thicknesses repeated measures ANOVA showed significant difference between the mean location measures within   





Table 9.15 Association of subfoveal choroidal thickness with best corrected visual 
acuity in young, extremely high myopic eyes (SE<-10D, n = 105) 
 
 Best corrected visual acuity (LogMAR) 
 Β 95% CI P-value 
Model 1    
SFCT -0.039 -0.070 to -0.008 0.015 
Model 2    
SFCT + SE  0.005 -0.027 to 0.037 0.761 
Model 3    
SFCT + SE + presence of any  
pathological myopia lesions* 
-0.001 -0.036 to 0.033 0.937 
  Model 1: univariate 
  Model 2: adjusted for SE 
  Model 3: adjusted for SE and presence of any pathological myopia lesions* (posterior   
  staphyloma, lacquer cracks or chorio-retinal atrophy). 
  SFCT was analysed per 100 µm. 
  SFCT = subfoveal choroidal thickness (µm); SE = spherical equivalent (diopter); LogMAR  





Table 9.16 Summary of macular choroidal thickness and other variables in various studies in high myopia  











Mean CT,* µm 
Current study 520 21.59 27.32 -8.68 Spectralis SD-OCT Yes 225.87 (5.51) 
Flores-Moreno et al. 2013
28
 120 54.4 29.17 -14.34 Topcon 3D-2000 OCT No 115.5 (85.3) 
Fujiwara et al. 2009
11
 55 59.7 - -11.9 Spectralis SD-OCT Yes 93.2 (62.5) 
Ikuno et al. 2009
12
 31 51.7 29.6 -15.5 Cirrus SD-OCT No 99.3 (58.8) 
Takahashi et al. 2012
63
 20 63.4 28.37 -10.8 Cirrus SD-OCT No 68.1 (10.5) 
Chen et al. 2012
64
 20 28.8 - -9.29 Spectralis SD-OCT Yes 156.07 (86.3) 
  EDI = enhanced depth imaging; SD-OCT = spectral domain optical coherence tomography; AL = axial length; CT = choroidal thickness; SE =   
  spherical equivalent; “-“not available. 






Table 9.17 Summary of peripapillary choroidal thickness and other variables in various studies in normal eyes  
 












Current study (Myopes) 448 21.63 (1.15) 27.23 (1.07) -8.52 (1.80) Spectralis SD-OCT Yes 142.62 (43.84) 
Current study (Emmetropes) 116 22.03 (0.96) 23.70 (0.61) 0.11 (0.24) Spectralis SD-OCT Yes 181.90 (46.43) 
Huang et al. 2013
13
 76 56.95 (12.99) 23.20 0.31 (1.12) Spectralis SD-OCT Yes 165.03 (40.37) 
Oh et al. 2013
14
 40 41.2 (20.6) - -0.4 (1.1) Topcon 3D- OCT No 191.2 (62) 
Tanabe et al. 2012
11
 28 54.1 (20.0) - -3.6 (4.1) Spectralis SD-OCT Yes - 
Ho et al. 2011
12
 36 48 (16) - - Cirrus SD-OCT No - 
  AL = axial length; SE = spherical equivalent; EDI = enhanced depth imaging; PPCT = peripapillary choroidal thickness; “-” not available. 






CHAPTER IX FIGURES 
 
Figure 9.1 Enhanced depth imaging optical coherence tomography image demonstrating peripapillary region scanned using a 360°, 3.5 
mm diameter circle centered on the optic disc. The peripapillary choroidal thickness was measured as the perpendicular distance between 
Bruch’s membrane and the choroid-scleral interface at the following locations: T = temporal; ST = superotemporal; S = superior; SN = 







Figure 9.2 Comparison of EDI-OCT scans of choroidal thickness between 
emmetrope and myope. (A) A 22-year-old male with no refractive error (AL = 23.61 
mm) and an average choroidal thickness of 325 µm. (B) A 23-year-old male with SE 
of -12.25D (AL = 29.35 mm) and an average choroidal thickness of 117 µm. 
 
 
(A) A 22-year-old male with no refractive error (AL = 23.61 mm) and an average 
choroidal thickness of 325 µm. 
 
(B) A 23-year-old male with SE of -12.25D (AL = 29.35 mm) and an average choroidal 
















Figure 9.4 Visualization of choroid morphological and vascular parameters obtained 

















              Line passing through fovea 
              Foveal region: 1.5 mm centered on fovea 
              Macular region: 6 mm centered on fovea 
              Position of thickest choroid 






Figure 9.5 Validation of Niblack binarization against manual delineation of stromal 
areas; (A) Original choroid cross-sectional scans with RPE choroid-scleral 
boundaries; (B) Identification of choroid vasculature by automated binarization with 









Figure 9.6 Graph showing the differences in macular choroidal thickness in the high myopic groups and emmetropic group along the 
horizontal axis (A) and vertical axis (B). Mean thickness at each of the nasal, temporal, superior, and inferior locations measured at 1.5 
mm and 3 mm intervals eccentric to the sub-foveal area. Error bars indicate standard error. SFCT is sub-foveal choroidal thickness. 
 
Emmetrope, -0.5 to 1D 
Myopia, <-6 to -8D 
Myopia, <-8 to -10D 
Myopia, <-10D 
 





Figure 9.7 (A) Scatterplot showing negative correlation between subfoveal choroidal thickness and axial length in all myopes. (B). 
Scatterplot showing positive correlation between subfoveal choroidal thickness and spherical equivalent in all myopes. (C). Scatterplot 







Figure 9.8 (A) Scatterplot showing negative correlation between LogMAR visual 
acuity and subfoveal choroidal thickness in all myopes. (B). Scatterplot showing 
negative correlation between Log contrast sensitivity and subfoveal choroidal 













Figure 9.9 Graph showing the distribution of mean peripapillary choroidal thickness 
(micrometer, µm) in high myopic and emmetropic groups at different locations 
around the optic disc. The x-axis represents the locations of the measurements of 
peripapillary choroidal thickness around the optic disc. T = temporal, ST = 
superiotemporal, S = superior, SN = superionasal, N = nasal, IN = inferonasal, I = 
inferior, IT = inferotemporal. Error bars indicate standard error.  
 
Emmetrope, -0.5 to 1D 
Myopia, <-6 to -8D 







 Figure 9.10 Distribution profiles of choroidal and retinal thicknesses at different locations in high 
myopic and emmetropic groups. Mean thickness at each of the nasal, temporal, superior, and inferior 
locations was measured at 1.5 mm and 3 mm intervals eccentric to the sub-foveal area. Error bars 
indicate standard error. SFCT=sub-foveal choroidal thickness; SFRT=sub-foveal retinal thickness; 





































































CHARACTERIZATION OF CHOROID IN DIABETES AND DIABETIC 
RETINOPATHY 
In Chapter IX, we demonstrated that choroidal attributes, in particular, 
curvature of the CSI, inflection points and vascular area are significantly altered in 
high myopes. Given that choroid is implicated in the pathogenesis of diabetes and 
DR, in this Chapter, we performed characterization of morphological and vascular 
traits of the choroid in subjects with diabetes and DR. Since both diabetes and DR are 
accompanied by focal changes in the choroid, we hypothesize that the above 
choroidal features might be altered in these diseases. 
 
 
The manuscript relevant to the contents of this chapter has been published in: 
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Diabetes mellitus is a metabolic disease characterized by both macrovascular 
and microvascular complications.
1
 Diabetic retinopathy (DR) is the most common 
microvascular complication, primarily caused by chronic hyperglycemia leading to 
loss of pericytes of retinal capillaries and subsequent ischemia.
2
 The pathogenesis and 
clinical features of DR are primarily attributed to retinal vascular damage;
3
 however, 
there is increasing evidence of choroidal involvement as persons with diabetes have 
been found to have various choroidal abnormalities including choroidal vascular 
degeneration, choroidal aneurysms, choroidal neovascularization, obstruction of the 
choriocapillaris, and increased tortuosity and narrowing of the choroidal vessels.
4-6
  
The choroid is an integral part of metabolic exchange in the outer retina, in 
particular, foveal avascular zone, due to lack of retinal vasculature and a high 
metabolic demand from an increased photoreceptor density.
7, 8
 Therefore, the choroid 
plays an important physiological role in ocular health, and is involved in the 
pathogenesis of many ocular diseases including DR.
9-13
  
The recent availability of enhanced depth imaging (EDI) optical coherence 
tomography (OCT) has allowed the non-invasive quantitative assessment of the 
choroid.
14
 Since then various studies have proposed choroidal thickness (CT) as a 
marker to assess different disease conditions
15-19
 including diabetes. However, reports 





 or even no change.
20
 This could possibly be due to confounding effects from factors 
such as age, gender, refractive error, axial length, diurnal variation etc. which have 
been shown to influence CT.
21-24
 Thus measurements of CT alone may not be 





dimentional structure predominantly composed of interconnected network of blood 
vessels surrounded by stromal tissue.
7
 Thus, a more detailed investigation of 
choroidal structure and vasculature may provide better understanding of the choroid 
in diseases such as diabetes and DR where to date there has been no consensus as to 
whether there is increase or decrease in CT.  
Nevertheless, there are limited in-vivo reports on a few choroidal 
morphological features and vessel layer measurements in DR.
25, 26
 There has been no 
attempt to define and quantify morphological traits such as curvature of the choroid-
scleral interface (CSI) and vascularity of the choroid in persons with diabetes and DR. 
In view of paucity of data on these features and given the rising trend in the 
prevalence of both diabetes and DR among Asian,
27, 28
 it is imperative to have in-vivo 
baseline measurements of the choroidal morphometric and vascular features in 
persons with diabetes and DR.  
The aim of this study was to characterize the morphological and vascular 
features of the choroid in a sample of Indian adults with diabetes and DR using novel 
segmentation methods on choroidal images obtained by EDI SD-OCT. 
 
10.2 MATERIALS AND METHODS 
10.2.1 Study Subjects 
In this cross-sectional study, 500 consecutive subjects were recruited during 
their 6-year follow-up examination from a total of 2200 subjects who participated in 
Singapore Indian Eye Study-2 (SINDI-2, 2013-2015), a population-based cohort 









Each subject underwent an interview and detailed ocular examination 
according to a standardized study protocol,
29
 including imaging of the choroid using 
Spectralis SD-OCT with EDI (Spectralis SD-OCT; Heidelberg Engineering GmbH, 
Heidelberg, Germany). The study protocol was approved by the SingHealth 
Centralized Institutional Review Board and adhered to the ethical principles outlined 
in the Declaration of Helsinki, 2008. Written voluntary informed consent was 
obtained from each subject.   
10.2.2 Exclusion Criteria 
Among non-diabetic and diabetic group (including those with and without 
DR), subjects with refractive error <-6.00 diopters, age related macular degeneration 
(AMD), glaucoma and those whose choroidal images were of insufficient quality 
(quality index of < 18 decibels for Spectralis OCT as suggested by the manufacturer 
for the image quality assurance) were excluded. However, subjects with DR that had 
received treatments such as intravitreal injections or laser photocoagulation (more 
than 6 months of their participation into the study) were not excluded.  
10.2.3 Ocular and Systemic Examination 
Each subject underwent an interview and detailed systemic and ocular 
examination according to a standardized study protocol, as described in Chapter III of 
the thesis.  





The choroid was imaged using EDI mode of Spectralis SD-OCT. The details 
on choroidal image acquisition protocol have been described in Chapter III of the 
thesis. Although choroidal images of both eyes of each study subject were obtained, 
due to strong inter-eye correlation only the right eye of each subject was delineated 
for detailed morphological and vascular analyses. Raw OCT images were loaded on a 
custom-written application on MATLAB that enabled delineation of RPE and CSI 
(described in detail in Chapter IX).  
10.2.5 Measurement of Choroidal Morphological and Vascular Parameters 
For each eye, the horizontal cross-sectional scan passing through the fovea 
was identified. Based on this cross-sectional scan, we defined and calculated (in 
MATLAB) the following choroidal morphological and vascular parameters: CSI 
curvature, inflection points, thickest point distance from the fovea, CT, choroidal 
volume and choroidal vascular area within foveal and macular regions. Our technique 
of image binarization to identify stromal and luminal areas within the choroid was 
validated against manual delineations. The above choroidal morphological and 
vascular features and validation of image binarization technique are both described in 
detail in Chapter IX of this thesis and in Figures 9.4 and 9.5. 
10.2.6 Statistical Analyses 
 
To compare the characteristics of participants among groups, independent t-
test was performed for continuous variables and chi-square tests or Fisher’s exact test 
for categorical variables. Data was expressed as mean ± standard deviation (SD). 
Multiple linear regression analysis was used to assess differences in choroidal 
characteristics by diabetes (in reference to no diabetes) and DR (in reference to no 





plausible factors  such as age, sex and AL. Statistical significance was set at p < 0.05 
unless otherwise indicated. All statistical analyses were carried out using SPSS (v 




Of the 500 subjects initially enrolled, 37 were excluded based on our clinical 
exclusion criteria; myopia <-6.00 D (n=6), age related macular degeneration (n=4), 
glaucoma or glaucoma suspect (n=13) and poor OCT image quality (n=14), leaving 
463 subjects for analysis. Of the 463 subjects included, 273 had no diabetes, 100 had 
diabetes but no DR, and 89 had DR.  
The demographic, clinical and choroidal characteristics of the subjects with 
and without diabetes are depicted in Table 10.1. There were significant differences in 
characteristics (clinical and choroidal) between the two groups. Total choroidal area, 
vascular area and choroidal vascularity was lower in subjects with diabetes compared 
to non-diabetics (all p<0.001). There was no significant difference in choroidal 
stromal area between the two groups. Of the subjects, 86.4% without diabetes had one 
inflection point vs. 24% of those with diabetes.  
In the multiple regression analysis after accounting for relevant confounders 
such as age, gender, SBP, DBP, ocular perfusion pressure (OPP), HbA1c and 
presence of hypertension (Model 2), subjects with diabetes had significantly thinner 
CT at all the studied locations (all p<0.001), including thinner mean CT (mean 
difference [MD]=-25.19µm, p=0.001), lesser choroidal volume (MD=-0.23mm
3
, 





diabetes (Table 10.2). They also had lesser total choroidal area, choroidal vascular 
area and choroidal vascularity within the foveal and macular regions. 
Of the diabetics, subjects with DR had significantly thicker choroid, greater 
choroidal volume, more posteriorly curved CSI and lesser inflection points (all 
p<0.05). Total choroidal, vascular and stromal areas within foveal and macular 
regions were significantly greater in those with the DR compared with those without 
(Table 10.3).  
In the multiple regression analysis after adjusting for potential confounders 
such as age, gender, axial length, SBP, HbA1c, duration of diabetes and insulin use 
(Model 2), compared to diabetic subjects with no DR, those with DR exhibited 
significantly thicker CT at all the studied locations (all p<0.001) including, thicker 
mean CT (MD=25.91µm, p=0.001), greater choroidal volume (MD=0.24mm
3
, 
p=0.009) and lesser inflection points (MD=-0.478, p=0.045). In addition, they 
demonstrated greater total choroidal, vascular and stromal areas at foveal and macular 
regions (all p<0.05). However, at the macular region, choroid was less vascular in 
subjects with DR (Table 10.4). 
DR subjects were classified according to their stage of DR. Of the 89 subjects 
with DR, 58 (65.1%) had minimal to mild DR, 24 (26.9%) had moderate non 
proliferative DR, while none of our subjects had severe non proliferative DR and 7 
(7.8%) subjects had proliferative DR. Comparison of choroidal traits across different 
DR severity groups showed no significant trend in any of the choroidal attributes (p 
for trend >0.05 for all traits, Table 10.5).  
Given laser treatments in particular PRP have been shown to result in 
choroidal thinning,
25





diabetic subjects with DR. However, since two third of our subjects had only minimal 
to mild DR, number of subjects with laser treatment is also limited. Of the 89 subjects 
with DR, 74 (83.14%) had no previous laser treatment while 13 (14.6%) subjects had 
undergone focal laser and only 2 (2.24%) had PRP done. Comparison of choroidal 
features between subjects who had previous laser treatments (focal or PRP) vs. those 
with no laser treatment showed no significant difference in any of their choroidal 
traits (all p>0.05, Table 10.6). Similar results were observed when further adjusted 
for DR stages. 
 
10.4 DISCUSSION 
To the best of our knowledge, this is the first study to characterize morphology 
and vasculature of the choroid in persons with diabetes and DR using the technique of 
image binarization in choroidal images obtained using EDI, SD-OCT. Our results 
demonstrated significant alterations in choroidal structural and vascular characteristics 
in both diabetes and DR. As speculated, subjects with diabetes showed significantly 
thinner choroid and lower vascular area, which is consistent with capillary drop-out 
wherein decreased choroidal blood flow plays a key role in the pathogenesis. 
Conversely, among the diabetic group, subjects with DR displayed thicker choroid 
and significantly higher vascular area compared to no DR. These findings indicate 
that the choroidal morphology and function are distinctly different in two conditions. 
Knowledge about choroidal structural and vascular traits in-vivo remains 
limited. There are only couple of reports on some of the choroidal morphological 
features and vessel layer thickness measurements in healthy and DR eyes using Cirrus 
OCT.
25, 30





structures, as the line of peak sensitivity is placed at posterior vitreous, allowing better 
visualization of retinal structures.
31
 This gives a poor quality of choroidal image, 
compromising the validity of existing studies, in particular their vascular analysis. In 
addition, there is no report on choroidal features in diabetic persons, except for CT. 
Given the increasing trend in the prevalence and severity of diabetes and DR among 
Asians, it is important to have in-vivo baseline measurements of choroidal traits to 
provide better insight into the choroidal angiopathy associated with the disease. 
 We demonstrated that in persons with diabetes there is significant increase in 
inflection points indicating irregular contour of the CSI. This finding is supported by 
the clinical observation of focal changes (either thickening or thinning) in the choroid 
of diabetic persons.
32
 In terms of CT our finding are consistent with the existing 
studies which reported choroidal thinning in diabetes.
9, 11
 Distribution profiles of CT 
in persons with diabetes are similar to that in non-diabetic eyes; the choroid was 
thickest subfoveally and thins out much more nasally than temporally. Our results are 
congruent to what was observed in few other studies of horizontal variation in CT 
among subjects with diabetes.
10, 12 Since the blood supply for the choroid originates 
from the posterior ciliary arteries in the macula and then travels to the so-called 
“watershed zones” of the choroid periphery, this may be the reason for the reduction 
in CT towards the nasal regions.
33
 
Interestingly, in comparison to non-diabetic eyes, choroidal vascular area was 
markedly reduced in persons with diabetes. In view of contradictory results of current 
studies on CT in diabetes
9, 11, 13, 20
 it is still uncertain how diabetes affects the choroid. 
Because diabetes is primarily a vascular disease affecting both retinal and choroidal 
vasculature, knowledge of individual components of the choroid in particular vascular 





speculated reduction in luminal area in diabetes as there is narrowing of choroidal 
arterioles, choriocapillaris atrophy, and capillary dropout (shown by histologic 
studies),
5, 34
 which in turn leads to a decreased choroidal blood flow in diabetic eyes 
(shown by circulatory studies using Laser Doppler Flowmetry).
35
 The results of this 
study support our hypothesis of reduced choroidal vascularity in diabetic subjects.  
On the other hand, compared to subjects without DR, persons with DR showed 
decrease in inflection points. Although, there was a displacement of the thickest point 
of choroid from under the foveal centre towards temporal location, the displacement 
was lesser compared to that seen in subjects with diabetes and was not significant. 
Contrary to diabetes (without DR), there was a significant increase in CT (at all the 
locations), choroidal volume and vascular area within foveal and macular regions in 
DR. We hypothesize that the increase production of VEGF or other cytokines in DR 
might result in choroidal vasodilation and elevation in choroidal blood flow, which 
subsequently increase the thickness and vascular area of the choroid. 
There was no significant difference in any of the choroidal traits in DR 
subjects with or without laser treatment. We speculate the reason for no difference in 
choroidal features across the two groups to be the lesser number of subjects in 
treatment group compared to no treatment. It is more likely a power issue and we 
recommend future studies with more number of subjects in treatment group to study 
the likely effect of lasers on choroidal attributes. 
The strengths of our study included a relatively large sample size with a single 
common ethnicity, standardized clinical examination protocols, reliable 
differentiation and quantifications of choroidal parameters. Furthermore, our analysis 
included a comprehensive list of potential confounding factors; choroidal 





factors. However, this study also has limitations. Our OCT images were binarized at 
standard threshold, yet there was a possibility of over or under estimation of both 
vascular and avascular areas. Choroidal attributes were assessed from a horizontal 
cross-sectional scan passing through the fovea. Future studies using more dense 
volume scan protocols are warranted. Also future improved software will be able to 
perform binarization of volume scans and will provide data not limited to single scan. 
We did not have information on prior intravitreal anti-VEGF injection for our diabetic 
subjects with DR. However, given that two third of our subjects had only minimum to 
mild DR, it is unlikely to influence our findings. DR subjects were classified 
according to their stage of DR. However, the statistical power to perform subgroup 
analysis by stage may be limited. Future studies with large sample in different DR 
severity groups are warranted. Choroidal scans were only performed for one time 
point in the day. The effect of diurnal variation on choroidal features
22, 36
 could not be 
assessed due to the inherent limitation of our study design.  
 
10.5 CONCLUSION 
In conclusion, we report significant alterations in choroidal morphometric and 
vascular attributes in persons with diabetes and DR. These findings will be useful in 
further understanding the role and contribution of choroidal measures in the 
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CHAPTER X TABLES 
Table 10.1 Clinical and choroidal characteristics of study subjects in the non-diabetic and 
diabetic groups  
 
Without Diabetes 
(n = 273) 
With Diabetes 




Age, years 60.10 (6.82) 62.14 (6.81) <0.001 
Gender, male (%) 138 (50.9) 103 (54.5) 0.507 
Axial length, mm 23.38 (1.11) 23.22 (0.95) 0.019 
BMI, kg/m
2
 26.16 (4.63) 27.05 (3.90) 0.031 
SBP, mmHg 132.32 (17.66) 135.66 (17) 0.043 
DBP, mmHg 78.80 (9.87) 73.99 (7.47) <0.001 
MOPP, mmHg 54.48 (7.35) 52.20 (6.28) <0.001 
HbA1c, % 5.60 (0.43) 7.74 (1.53) <0.001 
Duration of diabetes, years - 15.23 (8.52) - 
Insulin use (Y) - 43 (22.75) - 
Hypertension (Y) 141 (51.6) 142 (75.1) <0.001 
Choroidal Characteristics 
Mean CT, µm 276.11 (56.02) 249 (54.30) <0.001 
Sub-foveal CT, µm 301.92 (63.10) 269.46 (61.02) <0.001 
Nasal 3 mm CT, µm 269.04 (67.09) 241.41 (64.64) <0.001 
Temporal 3 mm CT, µm 283.23 (53.20) 256.63 (51.86) <0.001 
Choroidal volume, mm
3
 2.42 (0.48) 2.195 (0.605) <0.001 
CSI curvature, mm
-1
 -0.093 (0.044) -0.087 (0.040) 0.097 
No of inflection points 1.16 (0.45) 2.70 (1.47) <0.001 
Thickest point distance from fovea, mm 0.026 (1.038) -0.436 (1.46) <0.001 
Sub Foveal (1.5 mm region)    
Total choroidal area, mm
2
 0.452 (0.094) 0.404 (0.091) <0.001 
Vascular area, mm
2
 0.241 (0.052) 0.196 (0.047) <0.001 
Stromal area, mm
2
 0.211 (0.087) 0.207 (0.051) 0.617 
Choroidal vascularity 0.555 (0.214) 0.485 (0.052) <0.001 
Macular (6 mm region)    
Total choroidal area, mm
2
 1.670 (0.327) 1.494 (0.325) <0.001 
Vascular area, mm
2
 0.884 (0.185) 0.719 (0.167) <0.001 
Stromal area, mm
2
 0.786 (0.302) 0.774 (0.174) 0.608 
Choroidal vascularity 0.548 (0.199) 0.480 (0.039) <0.001 
Data presented are means (standard deviations) or number (%). 
a 
Based on independent sample t-test for continuous variables or Chi-square/Fisher’s exact test for 
categorical variables. 
BMI=body mass index; SBP=systolic blood pressure; DBP=diastolic blood pressure; MOPP=mean 







Table 10.2 Differences in choroidal characteristics (dependent variables) in subjects with diabetes (n = 189), compared to those without diabetes 
(n = 273) 









(95% CI) P-value 
Mean CT, µm -17.82 (-28.05, -7.60) <0.001 -25.19 (-40.37, -10.02) 0.001 
Sub-foveal CT, µm -23.44 (-35.07, -11.82) <0.001 -29.13 (-46.45, -11.81) 0.001 
Nasal 3 mm CT, µm -17.69 (-29.79, -5.58) 0.004 -27.73 (-45.40, -10.06) 0.002 
Temporal 3 mm CT, µm -17.97 (-27.89, -8.06) <0.001 -22.67 (-37.71, -7.63) 0.003 
Choroidal volume, mm
3
 -0.142 (-0.243, -0.041) 0.006 -0.230 (-0.384, -0.077) 0.003 
CSI curvature, mm
-1
 0.007 (-0.001, 0.016) 0.092 0.009 (-0.004, 0.022) 0.173 
No of inflection points 1.487 (1.292, 1.682) <0.001 1.780 (1.48, 2.07) <0.001 
Thickest point distance from fovea, mm -0.426 (-0.660, -0.192) <0.001 -0.233 (-0.584, 0.119) 0.194 
Sub Foveal (1.5 mm region)     
Total choroidal area, mm
2
 -0.035 (-0.053, -0.018) <0.001 -0.044 (-0.070, -0.018) 0.001 
Vascular area, mm
2
 -0.042 (-0.052, -0.032) <0.001 -0.043 (-0.058, -0.028) <0.001 
Stromal area, mm
2
 0.007 (-0.007, 0.021) 0.344 -0.001 (-0.022, 0.020) 0.935 
Choroidal vascularity -0.090 (-0.123. -0.058) <0.001 -0.077 (-0.124, -0.031) 0.001 
Macular (6 mm region)     
Total choroidal area, mm
2
 -0.120 (-0.181, -0.060) <0.001 -0.159 (-0.250, -0.069) 0.001 
Vascular area, mm
2
 -0.151 (-0.185, -0.117) <0.001 -0.160 (-0.212, -0.107) <0.001 
Stromal area, mm
2
 0.031 (-0.017, 0.079) 0.210 0.000 (-0.071, 0.072) 0.991 
Choroidal vascularity -0.088 (-0.117, -0.058) <0.001 -0.077 (-0.121, -0.033) 0.001 
Model 1: adjusted for age and sex.  




difference in choroidal characteristics in subjects with diabetes with reference to non-diabetes. 





Table 10.3 Clinical and choroidal characteristics of study diabetic subjects without and with 
diabetic retinopathy  
 
Without DR 
(n = 100) 
With DR 





Age, years 61.85 (7.47) 62.48 (6.01) 0.525 
Gender, male (%) 49 (49) 54 960.7) 0.108 
Axial length, mm 23.38 (1.11) 23.04 (0.70) 0.015 
BMI, kg/m
2
 26.89 (3.43) 27.23 (4.39) 0.555 
SBP, mmHg 132.19 (15.75) 139.56 (17.58) 0.003 
DBP, mmHg 73.81 (7.28) 74.19 (7.71) 0.727 
MOPP, mmHg 51.67 (5.91) 52.81 (6.66) 0.213 
HbA1c, % 7.49 (1.33) 8.02 (1.69) 0.019 
Duration of diabetes, years 14.71 (8.63) 15.83 (8.40) 0.366 
Insulin use (Y) 14 (14) 29 (33) 0.002 
Hypertension (Y) 73 (73)       69 (77.5) 0.472 
Choroidal Characteristics 
Mean CT, µm 233.50 (47.09) 266.41 (56.78) <0.001 
Sub-foveal CT, µm 251.79 (52.72) 289.31 (63.83) <0.001 
Nasal 3 mm CT, µm 224.38 (57) 260.54 (67.60) <0.001 
Temporal 3 mm CT, µm 242.66 (46.71) 272.33 (53.11) <0.001 
Choroidal volume, mm
3
 2.05 (0.43) 2.35 (0.72) <0.001 
CSI curvature, mm
-1
 -0.081 (0.042) -0.093 (0.037) 0.033 
No of inflection points 2.96 (1.44) 2.41 (1.46) 0.001 
Thickest point distance from fovea, mm -0.56 (1.51) -0.29 (1.39) 0.200 
Sub Foveal (1.5 mm region)    
Total choroidal area, mm
2
 0.377 (0.079) 0.433 (0.095) <0.001 
Vascular area, mm
2
 0.186 (0.045) 0.207 (0.048) 0.002 
Stromal area, mm
2
 0.191 (0.042) 0.226 (0.054) <0.001 
Choroidal vascularity 0.491 (0.055) 0.478 (0.049) 0.102 
Macular (6 mm region)    
Total choroidal area, mm
2
 1.401 (0.282) 1.598 (0.340) <0.001 
Vascular area, mm
2
 0.682 (0.150) 0.760 (0.176) 0.001 
Stromal area, mm
2
 0.718 (0.148) 0.837 (0.180) <0.001 
Choroidal vascularity 0.485 (0.040) 0.473 (0.037) 0.049 
Data presented are means (standard deviations) or number (%). 
a
 Based on independent sample t-test for continuous variables or Chi-square/Fisher’s exact test for 
categorical variables. 
DR=diabetic retinopathy; BMI=body mass index; SBP=systolic blood pressure; DBP=diastolic blood 
pressure; MOPP=mean ocular perfusion pressure; HbA1c=haemoglobin A1c; CT=choroidal 





Table 10.4 Difference in choroidal characteristics (dependent variables) in diabetic subjects with diabetic retinopathy (n = 89), compared to 
those without diabetic retinopathy (n = 100) 





(95% CI) P-value 
Beta coefficient
a  
(95% CI) P-value 
Mean CT, µm 32.75 (19.11, 46.40) <0.001 25.91 (11.12, 40.69) 0.001 
Sub-foveal CT, µm 36.71 (21.07, 52.35) <0.001 30.50 (13.61, 47.39) <0.001 
Nasal 3 mm CT, µm 34.92 (18.61, 51.22) <0.001 23.93 (6.44, 41.43) 0.008 
Temporal 3 mm CT, µm 30.60 (17.10, 44.10) <0.001 27.89 (13.06, 43.73) <0.001 
Choroidal volume, mm
3
 0.310 (-0.148, 0.472) <0.001 0.240 (0.06, 0.41) 0.009 
CSI curvature, mm
-1
 -0.013 (-0.014, 0.009) 0.030 -0.008 (-0.021, 0.004) 0.201 
No of inflection points -0.586 (-1.00, -1.67) 0.006 -0.478 (-0.944, -0.011) 0.045 
Thickest point distance from fovea, mm 0.209 (-0.206, 0.624) 0.322 0.021 (-0.426, 0.469) 0.926 
Sub Foveal (1.5 mm region)     
Total choroidal area, mm
2
 0.055 (0.032, 0.079) <0.001 0.046 (0.020, 0.071) <0.001 
Vascular area, mm
2
 0.021 (0.009, 0.033) 0.001 0.016 (0.003, 0.030) 0.019 
Stromal area, mm
2
 0.034 (0.021, 0.048) <0.001 0.030 (0.015, 0.044) <0.001 
Choroidal vascularity -0.013 (-0.028, 0.002) 0.081 -0.014 (-0.029, 0.002) 0.087 
Macular (6 mm region)     
Total choroidal area, mm
2
 0.197 (0.115, 0.278) <0.001 0.155 (0.067, 0.244) 0.001 
Vascular area, mm
2
 0.078 (0.036, 0.120) <0.001 0.057 (0.011, 0.102) 0.016 
Stromal area, mm
2
 0.119 (0.074, 0.164) <0.001 0.099 (0.051, 0.147) <0.001 
Choroidal vascularity -0.012 (-0.023, -0.001) 0.038 -0.012 (-0.024, -0.001) 0.036 
Model 1: adjusted for age and sex.  
Model 2: adjusted for age, sex, axial length, SBP, HbA1c, duration of diabetes and insulin use. 
a
 Beta coefficient represents difference in choroidal characteristics in diabetic subjects with DR in reference to those without DR.  





Table 10.5. Choroidal characteristics of study subjects in the diabetic group with stages of diabetic retinopathy (minimal-mild DR, moderate 
NPDR and PDR). 
    
Changes in choroidal 
traits across DR stages 
Choroidal Characteristics 
Minimal-Mild DR 
(n = 58) 
Moderate NPDR 
(n = 24) 
PDR 
(n = 7) 
Beta P for trend 
Mean CT, µm  268.10 (56.70) 267.97 (60.57) 262.11 (65.84) -1.915 0.847 
Sub-foveal CT, µm 290.57 (63.23) 289.17 (68.66) 294.22 (75.84) 0.605 0.957 
Nasal 3 mm CT, µm 261.82 (63.90) 264.78 (78.48) 255.32 (78.74)   -0.910    0.938 
Temporal 3 mm CT, µm 274.43 (55.03) 271.21 (53.38) 268.96 (59.71)   -2.916    0.753 
Choroidal volume, mm
3
 2.38 (0.84) 2.33 (0.54) 2.27 (0.59) -0.054 0.672 
CSI curvature, mm
-1
 -0.08 (0.03) -0.09 (0.03) -0.11 (0.03) -0.009 0.166 
No of inflection points 2.53 (1.62) 2.42 (1.24) 2.00 (1.00) -0.207 0.412 
Thickest point distance from fovea, mm -0.26 (1.40) -0.26 (1.52) -0.42 (1.34) -0.024 0.831 
Sub Foveal (1.5 mm region) 
Total choroidal area, mm
2
 0.435 (0.094) 0.433 (0.102) 0.441 (0.113) 0.001 0.957 
Vascular area, mm
2
 0.208 (0.047) 0.204 (0.050) 0.210 (0.058) -0.001 0.921 
Stromal area, mm
2
 0.227 (0.053) 0.229 (0.062) 0.230 (0.059) 0.002 0.855 
Choroidal vascularity 0.478 (0.043) 0.471 (0.053) 0.475 (0.355) -0.003 0.690 
Macular (6 mm region) 
Total choroidal area, mm
2
 1.608 (0.340) 1.607 (0.363) 1.572 (0.395) -0.011 0.847 
Vascular area, mm
2
 0.761 (0.172) 0.766 (0.188) 0.723 (0.227) -0.010 0.736 
Stromal area, mm
2
 0.846 (0.184) 0.841 (0.186) 0.849 (0.172) -0.001 0.971 
Choroidal vascularity 0.472 (0.037) 0.474 (0.031) 0.452 (0.041) -0.006 0.361 
Data presented are means (standard deviations).  





Table 10.6. Choroidal characteristics of subjects with DR who had laser treatment (focal or grid) vs. those with no laser treatment. 
Choroidal Characteristics 
No laser 
treatment (n = 
74) 
Lasers (focal or PRP) 






Mean CT, µm 270.13 (59.08) 248.59 (45.83) 0.272 0.222 
Sub-foveal CT, µm 292.95 (66.55) 272.16 (51.44) 0.346 0.225 
Nasal 3 mm CT, µm 265.57 (68.83) 236.60 (65.36)   0.213    0.136 
Temporal 3 mm CT, µm 274.73 (56.39) 260.62 (34.65)   0.444    0.474 
Choroidal volume, mm
3
 2.39 (0.77) 2.16 (0.44) 0.361 0.413 
CSI curvature, mm
-1
 -0.90 (0.03) -0.106 (0.03) 0.227 0.633 
No of inflection points 2.51 (1.53) 2.00 (0.81) 0.305 0.506 
Thickest point distance from fovea, mm -0.21 (1.41) -0.70 (1.46) 0.312 0.273 
Sub Foveal (1.5 mm region) 
Total choroidal area, mm
2
 0.439 (0.099) 0.408 (0.077) 0.346 0.225 
Vascular area, mm
2
 0.208 (0.049) 0.201(0.048) 0.675 0.656 
Stromal area, mm
2
 0.231 (0.057) 0.206 (0.031) 0.198 0.082 
Choroidal vascularity 0.474 (0.049) 0.488 (0.036) 0.379 0.164 
Macular (6 mm region) 
Total choroidal area, mm
2
 1.620 (0.354) 1.491 (0.275) 0.272 0.222 
Vascular area, mm
2
 0.766 (0.180) 0.709 (0.175) 0.348 0.361 
Stromal area, mm
2
 0.854 (0.188) 0.782 (0.111) 0.242 0.154 
Choroidal vascularity 0.471 (0.035) 0.470 (0.044) 0.908 0.592 
 Data presented are means (standard deviations). 
a 
Based on independent sample t test. 
b








CHARACTERIZATION OF CHOROID IN  
AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL 
CHOROIDAL VASCULOPATHY 
In Chapter X, we demonstrated significant alterations in choroidal 
morphological and vascular characteristics in persons with diabetes and DR. Given 
the involvement of choroid in the pathogenesis of AMD and PCV, in this Chapter, we 
extended the characterization of morphological and vascular traits of the choroid in 
subjects with AMD and PCV with a hypothesis that the above choroidal features will 
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Age related macular degeneration (AMD), a leading cause of blindness in the 
elderly population globally,
1-3
 is traditionally characterized by changes seen in the 
retinal pigment epithelium (RPE) and Bruch’s membrane.4 With the advent of 
spectral-domain optical coherence tomography (SD-OCT), coupled with the enhanced 
depth imaging (EDI) mode, changes in the choroid such as choroidal thickness (CT), 
have been increasingly recognized as another key feature in the evolution and 
possibly pathogenesis of AMD.
5-8
 Polypoidal choroidal vasculopathy (PCV) is a 
subtype of AMD, more commonly seen in Asians than white Caucasian populations, 
which is often associated with thickened choroid and choroidal hyperpermeability 
compared to typical AMD.
5, 8-11
  In this regard, histological studies of eyes with PCV 
reported abnormal dilatation of choroidal vessels with hyalinization, arteriosclerosis, 
exudation and loss of smooth muscles.
12-14
  Furthermore, several groups have reported 
that anti-vascular endothelial growth factor (VEGF) therapy is less effective in eyes 
with PCV with thickened choroid.
15
  
Although the choroid is predominantly composed of blood vessels surrounded 
by stromal tissues,  and CT and choroidal hyperpermeability have been shown to be 
closely related,
9, 15, 16
 measurement of CT alone may not capture the specific changes 
within the choroid, .
17
 A wide variation in CT exists even within the subgroup of eyes 
classified to have PCV. Therefore a method to analyze details of the choroid in terms 
of its morphometric and vascular features is essential to better understand the role of 
choroid in typical AMD and PCV. The pachychoroid phenotype has recently been 
characterized to include not only increased CT, but also the presence of pathologically 
dilated outer choroidal vessel (pachyvessels), attenuation and thinning of 
choriocapillaris and Sattler vessels, regional choroidal hyperpermeability.
18





these features, a subtype of PCV, called “polypoidal choroidal neovascularization 
(CNV)” may be classified based on presence of polypoidal lesions in the absence of 
pachychoroidal features. It has been proposed that polypoidal lesions in polypoidal 
CNV may represent a structural variant of neovascular tissue.
19
  
The detailed analysis of choroidal morphometric features such as presence of 
pachyvessels can be subjective and lack quantitative endpoints. Recently Sonodo et 
al. described a method to separately quantify choroidal luminal and interstitial areas in 
eyes with AMD.
20
  In this study, we aim to apply the binarization of OCT images 
technology to characterize detailed morphological and vascular features of the choroid 
in eyes with typical exudative AMD and PCV, and to investigate whether PCV can be 
sub-classified into typical PCV and polypoidal CNV based on these choroidal 
vascular features. Our hypothesis is that eyes with PCV may be sub-classified into 2 




11.2.1 Study Subjects 
The data for this study was taken from a prospective, observational cohort 
study involving patients with exudative AMD in the Asian AMD Phenotyping 
Study.
21
 Detailed methodology has been published elsewhere.
21-23
 The study was 
approved by the Centralized Institutional Review Board (CIRB) of SingHealth, 
Singapore (protocol number R697/47/2009) and conducted in accordance with the 






11.2.2 Clinical Examination and Diagnosis 
 At baseline, all patients underwent an interview and comprehensive ocular 
examination including best corrected visual acuity testing using logarithm of the 
minimal angle of resolution (logMAR), refraction, slit-lamp biomicroscopy 
examination, and imaging according to standardized protocol, which included color 
fundus photography and angiography with fluorescein and indocyanine green (TRC-
50X/ IMAGEnet 2000; Topcon, Tokyo, Japan or Spectralis; Heidelberg Engineering, 
Heidelberg, Germany). Information including medical history and smoking was 
obtained using standardized questionnaire. 
Patients were classified as typical AMD and PCV based on fundus fluorescein 
angiogram and indocyanine green (ICG) angiogram as described in detail 
previously.
24-27
 Briefly, typical AMD is graded based on presence or absence of CNV 
according to the Macular Photocoagulation Study.
24
 PCV is diagnosed based on 
presence of characteristic polypoidal lesions seen in ICG.
25-27
  
To study the differences in choroidal traits between AMD and PCV subtypes, 
patients with PCV were further categorized on the basis of CT into typical PCV (with 
CT≥250um) and PCV without thick choroid. 
11.2.3 Ocular and Systemic Examination 
Each subject underwent an interview and detailed systemic and ocular 
examination according to a standardized study protocol, as described in Chapter III of 
the thesis.  





The choroid was imaged using EDI mode of Spectralis SD-OCT. OCT raster 
scans with EDI were acquired at the macular region of both eyes of each subject. Each 
set of images comprised 25 serial horizontal B-scans (each composed of 1536 A-
scans) covering a rectangular region of 20º X 20º centered on the fovea. Distance 
between consecutive scans was on average about 240 μm and each scan was 8.9 mm 
in length. To reduce speckle noise, each B-scan was averaged 9 times during 
acquisition. OCT images were loaded on a custom-written application on MATLAB 
that enabled delineation for detailed morphological and vascular analyses (described 
in detail in Chapter IX).  
11.2.5 Measurement of Choroidal Morphological and Vascular Parameters 
For each eye, the horizontal cross-sectional scan passing through the fovea 
was identified. Based on this cross-sectional scan, we defined and calculated (in 
MATLAB) choroidal morphological and vascular parameters such as CSI curvature, 
number of inflection points, thickest point distance from the fovea, CT and choroidal 
vascular area within foveal and macular regions. Our technique of image binarization 
to identify stromal and luminal areas within the choroid was validated against manual 
delineations. The above choroidal morphological and vascular features and validation 
of image binarization technique are both described in detail in Chapter IX of this 
thesis and in Figures 9.4 and 9.5. 
11.2.6 Statistical Analyses 
To compare the clinical and choroidal characteristics of AMD and PCV eyes, 
independent t-test was performed for continuous variables and chi-square tests or 
Fisher’s exact test for categorical variables. All data were expressed as mean ± 





of subtypes of PCV, we divided them into two groups based on their mean CT: typical 
PCV (with mean CT ≥ 250 µm) and PCV without thick choroid (CT < 250 µm). 
Multiple linear regression analysis was performed to assess differences in choroidal 
characteristics between patients with typical AMD and different PCV subtypes after 
adjusting for the effect of confounding factors which were significantly different (p 
≤0.05) between the groups. All statistical analyses were carried out using SPSS (v 




A total of 156 eyes of 156 patients (78 affected eyes of 78 patients with typical 
AMD and 78 affected eyes of 78 patients with PCV) were analyzed. Baseline 
demographics are summarized in Table 11.1. Patients with PCV were significantly 
younger than patients with typical AMD (66.3 vs. 71.8 years, P < 0.001). There was 
no significant difference in gender, refractive error and other clinical characteristics 
between the two study groups. After adjusting for age and gender, patients with PCV 
were more likely to have hypertension (47.2 vs. 74.6%, P=0.001) and had lower total 
cholesterol (5.31 vs 5.67 mmol/L, p=0.011) compared to patients with typical AMD. 
Best corrected visual acuity was similar between the two groups.  
In terms of baseline choroidal characteristics, eyes with PCV generally had 
thicker baseline CT at all the measured locations across the macula than eyes with 
typical AMD. Likewise, choroidal vascular area within the macular (6 mm centered 
on fovea) and foveal (1.5 mm centered on fovea) regions was significantly greater 





for differences in age and hypertension, only CT in nasal location remained 
significantly thicker in the PCV group (Table 11.2). There were no significant 
variations in other morphological traits such as curvature of the CSI and inflection 
points between the groups. 
We further divided PCV group into typical PCV (with CT≥250um) and PCV 
without thick choroid. Eyes with typical PCV (n=40) had significantly greater 
choroidal vascular area within the macular and foveal regions in addition to having 
thicker choroid at all the measured locations (all P<0.001) compared to eyes with 
AMD (Table 11.3). In contrast, eyes with PCV without thick choroid (n=38) had low 
choroidal vascular area which were similar to those in eyes with AMD (Table 11.4).  
 
11.4 DISCUSSION  
Our understanding of the pathogenesis and characteristics of AMD continues 
to evolve, with observations that some of the changes seen occur in the choroid. To 
the best of our knowledge, our study is the first to provide characterization of detailed 
morphology and vasculature of the choroid in Asian patients with typical AMD and 
PCV subtypes using the technique of image binarization in choroidal images obtained 
using EDI, SD-OCT. Our results demonstrate that although eyes with PCV had 
thicker choroid than typical AMD, the difference in choroidal morphologic and 
vascular attributes were not significantly different after adjustment for major 
confounding parameters such as age and hypertension. Therefore CT measurement 
may not entirely reflect the detailed structural and functional alterations within the 
choroid in different exudative maculopathy. Compared to eyes with PCV, eyes with 
AMD had more inflection points indicating more variation in CSI and the CSI was 





observed that there is significant heterogeneity within the PCV group, suggesting two 
subtypes with different choroidal features. As we hypothesized, patients with typical 
PCV with thick choroid had significantly higher vascular area, which is consistent 
with the pachychoroid spectrum in which choroidal vessel dilatation plays a key role 
in the pathogenesis. Both CT and vascular area were significantly higher in eyes with 
typical PCV compared to eyes with AMD, indicating that the choroidal morphology 
and function are distinctly different from that in eyes with typical AMD. The 
pathogenic mechanisms that account for dilated choroidal vessels and pachychoroid 
remain unclear. Among the various plausible hypotheses for the pathogenesis of PCV; 
engorgement of the vortex vein,
28





 have been proposed but remain to be validated 
further. 
In contrast to typical PCV, choroidal features in eyes with PCV without thick 
choroid are less well understood. It has been suggested that the pachychoroid 
phenotype may have normal or low CT when luminal volume increases secondary to 
choroidal vessel dilation occur concurrently with reduction in tissue volume from 
atrophy of the choriocapillaris.
19
 We were interested to investigate whether this 
subgroup of PCV eyes had features suggestive of choroidal vessel dilatation despite 
thin choroid. Studying vascular area offered a novel, objective, semi-automated 
technique for this purpose. Our results indicate that eyes with PCV and thin choroid 
had significantly lower vascular area than typical PCV group, and vascular area 
measurements were similar to that in eyes with typical AMD. These findings suggest 
this subtype of PCV does not fall within the pachychoroid spectrum and may be more 
appropriately considered polypoidal CNV. The pathogenesis of this subtype is 





less important role than in typical PCV. Accordingly, treatment response in 
polypoidal CNV can be expected to be similar to that in neovascular AMD, but 
different to eyes with typical PCV. Similarly, the benefit of photodynamic therapy 
polypoidal CNV is less clear compared to typical PCV.
30, 31
  
Our findings in the present study are important for clinicians as our results 
further confirm that differences in choroidal vascular attributes have important 
implications in the pathogenesis and possibly treatment response in AMD and PCV 
subtypes. The OCT binarization technique provides an objective measure of choroidal 
vascularity which can help to determine whether an eye belongs to the pachychoroid 
spectrum. There are currently no clear definition of what constitutes a ‘pachyvessel’ 
and grading may lack objectivity and repeatability. Similarly grading of choroidal 
hyperpermeability based on indocyanine green angiography is subjective and also 
dependent on the phase of angiography and instrument used for image acquisition 
(camera-based versus scanning laser ophthalmoscopy based).  
The strengths of our study include the prospective nature of recruitment and 
relatively large sample size. Hence, our findings were unlikely to be confounded by 
selection bias. Standardized clinical examination protocols, reliable differentiation 
and quantifications of choroidal parameters were used in our study. Unlike other 
studies where the choroidal characteristics in particular CT, were evaluated post 
treatment and were thus biased, our study assessed choroidal attributes in treatment 
naïve eyes. Furthermore, our analysis included a comprehensive list of potential 
confounding factors; choroidal characteristics in different groups were confirmed 
after adjusting for effect of these factors. However, this study also has limitations. 
Although our images were binarized at standard threshold, there is a possibility of 





only performed for one time point in the day. The effect of diurnal variation on 
choroidal features
32, 33
 could not be assessed due to the inherent limitation of our 
study design. We acknowledge the choice of choroidal thickness of 250um as cut-off 
between two subtypes of PCV was an arbitrary definition.  Lastly, the cross-sectional 
design of our study prevented inferring causality.  
 
11.5 CONCLUSIONS 
In conclusion, our findings indicate significant alterations in specific choroidal 
characteristics in addition to CT, in typical PCV compared to typical AMD. Choroidal 
vascular characteristics can be used to sub-classify PCV into two subtypes. The 
subtype of PCV without thick choroid (polypoidal CNV) has similar choroidal 
vascular characteristics to eyes with AMD. This subtype, unlike typical PCV, does 
not fall within the pachychoroid spectrum. Our results highlight the relevance of 
further understanding phenotypic manifestations of choroidal vasculature in the 
diagnostic criteria for PCV subtypes and AMD. Thus, the diagnostic criteria for PCV 
should incorporate the phenotypic manifestations of the choroidal vasculature that are 
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CHAPTER X1 TABLES 
 
Table 11.1 Clinical characteristics of study subjects between AMD and PCV  





P value* P value** 
Age, yrs 71.80 (9.19) 66.30 (9.69) <0.001 - 
Gender, male (%) 45 (57.7) 42 (53.8) 0.747 - 
Hypertension, yes 53 (74.6) 34 (47.2) 0.001 0.015 
Diabetes, yes 24 (33.8) 25 (34.2) 1.000 0.594 
Current smoker, yes 12 (15.4) 12 (16.4) 1.000 0.963 
Hba1c, % 6.16 (1.14) 5.98 (0.88) 0.337 0.579 
Total cholesterol, mmol/l 5.67 (1.32) 5.31 (1.09) 0.095 0.011 
Spherical equivalent, diopter -0.18 (1.40) -0.06 (2.19) 0.684 0.764 
Best-corrected visual acuity, logMAR 0.85 (0.54) 0.86 (0.55) 0.884 0.868 
  Data presented are means (SD) or number (%) 
  * Based on independent sample t-test for continuous variables or Chi-square/Fisher’s exact test for categorical variables 





Table 11.2 Choroidal characteristics of study subjects between AMD and PCV 
  Unadjusted Adjusted 
Choroidal Characteristics 
All AMD  
(N=78) 
All PCV  
(N=78) 
P value* Difference† (95% CI) P value** 
Mean CT, um 224.33 (72.67) 263.62 (93.79) 0.004 23.17 (-4.65, 51.00) 0.102 
Sub-foveal CT, um 243.47 (80.79) 288.54 (99.04) 0.002 29.61 (-0.511, 59.73) 0.054 
Mean nasal CT, um 205.66 (75.49) 257.52 (107.95) 0.001 34.21 (3.48, 64.94) 0.029 
Mean temporal CT, um 243.10 (77.66) 269.82 (86.22) 0.044 12.16 (-15.58, 39.91) 0.388 
CSI curvature, mm^-1 0.578 (0.264) 0.532 (0.280) 0.300 -0.034 (-0.132, 0.065) 0.477 
No of inflection point  1.92 (1.33) 1.88 (1.33) 0.858 0.043 (-0.426, 0.513) 0.855 
Thickest point distance from fovea -0.003 (1.63) 0.350 (1.27) 0.134 0.192 (-0.315, 0.699) 0.455 
Vascular area (sub-fovea), mm^2 0.148 (0.053) 0.177 (0.064) 0.003 0.020 (0.000, 0.040) 0.053 
Vascular area (6 mm region), mm^2  0.554 (0.195) 0.639 (0.227) 0.013 0.051 (-0.020, 0.122) 0.158 
Data presented are means (SD) 
*P value calculated are based on independent t-test 
** P value are based on linear regression after adjusting for age and hypertension 





Table 11.3 Choroidal characteristics of study subjects between AMD and typical PCV (choroidal thickness ≥250µm) 






P value* Difference† (95% CI) P value** 
Mean CT, um 224.33 (72.67) 334.45 (72.26) <0.001 89.89 (59.43, 120.35) <0.001 
Sub-foveal CT, um 243.47 (80.79) 361.16 (75.53) <0.001 98.04 (64.91, 131.16) <0.001 
Mean nasal CT, um 205.66 (75.49) 334.50 (92.60) <0.001 107.23 (73.21, 141.26) <0.001 
Mean temporal CT, um 243.10 (77.66) 334.52 (62.98) <0.001 72.58 (41.13, 104.03) <0.001 
CSI curvature, mm^-1 0.578 (0.264) 0.522 (0.280) 0.289 -0.039 (-0.161, 0.083) 0.530 
No of inflection point  1.92 (1.33) 1.75 (1.31) 0.505 0.123 (-0.711, 0.464) 0.678 
Thickest point distance from fovea -0.003 (1.63) 0.377 (1.186) 0.151 0.136 (-0.516, 0.787) 0.680 
Vascular area (sub-fovea), mm^2 
    Mean (SD) 
    Lowest quartile 










0.053 (0.029, 0.077) 
0.072 (0.056, 0.087) 




Vascular area (6 mm region), mm^2 
    Mean (SD) 
    Lowest quartile 










0.195 (0.113, 0.278) 
0.276 (0.223, 0.328) 




Data presented are means (SD) 
*P value calculated are based on independent t-test 
** P value are based on linear regression after adjusting for age and hypertension 






Table 11.4 Choroidal characteristics of study subjects between AMD and PCV without thick choroid (choroidal thickness<250µm) 
 





thick choroid  
(N=38) 
P value* Difference† (95% CI) P value** 
Mean CT, um 224.33 (72.67) 189.05 (40.84) 0.002 -33.86 (-61.15, -6.56) 0.016 
Sub-foveal CT, um 243.47 (80.79) 212.09 (51.95) 0.042 -27.78 (-58.65, 3.07) 0.077 
Mean nasal CT, um 205.66 (75.49) 176.49 (45.44) 0.016 -29.53 (-58.71, -0.350) 0.047 
Mean temporal CT, um 243.10 (77.66) 201.72 (44.76) 0.001 -38.16 (-66.87, -9.45) 0.010 
CSI curvature, mm^-1 0.578 (0.264) 0.543 (0.283) 0.481 -0.031 (-0.149, 0.087) 0.604 
No of inflection point  1.92 (1.33) 2.03 (1.36) 0.662 -0.103 (-0.467, 0.673) 0.721 
Thickest point distance from fovea -0.003 (1.63) 0.320 (1.375) 0.307 -0.206 (-0.443, 0.854) 0.531 
Vascular area (sub-fovea), mm^2 
    Mean (SD) 
    Lowest quartile 










-0.008 (-0.029, 0.013) 
0.003 (-0.004, 0.010) 




Vascular area (6 mm region), mm^2 
   Mean (SD) 
   Lowest quartile 










-0.07 (-0.143, 0.003) 
-0.007 (-0.729, 0.473) 




Data presented are means (SD) 
*P value calculated are based on independent t-test 
** P value are based on linear regression after adjusting for age and hypertension 





CHAPTER XI FIGURES 
 
Figure 11.1 Comparison of FFA, ICG, choroidal thickness and vascular area across 
AMD and PCV subtypes.  
 
11.1A Typical AMD with thin choroid and low vascular area. Choroidal 









        
 
11.1B Typical PCV with thick choroid and high vascular area. Choroidal thickness: 















































DISCUSSION AND FUTURE DIRECTIONS 
 
12.1 SUMMARY OF THE FINDINGS 
In this doctoral work, we have successfully developed novel (semi- and fully-
automated) image processing techniques to provide fast, reliable and comprehensive 
assessment of the choroid in-vivo. Using our fully automated choroidal segmentation 
technique we performed a population-based evaluation of the distribution and 
determinants of most commonly used macular and peripapillary choroidal traits: 
thickness and volume. Distribution and determinants of these traits were then 
established in most common chorio-retinal diseases such as myopia, AMD and DR. 
Lastly, in addition to CT and volume (which may not capture the specific changes 
within the choroid), we performed detailed characterization of choroidal 
morphometric and vascular attributes in the above eye diseases and their comparison 
with healthy eyes.  
 
The salient findings from our various studies are summarized below: 
We found that only 60% of EDI images had well-defined CSI and the 
variability in CT measurement was higher in the images with poorly defined CSI 
(ICC: 0.97 for images with well-defined CSI vs. ICC: 0.51 for images with poorly 
defined CSI), highlighting that visibility of CSI was critical for accurate determination 
of CT (Chapter 4).  
We overcame the primary challenge of poor CSI visibility by enhancing the 





After applying adaptive compensation to enhance our images, the contrast between 
choroid and sclera was significantly increased (from 0.50 ± 0.14 to 0.90 ± 0.10, p < 
0.001; paired t-test) and CT measurements were more reliable (ICC: 0.93 to 0.97) 
than the non-enhanced images (ICC: 0.90 to 0.93). Nevertheless, such technique still 
required manual input to mark the CSI and measure CT, thus subject to measurement 
errors, limiting its clinical utility.  
To overcame the above limitations of the semi-automated technique, we 
further developed and evaluated novel fully automated choroidal image processing 
technique which defined the CSI and measured CT as well as choroidal volume at 
both macular and peripapillary regions objectively (Chapter 6). Comparing our 
automated technique with the reference standard (manual measurement by trained 
readers), we found excellent agreement (ICC: 0.90 to 0.96) between the 2 
assessments, demonstrating that our automated choroidal image processing technique 
was valid and comparable to existing manual CT measurement. 
We adapted our validated fully automated choroidal image processing 
technique to obtain distribution and determinants of choroidal measures such as 
thickness and volume (in macular and peripapillary regions) in a multi-ethnic 
population in Singapore (Chapter 7). After adjusting for the differences in population 
specific characteristics, we observed slight ethnic difference in macular CT (mean 
difference 12 µm, p=0.011), macular choroidal volume (mean difference 0.02 mm
3, 
p=0.002) and peripapillary CT (mean difference ~32 µm, p<0.001) among ethnic 
Malays and Indians. Indians tend to have slightly thicker choroid than Malays. 
With regards to topographical distribution, both macular and peripapillary 
choroid was asymmetrically distributed (macular: thickest subfoveally and thinnest 





no difference in topographical profile of macular and peripapillary choroid among 
ethnic Malays and Indians.  
Factors such as age, gender and AL were the major determinants of CT and 
volume among both ethnic groups and should be taken into account when interpreting 
EDI OCT based CT measurements in clinical settings.  
We assessed vascular status of the choroid through image binarization of EDI 
SD-OCT images in healthy eyes from a population-based study (Chapter 8). To 
represent vascular status of the choroid we computed OCT derived quantitative 
parameter called “choroidal vascularity index (CVI)”. Two-third (~66%) of the 
subfoveal choroid was found to be vascular in healthy eyes. 
On performing detailed characterization of choroidal morphological and 
vascular traits in young, high myopes (Chapter 9) we found that macular and 
peripapillary CT was significantly lower in high myopic eyes over a range of 
eccentricities. Mean sub-foveal CT in myopes was 225.87 ± 5.51 µm as compared to 
375.15 ± 6.58 µm in emmetropes. Mean PPCT in myopes was 142.62 ± 43.84 µm vs. 
181.90 ± 46.43 µm in emmetropes. There was further decrease in macular and 
peripapillary CT with increase in severity of myopia.  
Macular and peripapillary CT distribution followed a different profile in high 
myopes compared to emmetropes. Macular CT in myopic eyes was thickest superiorly 
whereas in emmetropes it was thickest at the fovea. However, in both the groups 
macular choroid was thinnest nasally. Peripapillary choroid was thickest at the 
superior location in myopic eyes, whereas in emmetropes it was thickest at the 






 AL, presence of posterior staphyloma and chorio-retinal atrophy were the 
significant predictors of macular CT in high myopia. For PPCT: AL, IOP and 
presence of posterior staphyloma were independent determinants. These factors must 
be taken into account when interpreting the data on CT. Given the large number of 
people with myopia in the world, these findings seem to have widespread 
implications. 
Our result demonstrates significant alterations in choroidal morphological and 
vascular features in high myopes. CSI was less curved posteriorly and had more 
inflection points in high myopes with myopic macular degeneration. Choroidal 
vasculature was significantly reduced in high myopic eyes; however, this was more 
prevalent in eyes with myopic macular degeneration. 
We further report that high myopic eyes had thinner choroid but CT was not 
an independent predictor of visual acuity. Other factors related to myopia were likely 
responsible for the diminished visual acuity in young highly myopic eyes. 
There were significant alterations in choroidal structural and vascular 
characteristics in both diabetes and DR (Chapter 10). As speculated, subjects with 
diabetes showed significantly thinner choroid and lower vascular area, which is 
consistent with capillary drop-out wherein decreased choroidal blood flow plays a key 
role in the pathogenesis. Conversely, among the diabetic group, subjects with DR 
displayed thicker choroid and significantly higher vascular area compared to no DR.  
Although eyes with PCV had thicker choroid than typical AMD, the difference 
in choroidal morphologic and vascular attributes were not significantly different after 






We observed significant heterogeneity within the PCV group, suggesting two 
subtypes with different choroidal features: typical PCV with thick choroid and PCV 
without thick choroid (polypoidal CNV). Both CT and vascular area were 
significantly higher in eyes with typical PCV compared to eyes with AMD, indicating 
that the choroidal morphology and function are distinctly different from that in eyes 
with typical AMD. PCV and thin choroid had significantly lower vascular area than 
typical PCV group, and vascular area measurements were similar to that in eyes with 
typical AMD. 
 
12.2 CLINICAL SIGNIFICANCE 
1. Good visibility of CSI is critical for accurate measurement of CT. But 
despite the technique of EDI in SD-OCT, CSI is not clearly visible. We 
used adaptive compensation technique to enhance the contrast at the CSI 
which significantly reduced the variability in manual measurements of CT, 
making CT an important diagnostic parameter for evaluating diseases 
where choroid is implicated in pathophysiology. 
2. We developed automated choroidal segmentation software which provided 
fast (~1 second vs. ~3-4 minute per image manually) and accurate 
measurements of CT at both macular and peripapillary locations. This will 
help in distinguishing clinically significant change of CT as well as in risk-
profiling of various diseases. Furthermore, our automated software 
provided comprehensive assessment of the choroid in terms of choroidal 
volume which can better reflect the profile of the entire choroid. 
Therefore, our fast, reliable and comprehensive assessment of the choroid 





3. We provide race-specific clinical information to better understand the 
chorio-retinal pathologies in different ethnic groups. 
4. Information on distribution and determinants of CT and CV is useful for 
clinicians to better diagnose the disease. 
5. Given choroidal vascular dysfunction are thought to be associated with 
many pathologic conditions our detailed characterization of the choroidal 
vascular area, stromal area and vascularity is useful to study specific 
changes in the choroid. Particularly choroidal vascularity index is used to 
gain insight into the vascular status of the choroid. 
6. Detailed characterization of various morphological and vascular traits of 
the choroid has important implication in the pathogenesis and possibly the 
treatment response. 
7. We found significant alteration in choroidal structural and vascular 
characteristics in diseases such as high myopia, diabetic retinopathy, AMD 
and PCV. These specific changes in choroidal traits highlight the relevance 
of further understanding phenotypic manifestations of choroidal 
vasculature in the diagnostic criteria for these diseases. 
12.3 STUDY LIMITATIONS 
1. Although the location of the CSI on Spectralis images was determined 
qualitatively as the junction between posterior choroid and sclera, there 
was no reference standard to confirm where this structure is actually 
located in the eye. 
2. Single line scan protocol was used to determine the CT profile. Future 





thickness profile of the choroid, will likely provide additional insights into 
the changes in the choroid associated with diseases. 
3. The study population only consisted of subjects of Malay and Indian 
ethnicities, and the findings may vary in other racial groups. Further 
studies in other ethnic populations, in particular Chinese are thus 
warranted. 
4. As in any population based study, our investigation included all eligible 
and participating subjects from the study. Some of them have eye diseases 
that may have changed choroidal traits. Therefore, the distribution of 
choroidal traits determined in this study may represent the choroidal 
attributes not in healthy eyes but in eyes of the general adult and elderly 
populations. However, this would not affect the observed associations 
because, in our multiple regression analysis model, we have adjusted for 
the potential ocular diseases in elderly people that might influence 
choroidal features. 
5. For detailed characterization of the choroid, although our images were 
binarized at standard threshold, there is a possibility of over or 
underestimation of both luminal and stromal areas. 
6. Our subjects were examined only at a single time point, and thus we are 
not able to take the diurnal variation of choroidal thickness into account. 
However, the CT measurements in our study were not performed at the 
same time of the day; each participant underwent the OCT examination in 
a randomized manner with respect to when the readings were obtained. It 






7. Due to our cross-sectional study design, we were unable to determine the 
causal relationships between the various risk factors and choroidal traits. 
Longitudinal studies to determine the sequence of changes as they relate to 
disease progression would prove beneficial. 
 
12.4 FUTURE DIRECTIONS 
Outcomes from this dissertation provide some interesting opportunities to 
explore important future directions in the field of choroidal imaging. Some of these 
studies have commenced while other ideas can be explored in future.  
We have characterized various choroidal morphological and vascular traits 
using our novel image processing techniques. We established the topographical 
distribution as well as ocular and systemic risk factors for the most commonly used 
choroidal attributes such as thickness and volume in a multi-ethnic population in 
Singapore. Singapore has 3 major racial/ethnic groups: Malays, Indians and Chinese. 
This gives us a unique opportunity to study the effect of ethnic variation in CT among 
Asians in a relatively common geographic and socio-economic environment. 
However, this doctoral work was confined to only two ethnic groups: Malays and 
Indians. Due to time constraints we could not evaluate the distribution and 
determinants of choroid in ethnic Chinese. Since Chinese ethnic group accounts for 
~80% of the population of Singapore, we therefore, are expanding our work to 
evaluate choroidal characteristics in Chinese. 
In order to better understand the chorio-retinal pathologies in Asians and 
Caucasians (such as PCV), next step could be to compare choroidal attributes between 






In our algorithm for detailed analyses of the choroid, delineation of CSI was 
based on markings of few most prominent points at the junction of the choroid and the 
sclera. These were further extrapolated to mark the entire CSI.  Future algorithm 
marking the CSI without extrapolating the points would result in a more precise 
assessment of the choroid. 
For the myopic group, all our study subjects were males, and thus, some of our 
findings may not be generalized to females. Future studies involving females in 
different degree of myopic refractive error would give better understanding of the 
choroid in myopia. 
In diabetes, to date, there is no consensus as to whether there is thinning or 
thickening of the choroid. However, it has been postulated that blood flow may play a 
crucial role in the variation of CT. Therefore, newer imaging techniques such as 
choroidal angiography may be explored to explain this further. Although, we did 
study the effect of severity of DR on choroidal features but our analysis was limited 
by sample size. Further studies to correlate the severity of DR with choroidal traits in 
larger sample may provide a better insight into the choroidal angiopathy associated 
with DR and its effect on the progression of the disease.  
Likewise, the effect of different treatment modalities such as intravitreal 
injections, lasers such as focal or PRP on choroidal parameters was investigated but 
again we did not find significant difference in any of the choroidal traits in DR 
subjects with or without laser treatment. We speculate the reason for no difference in 
choroidal features across the two groups to be the lesser number of subjects in 





recommend future studies with more number of subjects in treatment group to study 
the likely effect of lasers on choroidal attributes. 
Lastly, recent innovations in technology such as longer wavelength OCT 
including swept source (SS) technology along with OCT angiograpgy (OCT-A) and 
en-face imaging may provide an even better understanding of choroidal involvement 
in retinal diseases due to following features: 
Longer Wavelength and Swept Source Technology: OCT systems using longer 
wavelength (1050 nm) and SS-OCT technology have demonstrated an enhanced 
visualization of the choroid, even through opaque media.
1
 Swept laser light sources 
can rapidly sweep the required frequencies, the acquisition of scans is much faster 
with axial scan rates of up to 100 000–236 000 A-scans per second (5 to 10 times that 
of the SD-OCT), and can achieve axial resolutions of 11 μm in tissue.2 Because data 
can be acquired much faster, volumetric assessment of the choroid is also feasible.
3
  
Significant improvement in the visualization of CSI using these techniques is 
important in diseases such as CSCR, where the choroid is thicker than normal, and 
thus difficult to evaluate across its entire width. In addition, volumetric analysis of the 
choroid, as well as that of the various pathological features such as CNV and 
subretinal/intraretinal fluid, may be possible. Such a volumetric analysis is expected 
to help with monitoring the progression of diseases such as wet AMD, CSCR and DR, 
as well as assessment of the response to treatments such as anti-VEGF agents, laser 
photocoagulation and PDT. 
OCT Angiography (OCT-A): In contrast to ICG and FFA, which are two-
dimensional investigations for blood flow analysis, OCT-A emerges as a novel, high-





retinal and choroidal vessels and potentially identify angiographic abnormalities in the 
retinal and choroidal microvasculature. The novel OCT-A adopts the split-spectrum 
amplitude-decorrelation angiography (SSADA) technology and detects blood flow 
through motion contrast generated by moving red blood cells at various retinal and 
choroidal layers.
4, 5
 This new technology allows OCT-A to characterize vascular 
information in various segmented retinal and choroidal layers and provide 
unprecedented quantitative measurements of retinal and choroidal microcirculation by 
generating retinal/choroidal vascular perfusion density parameters which are proxy 
measures of retinal/choroidal blood flow. Thus OCT-A’s retinal vascular perfusion 
parameter can be potentially used as an imaging diagnostic tool.  
 
En-face Imaging: This allows the clinician to visualize three-dimensional data in a 
fundus projection. Although cross-sectional images (B-scans) have helped delineate 
pathological features in retinal diseases, microstructural changes and morphology of 
the retinal and choroidal vasculature are difficult to evaluate using B-scans. This is 
expected to improve as en-face imaging provides further detail about the subtle 
pathological features in the retina and choroid in diseased states.
6
 In addition, the 
involvement of the specific vascular layers of the choroid in different diseases is 
expected to delineate in further detail using this technique. We hypothesize that such 
an attempt can be useful not only as an adjunctive diagnostic tool, but it can also lead 
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s u r v e y o f o p h t h a lmo l o g y x x x ( 2 0 1 6 ) 1e1 621. Introduction amplitude of 33.7  21.5 mm. A progressive decrease inThe choroid is the most vascular layer of the eye and plays an
instrumental role in the physiology of the eye and in the
pathogenesis of various ocular diseases. Per unit weight, the
choroid has the highest blood flow of any tissue in the body7
and is the vascular supply to the outer retina, retinal pigment
epithelium, possibly a portion of the optic nerve,44 and is the
only source of metabolic exchange for the avascular fovea.80
A structurally and functionally normal choroidal vascula-
ture is essential for retinal function. Abnormal choroidal blood
volume and/or compromised flow may result in photorecep-
tors dysfunction and death with resultant vision loss.16
Consequently, the choroid plays a vital role in the pathophys-
iology of many conditions, such as central serous chorioretin-
opathy,27 choroidal neovascularization related to age-related
macular degeneration,68,74 polypoidal choroidal vasculop-
athy,68,74 multifocal choroiditis,55 angioid streaks,6 and high
myopia-related chorioretinal atrophy.20 In addition, the high
flow of blood in the choroid predisposes it as a site for meta-
static and embolic spread of tumors and infections.80 Basically,
as a result of the vascular nature of the choroid, potentially any
disease affecting vasculature could also affect choroid health.
Quantitative assessment of the choroid has always been a
challenging task with conventional imaging modalities such
as indocyanine green angiography and ultrasonography
because of limited image resolution and repeatability.22,43
Histological evaluation is difficult because of the lack of sam-
ples and may not be accurate owing to changes in the choroid
after fixation; however, our understanding of the choroid has
been vastly augmented in recent times since the introduction
of imaging the choroid in vivo using enhanced depth imaging
technique of optical coherence tomography (EDI-OCT).104
This innovation in technology has sparked a rise in the
amount of research done with regard to choroidal thick-
ness,71,86,104 which ismeasured on the EDI-OCT from the outer
border of the retinal pigment epithelium, represented by a
hyperreflective line, to the inner border of the suprachoroidal
space, represented by a hyporeflective line. There is, however,
only limited literature published on systemic diseases
affecting choroidal health.10 We consolidate the current
knowledge on the effects of systemic health on choroidal
thickness and attempt to provide insights on how choroid
thickness may be an indicator of systemic health (Table 1).
Infections and diseases limited to the eye without any sys-
temic involvement have been excluded.2. Physiological changes in choroidal
thickness
2.1. Diurnal variation
There have been few studies determining the diurnal varia-
tion of choroidal thickness in healthy patients.17,106,109,113 A
prospective study conducted by Tan et al of 12 healthy vol-
unteers studied the choroidal thickness over 2 separate days
in 5 fixed, 2-hour intervals.106 This study revealed that there is
a significant variation in choroidal thickness, with meanchoroidal thickness occurred from 9 AM till 5 PM, with good
reproducibility of the diurnal pattern between 2 visits. A study
conducted in Japanese patients by Usui et al113 performed over
a 24-hour period showed a similar decreasing trend in
choroidal thickness from 9 AM to 6 PM The amplitude reported,
33.0  14.3 mm, was also similar to the reported values in Tan
et al. In contrast, a study by Toyokawa et al109 on Japanese
subjects showed a smaller mean amplitude of 20.3 mm and an
apparent increase in choroidal thickness from morning to
evening. Current literature suggests that there is pattern of
change of choroidal thickness; however, the exact pattern
remains uncertain. Findings suggest that the time of mea-
surements is important to consider when assessing choroidal
thickness in clinical practice and in trials. A possible
hypothesis is that diurnal variation occurs because of the
circadian rhythm of hormonal changes affecting the blood
supply of the body,67 reflected in the vascular supply of the
choroid, influencing its thickness. Increased vascular supply
from sympathetic over activity in the morning67 may be re-
flected in the vascularity of the choroid and hence results in a
thicker choroid in the morning.
2.2. Age-related changes
Age is one of the biggest contributing factors to choroidal
thickness (Fig. 1).37,102 Previous histologic studies have shown
a decrease in vascular density, overall luminal area, and
diameter of the choriocapillaris with age.34,87,97 This leads to a
decrease in physiological functions of the choroid, that is, the
ability of the choroid to provide sufficient levels of oxygen and
other metabolites to the retinal pigment epithelium and outer
retina may decrease,104 contributing to the onset of many
diseases in the elderly. Similar to histologic studies, age-
related choroidal thinning in healthy eyes is confirmed by
numerous clinical studies.11,37,49,70,71,91,96 In healthy eyes,
Margolis et al and Ikuno et al reported a decrease in choroidal
thickness by 15.6 mm and 14 mm, respectively, for each decade
of life.49,71 Ding et al reported that age-related thinning occurs
only after age 60.31 Barteselli et al reported decrease in
choroidal volume by 7.32% for every decade.11 There are
increasing data from recent population-based studies that
indicate that both choroidal thickness and choroidal volume
decrease with advancing age.42,115
A study84 involving 96 eyes from 48 healthy children (mean
age of 6.7 years) and 54 eyes from 27 healthy adults (mean age
of 30.7 years) analyzed the choroidal thickness of the 2 pop-
ulations and found that choroidal thickness was significantly
greater in adults than in children. Thus, it is essential that age
be taken into consideration when choroidal thickness is
evaluated; however, no nomogram with age existents, and it
may be time to develop one.
2.3. Gender differences
There are gender differences in the epidemiology of certain
macular diseases. For example, a large number of studies have
shown that central serous chorioretinopathy ismore common
in men, with a male-to-female ratio of up to 8:1.66 Several
Table 1 e Summary and possible mechanisms of choroidal changes in health and disease
Physiological changes Increase in choroidal thickness Decrease in choroidal thickness Proposed mechanism(s)
Diurnal variation Decrease in thickness may be observed until
evening, although there may be fluctuations
Circadian rhythm and hormonal influences;
increased vascular supply due to sympathetic
over activity during daytime17,67,106,109,113
Age Choroidal thinning is associated with increasing
age
Decrease in vascular density, luminal area, and
diameter of the choriocapillaris with advancing
age11,37,49,70,71,84,91,96,115
Gender Choroid is thicker in men than in women Lower basal sympathetic tone inmen23,65,83,110,121
Female and hormonal changes
Menstrual cycle Decrease in thickness during the midluteal phase Hormonal changes affecting choroidal
vasculature78,112
Pregnancy Increase in thickness during the second trimester Pregnancy-related fluid retention during the
second trimester; hormonal changes8,40,98
Preeclampsia Increase in thickness may be less than normal
pregnant women
In a few patients, thinning of the choroid may
occur
Changes may depend on severity of
preeclampsia; decreased thickness may be linked
with generalized systemic vasospasm8,38,98
Metabolic diseases
Diabetes mellitus Decrease in thickness compared to nondiabetic
healthy controls
Possible relationship with diabetic
microangiopathy33,60,85,90,114,120
Hypercholesterolemia Increased thickness compared to healthy
controls
Further studies needed to confirm association
and possible mechanisms118
Cardiovascular diseases
Hypertension Increased thickness compared to healthy
controls
Interstitial fluid accumulation; further studies
needed to confirm possible mechanisms3
Respiratory diseases
Smoking Significant decrease in thickness compared to
nonsmokers
Vascular dysfunction caused by decrease in nitric
oxide bioavailability; increased systemic vascular
resistance100,101,111
Systemic inflammatory conditions
Ankylosing spondylitis Increased thickness Inflammation of the uveal tract63
Raynaud’s phenomenon Decrease in thickness Gender association; higher basal sympathetic
tone; systemic vasospasm or sclerosis
associated23,50
Vogt-Koyanagi-Harada syndrome Increased thickness during active disease Decreased thickness during chronic, resolution
phase
Inflammation of the uveal tract25,72,105
Behc¸et’s disease Variable; but reports suggest increased thickness
during active disease
Inflammation of the uveal tract24,48,52,61
Sarcoidosis Increased thickness is usually associated with
presence of lesions such as granulomas
Presence of lesions in the choroid resulting in
increased volume79,92
Tumors
Metastatic cancer Localized increased thickness with dome or
plateau-shaped elevation; skin melanomas and
breast metastasis are flattest, whereas lung,
gastrointestinal, kidney and prostate metastasis
are thicker
Presence of lesions in the choroid resulting in
increased volume5,90
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ness or volume, for instance, Barteselli et al11 reported men
have a 7.4% greater choroidal volume thanwomen. Two of the
population-based studies, the Beijing Eye Study involving
3,233 subjects and the Singapore Malay Eye Study involving
540 subjects, showed male gender to be significantly associ-
ated with thicker choroid after adjusting for relevant con-
founders such as age and axial length.115 Similarly, Li et al
reported that choroidal thickness was 18% higher inmen than
in women after accounting for age and axial length.65 Simi-
larly, many other studies in healthy subjects determined
subfoveal choroidal thickness to be higher in men than in
women.83,110,121 In contrast, there are 2 studies that showed
no statistically significant difference in choroidal thickness
measurements between men and women94,96; however, as
most existing studies reporting thicker choroid inmen than in
women, gender differences should be considered when
interpreting an EDI SD-OCT scan of the choroid. This differ-
ence in the thickness of the choroid betweenmen andwomen
might also explain the gender differences in the epidemiology
of macular diseases. The difference in choroidal thickness in
men and women may be explained by the higher basal sym-
pathetic tone in women.23
2.4. Activity of the sympathetic system
The tone of the sympathetic system may have an important
bearing on the thickness of the choroid. As described in the
preceding sections, the basal tone of the sympathetic system
may be responsible, at least in part, for physiological varia-
tions such as diurnal changes and gender-based differences.
Studies have shown that sympathetic innervation of the
choroid may be a protective mechanism against over-
perfusion in conditions with acute rise in systemic blood
pressure.14 Experimentalmodels have shown that stimulation
of the cervical sympathetic chain results in frequency-
dependent vasoconstriction and reduction in choroidal
blood flow.14 Adrenergic innervation of the choroid that
originates from superior cervical ganglion has been also
demonstrated in a chicken model.41 Similarly, in a pigeon
model, stimulation of the parasympathetic Edinger-Westphal
nucleus dramatically increased choroidal blood flow. Such
findings were also confirmed using histology.35 As the basal
tone of the sympathetic systemmay have a significant role in
maintaining the choroidal blood flow and thickness, various
conditions that affect the ocular sympathetic innervationmay
have a direct bearing on choroidal thickness.3. Choroidal thickness in women
3.1. Menstrual cycle
Complex hormonal changes occur during themenstrual cycle,
and these fluctuations can affect vascular physiology and
cause hemodynamic changes during different phases of the
cycle.76,77 To assess the systemic hemodynamic changes via
choroidal vascular changes, a single prospective study112
looked at 23 eyes of 23 women with regular menstrual cy-
cles. This study showed that, compared to the early follicular
Fig. 1 e Comparison of choroidal thickness obtained using EDI-OCT scans in 2 subjects of different ages. A: A 46-year-old
man with subfoveal choroidal thickness of 326 mm. B: An 83-year-old man with subfoveal choroidal thickness of 163 mm.
EDI-OCT, enhanced depth imaging technique of optical coherence tomography.
s u r v e y o f o p h t h a lmo l o g y x x x ( 2 0 1 6 ) 1e1 6 5and ovulatory phases, choroidal thickness decreased signifi-
cantly during the midluteal phase. Choroidal thickness
reduced by 6.47% between the early follicular and midluteal
phase. The difference in choroidal thickness between the
early follicular phase and ovulatory phase was, however, not
statistically significant but suggests that the blood supply
during these phases may result in fluctuation of choroidal
vascularity and hence affecting the choroidal thickness. Hor-
monal changes in menstruation have been associated with
altered sympathetic outflow.78 The altered sympathetic
outflow may affect choroidal flow, which is possibly reflected
in choroidal thickness. These findings show that it may be
important to consider menstrual phase of the woman when
interpreting choroidal thickness measurements.3.2. Pregnancy
Many ocular changes may occur in pregnancy, including
changes in vision, ocular blood flow,21 decrease in intraocular
pressure,4,46,57 and an increase in central cornea thickness116
and curvature.46 Two studies from Atas et al8 and Sayin
et al98 with 76 and 119 participants, respectively, similarly
showed that the choroidal thickness was greater in normal
pregnant women than in normal, nonpregnant women. A
prospective study40 involving 90 healthy pregnant women in
their first, second, or third trimester and 30 nonpregnant
healthy women compared the choroidal thickness in these 4
groups. There was increased choroidal thickness in women in
the second trimester as compared to nonpregnant women.There was no significant difference of choroidal thickness
among the other groups. This suggests that choroidal thick-
ening can occur in the second trimester. A likely mechanism
for this finding is the increase of pregnancy-related fluid
retention in the choroid.83.3. Pre-eclampsia
Pre-eclampsia is an obstetrical complication characterized by
placental ischemia and systemic inflammation and vascular
changes that lead to widespread vasoconstriction and sys-
temic hypertension and proteinuria.47 Patients with severe
preeclampsia may have cerebral or visual disturbances, pul-
monary edema, impaired liver function, and thrombocyto-
penia. Approximately 40% of women with preeclampsia
report subjective visual disturbances.93
Atas et al8 and Sayin et al98 studied the effect of pre-
eclampsia on choroidal thickness and found that the increase
of choroidal thickness in pre-eclamptic patients was signifi-
cantly less than innormalpregnant patients andwassimilar to
the choroidal thickness in normal, nonpregnant women. A
study38 was conducted based on 15 severe preeclampsia cases
and 15 healthy subjects of matched ethnicity and parity. A
reference group of 19 age-matched, nongravid normotensive
women was also studied. Severe pre-eclampsia cases demon-
strated greater mean choroidal thickness than controls.
The difference in findingsmay be the result of the difference
inseverityof thepreeclampsia.Ononehand, increasedvascular
permeabilitymay increase the choroidal volume and thickness
Fig. 2 e AeC: Enhanced depth imaging optical coherence tomography scans of 3 patients with idiopathic panuveitis. The
figure demonstrates increased choroidal thickness that correlates with disease activity and presence of macular edema and/
or disruption of the outer retinal layers. The yellow arrowheads indicate dilated choroidal vasculature.
s u r v e y o f o p h t h a lmo l o g y x x x ( 2 0 1 6 ) 1e1 66because of vascular leakage, whereas decrease in choroidal
thickness amongpatientswithpre-eclampsiamay be the result
of the increased systemic vascular vasospasm.8 The exact
mechanism resulting in decreased choroidal thickness from
vasospasm in pre-eclampsia is not understood. Increased
systemic vasospasm may decrease choroidal blood flow,
resulting in decreased choroidal thickness. Thus, choroidal
thickness may be a useful tool to screen for pre-eclampsia.4. Choroidal thickness in metabolic diseases
4.1. Diabetes mellitus
Diabetes mellitus is a vascular disease characterized by
macrovascular and microvascular abnormalities. In diabetic
eyes, in addition to changes in retinal circulation, alterations
to the underlying choroidal vasculature also seem to play a
vital role as studies on diabetic eyes have reported various
abnormalities, including choroidal vascular degeneration,
choroidal aneurysms, choroidal neovascularization, obstruc-
tion of the choriocapillaris, and increased tortuosity andnarrowing of the choroidal vessels.16,45,75 Given that choroid is
an integral part of the nutrient and oxygen exchange with the
outer third of the retina82 and choroidal thickness is consid-
ered proxy measure of choroidal blood flow, compromised
choroidal circulation might lead to structural changes in the
choroid including choroidal thickness.
Although various studies have reported choroidal thick-
ness in patients with diabetes mellitus, the results have been
somewhat contradictory. Vujosevic et al did not find any sig-
nificant difference in the mean choroidal thickness between
their controls and diabetic patients.114 Regatieri et al reported
similar choroidal thickness between their controls and non-
proliferative diabetic retinopathy.90 Meanwhile, Esmaeelpour
et al and Querques et al both showed that patients with dia-
betes mellitus had significantly thinner choroids than non-
diabetics regardless of their diabetic retinopathy status.33,85 In
contrast, Kim et al showed that early diabetic retinopathy
patients had thinner choroids compared to nondiabetics, but
there was progressively thickening with increasing severity of
diabetic retinopathy.60 Xu et al in the Beijing Eye Study
measured choroidal thickness in 246 subjects with diabetes
mellitus and concluded subfoveal choroid to be thicker in
Fig. 3 e A and B: Enhanced depth imaging OCT scan of 2 patients with Vogt-Koyanagi-Harada syndrome demonstrates an
increased choroidal thickness during the active stage of the disease along with presence of subretinal fluid.
s u r v e y o f o p h t h a lmo l o g y x x x ( 2 0 1 6 ) 1e1 6 7those with diabetes, whereas the presence and stage of dia-
betic retinopathy were not associated with change in sub-
foveal choroidal thickness after accounting for relevant
confounders.120 Thus, the effect of diabetes on the choroid is
still not clear. The general consensus is that diabetes causes a
decrease in choroidal thickness; however, different ocular
parameters need to be explored to understand the patho-
physiology of diabetes mellitus in the choroid.4.2. Hypercholesterolemia
Because of its high blood flow, the choroid has been consid-
ered as a potential site for the atherosclerotic changes95 that
occur in presence of hypercholesterolemia; however, to
date, there is only one study118 on the effect of hypercholes-
terolemia on choroidal thickness. Wong et al did a cross-
sectional observational study on 322 healthy eyes of 161 sub-
jects (mean age 60 years) found subfoveal choroidal thickness
to be significantly higher in subjects with hypercholesterole-
mia (306  111 mm) than controls (258  97 mm). Thus, hyper-
cholesterolemia might be an important factor to be taken into
consideration when analyzing choroidal thickness; however,
further studies are needed to confirm this association.5. Choroidal thickness in cardiovascular
diseases
5.1. Hypertension
Hypertension is a known cause of pathology in vascular sys-
tems in the heart, brain, kidneys, and eyes. Ocular changes inhypertension include retinal hemorrhages, cotton wool spots,
intraretinal lipid accumulation, and vessel closure in the
retinal capillaries and the choriocapillaris. Although both
retinal and choroidal changes are observed in hypertension,
the mechanism of choroidal damage remains unknown. Ahn
et al3 in 42 eyes with hypertensive retinopathy demonstrated
significant increase in subfoveal choroidal thickness, possibly
due to interstitial fluid accumulation in the choroid caused by
choroidal permeability changes. Thus, hypertension may be
considered as a potential determinant of the thickness of the
choroid; however, further prospective studies with a larger
sample size and longer follow-up periods are needed to
confirm this finding.6. Choroidal thickness in respiratory
diseases
6.1. Smoking
Smoking, an important modifiable risk factor for many car-
diovascular, respiratory, andother systemicdiseases,119 is also
a risk factor for ocular vascular diseases such as hypertensive
retinopathy, age-related macular degeneration, and anterior
ischemic optic neuropathy.18,19,59 Smoking cause vascular al-
terations, including decrease in retinal and choroidal blood
flow.58,64,117 Because smoking influences choroidal vascula-
ture, this in turn might lead to structural changes in the
choroid. Several studies have now shown significant decrease
in choroidal thickness in smokers.100,101,111 These studies
proposed reduction in choroidal thickness caused by smoking
to be related to vascular dysfunction caused by decrease in
s u r v e y o f o p h t h a lmo l o g y x x x ( 2 0 1 6 ) 1e1 68nitric oxide bioavailability. This leads to peripheral vasocon-
striction, causing an increase in the peripheral resistance to
flow and thereby a decrease in choroidal thickness.7. Choroidal thickness in systemic
inflammatory conditions
Systemic inflammatory conditions may affect the ocular tis-
sues and result in choroidal changes that often relate to the
disease activity. Choroidal changes in such inflammatory
conditions are demonstrated in Figure 2.
7.1. Ankylosing spondylitis
Ankylosing spondylitis is a chronic inflammatory disease that
may also involve the eye, causing anterior uveitis. Uveitis is
one of the classification criteria for seronegative spondyloar-
thritis and is its most common extra-articular manifestation.
To date, only 1 study63 was done to determine the effect of
ankylosing spondylitis on the choroid. They studied 168 eyes
of 84 ankylosing spondylitis patients and 126 eyes of 63
healthy subjects and found that choroidal thickness was
increased. There was, however, no correlation between
choroidal thicknesses and the severity or duration of anky-
losing spondylitis. The inflammation of the uveal tract may
explain the increase in choroidal thickness. Choroidal
thickness may, therefore, be a good indicator of ankylosing
spondylitis disease activity and could help in identifying cases
in which uveitis may develop.
7.2. Raynaud phenomenon
Raynaud phenomenon is a reversible vasospastic response of
the extremities to cold or emotion and is a recognized early
manifestation of systemic sclerosis. The effect on vasodilation
and vasoconstriction is not limited to skin in the peripheries
but also is known to affect other organs, such as the choroidalFig. 4 e A and B: Enhanced depth imaging OCT scans of 2 patie
retinochoroidal changes such as increased choroidal thickness, a
choroid due to the tumor mass.plexus of the eye. A study50 was done, involving 30 patients
without visual symptoms, classified as primary Raynaud
phenomenon, Raynaud phenomenon secondary to suspected
systemic sclerosis, and overt systemic sclerosis, and 27
normal subjects. In patients with primary Raynaud phenom-
enon, a thinning of choroidal thickness was observed. The
thinning is more severe in Raynaud phenomenon secondary
to suspected systemic sclerosis and in overt systemic
sclerosis. Perhaps, the thinning of choroid in Raynaud phe-
nomenon is reflection of the systemic hemodynamic changes.
The effect of blood circulation in Raynaud phenomenon has
also been investigated, and it has an association with basal
sympathetic tone, also it has a higher incidence in women.23
Altered choroidal thickness once again may be an index of
systemic blood circulation.7.3. Vogt-Koyanagi-Harada syndrome
Vogt-Koyanagi-Harada (VKH) syndrome is a multisystemic,
autoimmune, granulomatous inflammatory disease affecting
themelanocyte-containing tissues such as the uvea, ear, skin,
and meninges. In the eye, VKH causes bilateral granuloma-
tous panuveitis initially presenting as diffuse choroiditis with
multifocal serous detachments that may result in serous
retinal detachment. In the later stages of the disease, there is
chorioretinal depigmentation, sunset glow fundus, or peril-
imbal vitiligo.88 There are 4 phases of the disease: prodromal,
acute uveitis, convalescent, and chronic-recurrent phases.
In 8 patients with active VKH syndrome, EDI-OCT mea-
surements found that their mean choroidal thickness was 805
 173 mm, which is much thicker than in normal eyes.72 The
choroidal thickness decreased in response to corticosteroid
treatment to 341  70 mm by the 14th day.
Takashi et al105 studied 1 randomly selected eye from 19
patients with VKH syndrome of durationmore than 3 years, of
which 12 eyes had severe sunset glow fundus and 7 with little
or no depigmentation. Themean choroidal thickness of the 12
eyes with severe sunset glow fundus was 144  72 mm, whichnts with choroidal hemangioma demonstrates
ltered pattern of choroidal vasculature, and elevation of the
Fig. 5 e A: Optical coherence tomography (OCT) of a patient with choroidal metastasis secondary to breast carcinoma shows
presence of choroidal infiltration with undulating and seasick appearance of the choroid. B: OCT scan of a patient with
metastatic lymphoma showing presence of lymphoid infiltration and collection of metastatic material at the level of the
retinal pigment epithelium. C: Appearance of a choroidal nevus on OCT. D: OCT appearance of a choroidal osteoma in the
posterior pole.
s u r v e y o f o p h t h a lmo l o g y x x x ( 2 0 1 6 ) 1e1 6 9was significantly thinner than that of the 7 eyes with little or
no depigmentation. It was found that choroidal thickness was
inversely correlated with disease duration and the degree of
depigmentation.
Similarly, a prospective case-control study25 was con-
ducted on 16 patients (30 eyes) with VKH syndrome for more
than 6months and 17 normal individuals (32 eyes). Their eyes
were examined by the EDI-OCT, and choroidal thickness was
correlated to disease duration, clinical disease activity, and
severity. The mean subfoveal choroidal thickness in the con-
trol groupwas 333 mm (85.8), compared to 250.7 mm (93.3) in
VKH patients. Choroidal thicknesswas significantly decreased
in patients with VKH, with a negative correlation between
choroidal thickness and disease duration.
These studies demonstrate an increase in choroidal
thickness during periods of active inflammation and a
reduction during the chronic phase (Fig. 3). Choroidal thick-
ness measurement may be a noninvasive tool to monitor
disease activity and guide treatment decisions.7.4. Behc¸et disease
Behc¸et disease is an idiopathic, multisystem disease charac-
terized by recurrent orogenital ulceration and vasculitisinvolving small, medium, and large veins and arteries. Ocular
complications occur in 95% of men and 70% of women. It
usually presents bilaterally and can cause acute panuveitis,
retinitis, retinal vasculitis, and vitritis. End-stage disease is
marked by vascular occlusion, optic atrophy, and gliotic
sheathing.81
In 30 patients with Behc¸et disease, the mean subfoveal
choroidal thickness in affected eyes was significantly greater
in the acute phase of disease than the quiescent phase (398.77
 155.59 mm vs 356.72  141.09 mm).61 Even during the quies-
cent phase, the choroidal thickness in affected eyes was
thicker in patients with Behc¸et disease than the general pop-
ulation (259.96  65.16 mm). Interestingly, the uninvolved eye
in patients with Behc¸et disease also had a greater choroidal
thickness as compared to the general population, suggesting
that there may be choroidal infiltration even in the clinically
uninvolved eye. A second study52 conducted on 23 eyes of 13
patients similarly observed a dilation of choroidal vessels
during the active phase of uveitis, with the choroidal thick-
ness being significantly greater than when the disease was in
remission. In addition, the choroidal thickness was signifi-
cantly reduced after treatmentwith infliximab. Iccarino et al48
confirmed these results, with 23.3% of the 30 eyes from 15
patients having no increase in choroidal thickness and 76%
with an increase in choroidal thickness.
Fig. 6 e Imaging of metastatic melanoma in 2 patients using enhanced depth imaging OCT. A: Large metastatic choroidal
melanoma in a patient superior to the optic nerve head and B: appearance of a metastatic choroidal melanoma after
treatment with radiotherapy and systemic chemotherapy.
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disease found that choroidal thickness was significantly
reduced as compared to normal controls. This difference may
be explained by the disease duration. In the first 2e3 years of
Behc¸et disease, there is progressive fibrosis and thinning of
choroid due to ischemic changes in the choroid from the
recurrent inflammation.Fig. 7 e A and B: Composite image matrix representing
variations in choroidal thickness in physiologic conditions
on EDI-OCT scans. Image segmentation tools are used to
demarcate the C: choroid and further segment the choroid
into vascular and stromal segments using image
binarization techniques facilitating calculation of
proportion of vascular channels in the choroid, which can
be further termed as Choroidal Vascularity Index. D:
Segmenting the choroid on EDI OCT scans. EDI-OCT,
enhanced depth imaging technique of optical coherence
tomography.7.5. Sarcoidosis
Sarcoidosis is amultisystemic T-cell mediated granulomatous
inflammatory disorder of unknown cause. There is a wide
spectrum of disease, potentially affecting the mediastinal and
superficial lymph nodes, lungs, liver, spleen, skin, parotid
glands, pharyngeal bones, and the eye. In the eye, it has vari-
able manifestations as anterior, intermediate, or panuveitis.
Choroidal and optic disc granulomas, multifocal choroiditis,
and segmental and rarely occlusive phlebitismay also be seen.
Only isolated case reports have described the imaging of
choroid and assessment of choroid involvement in sarcoid-
osis. In the first study,79 the eye of a 63-year-old woman with
biopsy-proven sarcoidosis was examined with EDI-OCT. She
presented with unilateral multifocal choroidal granuloma,
which was seen as a homogenous hyporeflective lesion with
choriocapillaris thinning. The surrounding choroid was
spared. The choroidal granuloma decreased in size after
treatment with immunosuppressive agents.
In a second case study,92 a 49-year-old woman with a
choroidal granuloma secondary to sarcoidosis, the choroidal
granuloma appeared as a localized hyporeflective choroidal
thickening. The choroidal thickness decreased after 2 weeksof systemic corticosteroid treatment from 568 mm to 356 mm;
after 5 months, it decreased to 274 mm, and after 11 months, it
reached 150 mm.
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8.1. Metastasis
The choroid is the most common site for uveal metastases,
accounting for approximately 90%, followed by the iris and
ciliary body. The most common primary site is breast, fol-
lowed by lung. Other possible primary sites are the gastro-
intestinal tract, kidney, skin melanoma, and, rarely, the
prostate. Metastasis to the choroid may occur unilaterally or
bilaterally and may be multifocal or unifocal. As such, un-
like other systemic diseases, choroid metastases do not
cause generalized increase or decrease in choroidal thick-
ness. Shields et al99 examined 520 eyes and found that most
metastatic choroid tumors are dome or plateau shaped and
measured 3-mm thick. The tumors were differentiated ac-
cording to their primary sites, and it was found that the
choroidal metastatic tumors from breast cancer are usually
bilateral and multifocal, with a flatter tumor of 2 mm at the
thickest tumor focus. Thicker tumors were more often
found in lung, gastrointestinal, kidney, and prostate can-
cers, with the mean thickness in gastrointestinal and kid-
ney cancers being 4 mm. Metastatic tumors from skin
melanomas were the flattest, with a mean thickness of
1 mm. A study5 that aimed to describe imaging features of
choroidal metastasis using EDI-OCT examined 31 eyes with
choroidal metastasis and found that the tumor has a
characteristic “lumpy bumpy” anterior surface, with outer
retina layer disruption, but preservation of inner layers of
the retina. It also found that the choroidal metastases had
an average thickness of 987 mm. The conclusion was that SD
EDI-OCT allows visualization and imaging of choroid
metastases.
The appearance of choroid in hemangioma andmetastasis
is demonstrated in Figures 4e6.8.2. Sturge-Weber syndrome
Sturge-Weber syndrome involves congenital hamartomatous
malformations that affect the eye, central nervous system,
and eye. The most prevalent ocular malformation is the
choroidal hemangioma, which usually enlarges slowly and
affects over half of the choroid. Diffuse choroidal hemangi-
omas occur almost exclusively in patients with Sturge-Weber
syndrome and associated with serous retinal detachment.
This disease is known to cause an increase in choroidal
thickness due to the vascular malformations.
An 18-year-old white boy with a known diagnosis of
Sturge-Weber syndrome had diffused choroidal
hemangiomas and serous retinal detachment treated with
photodynamic therapy.15 Optical coherence tomography ex-
aminations were done at baseline and 3 and 12 months after
photodynamic therapy. The subfoveal choroidal thickness
showed a reduction in thickness from 251 to 83 mm after
photodynamic therapy. Thus, choroidal thickness measure-
ment might be a beneficial parameter to follow the response
to treatment for patients with diffuse choroidal
hemangiomas.9. Choroidal thickness in hematological
diseases
9.1. Sickle cell disease
Sickle cell disease is caused by abnormal hemoglobins, which
cause the red blood cells to assume an abnormal shape. This is
characterized by the presence of mutant hemoglobin S.
Because of their abnormal shape, the red blood cells may
cause vaso-occlusion, producing tissue hypoxia and
ischemia.89 Sickle cell disease can cause either proliferative or
nonproliferative sickle cell retinopathy.
A study conducted on 208 eyes of 107 patients referred for
screening of sickle cell disease3 found that choroidal thickness
was significantly decreased in patients with sickle cell disease
as compared to age, gender, and ethnicity matched controls.
This may be the result of the slower blood flow in the cho-
riocapillaris because of the sickling of the red blood cells.
Interestingly, there was no difference in choroidal thickness
between eyes in patients with sickle cell disease eyeswith and
without macular thinning. This indicates that microarteriolar
occlusions in the macula are independent of changes in the
choroidal circulation.
9.2. Leukemia
Leukemia is a disease of the hematopoietic stem cells, causing
abnormal proliferation of white blood cells. Ocular involve-
ment may occur in virtually any part of the eye and is more
common in acute than in chronic leukemias. Primary
leukemic infiltration is rare and must be differentiated from
the chronic sequelae of the disease in the form of anemia,
thrombocytopenia, hyperviscosity, and opportunistic in-
fections. Choroidal deposits may occur, and present with a
“leopard skin” appearance.
The effect of leukemia on choroidal thickness has not been
extensively studied, possibly because of the many other sec-
ondary complications that would affect results. One 52-year-
old man newly diagnosed with acute lymphocytic leukemia
had EDI-OCT imaging that showed diffuse choroidal thick-
ening in both eyes, with subfoveal choroidal thickness being
500 and 503 mm for the right and left eye, respectively.9 After
4 weeks of systemic chemotherapy, there was a marked
decrease in choroidal thickness bilaterally (315 and 325 mm).
This suggests that choroidal thickness measurements could
be a noninvasive tool to monitor disease activity and treat-
ment outcomes in patients with leukemia; however, since this
is only one case report.10. Choroidal thickness in neurological
diseases
10.1. Alzheimer disease
Cerebral vascular impairment is one of the earliest patholog-
ical features in Alzheimer disease,12,28 and recent studies have
speculated that retinal vasculature changes show similar
pathogenetic alterations as cerebral vasculature.13,36 One
s u r v e y o f o p h t h a lmo l o g y x x x ( 2 0 1 6 ) 1e1 612prospective study39 involving 42 eyes of 21 patients with a
diagnosis of mild-to-moderate Alzheimer disease, and 42 eyes
of 21 age-matched normal subjects showed that choroidal
thickness was significantly decreased in Alzheimer disease (P
< 0.05). This suggests that choroidal thickness may be a
noninvasive parameter to diagnose and monitor treatment
progression in Alzheimer disease.10.2. Migraine
Migraine, an episodic chronic neovascular disorder with
recurrent throbbing, often severe, headaches, is divided into 2
main clinical subtypes based on the presence or absence of an
aura.51 Patients with migraine commonly have visual symp-
toms and have an increased prevalence of visual field defects
and glaucoma.62 The visual aura and headaches experienced
by patients with migraine are explained by vasospasm, and
this in turn may affect choroid vasculature.
Four studies by Ekinci et al, Dervisogullari et al, Dermir-
can et al, and Zengin et al determined that patients with
migraine had a significantly thinner choroid as compared
either to controls or to themselves when they were not
having an attack.29,30,32,122 Zengin et al and Dervisogullari
et al found that patients with migraine had choroidal thin-
ning during their attacks as compared to controls.30,122
Interestingly, Zengin also studied 5 patients both while
they were having an attack and when they were not and
determined that there was a sharp decrease in choroidal
thickness during the attack.122 This suggests that there may
be decreased ocular blood flow from vasospasm during a
migraine attack. Demircan and Ekinci conducted their study
on patients with a history of migraine and similarly deter-
mined that there was choroid thinning in patients with
migraine.29,32 This suggests that the effects of the migraine
on the choroid is not limited to the time of the attack, but
causes long-term effects.
In contrast, 2 studies by Karalezli et al and Dadaci et al
determined that there was choroid thickening in patients
with migraine26,56; however, because there is much more
evidence for choroid thinning in patients with migraine, it is
more likely that conclusion is accurate. The knowledge of
the effect of migraine on choroidal thickness allows us to
better understand the pathophysiology behind the disease.
Clinically, it is important to take into account a history of
migraine when using choroidal thickness measurements.11. Future scope
A recent further development is image segmentation of EDI-
OCT scans, which allows for analysis of structures within
the choroid (Fig. 7). This analysis may determine which
structures, vascular or interstitial, in the choroid change in
these diseases, giving us a better understanding of the path-
ophysiology of the change in choroid thickness. Moreover,
assessing the proportion of vasculature in the choroid, which
can be termed as “Choroidal Vascularity Index” may provide a
noninvasive tool to screen for and monitor diseases not justrestricted to the eye but for systemic microcirculatory disor-
ders (Fig. 7). Choroidal Vascularity Index is a method to
quantify choroidal blood flow by calculating the proportion of
luminal area to the total subfoveal choroidal area using semi-
automated image analysis of EDI-OCT scans. The methodol-
ogy and applications of Choroidal Vascularity Index in pan-
uveitis have been recently described.1,2 This technique
involves binarization of the EDI-OCT scan using a detailed
image analysis algorithm.107
Recently, there has been interest in the field of nonin-
vasive retinochoroidal imaging using OCT angiography and
swept-source optical coherence tomography. OCT angiog-
raphy is based on split-spectrum amplitude-decorrelation
angiography that allows detection of endoluminal flow
without a need to inject fluorescein dye.53,103 The technique
of OCT angiography has been shown to be useful in
detection of various abnormalities such as irregular flow
patterns that correspond well with invasive imaging tech-
niques like indocyanine green angiography in conditions
such as central serous chorioretinopathy and choroidal
neovascularization.54,108 Swept-source OCT provides a
deeper range of imaging in the eye with a fast scanning
speed. This technology has been used to obtain valuable
information in various choroidal pathologies such as
choroidal tumors.6912. Conclusions
The study of choroidal thickness is a relatively new and
exciting one, owing to the recent development of OCT. There
has been a recent surge in research on the effects of systemic
health on choroidal thickness. It is clear that many systemic
and physiological conditions impacting hemodynamics have
consequential effect on choroidal thickness (Table 1),
although the pattern of these effects may not yet be certain.
We consolidate current knowledge to give a clearer picture of
the future of choroidal research, in particular, in the under-
standing of the effects of systemic health on choroidal thick-
ness. We feel that choroidal has promise as a disease-
monitoring tool and that systemic conditions must be
considered when conducting future studies on choroidal
thickness.13. Method of literature search
A systematic literature search of the Medline/PubMed data-
base (www.ncbi.nlm.nih.gov/pubmed) was performed in May
2015, using the following search parameters: Choroid thick-
ness in combination with diurnal variation, age, gender,
menstrual cycle, pregnancy, preeclampsia, diabetes mellitus,
hypercholesterolemia, hypertension, smoking, ankylosing
spondylitis, Raynaud’s phenomenon, Vogt-Koyanagi-Harada
syndrome, Behc¸et’s disease, sarcoidosis, metastatic cancer,
tumors, Sturge-Weber syndrome, sickle cell disease, leuke-
mia, Alzheimer’s disease, and migraine. The reference lists of
s u r v e y o f o p h t h a lmo l o g y x x x ( 2 0 1 6 ) 1e1 6 13the identified publications provided additional information
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Abstract
Purpose: To evaluate a simplified method to measure choroidal thickness (CT) using commercially available enhanced
depth imaging (EDI) spectral domain optical coherence tomography (SD-OCT).
Methods: We measured CT in 31 subjects without ocular diseases using Spectralis EDI SD-OCT. The choroid-scleral interface
of the acquired images was first enhanced using a post-processing compensation algorithm. The enhanced images were
then analysed using Photoshop. Two graders independently graded the images to assess inter-grader reliability. One grader
re-graded the images after 2 weeks to determine intra-grader reliability. Statistical analysis was performed using intra-class
correlation coefficient (ICC) and Bland-Altman plot analyses.
Results: Using adaptive compensation both the intra-grader reliability (ICC: 0.95 to 0.97) and inter-grader reliability (ICC:
0.93 to 0.97) were perfect for all five locations of CT. However, with the conventional technique of manual CT measurements
using built-in callipers provided with the Heidelberg explorer software, the intra- (ICC: 0.87 to 0.94) and inter-grader
reliability (ICC: 0.90 to 0.93) for all the measured locations is lower. Using adaptive compensation, the mean differences (95%
limits of agreement) for intra- and inter-grader sub-foveal CT measurements were21.3 (23.33 to 30.8) mm and21.2 (236.6
to 34.2) mm, respectively.
Conclusions: The measurement of CT obtained from EDI SD-OCT using our simplified method was highly reliable and
efficient. Our method is an easy and practical approach to improve the quality of choroidal images and the precision of CT
measurement.
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Introduction
The choroid is important to support retinal and visual function
as it supplies nutrients and oxygen to retinal pigment epithelial
(RPE) cells and photoreceptors [1]. Therefore, the choroid may
play a role in the pathophysiology of many vision threatening
retinal diseases such as age-related macular degeneration [2,3],
polypoidal choroidal vasculopathy [4,5], central serous chorior-
etinopathy [6,7], Vogt-Koyanagi-Harada [8] disease and myopic
macular degeneration [9–12]. To elucidate the mechanisms
through which the choroid affects these retinal diseases, quanti-
tative assessment of choroidal characteristics such as choroidal
thickness (CT) is required.
However, it was not trivial to image CT because of its posterior
location and pigments in the RPE layer [13], until the advent of
spectral domain optical coherence tomography (SD-OCT) with
enhanced depth imaging (EDI). EDI SD-OCT has provided many
new insights into choroidal qualitative morphology. However, to
date a notable disparity exists between the CT measurements
obtained in different studies. Such variations could be due to
unavailability of a standardized and simple to use measurement
method and absence of built-in automated software to measure
CT in most of the commercially available OCT machines [14]. At
present, most of the studies perform the measurements manually
by using the in-built caliper system provided by the machine,
which is prone to measurement errors. The manual method is also
PLOS ONE | www.plosone.org 1 May 2014 | Volume 9 | Issue 5 | e96661
time- and effort-consuming, making it unfeasible especially when
dealing with large population data.
As a result, while many studies have published the distribution
of CT in patients with retinal diseases and normal controls [15–
19], none of these studies have clearly described the method used
in detailed to measure CT. Therefore, the reliability of the CT
measurement methods in most of the papers is unknown. In this
paper, we describe a simple, semi-automated, time-efficient
method to measure CT using images acquired by EDI SD-OCT
and available compensation algorithms. We aimed to assess the
reliability of this new CT measurement technique in a sample of
healthy eyes.
Materials and Methods
Study Subjects and Design
Data for this analysis were derived from the Singapore Malay
Eye Study (SiMES), a population-based cross-sectional study of
eye diseases in Malay adults, age ranged from 40–80 years living in
Singapore. Details of the study design, sampling plan, and
methodology have been reported elsewhere [20]. In brief,
participants recruited in the current study underwent standardized
and detailed ophthalmic examination, including Spectralis EDI
SD-OCT imaging (see next section). The study was approved by
the Institutional Review Board of Singapore Eye Research
Institute. It followed the tenants of the Declaration of Helsinki
and written informed consent was obtained from the subjects after
explanation of the nature and possible consequences of the study.
Spectralis images of 31 subjects were randomly selected using a
random number generated in Stata (College par, Texas, USA).
Choroidal images were only selected from right eye of each subject
as our measurement technique can be applied uniformly between
right and left eyes. Therefore only the right eyes of the subjects
were evaluated. In addition, selecting only one eye from
individuals would help to avoid inter-eye correlation issue in
statistical analysis. ‘‘Normal fundus’’ was defined as free of any
macular or vitroretinal diseases on the basis of clinical fundus
examination by experienced Ophthalmologist and the results of
OCT imaging. Exclusion criteria for the normal participants
included: best corrected LogMAR VA .0.3, evidence of macular
or vitroretinal diseases, previous retinal or refractive surgery, past
history of intraocular surgery, or clinical features compatible with
a diagnosis of glaucoma suspect or glaucoma.
To evaluate the intra-grader and inter-grader reliability, 31
Spectralis images were randomly selected for the initial grading
Figure 1. Illustration of the raw versus the compensated image. (A) Raw OCT image of a healthy subject. The choroid-scleral interface is only
partially visible. Note the presence of blood vessels shadows as indicated by red asterisks. (B) Adaptive compensation was applied to the raw image
in order to remove blood vessels shadows, enhance contrast and improve visibility of the choroid-scleral interface (more uniform).
doi:10.1371/journal.pone.0096661.g001
Figure 2. Flow diagram of the measurement protocol.
doi:10.1371/journal.pone.0096661.g002
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phase. Grader A and grader B, masked to subject characteristics
and clinical diagnosis, independently graded these images to assess
inter-grader reliability. In addition, grader A repeated the
measurements after 2 weeks to assess intra-grader reliability. Both
graders assessed the same sets of training images before
commencing the grading task.
EDI SD-OCT Imaging
CT was obtained using Spectralis SD-OCT with EDI modality
(Wavelength: 870 nm; Heidelberg Engineering, Heidelberg,
Germany) after pupil dilation using tropicamide 1% and
phenylephrine hydrochloride 2.5%. Subjects’ keratometry read-
ings and the refraction data were entered into the software
program to estimate optical magnification and, therefore, to allow
for more accurate comparisons across individuals. A single
experienced examiner masked to the clinical diagnosis of the
subject performed the EDI-OCT examination. Seven sections,
each comprising 100 averaged scans (using the automatic
averaging and eye tracking features of the proprietary device),
were obtained in an angle of 5u–30u rectangle centered at the
fovea. The horizontal section passing through the center of the
fovea was selected for analysis. For each subject only the right eye
was chosen for subsequent analysis.
Measurement of Choroidal Thickness
The two major steps in our CT semi-automatic measurement
protocol are: (A) post processing of images by adaptive compen-
sation technique and (B) quantitative measurement of CT using
Photoshop software. On average, measurement of CT at multiple
locations (1.5 and 3 mm nasal and temporal to the fovea) requires
approximately 1 minute per image.
(A) Adaptive compensation technique. An accurate eval-
uation of the CT with EDI-OCT mainly relies on how well one
can delineate the choroid-scleral interface (CSI), which anatom-
ically represents the junction between the choroid and the sclera,
and is a principal landmark for quantitative measurements of
choroid. However, at present identification of CSI is highly
variable as there is no algorithm available in Spectralis for its
automatic detection. Therefore, in order to accurately determine
CT, once the EDI-OCT image was obtained, the CSI was
enhanced using a novel post-processing compensation algorithm
[21] which greatly improved the detection of CSI by correcting the
deleterious effects of light attenuation. In brief, this novel adaptive
compensation algorithm improved the ability to detect and
visualize the CSI. First, it removes noise over-amplification at
high depth and shadow artifacts casted by blood vessels (thus
decreasing the intra-layer contrast of the choroid). Second, it
improves the visibility of posterior choroid boundary, by
significantly increasing the inter-layer contrast across the CSI
(Figure 1).
(B) Measurement of CT using photoshop software. The
enhanced images were measured in Photoshop CS6 extended
(Adobe Systems Incorporated, San Jose, California). CT at sub-
foveal, 1.5 mm and 3 mm nasal and temporal from the fovea were
measured. Figure 2 shows a flow diagram summarizing the CT
measurement protocol. The detailed explanation of the steps
involved in quantification of CT measurement using Photoshop is
provided in Appendix S1.
Statistical Analysis
Statistical analysis was performed using MedCalc Version 12.6
(MedCalc Software, Ostend, Belgium) and SPSS Version 20.0
(SPSS, Inc., Chicago, IL, USA). Shapiro-Wilk tests were used to
check the normality of CT data at various locations. The reliability
of the CT measurement was assessed using intra- and inter-grader
agreements between two independent graders, measured by the
absolute agreement model of the intra-class correlation coefficient
(ICC) [22]. ICC value of 0.81–1.00 indicates almost perfect
agreement. Values of less than 0.40 indicate poor to fair
agreement. Bland Altman plot analyses [23,24] were performed
to see if there is any proportional bias between measurements. A
two-tailed paired sample t-test was used to analyze differences
between means in CT by location.
Results
Images from 31 eyes of 31 participants (aged 64.467.4 years)
were included in the analysis (Table 1). The mean (standard
deviation) sub-foveal CT in this study was 230.37 (66.66) mm
(average of 1st and 2nd measurements of grader A). CT measured
by the two graders is summarized in Table 2. The mean sub-
foveal CT measured by grader A for the 1st and 2nd measurements
was 229.74 (65.12) mm and 231 (69.14) mm, respectively, and was
232.19 (67.89) mm by grader B.
Using adaptive compensation both the intra-grader reliability
(ICC: 0.95 to 0.97) and inter-grader reliability (ICC: 0.93 to 0.97)
were perfect for all five locations of CT (Table 3). However, with
the conventional technique of manual CT measurements using
Table 1. Baseline characteristics of study subjects.
Characteristics Mean (SD)
Age, years 64.35 (7.42)
Gender, male 11 (35.48)
Axial length, mm 23.33 (0.88)
Average choroidal thickness,* mm
Sub-foveal 230.37 (66.66)
Nasal, 1.5 mm 214.33 (74.34)
Nasal, 3 mm 185.77 (69.96)
Temporal, 1.5 mm 224.53 (57.27)
Temporal, 3 mm 229.74 (52.03)
Data are expressed as mean (SD) except for gender, which is expressed as number (%).
*The average of 1st and 2nd measurement of Grader A.
doi:10.1371/journal.pone.0096661.t001
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built-in callipers provided with the Heidelberg explorer software,
the intra- (ICC: 0.87 to 0.94) and inter-grader reliability (ICC:
0.90 to 0.93) for all the measured locations is lower (Table 4).
Using adaptive compensation, the Bland Altman analysis of intra-
grader reliability for sub-foveal CT measurement showed 95%
LOA of 233.3 to 30.8 with a mean difference of 21.3 mm
(Figure 3). No significant systemic (except at nasal 3 mm,
p= 0.003) and proportional bias was detected in intra-grader
CT measurements at all locations. The Bland Altman analysis of
inter-grader reliability for sub-foveal CT measurement showed
95% LOA of 236.6 to 34.2 with a mean difference of 21.2 mm
(Figure 4). No significant proportional bias was observed in the
inter-grader CT measurements at all locations. Nonetheless, a
significant systemic bias at both 1.5 and 3 mm nasal locations was
found in the inter-grader CT measurement comparison
(p = 0.001). However, this could be due to thinnest CT at nasal
locations, making it more prone to systemic bias in CT
measurements.
In addition, the choroid intra-layer contrast (a measure of
shadow presence when high) and the CSI inter-layer contrast (a
measure of boundary visibility when high) were computed for all
images (n = 31) before and after applying adaptive compensation
(as in [25]). We found that the intra-layer contrast significantly
decreased from 0.8460.07 to 0.6060.07 (p,0.001; t-test),
whereas the inter-layer contrast significantly increased from
0.5060.14 to 0.9060.10 (p,0.001; paired t-test) after applying
adaptive compensation (Table 5).
Discussion
Despite significant advances in imaging technology there are
considerable variations in CT measurements across clinical
studies. In this report, we described a simple, semi-automated
method using adaptive compensation to measure CT from images
acquired by EDI SD-OCT. The results showed that the method
permits a highly reproducible tool for assessing CT from EDI SD-
OCT images. Our measurement method is also simple and
requires little time to perform (on average ,1 minute per image).
With these features, our method may have great potential for use
in both clinical and population-based studies which involve large
number of images.
Table 2. Summary of choroidal thickness measurements at various locations.
Location Grader A, 1st Measurement Grader A, 2nd Measurement Grader B Measurement
Sub-foveal 229.74 (65.12) 231.00(69.14) 232.19 (67.89)
Nasal, 1.5 mm 213.84 (75.12) 214.84(75.49) 221.52(76.08)
Nasal, 3 mm 191.13 (72.79) 180.42(68.25) 187.55(71.06)
Temporal, 1.5 mm 223.94 (56.33) 225.13(59.24) 231.65 (60.82)
Temporal, 3 mm 228.68 (50.64) 230.81(54.57) 230.71 (53.80)
Data are mean (SD).
doi:10.1371/journal.pone.0096661.t002
Table 3. Intra- and inter-grader agreements for the choroidal thickness measurement at 5 horizontal locations using adaptive
compensation.
Assessment of proportional biasd
Locations, CT
measurement ICC (95% CI)
Mean difference
(95% LOA) P Valuec
Pearson’s
correlation
coefficient, r P Value
Intra-grader
Reliabilitya
Sub-foveal 0.97 (0.94 to 0.98) 21.3 (233.3 to 30.8) 0.672 0.248 0.179
Nasal, 1.5 mm 0.95 (0.90 to 0.97) 21.0 (248.0 to 46.0) 0.818 20.160 0.933
Nasal, 3 mm 0.95 (0.87 to 0.98) 10.7 (225.3 to 46.7) 0.003 0.249 0.176
Temporal, 1.5 mm 0.96 (0.92 to 0.98) 21.2 (231.9 to 29.5) 0.674 20.187 0.313
Temporal, 3 mm 0.95 (0.90 to 0.97) 22.1 (233.5 to 29.2) 0.464 20.248 0.178
Inter-grader
Reliabilityb
Sub-foveal 0.96 (0.93 to 0.98) 21.2 (236.6 to 34.2) 0.715 0.070 0.708
Nasal, 1.5 mm 0.97 (0.92 to 0.99) 29.0 (234.4 to 16.4) 0.001 20.127 0.495
Nasal, 3 mm 0.97 (0.89 to 0.98) 29.8 (237.4 to 17.8) 0.001 20.230 0.212
Temporal, 1.5 mm 0.93 (0.86 to 0.96) 26.5 (248.3 to 35.3) 0.099 20.075 0.687
Temporal, 3 mm 0.94 (0.88 to 0.97) 0.1 (235.5 to 35.7) 0.977 0.043 0.818
LOA, Limits of Agreement; ICC, Intraclass Correlation Coefficient; CI, Confidence Interval.
aMean difference was determined from the1st time measurement minus the 2nd time measurement.
bMean difference was determined from Grader A measurement minus Grader B measurement.
cP value of one sample t-tests (comparing between mean difference and zero value) to indicate presence of systemic bias.
dUsing Pearson’s correlation coefficients of regression line.
doi:10.1371/journal.pone.0096661.t003
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There are considerable differences in CT measurements across
studies. Even though advances in OCT technology have reduced
acquisition time, adequate visualization of choroid is still lacking.
There are several challenges in imaging the choroid. First, the
choroid is located behind the RPE and Bruch’s membrane,
making it less accessible than the retina and more difficult to be
visualized. Second, the pigmentation in the RPE and the choroid
itself decreases the signal intensity. Lastly, unlike retinal imaging
[26], wherein the RPE and internal limiting membrane are thin
and clearly identifiable, the transition zone between the choroid
and sclera (i.e. CSI) has blurred border and is broader, making
CSI difficult to identify.
However, it is not always easy to distinguish CSI on acquired
images, which may be related to scan quality or anatomic
variation. Some choroidal scans have a distinct hypo-reflective line
corresponding to the supra-choroidal space, but often this line can
be indistinct leading to measurement error [27]. At present,
identification of CSI is highly variable. To overcome these
challenges, in this study we enhanced choroidal-scleral junction
using a post-processing adaptive compensation algorithm [21].
Measurement of CT was performed in the post-processed images
using Photoshop (Adobe Systems Incorporated, San Jose,
California), a readily available and easy-to-use program.
Adaptive compensation provides two major improvements.
First, the intra-layer contrast (of the choroid) significantly
decreased after applying adaptive compensation, indicating
successful shadow correction within the choroid. Second, the
inter-layer contrast (across the CSI) significantly increased after
applying adaptive compensation, indicating better visualization of
CSI and therefore allowing for precise measurement of CT. These
results are consistent with a previous study on standard
compensation [25] and indicate significant improvements in
image quality. Also, a study by Lin et al. established outer
choroidal contrast as a valid quantifiable measure of choroidal
Table 4. Intra- and inter-grader agreements for the choroidal thickness measurement at 5 horizontal locations using Spectralis SD-
OCT with conventional manual technique.
Locations, CT measurement ICC (95% CI) Mean difference (95% LOA)
Intra-grader Reliabilitya Sub-foveal 0.94 (0.87to 0.97) 9.7 (230.3 to 49.7)
Nasal, 1.5 mm 0.92 (0.85 to 0.96) 2.9 (241.1 to 54.9)
Nasal, 3 mm 0.92 (0.85 to 0.96) 4.1 (236.1 to 44.3)
Temporal, 1.5 mm 0.87 (0.75 to 0.93) 27.0 (252.1 to 38.1)
Temporal, 3 mm 0.88 (0.77 to 0.94) 21.9 (244.9 to 48.6)
Inter-grader Reliabilityb Sub-foveal 0.90 (0.60 to 0.96) 219.1 (263.7 to 25.6)
Nasal, 1.5 mm 0.93 (0.68 to 0.97) 18.3 (259.7 to 23.2)
Nasal, 3 mm 0.91 (0.67 to 0.96) 215 (254.3 to 24.3)
Temporal, 1.5 mm 0.91 (0.72 to 0.96) 212.7 (249.8 to 24.4)
Temporal, 3 mm 0.90 (0.58 to 0.96) 215.7 (251.3 to 19.9)
LOA, Limits of Agreement; ICC, Intraclass Correlation Coefficient; CI, Confidence Interval.
aMean difference was determined from the1st time measurement minus the 2nd time measurement.
bMean difference was determined from Grader A measurement minus Grader B measurement.
doi:10.1371/journal.pone.0096661.t004
Figure 3. Bland Altman plot of intra-grader reliability of sub-
foveal choroidal thickness (CT) measurement. The difference was
calculated by the 1st measurement minus the 2nd measurement. Pink
dashed line represents regression line of difference between 1st and
2nd measurements.
doi:10.1371/journal.pone.0096661.g003
Figure 4. Bland Altman plots of inter-grader reliability of sub-
foveal choroidal thickness (CT) measurement. The difference was
calculated by the grader A measurement minus the grader B
measurement. Pink dashed line represents regression line of difference
between the two graders measurements.
doi:10.1371/journal.pone.0096661.g004
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image quality and demonstrated that inverted SD-OCT imaging
optimizes visualization of CSI and choroidal vessels through
improved outer choroid contrast [28].
With improved intra- and inter-layer contrast, the compensated
images are likely more accurate than the non-compensated images
as the deleterious effects of OCT light attenuation have been
corrected, thus making the CSI more visible. The post-compen-
sation images are more representative of the eye tissue architec-
ture, since better estimates of the ocular tissues optical properties
(e.g. reflectivity) are provided. This has been formally demon-
strated in the original article by Girard et al. [25], and in the
following studies [21,29,30]. Lastly, although adaptive compensa-
tion is useful in all images, it is likely to be more useful when the
CSI is poorly visible, e.g. in images where light attenuation is
strong (Figure 1), emphasizing further the need for compensation
for more accurate thickness measurement of the choroid.
Adaptive compensation achieves high intra-grader (ICC: 0.95 to
0.97) and inter-grader (ICC: 0.93 to 0.97) repeatability in CT
measurements compared to conventional method (intra-grader
ICC: 0.87 to 0.94, inter-grader ICC: 0.90 to 0.93), suggesting the
use of adaptive compensation to improve the visualization of CSI
and to obtain more reliable CT measurements. However, the high
repeatability can be explained by the standardization and strict
adherence to a rigorous grading protocol in the present study. In
addition, both graders underwent the same training set for
standardization purpose before embarking on the actual grading
task. The present results are in line in the studies by Ikuno et al.
[31] and Yamashita et al. [32] who reported an inter-grader ICC
of 0.97 and 0.94, respectively, for sub-foveal CT measurements.
However, in these two previous studies the intra-grader repeat-
ability was not evaluated, and it is not clear how the choroid
images, where CSI could not be clearly visualized, were processed.
But the present study has its own limitations, as the
measurement of CT was subjective in nature, and was therefore
subject to measurement bias. However, our method may be less
prone to observer error because the CSI was enhanced by
adaptive compensation to give better visibility. An automated, and
thus may be more objective, method of measuring CT would be of
potential interest to facilitate, speed-up and render operator-
independent such analyses.
There are few recent studies on automatic choroidal segmen-
tation in OCT images. Zhang et al. proposed an automatic
segmentation algorithm for the choroidal vessels using Cirrus
OCT in 24 normal subjects. But their aim was to quantify
choroidal vasculature thickness and choroicapillaries equivalent
thickness rather than the CT [33]. Likewise, Torzicky et al. [34]
and Duan et al. [35] developed the automatic algorithms to detect
the boundary between the choroid and sclera based on polariza-
tion sensitive OCT which are not commercially available.
Although, Tian et al. [36] in 2013 proposed an automatic
algorithm that could segment choroid in commercially available
Spectralis OCT, but their algorithm was tested only on 20 EDI
OCT images and need to be validated on more images to prove
the robustness of algorithm before its application in clinical studies.
While we are preparing the manuscript, a commercially available
CT measurement algorithm in swept-source OCT (Topcon Corp.,
Tokyo, Japan) is being made available. However, in view of lack of
supporting agreement studies on the algorithm and manual
choroidal segmentation (in both normal and diseased eyes), the
accuracy and reliability of automated CT analysis by using swept-
source OCT is yet to be established for use in clinical settings.
In conclusion, we described a simplified, semi-automated and
practical method ‘‘adaptive compensation followed by using
Photoshop’’ that gives excellent intra- and inter-grader reliability
(ICC.0.93) to quantify CT in the EDI SD-OCT images. This
method has great potential usage in both clinical and population
based studies, as reliable and accurate measurements of CT from
EDI-OCT images are essential in distinguishing clinically signif-
icant change of CT and assisting in risk-profiling for various
posterior segment diseases.
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Relationship of ocular and systemic factors to the
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ABSTRACT.
Purpose: To assess the visibility of the choroidal–scleral interface (CSI) from
spectral domain optical coherence tomography (SD-OCT) and evaluate the
ocular and systemic factors inﬂuencing the visibility of CSI in healthy eyes from
population-based Malay sample.
Methods: Participants were consecutively recruited from the population-based
Singapore Malay Eye Study-2 (SiMES-2). SD-OCT images were obtained by
Spectralis OCT with enhanced depth imaging (EDI) mode. Visibility of CSI was
assessed by a grading system ranging from 0 to 2 scores. The reliability of
choroidal thickness measurement in diﬀerent grades of CSI visibility was
assessed using intraclass correlation coeﬃcient. Ordinal regression analyses
were performed to evaluate a range of ocular and systemic factors inﬂuencing the
visibility of CSI.
Results: A total of 176 healthy eyes were analysed, and 59.1% of our subjects had
well-deﬁned CSI (score 2), 8.5% had poorly deﬁned CSI (score 0), and 32.4% had
CSI between well and poorly deﬁned (score 1). The reliability of subfoveal
choroidal thicknessmeasurement decreasedwith each grade ofCSI visibility score.
Decreased axial length (AL) (estimate of ordinal regression [OR] = 0.465,
p = 0.003), thicker retinal thickness (estimate of OR = 0.030, p = 0.004),
younger age (estimate of OR = 0.045, p = 0.030) and diabetes (estimate of
OR = 0.746, p = 0.004) were associated with lower CSI visibility score.
Conclusions: Only 60% of normal healthy eyes had well-deﬁned CSI from SD-
OCT images. Our data suggest that choroidal thickness measurements can be
substantially aﬀected by the visibility of CSI. The visibility of CSI varies with
AL, retinal thickness, age and diabetes.
Key words: choroidal thickness – choroid–scleral interface – EDI SD-OCT – visibility of chor-
oid-scleral interface
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Introduction
The choroid is a major vascular layer
of the eye which provides oxygen and
nourishment to the outer layers of the
retina including the photoreceptors
(Linsenmeier & Padnick-Silver 2000).
Abnormalities in choroidal vasculature
(e.g. vascular hyperpermeability, vas-
cular changes and loss, and thinning)
are of importance in the pathophysiol-
ogy of a number of retinal diseases
such as age-related macular degenera-
tion (Grossniklaus & Green 2004;
Koizumi et al. 2011), polypoidal cho-
roidal vasculopathy (Gomi & Tano
2008; Chung et al. 2011), central serous
chorioretinopathy (Gupta & Mohamed
2011; Imamura et al. 2009) and high
myopia-related chorioretinal atrophies
(Fitzgerald et al. 2002; Fujiwara et al.
2009; Ikuno & Tano 2009). To eluci-
date the mechanisms how the choroid
may aﬀect chorioretinal diseases, an
easy, objective and quantitative analy-
sis of the choroid is required. Indocy-
anine green angiography and, to a
lesser extent, ﬂuorescein angiography
are the current standards to evaluate
the choroidal circulation in clinic; how-
ever, they are invasive and can only
provide qualitative assessment of cho-
roid.




depth imaging (EDI-OCT) by Spaide
and colleagues (Spaide et al. 2008), this
technique has been used to study the
changes in choroidal thickness in many
conditions (Chung et al. 2011; Fujiw-
ara et al. 2009; Gomi & Tano 2008;
Grossniklaus & Green 2004; Ikuno &
Tano 2009; Imamura et al. 2009) as
well as other ocular abnormalities
(Beck et al. 2015). Nonetheless, an
accurate estimation of choroidal thick-
ness with EDI-OCT relies mainly on
the visibility of choroid–scleral inter-
face (CSI), which anatomically repre-
sents the junction between the choroid
and the sclera and is a principal land-
mark for quantitative measurements of
choroid. However, unlike retinal lay-
ers, the contrast between the choroid
and scleral border is weak (Chiu et al.
2010; Ghorbel et al. 2011; Duan et al.
2012; Kajic et al. 2012), giving CSI a
variable visibility leading to variations
and inaccuracy in choroidal thickness
measurements across the clinical stud-
ies. There have been no studies which
investigate factors which may deter-
mine the visibility of the CSI.
The aim of this study was to assess
the visibility of CSI in EDI-OCT
images in healthy eyes and to deter-
mine the eﬀects of a range of ocular




Data for this analysis were derived
from the Singapore Malay Eye Study-2
(SiMES-2), a population-based cohort
study of eye diseases in Malay adults
aged 46–86 years living in Singapore.
Details of the baseline study design,
sampling plan and methodology
(SiMES-1), conducted in 2004–6, have
been reported elsewhere (Foong et al.
2007). The follow-up examination,
SiMES-2, is ongoing (Rosman et al.
2012). For this analysis, we enrolled
176 consecutive participants of the
SiMES-2 from June 2012 to January
2013. Participants recruited in this
phase underwent standardized and
detailed ophthalmic examination,
including Spectralis EDI SD-OCT.
Normal participants had no history
of ocular disease except cataract. Par-
ticipants were excluded based on the
following characteristics: best-cor-
rected LogMAR VA >0.3, evidence of
macular or vitreoretinal diseases, dia-
betic retinopathy, previous retinal or
refractive surgery, past history of intra-
ocular surgery, or clinical features
compatible with a diagnosis of glau-
coma suspect or glaucoma. A glau-
coma suspect was deﬁned as having
any of the following criteria in the
presence of normal visual ﬁeld: (1)
abnormal anterior segment signs con-
sistent with pseudoexfoliation or pig-
ment dispersion syndrome, (2) narrow
angles (posterior trabecular meshwork
visible for <180 degrees during static
gonioscopy), (3) vertical cup-to-disc
ratio (VCDR) > 0.6 or VCDR asym-
metry >0.2 and (4) peripheral anterior
synechiae or other ﬁndings consistent
with secondary glaucoma (Shen et al.
2008). Glaucoma was diagnosed and
classiﬁed using the International Soci-
ety of Geographic and Epidemiological
Ophthalmology (ISGEO) scheme (Fos-
ter et al. 2002), based on the ﬁndings
from gonioscopy, optic disc character-
istics and visual ﬁelds results. The
study was approved by the Institu-
tional Review Board of Singapore Eye
Research Institute. It followed the
tenants of the Declaration of Helsinki,
and written informed consent was
obtained from the subjects.
EDI-OCT imaging
Choroidal thickness was obtained
using a SD-OCT (Spectralis, Heidel-
berg Engineering, Heidelberg, Ger-
many) with EDI modality after pupil
dilation using tropicamide 1% and
phenylephrine hydrochloride 2.5%.
The EDI mode places the retinal pig-
mented epithelium near the zero-delay
line while producing an upright
enhanced choroidal images. Seven sec-
tions, each comprising 100 averaged
scans (using the automatic averaging
and eye tracking features of the pro-
prietary device), were obtained in an
angle of 5–30° rectangle centred onto
the fovea. According to Spectralis user
manual guidelines, subjects’ keratome-
try readings and the most recent refrac-
tion were entered into the software
program to estimate optical magniﬁca-
tion and, therefore, to allow for more
accurate comparisons across individu-
als. All the scans included in the study
had signal strength of at least 18, which
is considered as acceptable quality. One
of the authors (PG) who was masked
to subject characteristics and clinical
diagnosis performed the EDI-OCT
examination. Only the horizontal sec-
tion passing through the centre of the
fovea was selected for analysis.
Image analysis
Choroidal thickness measurement
Using the Spectralis linear measure-
ment tool, a single observer (PG)
measured choroidal thickness perpen-
dicularly from the outer portions of the
hyper-reﬂective line, corresponding to
the retinal pigment epithelium (auto-
matically detected by the instrument),
to the hyporeﬂective line or margin
corresponding to the sclerochoroidal
interface (drawn manually) at subfo-
veal location.
CSI visibility grading system
We developed a new grading system to
assess the visibility of CSI for EDI-
OCT images. Two blinded observers
evaluated all the OCT scans to locate
the CSI on each EDI-OCT image. The
CSI was deﬁned as a hyporeﬂective line
between the large vessel layer of the
choroid and the sclera (Fig. 1). For the
grading of CSI visibility, the EDI-OCT
images were given a score between 0
and 2. A score of ‘2’ was assigned if the
image contained a well-deﬁned CSI. A
score of ‘1’ was assigned if the visibility
of CSI was between well-deﬁned and
poorly deﬁned CSI, and a score of ‘0’
was given if the image had poorly
deﬁned CSI visibility, that is no clearly
identiﬁable border between the choroid
and sclera was seen. Figure 1 demon-
strates examples of well-deﬁned, mod-
erately deﬁned and poorly deﬁned CSI
in EDI-OCT images in the SiMES-2
cohort.
Reliability assessment
We evaluated both the intra- and
interobserver reliability in assessing
CSI visibility. For intra-observer reli-
ability, 176 Spectralis images were
assessed again by the same grader
(grader 1 versus grader 1) after an
interval of 1 week. Two independent
graders (grader 1 versus grader 2)
assessed the interobserver reliability of
CSI visibility in 176 Spectralis images.
In addition, subfoveal choroidal
thickness at the foveal centre was
measured twice by the same grader to
assess the reliability of choroidal thick-
ness measurement in each score of CSI
visibility (15 images for each score).
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Measurement of ocular factors
All participants underwent an extensive
and standardized examination proce-
dure, which included measurement of
visual acuity monocularly using Log-
MAR number chart (Lighthouse Inter-
national, New York, NY, USA) at a
distance of 4 m. Intraocular pressure
was measured with a Goldmann
applanation tonometer (Haag-Streit,
Bern, Switzerland) before pupil dila-
tion. The static refraction of each eye
was measured using an autorefractor
(Canon RK 5 Auto Ref-Keratometer,
Canon Inc. Ltd., Tochigiken, Japan).
Spherical equivalent refraction was
calculated as the sum of the value of
the spherical value and half of the
cylindrical value. Central corneal thick-
ness was measured with an ultrasound
pachymeter (Advent, Mentor O & O,
Norwell, MA, USA), and the mean of
ﬁve measurements was used in the
analysis. Axial length (AL), corneal
curvature and anterior chamber depth
were measured with a non-contact
partial coherence laser interferometry
(IOLMaster V3.01, Carl Zeiss Meditec
AG, Jena, Germany), and the mean of
ﬁve measurements was used in the
analysis. Lens opacity was assessed by
trained ophthalmologists using Lens
Opacities Classiﬁcation System
(LOCS) III (Chylack et al. 1993) with
a Haag-Streit slit-lamp microscope
(model BQ-900) in comparison with
standard photographic slides for
nuclear opalescence, nuclear colour,
cortical and posterior subcapsular
(PSC) cataract. Retinal thickness of
central 1-mm region was obtained from
Spectralis OCT after pupil dilation.
Assessment of demographic, lifestyle and
systemic factors
All participants underwent a detailed
interview using standardized question-
naires. Information on socio-demo-
graphic status, lifestyle risk factors
(e.g. smoking, alcohol consumption),
medication use and self-reported history
of systemic disease was collected.
Systolic and diastolic blood pressures
were measured using a digital automatic
blood pressure monitor (Dinamap
model Pro Series DP110X-RW, 100V2;
GE Medical Systems Information
Technologies, Inc., Milwaukee, WI,
USA), after subjects were seated for at
least 5 min. Bodymass index (BMI)was
calculated as bodyweight (in kilograms)
divided by body height (in metres)
squared. Smoking status was deﬁned as
those currently smoking, ex-smokers
and non-smokers. The number of packs
smoked per week was recorded. Non-
fasting venous blood samples were anal-
ysed at theNationalUniversityHospital
Reference Laboratory for biochemical
testing of serum total cholesterol, high-
density lipoprotein (HDL) cholesterol,
low-density lipoprotein (LDL) choles-
terol, triglycerides, glycosylated haemo-
globin (HbA1c), glucose and creatinine.
Statistical analysis
Statistical analysis was performed
using MEDCALC version 12.3 (Medcalc
Software, Ostend, Belgium) and SPSS
version 20.0 (SPSS, Inc., Chicago, IL,
USA). The intra–inter grader reliability
in assessing CSI visibility was measured
by weighted kappa statistics (Kw) (Fle-
iss & Cohen 1973). Κw values of 0.81–
1.00 indicate almost perfect agreement,
values of 0.61–0.80 indicate good
agreement, and values of 0.41–0.60
indicate moderate agreement. Values
of less than 0.40 indicate poor to fair
agreement. The reliability of choroidal
thickness measurement in each score of
CSI visibility was measured by the
absolute agreement model of the intra-
class correlation coeﬃcient (ICC). ICC
value of 0.81–1.00 indicates almost
perfect agreement. Values of less than
0.40 indicate poor-to-fair agreement.
As the dependent variable (CSI vis-
ibility scores 0, 1 & 2) is ordinal in
nature, we used ordinal regression for
our analysis. Univariate and multiple
ordinal regression analyses were per-
formed to assess the ocular and sys-
temic factors (independent variables)
related to the CSI visibility (dependent
variable). For multiple regression
analysis, gender and factors which
showed signiﬁcant association in uni-
variate analysis were included. The
three groups (CSI visibility score 0, 1
& 2) were not evenly distributed. Thus,
the Logit link function could not be
used, and instead, complementary log–
log (higher scores more probable) was
used. However, this function could
only determine the direction of the
relationship between each predictor




Fig. 1. The choroidal–scleral interface (CSI) is indicated by hyper-reﬂective line shown by
arrowheads. (A) demonstrates an example of a well-deﬁned CSI, (B) shows a moderately deﬁned
CSI, and (C) a poorly deﬁned CSI in EDI-OCT image in the SiMES-2 cohort.
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outcome. A p-value of < 0.05 was
considered statistically signiﬁcant. Right
eye (n = 161) of each subject was
selected for the analysis. However, when
images of right eye were not available,
then the images of left eye (n = 15) were
used.
Results
Table 1 shows the baseline character-
istics and the distribution of CSI visi-
bility grade of the study subjects. A
total of 176 eyes from 176 subjects
(85 men and 91 women) with a
mean  SD (standard deviation) age
of 60.44  8.19 years (range, 48–
86 years) were included in the study.
The CSI was clearly identiﬁable (score
2) in 59.1% (104/176 eyes), poorly
deﬁned (score 0) in 8.5% (15/176 eyes)
and was between clearly and poorly
deﬁned (score 1) in 32.4% (57/176 eyes)
of our subjects.
Table 2 shows the intra- and inter-
grader reliability assessment of CSI
visibility. Both the intra- and interob-
server reliability was moderate to good
(Kw = 0.78, 95% CI: 0.70–0.85 and
Kw = 0.74, 95% CI: 0.64-0.83 for
intra- and interobserver reliability,
respectively).
The reliability of subfoveal choroi-
dal thickness measurement was highest
for CSI visibility score 2 (ICC = 0.977,
95% CI, 0.935–0.992) followed by
score 1 (ICC = 0.734, 95% CI, 0.585–
0.940) and score 0 (ICC = 0.514, 95%
CI, 0.058–0.853), respectively. In addi-
tion, in our previously published paper
(Gupta et al. 2014), we have reported
that both the intragrader reliability
(ICC: 0.87–0.94) and intergrader reli-
ability (ICC: 0.90–0.93) for the choroi-
dal thickness measurement using
Spectralis SD-OCT were excellent.
Among the ocular factors, decreased
AL (p = 0.006), thicker retinal
(p < 0.001) and choroidal (p = 0.012)
thicknesses were more likely to have
lower CSI visibility score. Among other
factors, young individuals (p = 0.003)
and those with diabetes (p = 0.033)
were associated with lower CSI visibil-
ity score. We did not observe any
associations between CSI visibility with
other factors, for example gender,
BMI, systolic and diastolic blood
pressure, HDL and LDL cholesterol,
blood creatinine, triglycerides, serum
blood glucose level, HbA1c, smoking
status and hypertension (all p > 0.10)
(Table 3). Factors with p < 0.10 in the
univariate analysis were further
included into the multivariate analysis.
However, because of the collinearity
between AL and spherical equivalent,
only AL was selected and retained in
the multivariate analysis.
In the multivariate-adjusted model,
decreased AL (estimate of ordinal
regression = 0.465, p = 0.003), thicker
retinal thickness (estimate of ordinal
regression = 0.030, p = 0.004), youn-
ger age (estimate of ordinal regres-
sion = 0.045, p = 0.030) and diabetes
(estimate of ordinal regres-
sion = 0.746, p = 0.004) were signiﬁ-
cantly and independently associated
with lower CSI visibility score
(Table 4).
In this sample, we found that 10.9%
of younger people (age less than
60 years), 12.5% of those with thicker
retinal thickness (≥280 lm), 11.8% of
those with shorter AL (≤23 mm) and
11.76% of those with diabetes had
poor CSI visibility (grade 0).
Discussion
In this study, we found that only 60%
of subjects had well-delineated CSI
that allowed good visualization of the
choroid, and the choroidal thickness
measurements had higher variability in
the images with poor visualization of
CSI. Moreover, we demonstrated that
the visualization of CSI was poorer in
eyes with shorter eye ball, thicker
retinal thickness, and in younger per-
sons and persons with diabetes.
Correct identiﬁcation and knowl-
edge of factors determining CSI visi-
bility is essential for the accuracy and
performance of imaging programs that
aim to automatically detect this ana-
tomical structure. We found that youn-
ger age was associated with poorer
identiﬁcation of choroid scleral junc-
tion (Fig. 2). Previous histologic stud-
ies have shown a decrease in vascular
density, overall luminal area and diam-
eter of chorio-capillary vessels with
increase in age (Sarks 1976; Feeney-
Burns et al. 1990; Ramrattan et al.
1994). This leads to a decrease in
physiological functions of the choroid,
that is the ability of the choroid to
provide suﬃcient levels of oxygen and
other metabolites to the RPE, and
outer retina may decrease (Spaide et al.
2008) contributing to the onset of
many diseases in elderly people. There
Table 1. A summary of subjects’ demograph-
ics, ocular parameters and systemic factors.
Included
(n = 176)
Age, years 60.44 (8.19)
Gender, % male 48.3


















LOCS III cortical, % 56 (38.8)
LOCS III PSC, % 8 (4.5)








Body mass index, kg/m2 77.52 (9.84)
Current smoking, % 36 (20.05)
Diabetes mellitus, % 51 (29.0)
Hypertension, % 74 (42.0)
Visibility grade
Grade 0 15 (8.5)
Grade 1 57 (32.4)
Grade 2 104 (59.1)
Data are mean (SD), except for gender,
cataracts, HbA1c, current smoking, diabetes
hypertension and visibility grades which are
expressed as number (%).





Score 0 Score 1 Score 2 Total Score 0 Score 1 Score 2 Total
Score 0 12 4 1 17 8 10 0 18
Score 1 5 35 12 52 3 39 13 55
Score 2 1 10 96 107 0 10 93 103
Total 18 49 109 176 11 59 106 176
Gray shades indicate agreement of CSI visibility scores between the graders (intra and inter).
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is an increasing trend of data from
other older adult studies which states
that choroidal thickness decreases with
age (Fujiwara et al. 2012; Margolis &
Spaide 2009). Thicker choroid in youn-
ger age would undergo more attenua-
tion of incident light resulting in poor
visualization of the CSI. Nevertheless,
we did not ﬁnd any signiﬁcant associ-
ation between CSI visibility score and
choroidal thickness in the multiple
regression model (Table 4). Another
possible explanation of poorer CSI
visibility at younger age is higher con-
centration of choroidal melanin pig-
ments in young individuals, which tend
to progressively decrease with advanc-
ing age (Weiter et al. 1986).
In addition to age, persons with
diabetes had poorer visibility of
choroid–scleral junction. There is
inconsistency in literature in terms of
choroidal blood ﬂow, which is reported
to decrease, increase and remain
unchanged in patients with diabetes
(Langham et al. 1991; MacKinnon
et al. 1997; Schmidt et al. 2000). How-
ever, many studies have demonstrated
signiﬁcant decrease in choroidal blood
ﬂow in diabetic patients, especially
those with macular oedema (Langham
et al. 1991; Geyer et al. 1999). How-
ever, in our cohort, none of the diabetic
subjects had diabetic macular oedema
or intraretinal cystic changes. While
comparing the retinal thickness in dia-
betics (259.15 lm) and non-diabetics
(262.12 lm), we found no signiﬁcant
diﬀerence (p = 0.402) in thickness.
Thus, the reasons for diabetic people
having poor CSI visibility are still
unclear. We can only speculate that
poor CSI visibility in diabetics might
be associated with blood ﬂow changes
in choroid, but unfortunately, in our
study, we did not obtain any informa-
tion pertaining to blood ﬂow. An
alternative explanation could be the
hyper-reﬂectivity of incident light from
the intraretinal ﬂuid which can lead to
a shadowing eﬀect of the deeper layers
resulting in poorer CSI visibility (Adhi
et al. 2013).
Another reason for diabetic subjects
having poor CSI visibility could be the
fact that diabetes leads to a faster
development of cataract which in turn
might be associated with poorer visi-
bility of CSI. However, in a subgroup
analysis in diabetic subjects with cata-
racts, we found no signiﬁcant associa-
tion between the presence of cataract
and CSI visibility score (p = 0.074, chi-
square test), indicating that the pres-
ence of cataract in diabetic subjects
does not aﬀect the visibility of CSI. In
our study, we also found that thicker
retinal thickness was associated with
poorer CSI visibility. It is noted that
there were no relationships between
CSI visibility with most systemic fac-
tors such as BMI, blood pressure,
cholesterol, glucose and smoking.
Among the ocular factors, the visi-
bility of CSI was inﬂuenced by AL. CSI
was poorly distinct in eyes with shorter
AL (Fig. 3). Our results are compatible
with histologic ﬁndings that in eyes
with greater AL, the elongation of the
eyeball leads to mechanical stretch-
ing and thinning of retina (Lim et al.
2005; Lam et al. 2007). The excessive





Lower bound Upper bound
Ocular factors
Axial length (mm) 0.375 0.006 0.106 0.645
Spherical equivalent (D) 0.143 0.054 2.88 0.003
Anterior chamber
depth (mm)
0.290 0.383 0.942 0.362
Central corneal
thickness (lm)
0.004 0.229 0.003 0.011
Corneal curvature (mm) 0.104 0.197 0.054 0.262
Intraocular
pressure (mmHg)
0.021 0.605 0.059 0.101
LOCS III nuclear
cataract (no versus yes)
0.683 0.056 1.382 0.017
LOCS III cortical
(no versus yes)
0.011 0.966 0.487 0.509
LOCS III PSC
(no versus yes)
0.546 0.261 0.406 1.498
Retinal thickness (lm) 0.034 <0.001 0.052 0.016
Subfoveal choroidal
thickness (lm)
0.003 0.012 0.006 0.001
OCT signal strength 0.022 0.352 0.024 0.068
Systemic factors
Age (years) 0.048 0.003 0.016 0.080
Diabetes mellitus
(yes versus no)
0.524 0.033 1.006 0.042
Bolded font indicates statistical signiﬁcance.





Lower bound Upper bound
Axial length (mm) 0.465 0.003 0.160 0.771
LOCS III nuclear cataract
(no versus yes)
0.104 0.795 0.891 0.683
Age (years) 0.045 0.030 0.004 0.086
Retinal thickness (lm) 0.030 0.004 0.050 0.009
Subfoveal choroidal
thickness (lm)
0.002 0.278 0.005 0.001
Gender (male versus female) 0.218 0.413 0.304 0.740
Diabetes mellitus
(yes versus no)
0.746 0.004 1.256 0.236
Bolded font indicates statistical signiﬁcance.
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elongation aﬀects not only the retina
but also the choroid and Bruch mem-
brane. There is found to be choroidal
thinning in eyes with high myopia (T.
Fujiwara et al. 2009; Ikuno et al. 2010;
Ikuno & Tano 2009; Margolis & Spa-
ide 2009) due to signiﬁcant thinning of
the choriocapillaris and focal lack of
vessels (Okabe et al. 1982; Grossnikl-
aus & Green 1992; Hirata & Negi
1998). The sclera is also weaker in
myopes with a correlation between
high myopes and scleral thinning found
in human eyes (Avetisov et al. 1983).
The choroid adheres to the sclera
because of the ﬁxed position of the
blood vessels passing through the
sclera, and it is likely that the choroid
is stretched in myopic eyes (Wildsoet
1998). This allows more penetration of
light into the deep choroid giving
greater resolution and potentially bet-
ter speciﬁcation of the posterior cho-
roidal border. In addition, myopic
subjects usually have less pigmented
RPE which facilitates detection of the
scleral interface.
An important factor in standardiz-
ing choroidal thickness measurements
is the deﬁnition of the choroid–scleral
junction. While most EDI-OCT stud-
ies, including the landmark Spaide
et al. study, deﬁne the choroidal–
scleral junction as the inner border of
the sclera, a recent study by Yiu et al.
(2014) reported the presence of a hyp-
oreﬂective band likely corresponding to
the suprachoroidal layer (SCL). How-
ever, it is often diﬃcult to visualize
SCL, and in Yiu et al. study, SCL was
visible in only 45% of their healthy
Caucasian subjects. In contrast, in our
cohort of healthy Asian subjects, we
could not appreciate the presence of
SCL, and therefore, like majority of
other EDI-OCT studies on choroidal
thickness assessment, we considered
inner border of the sclera as posterior
boundary of the choroid. A probable
reason for invisible SCL in our subjects
of Asian descent is the presence of
greater pigmentation in Asian eyes
compared to Caucasians, thereby
aﬀecting the visibility of SCL.
The strengths of this study include its
unselected population-based sample,
standardized assessment of systemic
and ocular factors, and laboratory
investigations. Our study had some
limitations. Although the location of
the CSI on Spectralis images was deter-
mined qualitatively as the junction
between posterior choroid and sclera,
there was no reference standard to
conﬁrm where this structure is actually
located in the eye. The study population
only consisted of subjects of Malay
ethnicity, and the ﬁndings may vary in
other racial groups. Further studies in
other ethnic populations are thus war-
ranted. Although we performed a 7-line
scan, only the horizontal section passing
(A)
(B)
Fig. 2. Comparison of CSI visibility between EDI-OCT scans in two subjects of diﬀerent ages. (A)
A 46-year-old male with poorly demarcated CSI (subfoveal choroidal thickness of 326 lm). (B) A
83-year-old man with CSI distinctly visible (subfoveal choroidal thickness of 163 lm).
(A)
(B)
Fig. 3. Comparison of CSI visibility between EDI-OCT scans in two subjects according to
refractive status. (A) A 46-year-old male with no refractive error (AL = 23.41) and a poorly
demarcated CSI (subfoveal choroidal thickness of 275 lm). (B) A 46-year-old male with myopia
(AL = 29.57) with a well-deﬁned CSI (subfoveal choroidal thickness of 165 lm).
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through the centre of the fovea was used
to evaluate the CSI. It is ideal to assess
intrasession repeatability. However, in
this study, we did not assess intrasession
repeatability, the CSI visibility. Know-
ing that subject pigmentation might
inﬂuence signal penetration thus aﬀect-
ing the visibility of CSI, it was not
considered in our study. However, all
our subjects were of Malay ethnicity
having more or less similar pigmenta-
tion; therefore, there should be no
impact of pigmentation on our results.
Visualization of the choroidal scleral
boundary may vary across diﬀerent
OCT modalities. However, this study
only described the visibility of CSI using
the Spectralis OCT. Lastly, even though
we have explored series of ocular and
systemic factors aﬀecting CSI, reﬂectiv-
ity of the choroid might have inﬂuenced
the visibility of CSI.
Conclusions
In summary, we found that only 60%
of our images had well-delineated CSI
and the variability in the measurement
of choroidal thickness was higher in the
images with poorly deﬁned CSI. The
factors associated with poorer CSI
visibility are younger age, shorter AL,
thicker retinal thickness and diabetes.
The CSI visibility is critical for accu-
rate determination of choroidal thick-
ness which can help clinicians evaluate
chorioretinal disorders such as age-
related macular degeneration, central
serous chorioretinopathy as well as
monitoring the eﬀect of therapeutic
interventions.
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Thickness and Volume Using Automated
Segmentation Software in a Population-Based
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ECOSSE L. LAMOUREUX, TIEN YIN WONG, CHUI MING GEMMY CHEUNG, AND CHING-YU CHENG PURPOSE: To objectively quantify choroidal thickness
and choroidal volume using fully automated choroidal
segmentation software applied to images obtained from
enhanced depth imaging spectral-domain optical coher-
ence tomography (EDI SD OCT) in a population-based
study; and evaluate the ocular and systemic determinants
of choroidal thickness and choroidal volume.
 DESIGN: Prospective cross-sectional study.
 METHODS: Participants ranging in age from 45 to 85
years were recruited from the Singapore Malay Eye
Study-2 (SiMES-2), a follow-up population-based study.
All participants (n [ 540) underwent a detailed
ophthalmic examination, including EDI SD OCT for
measurements of thickness and volume of the choroid.
 RESULTS: The intrasession repeatability of choroidal
thickness at 5 measured horizontal locations and macular
choroidal volume using automated choroidal segmenta-
tion software was excellent (intraclass correlation coeffi-
cient, 0.97-0.99). Choroid was significantly thicker
under the fovea (242.28 ± 97.58 mm), followed by
3 mm temporal (207.65 ± 80.98 mm), and was thinnest
at 3 mm nasal (142.44 ± 79.19 mm) location. The
mean choroidal volume at central macular region (within
a circle of 1mm diameter) was 0.185 ± 0.69mm3. Among
the range of ocular and systemic factors studied, age, sex,
and axial length were the only significant predictors of
choroidal thickness and choroidal volume (all P< .05).
 CONCLUSIONS: Using a new automated choroidal seg-
mentation software,we provide fast, reliable, and objectiveupplemental Material available at AJO.com.
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 2015 BY ELSEVIER INC.measurements of choroidal thickness and volume in a
population-based sample. Male sex, younger age, and
shorter axial length are the factors independently associ-
ated with thicker choroid and larger choroidal volume.
These factors should be taken into consideration when
interpretingEDISDOCT–based choroidal thicknessmea-
surements in clinics. (Am J Ophthalmol 2015;159:
293–301.  2015 by Elsevier Inc. All rights reserved.)
T
HE CHOROID CONTRIBUTES BLOOD SUPPLY TO THE
outer retina1 and is therefore associated with the
pathogenesis of major diseases of the posterior
segment of the eye.2–10 Until recently, the choroid was
imaged by invasive techniques with limited image
resolution.11,12 Although the use of enhanced depth
imaging (EDI) in spectral-domain optical coherence to-
mography (SD OCT) is noninvasive and has now allowed
visualization of the choroidal structure in detail,13 the quan-
tification of choroidal thickness for evaluating chorioretinal
diseases is mostly performed manually and often at 1 or few
points around the foveal center.2,4,9,10,14–16
Owing to unavailability of automated choroidal segmen-
tation software, previous investigators have used a manual
(mostly single-point) measurement technique using built-
in calipers to evaluate choroidal thickness.17–20 However,
measurements of a few sampling points are influenced
by focal thickening or thinning of the choroid,21,22 or by
irregularity of the inner chorioscleral border,2,10 and thus
are highly dependent on location of measurements. In
addition, manual methods are further subject to intra- and
interobserver variation. Given the high anatomic
variability of choroid, these are impractical for clinical use
and epidemiologic research involving large samples, which
makes the measurements tedious and time consuming.
Thus, an objective and comprehensive assessment of the
choroid, such as choroidal thickness maps and volumetric
analysis, is required but is still unavailable.
A few studies23–26 have calculated choroidal volume
using the built-in software. However, the segmentation of
the choroid-scleral interface (CSI) is still done manually.
For EDI SD OCT to become a clinically practical tool to
determine choroidal thickness, an automatic and accurate
measurement algorithm must be developed.293ALL RIGHTS RESERVED.
This study used new, fully automated choroidal segmen-
tation software to objectively quantify choroidal thickness
and choroidal volume in the macular area, acquired using
EDI SD OCT in a population-based setting. We aimed to
obtain accurate distribution of choroidal thickness and
choroidal volume and to determine their associations
with ocular and systemic determinants at the macula. In
addition, we also assessed the intrasession repeatability of
both choroidal thickness and choroidal volume measures.
SUBJECTS AND METHODS
 STUDYPOPULATION: Data for this analysis were derived
from the Singapore Malay Eye Study-2 (SiMES-2), a
comprehensive, detailed population-based cohort study of
3280 Singaporean Malay adults aged 45-85 years. Details
of the baseline study design, sampling plan, and methodol-
ogy (SiMES-1 2004-2006) have been reported elsewhere.27
The follow-up examination, SiMES-2, started from 2011
and is ongoing.28 For this analysis, we enrolled consecutive
participants of the SiMES-2 from February 2012 to April
2013. Participants recruited in SiMES-2 underwent stan-
dardized and detailed ophthalmic examination, including
Spectralis EDI SD OCT. Ethics approval was obtained
from the institutional review board (IRB) of the Singapore
Eye Research Institute, and the IRB approved a protocol for
the prospective study. The study was conducted in accor-
dance with the World Medical Association’s Declaration
of Helsinki. Written informed consent was obtained from
all subjects.
 ENHANCED DEPTH IMAGING OPTICAL COHERENCE
TOMOGRAPHY IMAGE ACQUISITION PROTOCOL:
Choroidal thickness was obtained using SDOCT (Spectra-
lis; Heidelberg Engineering, Heidelberg, Germany) with
EDI modality after pupil dilation using tropicamide 1%
and phenylephrine hydrochloride 2.5%. A 7-horizontal-
line scan (30 3 5 degrees) centered on the fovea was
performed, with 100 frames averaged in each B-scan.
Each scan was 8.9 mm in length and spaced 240 mm apart
from each other.
All OCT scans were acquired by a single examiner
(P.G.), who is experienced at performing scans using
EDI-Spectralis. After each capture, each of 7 B-scans was
scrutinized manually in each eye by the same examiner
(P.G.), and images that had motion artifacts (n ¼ 14) or
were poorly focused (n¼ 26) were excluded from the anal-
ysis. Measurements of both eyes of each study participant
were obtained. However, because of intereye correlation is-
sues, only the right eye was used for this analysis.
 MEASUREMENTS OF CHOROIDAL THICKNESS AND
VOLUME: Following Spectralis user manual guidelines,
subjects’ keratometry readings and the most recent refrac-
tion were entered into the software program to estimate294 AMERICAN JOURNAL OFoptical magnification and, therefore, to allow for more
accurate comparisons across individuals. The choroidal
thickness at each location was defined as the distance
between the Bruch membrane (lower boundary of retinal
pigment epithelium [RPE]) and the CSI. In our study,
Bruch membrane and CSI were delineated with the auto-
matic segmentation algorithm developed by Tian and asso-
ciates.29 The authors evaluated the accuracy of their
algorithm with the ground truth (manual measurement of
choroidal thickness) and demonstrated good consistency
between the manual labelings and their algorithm (the
average of the Dice coefficients over 45 tested images was
90.5% with standard deviation of 3%).29
In our study, from the 7-horizontal-line scan, the line
passing through the fovea was selected by an experienced
examiner and the center of the fovea was detected as the
lowest point of internal limiting membrane automatically.
The choroidal thickness profile at the fovea and at 500-
mm intervals up to 3 mm temporal and nasal to the fovea
in horizontal section (Supplemental Figure; available at
AJO.com) was then automatically measured and created.
Figure 1 shows an example of an EDI SD OCT scan of the
macula with the automated segmentation lines. Further-
more, the choroidal volume of the 7-line scan (8.9 mm 3
1.5 mm) of the region {(x,y)j 3 mm < x < 3 mm,
720 mm < y < 720 mm} was calculated with the automati-
cally detected fovea as the center of origin, (0,0), and the
measurement points between lines were measured with
linear interpolation as illustrated in Figure 2. In addition,
choroidal volume in a 1-mm-diameter circle at the fovea
and thickness maps were obtained for all subjects.
 ASSESSMENT OF REPEATABILITY OF AUTOMATED
MEASUREMENTS: To access the intrasession repeatability
using EDI SDOCT and automated choroidal segmentation
software, images from the same eye of 20 subjects were
obtained twice at an interval of 10 minutes. Two images
from the same eyes were each measured by segmentation
software to assess the repeatability of choroidal thickness
and choroidal volume measurements.
 MEASUREMENT OF OCULAR FACTORS: All participants
underwent a standardized examination procedure. The
refraction of each eye was measured using an autorefractor
(Canon RK 5 Auto Ref-Keratometer; Canon Inc Ltd,
Tochigiken, Japan). Spherical equivalent (SE) was calcu-
lated as the sum of the spherical power and half of the cyl-
inder power. Best-corrected visual acuity (BCVA) was
measured monocularly using a logarithm of the minimal
angle of resolution (logMAR) chart (Lighthouse Interna-
tional, New York, New York, USA) at a distance of 4 m.
Biometry measurements (ie, axial length [AL], corneal cur-
vature, and anterior chamber depth [ACD]) were measured
with noncontact partial coherence laser interferometry
(IOL Master V3.01; Carl Zeiss Meditec AG, Jena, Ger-
many) and the mean of 5 measurements was used in theFEBRUARY 2015OPHTHALMOLOGY
FIGURE 1. Enhanced depth imaging optical coherence tomography image in the macular region demonstrating automated segmen-
tation of the Bruch membrane and the choroidal-scleral interface. The choroidal thickness was measured in the fovea (detected as the
lowest points of internal limiting membrane automatically) and at 500-mm intervals up to 3 mm temporal and nasal to the fovea in
horizontal section.
FIGURE2. An illustration of the color-coded choroidal volumemap obtained from the 7-line scans covering an area of 8.93 1.5mm.
The choroidal volume is expressed in millimeters cubed (mm3), with the warm and the cool colors representing thicker and thinner
choroidal volume, respectively. X and Y presents the transverse (from nasal to temporal) and interframe (from superior to inferior)
directions, respectively.
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TABLE 1. Demographic, Ocular, and Systemic
Characteristics of the 540 Study Participants in the
Singapore Malay Eye Study for Evaluation of Choroidal
Thickness and Volume Using Automated Segmentation
Software
Characteristic Value (N ¼ 540 Subjects)
Age (y) 62.70 (8.91)
Sex, male 251 (46.5)
Axial length, mm 23.59 (0.96)
Anterior chamber depth, mm 3.17 (0.34)
Corneal curvature, mm 7.66 (0.24)
Spherical equivalent, D 0.11 (1.74)
Best-corrected visual acuity, logMAR 0.16 (0.20)
Central corneal thickness, mm 541.76 (35.15)
Intraocular pressure, mm Hg 14.49 (3.10)
Ocular perfusion pressure, mm Hg 55.55 (8.19)
Systolic blood pressure, mm Hg 139.56 (19.68)
Diastolic blood pressure mm Hg 76.90 (10.66)
Mean arterial pressure, mm Hg 97.78 (12.37)
Body mass index, kg/m2 26.87 (5.07)
Serum glucose, mmol/L 7.22 (3.52)
HbA1c, % 6.35 (1.43)
Total cholesterol, mmol/L 5.36 (1.29)
Triglycerides, mmol/L 1.92 (1.30)
Blood creatinine, mmol/L 83.23 (41.23)
Current smoking, % 98 (18.1)
Diabetes mellitus, % 143 (26.5)
Arterial hypertension, % 323 (59.8)
Alcohol consumption, % 7 (1.3)
D ¼ diopter.
Data are mean (SD), except for sex, HbA1c, current smoking,
diabetes, arterial hypertension, and alcohol consumption which
are expressed as number (%).
TABLE 2. Assessment of Intrasession Repeatability of
Choroidal Thickness (at Various Horizontal Locations) and











Subfoveal 0.996 (0.992-0.998) 0.4 (21.5 to 20.7)
Nasal, 1.5 mm 0.992 (0.981-0.997) 2.1 (29.1 to 24.9)
Nasal, 3 mm 0.996 (0.991-0.998) 1.6 (15.6 to 18.8)
Temporal, 1.5 mm 0.995 (0.989-0.998) 0.1 (26.2 to 26.4)





0.999 (0.997-0.999) 0.0 (0.08 to 0.09)
aMean difference was determined from the first measurement
minus second measurement.
TABLE 3. Distribution of Mean Choroidal Thickness (at
Various Locations on the Horizontal Axis) and Volume
Measurements Using Automated Segmentation Software
(N ¼ 540 Subjects)
Location of Measurements Mean (SD)
Choroidal thickness in mm
Subfoveal 242.28 (97.58)
Nasal, 0.5 mm 237.11 (97.72)
Nasal, 1 mm 226.68 (98.10)
Nasal, 1.5 mm 208.35 (98.20)
Nasal, 2 mm 187.29 (94.21)
Nasal, 2.5 mm 166.02 (89.72)
Nasal, 3 mm 142.44 (79.19)
Temporal, 0.5 mm 241.93 (96.58)
Temporal, 1 mm 239.39 (92.83)
Temporal, 1.5 mm 232.17 (89.42)
Temporal, 2 mm 221.31 (84.12)
Temporal, 2.5 mm 216.19 (81.93)
Temporal, 3 mm 207.65 (80.98)
Choroidal volume in mm3
Choroidal volume of 7-line scan (8.93 1.5mm) 1.889 (0.693)
Choroidal volume at central macula (within
1-mm-diameter circle)
0.185 (0.071)analysis. Intraocular pressure (IOP) was measured using
Goldmann applanation tonometry (Haag-Streit, Bern,
Switzerland) before pupil dilation. Central corneal thick-
ness (CCT) was measured with an ultrasound pachymeter
(Advent; Mentor O & O, Norwell, Massachusetts, USA)
and the mean of 5 measurements was used in the analysis.
 ASSESSMENT OF DEMOGRAPHIC, LIFESTYLE, AND
SYSTEMIC FACTORS: All study participants underwent a
detailed interview using standardized questionnaires. Infor-
mation on demographic status, lifestyle risk factors (eg,
smoking, alcohol consumption), medication use, and self-
reported history of systemic diseases such as arterial hyper-
tension and diabetes mellitus were collected. Systolic and
diastolic blood pressures (BP) were measured using a digital
automatic blood pressure monitor (Dinamap model Pro
Series DP110X-RW, 100V2; GEMedical Systems Informa-
tion Technologies, Inc, Milwaukee, Wisconsin, USA),
after subjects were seated for at least 5 minutes with legs
uncrossed. A total of 3 measurements were taken, and
the average of the 2 closest BP readings was taken as296 AMERICAN JOURNAL OFeach participant’s BP. Mean ocular perfusion pressure
(OPP) was calculated using the following equation: mean
OPP ¼ (2/3 3 MAP – IOP), where MAP (mean arterial
pressure) ¼ diastolic BP þ (1/3 3 [systolic BP – diastolic
BP]). Systolic and diastolic OPP were calculated using
the following equations: systolic OPP ¼ systolic BP – IOP
and diastolic OPP ¼ diastolic BP –IOP, respectively.
Body mass index (BMI) was calculated as body weight (in
kilograms) divided by body height (in meters) squared.
Smoking status was defined as those currently smoking,FEBRUARY 2015OPHTHALMOLOGY
FIGURE 3. Graph showing the distribution of mean choroidal thickness in micrometers (mm) at each of the studied locations in 500-
mm (0.5 mm) intervals, up to 3 mm nasal and temporal to the fovea. The numbers on the x-axis are locations in mm from the fovea.
SF[ subfoveal; N[ nasal; T[ temporal. The choroid was thickest at the subfoveal region, followed by temporal, and was thinnest
at the nasal location.ex-smokers, and nonsmokers. Nonfasting venous blood
samples were analyzed at the National University Hospital
Reference Laboratory for biochemical testing of serum total
cholesterol, high-density lipoprotein (HDL) cholesterol,
low-density lipoprotein (LDL) cholesterol, triglycerides,
glycosylated hemoglobin (HbA1c), glucose, and creatinine.
 STATISTICAL ANALYSIS: Statistical analysis was perfor-
med using MedCalc version 12.3 (Medcalc Software,
Ostend, Belgium) and SPSS version 20.0 (SPSS, Inc,
Chicago, Illinois, USA). Univariate and multiple linear
regression analyses were performed to determine the associa-
tions of subfoveal choroidal thickness and choroidal volume
(dependent variables)with ocular and systemic factors (inde-
pendent variables). For multiple linear regression, factors
showing suggestively significant association in univariate
analysis (P< .10) were included. Eyes with other ocular dis-
eases, such as refractive errors, cataract, glaucoma, and reti-
nopathy, were not excluded if the quality of OCT image
was sufficient to be evaluated, as we aimed to determine
the choroidal thickness distribution in a general population
sample. In the assessment of associations with ocular and sys-
temic factors, we included glaucoma status, diabetic retinop-
athy, and age-related macular degeneration in the regression
models to adjust for potential confounding.
The intrasession repeatability of the choroidal thickness
and choroidal volume were measured by the absoluteVOL. 159, NO. 2 CHOROIDAL THICKNESS AND VOLUMagreement model of the intraclass correlation coefficient
(ICC).30 An ICC value of 0.81-1.00 indicates good agree-
ment. Values of less than 0.40 indicate poor to fair agree-
ment. We also performed Bland-Altman plot analyses31,32
to see the mean difference between the repeated
measurements. AllP values were 2-sided and considered sta-
tistically significant when the values were less than .05; 95%
confidence intervals (CIs) were presented.RESULTS
A TOTAL OF 540 EYES FROM 540 CONSECUTIVE SUBJECTS (251
men and 289 women) with amean (SD) age of 62.70 (8.91)
years were included in the study. In none of the images did
the automated software fail to detect the RPE and
choroidal borders; therefore, no eyes were excluded from
the analysis. The demographics and ocular and systemic
characteristics of the study population are shown in
Table 1.
Table 2 shows the intrasession repeatability of measure-
ments of choroidal thickness and choroidal volume using
automated choroidal segmentation software. Repeatability
of choroidal thickness at 5 measured horizontal locations
and macular choroidal volume was excellent (ICC ranging
from 0.97 to 0.99).297E IN POPULATION-BASED STUDY
TABLE 4. Univariate and Multivariate Analysis of the Association of Ocular and Systemic Factors With Subfoveal Choroidal Thickness
Measured Using Automated Segmentation Software (N ¼ 540 Subjects)








Beta Coefficient P Valueb
Ocular factors
Spherical equivalent, D 10.773 0.192 <.001 - - -
Axial length, mm 19.638 0.197 <.001 32.111 0.317 <.001b
Corneal curvature, mm 33.037 0.084 .063 20.160 0.051 .303
Anterior chamber depth, mm 0.870 0.003 .944 - - -
Central corneal thickness, mm 0.164 0.059 .170 - - -
Intraocular pressure, mm Hg 0.473 0.015 .727 - - -
Ocular perfusion pressure, mm Hg 0.269 0.023 .600 - - -
Systemic factors
Age, y 3.104 0.284 <.001 4.139 0.366 <.001b
Sex (female vs male) 19.432 0.099 .021 30.869 0.158 .001b
Mean arterial pressure, mmHg 0.172 0.022 .612 - - -
Body mass index, kg/m2 1.233 0.064 .137 - - -
Serum glucose, mmol/L 0.556 0.020 .651 - - -
HbA1c, % 3.230 0.047 .279 - - -
Total cholesterol, mmol/L 9.110 0.121 .005 4.495 0.060 .163
Triglycerides, mmol/L 7.209 0.096 .027 4.180 0.057 .185
Blood creatinine, mmol/L 0.035 0.015 .734 - - -
Current smoking, (yes vs no) 36.601 0.145 .001 1.028 0.004 .930
Diabetes mellitus, (yes vs no) 1.472 0.007 .878 - - -
Arterial hypertension, (yes vs no) 21.077 0.106 .014 3.723 0.019 .678
Alcohol consumption, (yes vs no) 34.549 0.040 .353 - - -
D ¼ diopter.
aAdjusted for glaucoma status, diabetic retinopathy, and age-related macular degeneration.
bThe values indicate statistically significant results.Table 3 shows the mean choroidal thickness and
choroidal volume. Choroidal thickness was measured at
13 different locations on the horizontal axis (Figure 3).
Choroid was thickest at the subfovea (242.28 6
97.58 mm), followed by temporal, and thinnest at the
3 mm nasal (142.44 6 79.19 mm) location (which is the
last point measured using the software). The mean macular
(1 mm diameter) and 7-line-scan choroidal volume were
0.185 6 0.071 mm3 and 1.889 6 0.69 mm3, respectively.
In the univariate analysis (Table 4), among the ocular fac-
tors only SE and AL showed significant association with
subfoveal choroidal thickness (both P < .001). For each
1-mm increase in AL, subfoveal choroidal thickness on
average decreased by 19.63 mm (P < .001). A decrease in
mean choroidal thickness by 10.77 mm was observed for
each myopic diopter increase (P < .001). Among the sys-
temic factors, younger age, male sex, higher serum choles-
terol or triglyceride levels, current smoking, and lack of
arterial hypertension were found to be significantly associ-
atedwith thicker subfoveal choroidal thickness (allP< .05).
Because of collinearity between AL and SE (correlation
coefficient ¼ 0.584), only AL was selected and retained
in the multivariate analysis, as it had a greater explanatory298 AMERICAN JOURNAL OFpower on subfoveal choroidal thickness change than did SE
(standardized b, 0.197 vs 0.192). In the multiple linear
regression model (Table 4) including all significant factors,
only shorter AL (P < .001), younger age (P < .001), and
male sex (P ¼ .001) remained significantly associated
with thicker subfoveal choroidal thickness.
Similarly, in the analysis of the association of choroidal
volume at central macula (1 mm diameter) with ocular and
systemic factors (Table 5), only shorter AL, younger age,
and male sex showed significant association with larger
central choroidal volume (all P < .001). Similar factors
were associated with greater choroidal volume of 7-line
scan (data not shown).DISCUSSION
ALTHOUGH SPECTRALIS OCTWITH EDI ALLOWS VISUALIZA-
tion of the choroidal structure in detail, the measurement
of choroidal thickness is still performed manually. To
date, none of the previous clinical studies used automated
measurements of thickness and volume of choroid, as inFEBRUARY 2015OPHTHALMOLOGY
TABLE 5. Univariate and Multivariate Analysis of the Association of Ocular and Systemic Factors With Choroidal Volume at Central
Macula Measured Using Automated Segmentation Software (N ¼ 540 Subjects)








Beta Coefficient P Valueb
Ocular factors
Spherical equivalent, D 0.009 0.207 <.001 - - -
Axial length, mm 0.014 0.189 <.001 0.021 0.280 <.001b
Corneal curvature, mm 0.014 0.049 .274 - - -
Anterior chamber depth, mm 0.003 0.013 .777 - - -
Central corneal thickness, per 10 mm 0.000 0.065 .135 - - -
Intraocular pressure, per 10 mm Hg 0.0007 0.003 .942 - - -
Ocular perfusion pressure, per 10 mm Hg 0.001 0.011 .795 - - -
Systemic factors
Age, y 0.003 0.320 <.001 0.003 0.396 <.001b
Sex, (female vs male) 0.016 0.109 .011 0.023 0.159 <.001b
Mean arterial pressure, per 10 mm Hg 0.0004 0.006 .886 - - -
Body mass index, kg/m2 0.001 0.058 .177 - - -
Serum glucose, mmol/L 0.000 0.007 .880 - - -
HbA1c, % 0.003 0.053 .227 - - -
Total cholesterol, mmol/L 0.007 0.131 .002 0.003 0.057 .175
Triglycerides, mmol/L 0.006 0.115 .008 0.003 0.065 .122
Blood creatinine, mmol/L 0.000 0.035 .420 - - -
Current smoking, (yes vs no) 0.033 0.175 <.001 0.006 0.032 .475
Diabetes mellitus, (yes vs no) 0.000 0.000 .996 - - -
Arterial hypertension, (yes vs no) 0.017 0.116 .007 0.001 0.007 .874
Alcohol consumption, (yes vs no) 0.018 0.029 .508 - - -
D ¼ diopter.
aAdjusted for glaucoma status, diabetic retinopathy, and age-related macular degeneration.
bThe values indicate statistically significant results.all of these studies demarcation of CSI, a principal land-
mark for accurate measurement of the choroid, was
performed manually. To our best knowledge, this is the first
study to use Spectralis OCT with EDI with a fully auto-
mated choroidal segmentation software to measure
choroidal thickness and choroidal volume in subjects
from a population-based study. Our fast (processing time
w1 second) and accurate algorithm has great potential us-
age in both clinical and population-based studies and may
improve the diagnosis and management of patients with
eye diseases in which the choroid is affected. We found
the choroid to be significantly thicker under the fovea,
followed by the temporal location, and thinnest at the
nasal location. Among the range of ocular and systemic fac-
tors studied, age, sex, and AL were the only significant pre-
dictors of choroidal thickness and choroidal volume
measurements.
Although previous studies have reported thickness and
volume of the choroid using SD OCT23,24,26,33 and Swept
Source OCT,25 their measurements were performed manu-
ally by displacing the built-in reference line of the retinal
boundary to the CSI, making it not only time consuming
but also prone to measurement errors. For example, in aVOL. 159, NO. 2 CHOROIDAL THICKNESS AND VOLUMstudy by Shin and associates,26 choroidal volume measure-
ments tookw2.8 minutes per image for 6-radial B-scan26 vs
1.25 seconds per image for 7-line scan in our study.29 These
limitations compromised the validity of existing studies.
On top of this, such time-consuming manual methods
make the measurements impractical for both large-scale
clinical and epidemiologic studies. We have recently suc-
cessfully designed an algorithm that can consistently mea-
sure choroidal thickness and volume automatically.29 In
this study, we further extend our experience using this auto-
mated program in a large population.
We reported automated choroidal volume at the central
macula (within 1 mm diameter) of 0.185 6 0.071 mm3.
Although previous clinic-based, small-scale studies have
reported choroidal volume, they used a manual choroidal
segmentation approach. For example, Hirata and associ-
ates25 in 31 healthy Japanese (mean age 64.6 years) and
Chhablani and associates24 in 60 eyes of 32 subjects
(mean age 44 years) reported choroidal volume of the cen-
ter 1-mm-diameter ETDRS ring to be 159 6 0.066 mm3
and 0.28-0.29 mm3, respectively. In addition to the central
macula, we also reported choroidal volume of 7-line scan
(8.9 3 1.5 mm) centered on the fovea of 1.889 6299E IN POPULATION-BASED STUDY
0.693 mm3. Our measurements of choroidal volume were
limited to the posterior pole and not over the entire retinal
area, but were in the region of clinically significant changes
in most of the posterior segment diseases.
Our results have confirmed the asymmetric distribution
of macular choroidal thickness. The mean choroidal thick-
ness measurements showed regional differences, being
thickest subfoveally, followed by temporally, and thinnest
at the nasal location. These observations are similar to
the results of previous EDI-OCT studies in normal eyes,
which have shown highest choroidal thickness at the fovea,
decreasing gradually on both temporal and nasal sides, but
more so nasally.13,18,34 The loss of choroidal tissue in the
nasal location could be a contributing cause for the
development of peripapillary atrophy and may play a role
in glaucoma, as previously speculated by Spaide and
associates.13
Among the ocular factors, the choroid was thicker and
choroidal volume was greater in eyes with shorter AL. Our
results are in concordance with histologic findings that in
eyes with greater AL, the elongation of the eyeball leads to
mechanical stretching and thinning of the retina35,36 and
choroid. Choroidal thinning was observed in eyes with
myopic refraction4,8,18,37 owing to significant thinning of
the choriocapillaris and focal lack of vessels.38–40
We acknowledge limitations to our study. Although the
location of the CSI on Spectralis images was determined
qualitatively as the junction between posterior choroid
and sclera, there was no reference standard to confirmwhere300 AMERICAN JOURNAL OFthis structure is actually located in the eye. Measurement of
choroidal thickness and choroidal volume was performed
only in the right eye of each study subject. There may exist
intereye differences, yet such differences should be small.
We have not analyzed the influence of lens opacity, which
was shown to affect the delineation of CSI and the thick-
ness measurements,41 on the measurements in this study.
Our subjects were examined only at a single time point,
and thus we are not able to take the diurnal variation of
choroidal thickness into account. As in any population-
based study, our investigation included all eligible and
participating subjects from the study. Some of them have
eye diseases that may have changed choroidal thickness.
Therefore, the distribution of choroidal thickness deter-
mined in this study may represent the choroidal thickness
not in healthy eyes but in eyes of the general adult and
elderly populations.
In conclusion, we objectively demonstrate a mean subfo-
veal choroidal thickness of 242.28 6 97.58 mm and a
choroidal volume at central macula of 0.185 6 0.69 mm3
in ethnic Malay adults. Male sex, younger age and shorter
AL are the factors that were independently associated
with thicker choroid and greater volume measures. Our
fully automated choroidal segmentation software allows
highly reliable and accurate measurements of choroidal
thickness and choroidal volume, which are essential in
distinguishing clinically significant changes in the choroid
and assisting in risk profiling for various chorioretinal dis-
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Aims To objectively quantify the thickness of
peripapillary choroid using spectral-domain optical
coherence tomography (SD-OCT) with enhanced depth
imaging (EDI) followed by a novel automated choroidal
segmentation software in Asian eyes and to evaluate its
systemic and ocular determinants.
Methods We recruited 520 subjects (1040 eyes) from
the Singapore Malay Eye Study, a cross-sectional
population-based study. Subjects underwent
standardised detailed ophthalmic examination including
SD-OCT (Spectralis) with EDI for measurement of
peripapillary choroidal thickness (PPCT).
Results The mean age of the subjects was 66.7
±10.4 years (range 47–88 years) and the mean spherical
equivalent was −0.01±2.28 D (range −18.50 to
+7.00 D). The intra-session repeatability of PPCT
measurements at four quadrants using automated
choroidal segmentation software was excellent (intraclass
correlation coefﬁcient 0.9998–0.9999). The overall mean
PPCT was 136.2±56.8 mm. Peripapillary choroid showed
geographical differences among the four quadrants,
being thickest in the superior quadrant (150.5
±59.6 mm), followed by the nasal (143.5±58.4 mm)
and temporal quadrants (139.4±68.9 mm), and thinnest
in the inferior quadrant (111.3±51.7 mm). Among the
range of ocular and systemic factors studied, shorter
axial length (p=0.002), younger age (p=0.018), lower
triglyceride level (p=0.015) and the presence of diabetes
(p=0.036) were the only signiﬁcant predictors of thicker
peripapillary choroid.
Conclusions Using novel automated choroidal
segmentation software, we provide reliable objective
measurements of PPCT in a population-based setting.
Shorter axial length, younger age, lower triglyceride
levels and the presence of diabetes are the factors
independently associated with thicker PPCT. These
factors should be taken into consideration when
interpreting Spectralis EDI SD-OCT-based PPCT
measurements in clinics.
INTRODUCTION
The choroid supplies blood to the outer retina1
and also to the anterior optic nerve head
(ONH).2 3 Although the circulation of the poster-
ior ciliary artery is the main source of blood supply
to the ONH, the prelaminar region of the ONH is
mainly nourished by the peripapillary choroid.3–5
Using spectral domain optical coherence tomog-
raphy (SD-OCT), studies have shown that the
peripapillary choroid is altered in eyes with glau-
coma6–8 and high myopia.9 Glaucoma eyes were
found to have a thinner peripapillary choroid,6–8
and an abnormal choroidal blood supply has been
suggested as one factor responsible for the occur-
rence of glaucomatous optic neuropathy in patients
with glaucoma.3 Knowledge of the distribution of
peripapillary choroidal thickness (PPCT) in the
population may therefore be useful in facilitating
the detection of abnormal changes in PPCT and
thus help in elucidating the pathophysiology of
such eye diseases.
However, to date only a few studies10–12 have
measured PPCT in normal healthy subjects using
different OCT devices, and these studies measured
PPCT manually with a relatively small sample size in
a clinic-based setting. With the limitation of manual
measurements being tedious, time consuming,
lacking objectivity and therefore having potential
intra- and inter-operator variability, regular assess-
ment of PPCTusing SD-OCT is impractical for both
clinical and large-scale quantitative studies.
This study used a novel automated choroidal seg-
mentation software to objectively quantify the
PPCTacquired using SD-OCTwith enhanced depth
imaging (EDI) in a population-based setting. We
aimed to obtain an accurate distribution of PPCT




The subjects in this study were enrolled from the
Singapore Malay Eye Study (SiMES), a population-
based cohort study of eye diseases in the Malay
population aged 40–80 years in Singapore.13 The
baseline examination was conducted between 2004
and 2006 and a follow-up examination of the
SiMES participants has been conducted since
January 2011, 6 years after the baseline examin-
ation. For this study, we consecutively recruited
540 subjects from SiMES participants who
attended the follow-up examination from February
2012 to July 2013. Subjects were excluded if their
choroidal images could not be successfully attained
due to unstable ﬁxation, opacities of the optic
media such as signiﬁcant cataract, or if the available
images were not of sufﬁcient quality (quality index
<28 dB), and those whose peripapillary atrophy
involved the OCT scanning ring. As our aim is to
determine the distribution of PPCT in a general
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population sample, any ocular disease including disorders of the
optic nerve or macula was not a reason to exclude a subject if
the quality of the OCT image was sufﬁcient to be evaluated.
Subjects underwent standardised ophthalmic examination
including Spectralis EDI SD-OCT (Heidelberg Engineering,
Heidelberg, Germany).
Peripapillary choroidal imaging
Peripapillary choroid was imaged using the EDI modality of
SD-OCT (wavelength 870 nm) after pupil dilation using tropica-
mide 1% and phenylephrine hydrochloride 2.5%. Following the
guidelines of the Spectralis user manual, the subjects’ keratome-
try readings and the most recent refraction were entered into
the software program to estimate optical magniﬁcation and,
therefore, to allow for more accurate comparisons across indivi-
duals. For measurements of PPCT, the peripapillary region was
scanned using a 360° 3.6 mm diameter circle that was centred
on the optic disc, each comprising 100 averaged scans (using
the automatic averaging and eye tracking features of the propri-
etary device).
Examinations were performed by a single experienced exam-
iner and measurements of PPCT on both eyes of the study sub-
jects were obtained and used for this analysis.
Automated measurement of PPCT
In our study, Bruch’s membrane and the choroidal–scleral inter-
face (CSI) were delineated with the automatic segmentation
algorithm recently developed by Tian et al14 (ﬁgure 1). This
algorithm demonstrated good consistency with the manual mea-
surements of choroidal thickness (mean (SD) Dice coefﬁcient
over 45 tested images was 90.5 (3)%).14
The PPCT at each location was deﬁned as the distance
between the Bruch’s membrane and the CSI. Here we deﬁne
locations in the radial scan in terms of the angle with the ﬁxed
diameter of 3.6 mm. The PPCT in the optic disc region was
automatically measured at the 12 discrete locations (30° apart)
as indicated by 12 vertical lines in ﬁgure 2. The mean PPCT
values in the temporal (T), superior (S), nasal (N) and inferior
(I) quadrants were also calculated (ﬁgure 2).
Repeatability of PPCT measurements
To assess the intra-session repeatability using EDI SD-OCT and
automated choroidal segmentation software, images from the
same eye of 30 subjects were obtained twice at an interval of
10 min. Two images from the same eyes were each measured by
segmentation software to assess the repeatability of PPCT
measurements.
Assessment of ocular factors
The refraction of each eye was measured using an autorefractor
(Canon RK 5 Auto Ref-Keratometer; Canon, Tochigiken,
Japan). The spherical equivalent was calculated as the sum of
the spherical power and half of the cylinder power. Best-cor-
rected visual acuity was measured monocularly using a loga-
rithm of the minimum angle of resolution (LogMAR) chart
(Lighthouse International, New York, USA) at a distance of 4 m.
Biometry measurements— that is, axial length (AL), corneal
curvature and anterior chamber depth—were measured with a
non-contact partial coherence laser interferometry (IOLMaster
V.3.01; Carl Zeiss Meditec, Jena, Germany) and the mean of
ﬁve measurements was used in the analysis. Intraocular pressure
(IOP) was measured using Goldmann applanation tonometry
(Haag-Streit, Bern, Switzerland) before pupil dilation. Central
corneal thickness was measured with an ultrasound pachymeter
(Advent; Mentor O & O, Norwell, Massachusetts, USA) and
the mean of ﬁve measurements was used in the analysis.
Assessment of demographic, lifestyle and systemic factors
All study participants also underwent a detailed interview using
standardised questionnaires. Information on demographic status,
lifestyle risk factors (eg, smoking, alcohol consumption), medication
use and self-reported history of systemic diseases such as arterial
hypertension and diabetes mellitus were collected. Systolic and dia-
stolic blood pressures (BPs) were measured using a digital automatic
BP monitor (Dinamap model Pro Series DP110X-RW, 100V2; GE
Medical Systems Information Technologies, Milwaukee, Wisconsin,
USA). A total of three measurements were taken, and the average of
the two closest BP readings was taken as each participant’s BP. Mean
ocular perfusion pressure (OPP) was calculated using the following
equation: mean OPP=(2/3×mean arterial pressure − IOP), where
MAP=diastolic BP + (1/3 × [systolic BP − diastolic BP]). Body
mass index (BMI) was calculated as kg/m2. Smoking status was
deﬁned as currently smokers, ex-smokers and non-smokers.
Non-fasting venous blood samples were collected for biochemical
testing of serum total cholesterol, high-density lipoprotein choles-
terol, low-density lipoprotein cholesterol, triglycerides, glycosylated
haemoglobin (HbA1c), glucose and creatinine.
Statistical analysis
Statistical analysis was performed using MedCalc V.12.3
(Medcalc Software, Ostend, Belgium) and SPSS V.20.0 (SPSS,
Chicago, Illinois, USA). Both eyes of the study subjects were
included in the analysis. Univariate and multiple linear regres-
sion analyses were used to assess the association between ocular
and systemic factors (independent variables) and average PPCT
Figure 1 Enhanced depth imaging optical coherence tomography image in the peripapillary region demonstrating automated segmentation of the
Bruch’s membrane (BM) and the choroidal–scleral interface (CSI). The peripapillary choroidal thickness at each measured location was deﬁned as the
distance between BM and the CSI.
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(dependent variable), adjusted for potential confounders such as
glaucoma status, diabetic retinopathy and age-related macular
degeneration. For multiple linear regression, age, gender and
factors showing suggestively signiﬁcant association in univariate
analysis (p<0.10) were included. Eyes with other ocular dis-
eases such as refractive errors, cataract, glaucoma and retinop-
athy were not excluded if the quality of the OCT image was
sufﬁcient to be evaluated, as we aimed to determine the PPCT
distribution in a general population sample. Generalised estimat-
ing equation, exchangeable correlation matrix, was used to
account for inter-eye correlations.
We assessed the intrasession repeatability of PPCT using the
intraclass correlation coefﬁcient (ICC).15 We also performed
Bland–Altman plot analyses16 to see the mean difference between
the repeated measurements. All p values were two-sided and con-
sidered statistically signiﬁcant when the values were <0.05.
RESULTS
Of the 1750 subjects from the SiMES-2 study, approximately a
quarter of our subjects had Spectralis OCT imaging performed.
Of the 520 subjects (1040 eyes) who had Spectralis OCT images
and were therefore recruited to this study, we further excluded
Figure 2 Illustration of automated peripapillary choroidal thickness (CHT) measured in the optic disc region. The numbers on the x-axis are
locations in clock hour sectors (30° apart). The location of the zero degree is always on the left-most point of the disc circle and the value of degree
increases in the clockwise direction. T, temporal; S, superior; N, nasal; I, inferior quadrants.
Table 1 Comparison of baseline characteristics of study subjects versus subjects excluded from the Singapore Malay Eye Study (SiMES-2)
population
Characteristics Total (n=1750) Included (n=452) Excluded (n=1298) p Value*
Age, years 63.30 (10.20) 66.76 (10.45) 62.09 (9.83) <0.001
Gender, % male 801 (45.8) 179 (39.6) 622 (47.9) 0.002
Axial length, mm 23.61 (1.11) 23.61 (1.08) 23.61 (1.12) 0.972
Anterior chamber depth, mm 3.14 (0.37) 3.11 (0.38) 3.15 (0.36) 0.064
Corneal curvature, mm 7.65 (0.25) 7.67 (0.25) 7.64 (0.25) 0.021
Spherical equivalent, D −0.122 (2.40) −0.60 (2.34) −0.143 (2.42) 0.542
Central corneal thickness, μm 540.11 (33.74) 538.37 (32.80) 540.85 (34.12) 0.196
Intraocular pressure, mm Hg 14.49 (3.15) 14.38 (3.23) 14.53 (3.12) 0.400
Ocular perfusion pressure, mm Hg 55.97 (8.14) 55.46 (9.05) 56.15 (7.79) 0.154
Systolic blood pressure, mm Hg 141.05 (20.24) 141.52 (21.52) 140.89 (19.78) 0.583
Diastolic blood pressure mm Hg 77.11 (10.58) 75.55 (11.53) 77.65 (10.17) 0.001
Mean arterial pressure, mm Hg 98.42 (12.29) 97.54 (13.49) 98.73 (11.83) 0.097
Body mass index, kg/m2 26.85 (5.20) 26.29 (5.68) 27.04 (5.01) 0.015
Serum glucose, mmol/L 7.08 (3.39) 7.19 (3.52) 7.04 (3.35) 0.399
HbA1c, % 6.32 (1.40) 6.28 (1.36) 6.33 (1.41) 0.590
Total cholesterol, mmol/L 5.36 (1.26) 5.35 (1.32) 5.37 (1.23) 0.761
Triglycerides, mmol/L 1.88 (1.22) 1.84 (1.36) 1.89 (1.17) 0.396
Blood creatinine, mmol/L 87.08 (65.98) 90.09 (59.95) 86.03 (67.92) 0.264
Current smoking, % 288 (16.5) 77 (17.0) 211 (16.3) 0.710
Diabetes mellitus, % 506 (28.9) 129 (28.5) 377 (29) 0.422
Arterial hypertension, % 1120 (64.0) 307 (67.9) 813 (62.6) 0.047
Alcohol consumption, % 15 (0.9) 5 (1.1) 10 (0.8) 0.553
Data presented are mean (SD) or n (%), as appropriate.
Ocular characteristics are presented for right eye only.
*p Value was obtained with independent sample t test for continuous variables and with χ2 tests for categorical variables.
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68 subjects because either their choroidal images were not suc-
cessfully attained (n=37), the available images were of insufﬁ-
cient quality (n=22) for a reliable determination of the PPCTor
their peripapillary atrophy involved the OCT scanning ring
(n=9), leaving 452 subjects (904 eyes) with complete data on
PPCT for analysis. In none of the images did the automated
software fail to detect the Bruch’s membrane and choroidal
borders and therefore no eyes were excluded from the analysis
because of software demarcation error.
Table 1 presents the baseline characteristics of the study sub-
jects included versus the subjects excluded from the SiMES-2
population. Compared with those SiMES-2 subjects excluded
from the analysis, the 452 study subjects tended to be older,
female, with steeper corneal curvature, lower diastolic BP and
BMI and tended to have hypertension.
Table 2 shows the proﬁle of major eye diseases among our
study cohort. A total of 351 (77.7%) participants did not have
any eye diseases; the remaining 101 (22.7%) had eye diseases
including diabetic retinopathy (8.4%), glaucoma (4.6%), high
myopia (4%) and early (4.9%) and late (0.4%) age-related
macular degeneration.
Table 3 shows the intra-session repeatability of PPCT meas-
urement using automated choroidal segmentation software. The
repeatability of PPCT at the four quadrants was excellent (ICC
0.9998–0.9999). The mean difference (95% limits of agree-
ment) for mean PPCTwas −0.16 (−1.53 to 1.20) mm.
Table 4 shows the mean PPCT measured at 12 clock hours
and four quadrants (superior, nasal, inferior and temporal). The
overall mean PPCT in our study subjects was 136.2±56.8 mm.
There were regional differences in PPCTamong clock hours and
different quadrants (ﬁgure 3A, B). Peripapillary choroid was
thickest (150.5±59.6 mm) at the superior quadrant and thinnest
(102.6±51.1 mm) at the inferior quadrant.
In the univariate linear regression analysis (table 5), AL, IOP,
triglyceride levels and diabetes showed a signiﬁcant association
with mean PPCT (all p<0.10). In the multiple linear regression
model (table 5) including age, gender and all suggestively signiﬁ-
cant factors (p<0.10) from the univariate analysis, shorter AL
(p=0.002), younger age (p<0.018), lower triglyceride levels
(p=0.015) and the presence of diabetes (p=0.036) remained
signiﬁcantly associated with thicker PPCT. The association with
IOP was no longer signiﬁcant (p=0.407). For each increase in
AL of 1 mm and increase in age of 1 year, PPCT on average
decreased by 6.59 mm (p=0.002) and 0.56 mm (p=0.018),
respectively. A decrease in mean PPCT by 4.88 mm was
observed for each mmol/L increase in triglyceride level
(p=0.015). The presence of diabetes increased the mean PPCT
by 13.73 mm (p=0.036). However, if gender and IOP were
removed from our multivariate model, the presence of diabetes
still remained signiﬁcantly associated with PPCT (regression
coefﬁcient 13.22, 95% CI 0.42 to 26.02, p=0.043). Table 6
presents the multivariate analysis results of the association of
PPCT with ocular and systemic factors by quadrant. In the
multivariate models, only younger age and shorter AL were
associated with a thicker inferior peripapillary choroid and
shorter AL, lower triglyceride level and the presence of diabetes
were associated with a thicker superior peripapillary choroid.
IOP was the only signiﬁcant factor associated with a thicker
nasal peripapillary choroid. For temporal PPCT, associated
factors were similar to those identiﬁed from overall PPCT.
DISCUSSION
To the best of our knowledge, this is the ﬁrst study to use
Spectralis OCT with EDI with an automated choroidal
segmentation software to measure PPCT in subjects from a
population-based study. We found the peripapillary choroid to
be signiﬁcantly thicker in the superior quadrant and thinnest at
Table 3 Intra-session repeatability of peripapillary choroidal








Inferior quadrant 0.99 (0.99 to 0.99) 0.2 (−2.7 to 2.2)
Superior quadrant 0.99 (0.99 to 1.00) −0.2 (−2.9 to 2.6)
Nasal quadrant 0.99 (0.99 to 0.99) 0.3 (−2.9 to 3.4)
Temporal quadrant 0.99 (0.99 to 0.99) −0.5 (−3.8 to 2.7)
Average 1.00 (0.99 to 1.00) −0.1 (−1.5 to 1.2)
*Mean difference was determined from the first measurement minus the second
measurement.
Table 2 Major eye diseases in the study population (n=452)
Presence of eye diseases N (%)
None 351 (77.7)
Diabetic retinopathy 38 (8.4)
Age-related macular degeneration (ARMD)
Early ARMD 22 (4.9)
Late ARMD 2 (0.4)
Glaucoma 21 (4.6)
High myopia (−6 dioptres or more) 18 (4.0)
Data presented are n (%).
Table 4 Distribution of peripapillary choroidal thickness at clock






















Average quadrant thickness 136.2 (56.8)
Data presented are mean (SD).
1 o’clock corresponds to the temporal region, 4 o’clock to the superior region,
7 o’clock to the nasal region and 10 o’clock to the inferior region.
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the inferior quadrant. Among the range of ocular and systemic
factors studied, AL, age, triglyceride level and diabetes were the
only signiﬁcant determinants of PPCT.
Previous studies have characterised the thickness and proﬁle
of peripapillary choroid in normal eyes but with limited valid-
ity.10–12 There are several reasons for compromised validity.
First, their measurements were not automated but involved
manual adjustment of the choroidal boundaries, making it time-
consuming and also prone to measurement errors. Second,
these studies were performed in clinic-based settings with a
potential selection bias and involved a smaller sample size,
affecting their generalisability. To address these issues we
therefore developed and used a novel technique of automated
choroidal segmentation14 to objectively and efﬁciently obtain
the PPCT in a population-based sample.
Our study showed a mean PPCTof 136.2±56.8 mm. Previous
studies have reported a mean thickness of 165–191.6 mm.10 11
The disparities in PPCT in our study compared with other
studies may be due to differences in the demographic data of
enrolled subjects such as ethnicity and age. Different studies
may have different age groups of study participants and, with
advancing age, the choroid may undergo further age-related
attenuation. The mean age of our participants was 67 years,
compared with 57 and 48 years in the studies by Huang et al11
Table 5 Associations of average peripapillary choroidal thickness (PPCT) with ocular and systemic factors using generalised estimating equation
(n=904 eyes)
Univariate analysis Multivariate analysis*
β (95% CI) p Value β (95% CI) p Value
Ocular factors
Spherical equivalent, D −0.22 (−0.23 to 1.88) 0.833 – –
Axial length, mm −4.23 (−8.88 to 0.40) 0.074 −6.59 (−10.86 to −2.33) 0.002
Corneal curvature, mm −13.14 (−30.39 to 4.10) 0.135 – –
Central corneal thickness, μm −0.01 (−0.14 to 0.12) 0.841 – –
Intraocular pressure, mm Hg 1.30 (0.20 to 2.40) 0.020 0.60 (−0.82 to 2.02) 0.407
Ocular perfusion pressure, mm Hg −0.18 (−0.64 to 0.27) 0.436 – –
Systemic factors
Age, years −0.20 (−0.61 to 0.19) 0.319 −0.56 (−1.03 to −0.09) 0.018
Gender, male −5.63 (−14.53 to 3.27) 0.215 5.60 (−5.08 to 16.29) 0.304
Systolic blood pressure, mm Hg −0.06 (−0.25 to 0.13) 0.538 – –
Diastolic blood pressure, mm Hg −0.00 (−0.36 to 0.34) 0.959 – –
Mean arterial pressure, mm Hg −0.05 (−0.36 to 0.25) 0.718 – –
Body mass index, kg/m2 0.18 (−0.55 to 0.91) 0.631 – –
Serum glucose, mmol/L 0.53 (−0.69 to 1.76) 0.392 – –
HbA1c, % 1.13 (−1.83 to 4.09) 0.455 – –
Total cholesterol, mmol/L 0.25 (−3.10 to 3.60) 0.883 – –
Triglycerides, mmol/L −2.42 (−5.13 to 0.29) 0.080 −4.88 (−8.80 to −0.95) 0.015
Blood creatinine, mmol/L 0.00 (−0.07 to 0.08) 0.818 – –
Current smoking −2.79 (−13.74 to 8.14) 0.616 – –
Diabetes mellitus 9.39 (−0.73 to 19.52) 0.069 13.73 (0.90 to 26.34) 0.036
Arterial hypertension 3.16 (−5.88 to 12.20) 0.493 – –
Alcohol consumption −7.99 (−38.18 to 22.19) 0.604 – –
Bold type indicates statistical significance.
β represents the change in PPCT per unit change in continuous variables and the difference in PPCT between groups for categorical variables.
*Adjusted for glaucoma status, diabetic retinopathy and age-related macular degeneration.
Figure 3 Variation trend of peripapillary choroidal thickness in mm. Distribution of mean peripapillary choroidal thickness at (A) clock hour sectors
(30° apart) and (B) four quadrants (inferior, superior, nasal and temporal) in 904 eyes. Error bars represents standard error.
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and Ho et al,10 respectively. In addition, differences in the chor-
oidal segmentation method, which was fully automated in our
study and was manual in previous studies, variations in OCT
device characteristics such as wavelength, eye tracking method
and averaging software among studies might contribute to the
observed variations in thickness across studies.
With regard to the proﬁle of the peripapillary choroid, our
results conﬁrmed the asymmetrical distribution of PPCT. The
mean PPCT measurements showed regional differences, being
thickest in the superior region, followed by the nasal and tem-
poral quadrants and thinnest in the inferior region. These obser-
vations are similar to the results of previous EDI-OCT studies in
normal eyes which have consistently shown the inferior region
to be thinner than other regions.10 11 17 The thinner choroid in
the inferior region makes this area more susceptible to retinal
and choroidal diseases. Several studies10 18 have hypothesised
that the thinnest peripapillary choroid in the inferior quadrant
may represent an area of lower blood supply which may predis-
pose the inferior region of the optic nerve to glaucomatous
ischaemic damage, suggesting a possible explanation for the
well-known observation that glaucoma typically affects the infer-
ior optic nerve region ﬁrst.
Among the other ocular factors, the peripapillary choroid
was thinner in eyes with longer AL, which is in agreement
with previous studies on macular choroidal thickness that have
shown a decrease in choroid in elongated eyes.9 19 In eyes with
greater AL, the elongation of the eyeball leads to mechanical
stretching and thinning of the retina20 21 and choroid due to
signiﬁcant thinning of the choriocapillaris and focal lack of
vessels.22–24
We found that the peripapillary choroid thinned with age,
similar to the ﬁndings of previous studies on PPCT.11 12
Thinning results in a reduced ability of the choroid to provide
sufﬁcient levels of oxygen and other metabolites to the ONH.
We speculate that such a gradual loss in physiological functions
of the peripapillary choroid may contribute to the onset of glau-
coma in elderly people.
In addition, we observed thickening of the peripapillary choroid
in persons with diabetes. However, the reasons for diabetic people
having thicker peripapillary choroid are still unclear as there is
inconsistency in the literature in terms of choroidal blood ﬂow,
which is reported to decrease, increase and remain unchanged in
patients with diabetes.25–27 This statistically signiﬁcant ﬁnding
could therefore be seen as exploratory and conﬁrmatory studies
are necessary to evaluate the results.
Tan et al reported that arterial BP had an effect on subfoveal
choroidal thickness. They found that a change in choroidal
thickness was positively correlated with the change in systolic
BP.28 However, in our study we did not ﬁnd any signiﬁcant asso-
ciation between BP and PPCT. Lastly, in our study lower levels
of triglyceride were associated with thicker PPCT. However, the
reasons for such an association are unknown and further studies
are needed to conﬁrm this relationship.
We acknowledge limitations to our study. First, recent studies
have reported diurnal ﬂuctuations in choroidal thickness in the
macular region.28–30 To the best of our knowledge there are no
data on the association between diurnal variation and choroidal
thickness in the peripapillary region. Our subjects were exam-
ined only at a single time point and thus we are not able to take
account of any diurnal variation of PPCT. Second, our investiga-
tion included consecutive participating subjects from a
population-based study and thus some of them had eye diseases
that might have changed choroidal thickness. The distribution
of PPCT determined in this study may not therefore represent
the PPCT in healthy eyes but in general adult and elderly popu-
lations. However, this would not affect the observed associations
because, in our multiple regression analysis model, we have
adjusted for the potential ocular diseases in elderly people that
might inﬂuence choroidal thickness.
In conclusion, we objectively demonstrated a mean PPCT of
136.2±56.8 mm in an Asian population. Shorter AL, younger
age, lower triglyceride levels and the presence of diabetes were
the factors independently associated with thicker peripapillary
choroid. Automated choroidal segmentation software allows
highly reliable, faster and more objective evaluation of choroid,
which may help provide further insight into diseases such as
glaucoma and myopia.
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Choroidal vascularity index as a 
measure of vascular status of the 
choroid: Measurements in healthy 
eyes from a population-based study
Rupesh Agrawal1,2,*, Preeti Gupta1,3,*, Kara-Anne Tan3, Chui Ming Gemmy Cheung1,3,4,  
Tien-Yin Wong1,3,4 & Ching-Yu Cheng1,3,4
The vascularity of the choroid has been implicated in the pathogenesis of various eye diseases. To date, 
no established quantifiable parameters to estimate vascular status of the choroid exists. Choroidal 
vascularity index (CVI) may potentially be used to assess vascular status of the choroid. We aimed to 
establish normative database for CVI and identify factors associated with CVI in healthy eyes. In this 
population-based study on 345 healthy eyes, choroidal enhanced depth imaging optical coherence 
tomography scans were segmented by modified image binarization technique. Total subfoveal 
choroidal area (TCA) was segmented into luminal (LA) and stromal (SA) area. CVI was calculated 
as the proportion of LA to TCA. Linear regression was used to identify ocular and systemic factors 
associated with CVI and subfoveal choroidal thickness (SFCT). Subfoveal CVI ranged from 60.07 to 
71.27% with a mean value of 65.61 ± 2.33%. CVI was less variable than SFCT (coefficient of variation 
for CVI was 3.55 vs 40.30 for SFCT). Higher CVI was associated with thicker SFCT, but not associated 
with most physiological variables. CVI was elucidated as a significant determinant of SFCT. While SFCT 
was affected by many factors, CVI remained unaffected suggesting CVI to be a more robust marker of 
choroidal diseases.
The choroid is the vascular layer of eye, with one of the highest blood flow of any tissue in the body1. The choroid 
is predominantly composed of blood vessels surrounded by stromal tissue comprising of connective tissue, mel-
anocytes, nerves and extracellular fluid2. The vascular layer of the choroid may be differentiated into 3 layers from 
internal to external, with increasing luminal diameter. The innermost layer is the choriocapillaris, the middle is 
Sattler’s layer with medium vessels, and the outer is Haller’s layer, with large vessels1.
Being a major vascular layer of the eye the choroid plays an important role in ocular health, and is involved 
in the pathogenesis of many intraocular diseases such as age-related macular degeneration, polypoidal choroi-
dal vasculopathy, central serous chorioretinopathy and myopic macular degeneration3–9. There is evidence from 
histological studies that the disease processes affect the stroma and vasculature of the choroid10–12. However, 
shrinkage occurs during the fixation of the tissues during the histological process, making it difficult to study the 
changes in vascular tone of the choroid13.
Choroid thickness (CT) has been reported as an indicator of ocular14–17 and systemic health18–22. Although, 
many studies have now reported changes in the thickness of the choroid in various ocular and systemic dis-
eases8–12 and proposed CT as a marker to assess these disease conditions, there exists a notable disparity in CT 
in various clinical studies. One such example is diabetes mellitus23–27, where there has been no consensus as to 
whether it causes an increase or decrease in CT. This raises the question of what structures in the choroid changes 
with increasing or decreasing CT and if there is a more robust marker to assess choroid health.
To answer this question, morphological and vascular analyses of the choroid may provide some clues and 
lead to the development of a more stable marker. The advent of enhanced depth imaging (EDI) optical coherence 
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tomography (OCT) has allowed more precise non-invasive quantitative assessment of the choroid28. Using EDI 
OCT, there have been attempts to assess the choroidal stromal and vascular structures13,29–32. Recently Sonoda et al. 
described a method for computing luminal and interstitial areas in the choroid as a means to quantify vascular 
status of the choroid30,31.
Adapting the image segmentation technique proposed by Sonoda et al.30,31, we further propose a new quanti-
tative parameter called choroidal vascularity index (CVI) to assess vascular status of the choroid through image 
binarization of EDI SD-OCT images in healthy eyes. Furthermore, we aimed to determine the ocular and sys-
temic factors affecting the CVI as well as CT in subjects enrolled from a population-based study in Singapore. 
This index may provide additional information on the morphology and physiology of the choroid and may be a 
more robust marker compared to CT.
Methods
Study population. The data for this study was derived from the Singapore Malay Eye Study-2 (SiMES-2), 
a population based cohort study of 45–85 years old Malay adults living in Singapore. This study was conducted 
as per the tenets set forth in the Declaration of Helsinki, and ethics committee approval was obtained from the 
Institutional Review Board of Singapore Eye Research Institute. Written informed consent was obtained from 
the subjects after explanation about the details of the study and any potential risks involved with the study and 
consequences of the study.
Study subjects. Details of the study design, and methodology have been reported elsewhere33. In this study, 
we enrolled 400 consecutive participants from February 2012 to April 2013. Exclusion criteria included: loga-
rithmic minimum angle of resolution (logMAR) visual acuity > 0.30, spherical equivalent (SE) < − 6 diopter, 
evidence of vitreo-retinal diseases such as age related macular degeneration and diabetic retinopathy, previ-
ous ocular surgery or clinical features compatible with a diagnosis of glaucoma and Spectralis OCT imaging 
with a quality index < 18 decibels. Glaucoma was defined using the International Society of Geographic and 
Epidemiological Ophthalmology scheme34, based on findings from gonioscopy, optic disc characteristics, and 
visual fields results.
Choroidal thickness assessment. The choroid was imaged using the EDI mode of SD-OCT (Spectralis, 
Heidelberg Engineering, Heidelberg, Germany). The macular region was scanned using a 7 horizontal line scan 
(30° × 5°) centred on the fovea, with 100 frames averaged in each B-scan. Each scan was 8.9 mm in length and 
spaced 240 μ m apart from each other. In our study, Bruch’s membrane and the choroid-scleral interface were 
delineated with the automatic segmentation algorithm developed by Tian et al.35 which demonstrated excel-
lent repeatability in our previously reported population-based study36. The choroidal thickness was automati-
cally measured as the distance between the Bruch’s membrane (lower boundary of retinal pigmented epithelium 
[RPE]) and the choroid-scleral interface. Although measurements of both eyes of each study participant were 
obtained, due to inter eye correlation only the right eye was used for further analysis.
Image binarization details. The same raster scan passing through the fovea was selected for binarization. 
It was segmented using the protocol described by Sonoda et al.30–31 with minor modifications. The image bina-
rization was done using public domain software, Image J (version 1.47; http://imagej.nih.gov/ij/). The subfoveal 
choroidal area with a width of 1.5 mm, centred at the fovea, was selected (Fig. 1A) and this constituted the region 
of interest. Only 1.5 mm of the macular area on the single line scan was selected as a representative segment of the 
Figure 1. Image binarization for choroid with normal choroidal thickness. (A) Original SD OCT image.  
(B) 1.5 mm segmentation block of the subfoveal choroidal area. (C) Segmented OCT image using modified 
image binarization approach. (D) Overlay of region of interest created after image binarization was performed 
on the SD OCT image.
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macular region due to segmental nature of the choroidal blood supply as described by Hayreh37. The posterior 
ciliary arteries and their branches along with terminal choroidal arterioles, the choriocapillaris, and the vortex 
veins have a segmental or lobular distribution in the choroid.
Image binarization techniques can be used to convert grey scale images into binarized images. This facilitates 
tasks such as image layout analysis and image skew estimation. An appropriate image binarization technique, 
taking into account the uneven illumination, image contrast variation and poor image resolution, is essential 
to accurately apply a threshold to an image. Different image binarization or thresholding techniques like Otsu’s, 
Bernsen’s and Niblack’s autolocal thresholding techniques were hence attempted38,39. Otsu’s is a global threshold-
ing technique while Bernsen’s is local thresholding technique. After comparing the different image segmentation 
techniques, we adopted Niblack’s autolocal threshold technique in our current study. This is because it takes into 
consideration the mean and standard deviation of all the pixels in the region of interest. In addition, given that 
binarization could be influenced by the variation in the amount of melanin in RPE in different eyes, and also 
affected by the direction of light and focussing issues, these were taken into account by using a distinct binariza-
tion threshold for individual subject.
Using Niblack’s autolocal threshold tool, the image was first binarized to get a clear view of the choroid-scleral 
interface (Fig. 1B). This was to allow more precise selection of the subfoveal choroid area. This is in contrast to 
Sonoda’s et al.30,31 protocol in which the polygonal area was selected prior to image binarization. In addition, we 
did not preselect vessels of size more than 100 um.
With the upper border marked at the RPE and the lower border the line of light pixels at the choroid scleral 
junction, the choroidal area was selected using polygon tool and added to the region of interest manager (Fig. 1B). 
The image was then converted to RGB (red, green, blue) colour to allow the colour threshold tool to select the 
dark pixels (Fig. 1C). The total subfoveal circumscribed choroidal area (TCA) and the area of dark pixels were 
calculated. The luminal area (LA) was defined as the area of dark pixels. Stromal area (SA) was further calculated 
by subtracting LA from TCA. To determine the vascularity status of the choroid, CVI was computed by dividing 
LA by TCA. In addition, the proportion of dark (LA) to light areas (SA) was also computed. Fig. 1D represents 
the overlay image of the region on interest on the original EDI OCT scan.
Inter-rater and Intra-rater agreement. 10% of the total images (35 images), were initially segmented 
by two graders (KAT and RA) to determine inter-rater agreement. The same set of images was segmented by 
one grader (KAT) after an interval of one week to compute intra-rater reliability. The intra- and inter-rater reli-
ability for the image binarization was measured by the absolute agreement model of the intra-class correlation 
coefficient (ICC)40. ICC value of 0.81–1.00 indicates good agreement. Values of less than 0.40 indicate poor to 
fair agreement. We also performed Bland-Altman plot analyses41,42 to determine the mean difference between 
the measurements. The Bland-Altman plots were constructed using MedCalc version 12.3 (Medcalc Software, 
Ostend, Belgium) software. Moreover, random scans, including those with thick and thin choroid, were further 
reviewed by both graders to ensure good inter-rater agreement. After obtaining good inter-rater and intra-rater 
agreement, all the scans were binarized by single author (KAT).
Measurement of ocular factors. Each participant underwent a standardized examination. Refraction 
and corneal curvature were measured using an auto-keratorefractor (Canon RK 5 Auto Ref-Keratometer, 
Canon Inc. Ltd., Tochigiken, Japan). SE was calculated as the sum of the spherical power and half of the cyl-
inder power. Best-corrected visual acuity was measured monocularly using a LogMAR chart (Lighthouse 
International, New York, USA) at a distance of 4 meters. Ocular biometry, including axial length (AL), was 
measured using non-contact partial coherence interferometry (IOL Master V3.01, Carl Zeiss Meditec AG, Jena, 
Germany). Intraocular pressure (IOP) was measured using Goldmann applanation tonometry (Haag-Streit, 
Bern, Switzerland) before pupil dilation. Standardized visual field testing was performed with static automated 
white-on-white threshold perimetry (SITA Fast 24-2, Humphrey Field Analyzer II; Carl Zeiss Meditec, Inc., 
Oberkochen, Germany). Slit-lamp biomicroscopy (Haag-Streit model BQ-900; Haag-Streit, Switzerland) was 
performed by the study ophthalmologists to examine the anterior chamber and lens after pupil dilation with 
tropicamide 1% and phenylephrine hydrochloride 2.5%.
Measurement of systemic factors. A detailed interviewer-administered questionnaire was used to collect 
demographic data, lifestyle risk factors (e.g. smoking, alcohol consumption), medical history (e.g. hypertension, 
diabetes), ocular history (e.g. glaucoma), and medication use from all participants. Systolic and diastolic blood 
pressures (BP) were measured using a digital automatic blood pressure monitor (Dinamap model Pro Series 
DP110X-RW, 100V2; GE Medical Systems Information Technologies, Inc., Milwaukee, WI), after subjects were 
seated for at least five minutes. BP was measured twice, with measurements 5 minutes apart. A third measurement 
was taken if the previous 2 systolic BP readings differed by more than 10 mmHg or the diastolic BP differed by 
more than 5 mmHg. The mean of the two closest BP readings was taken as each participant’s BP.
Mean ocular perfusion pressure (OPP) was calculated using the following equation: mean OPP = (2/3 × 
mean arterial pressure [MAP] – IOP), where MAP = diastolic BP + (1/3 × [systolic BP – diastolic BP]). Body 
mass index (BMI) was calculated as body weight (in kilograms) divided by body height (in meters) squared. 
Smoking status was defined as those currently smoking, ex-smokers and non-smokers. Nonfasting venous blood 
samples were analysed at the National University Hospital Reference Laboratory for biochemical testing of serum 
total cholesterol, triglycerides, glycosylated haemoglobin (HbA1c), serum glucose level and creatinine.
Statistical methods. Statistical analysis was performed using SPSS version 20.0 (SPSS, Inc., Chicago, IL, 
USA). Since CVI and subfoveal choroidal thickness (SFCT) have different measurement units, we used the coef-
ficient of variation (COV) to compare the variability between CVI and SFCT. Univariate and multiple linear 
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regression analyses were performed to determine the associations of SFCT and CVI (dependent variables) with 
ocular and systemic factors (independent variables). For multiple linear regression, factors showing significant 
association in univariate analysis (p < 0.10) were included. All p values were 2-sided and considered statistically 
significant when the values were less than 0.05.
Results
A total of 400 subjects were recruited for this study. We excluded 55 subjects for the following reasons: visual 
acuity worse than 0.30 (n = 9), SE < −6 diopter (n = 7), glaucoma (n = 6), presence of macular or vitreo-retinal 
diseases (n = 18) and poor OCT image quality (n = 15). A total of 345 eyes from 345 subjects were included in the 
final analysis; 190 (55%) subjects were female. The demographics, ocular, systemic and choroidal characteristics 
of the study subjects are shown in Table 1. In terms of choroidal characteristics, mean TCA was 0.74 ± 0.21 mm2 
and mean LA was 0.49 ± 0.15 mm2. Mean SFCT was 241.34 ± 97.11 μ m (range, 40.24–519.48 μ m) and mean CVI 
was 65.61 ± 2.33% (range, 60.07–71.27%).
CVI was found to have lower COV (3.55) than SFCT (COV = 40.30), indicating CVI to be less variable than 
SFCT. The histogram plots (Fig. 2A,B) represent the distribution of SFCT and CVI in relation to normal density 
plot.
Using image binarization, the intra- (ICC: 0.97 to 0.99 for TCA and ICC: 0.91 to 0.98 for LA) and inter-grader 
reliability (ICC: 0.90 to 0.97 for TCA and ICC: 0.89 to 0.97 for LA) were excellent for both TCA and LA (Table 2). 
Bland Altman plot analysis of intra- and inter-rater reliability for TCA (Fig. 3A,B) and LA (Fig. 3C,D) at 
sub-foveal location was excellent.
In Table 3, the multiple regression model shows younger age, shorter AL, higher IOP, higher LA and lower 
systolic blood pressure to be significantly (p < 0.05) associated with thicker sub-foveal choroid. However, among 
factors associated with CVI (Table 4), in the multiple regression model, SFCT was the only factor associated with 
CVI. A thicker sub-foveal choroid was significantly (p < 0.001) associated with higher CVI. There were no other 
statistically significant association between CVI and any other factors (Table 4).
Discussion
In this population-based study, using the modified Sonoda’s image binarization technique for EDI SD-OCT scans, 
we propose an OCT based metric termed “CVI” to assess vascularity of the choroid. Our results validated the 
findings obtained by Sonoda et al. and found that on a single cross sectional scan, nearly two third (~66%) of the 
subfoveal choroid is vascular in healthy eyes. Importantly, CVI showed lesser variability and was influenced by 
fewer physiologic factors as opposed to CT, indicating CVI to be a relatively stable index for studying the changes 
in the choroid. As the choroid is primarily a vascular structure, understanding of this new vascular index may 
Characteristics Mean ± SD Range
Age, yrs 61.53 ± 8.77 47.19 to 86.72
Gender, male (%) 155 (44.9%)
Axial length, mm 23.58 ± 0.96 21.60 to 27.89
IOP, mm Hg 14.41 ± 2.84 6 to 20
Ocular perfusion pressure, 
mmHg 55.68 ± 8.39 37.44 to 96.11
Systolic blood pressure, 
mmHg 139.21 ± 20.63 95 to 226.50
Diastolic blood pressure 
mmHg 77.27 ± 10.85 54.50 to 133
Body mass index, kg/m2 26.75± 5.13 12.15 to 52.95
Serum glucose, mmol/L 6.98 ± 3.35 2.8 to 22.9
HbA1c, % 6.26 ± 1.27 4.3 to 11.7
Total cholesterol, mmol/L 5.43 ± 1.26 2.49 to 10.40
Triglycerides, mmol/L 1.95 ± 1.38 0.42 to 14.95
Blood creatinine, mmol/L 78.92 ± 33.11 30 to 412
Current smoking, % 68 (19.8%)
Alcohol consumption, % 5 (1.5%)
Choroidal Parameters
 TCA, mm2 0.74 ± 0.21 0.198 to 1.237
 LA, mm2 0.49 ± 0.15 0.122 to 0.817
 SA, mm2 0.25 ± 0.06 0.076 to 0.441
 CVI (LA/TCA) 65.61 ± 2.33 60.07 to 71.27
 LA/SA 1.92 ± 0.20 1.50, 2.48
 SFCT, μ m 241.34 ± 97.11 40.24, 519.48
Table 1.  Demographics, clinical and choroidal characteristics of study subjects (n = 345). Data presented 
are means ± standard deviations, except for gender, HbA1c , current smoking and alcohol consumption which 
are number (%). TCA, total sub-foveal choroidal area; LA, luminal area; SA, stromal area; CVI, choroidal 
vascularity index; LA/SA, luminal area/ stromal area; SFCT, sub-foveal choroidal thickness.
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help to further elucidate the role of vascular processes within the choroid in disease development and progres-
sion. We hence propose CVI as an independent surrogate marker to assess choroidal health in future studies.
Several studies have assessed the vascular structures of the choroid by OCT13,29, but they required customized 
software that limited their widespread use. There are reports30,31 on the differentiation and quantification of the 
structural components of the choroid (luminal and interstitial areas), using freely and easily accessible software, 
Image J, these studies were performed in clinic-based settings with a potential selection and sampling biases. We 
have highlighted the significant differences in our protocol with that proposed by Sonoda et al.30,31 in Table 5. Our 
modification of applying auto local threshold prior to image binarization enabled us to accurately localise choroid 
scleral interface giving more precise selection of the choroid. In addition, the simple binarization technique with-
out pre-selection of larger choroidal vessels allowed nearly accurate estimation of vascularity of the choroid even 
with a very simple algorithm, which can be reproduced by the large research community.
Although there is no concrete evidence that the dark areas represented the vascular areas and the light areas 
the stromal areas, the findings of earlier studies and that of numerous empirical observations suggest that the 
dark areas were the vascular components in the binarized images13,29. In addition, a comparison of the original 
EDI-OCT images to the binary images (Fig. 1) revealed that the dark areas corresponded with vascular compo-
nents of the choroid, including both the larger and smaller choroidal vessels. Therefore, the binarization tech-
nique developed by Sonoda et al.30,31, which was further simplified by us, is valid and offers precise segmentation 
of choroidal vasculature from stroma.
Interestingly, when comparing the factors affecting SFCT to those that affect CVI, we found SFCT to be associ-
ated with many physiological factors such as age, AL, IOP and, most significantly, the vascular area in the choroid 
(LA), whereas stromal area did not have a significant association with SFCT. On the other hand, CVI was only 
affected by SFCT, but was not affected by most of the physiological variables. Moreover, SFCT demonstrated 
relatively greater variability (mean SFCT was 241.34 ± 97.11 μ m, COV = 40.30) compared to CVI (mean CVI 
was 65.61 ± 2.33%, COV = 3.55). Thus our results suggest CVI to be a better and relatively more stable marker 
to monitor choroid compared to CT, which is affected by more variables and demonstrated greater variability. 
Clinically, measuring the proportion of vascularity of the eye would provide us with a deeper understanding of 
how disease processes affect different structures in the eye, and therefore may be more informative compared to 
CT measurements alone.
We have demonstrated a significant association of SFCT with vascular area of the choroid. This signifies the 
fact that the vascular area is the predominant segment influencing the CT in normal population. An increase in 
CVI reflects either an increase in the number of blood vessels or in the diameter of the choroidal blood vessels 
within a designated area. Hayreh37 demonstrated the vulnerability of submacular choroidal supply to generalised 
chronic ischaemic disorders (age related macular degeneration), due to numerous watershed zones of the short 
posterior ciliary arteries in the choroid. There can be potential clinical implications of the CVI, which can be 
explored in further studies. A decrease in CVI on EDI OCT scans at baseline may be an indicator of choroidal 
ischemia in patients with macular disorders like age related macular degeneration or diabetes. On the other hand, 
Figure 2. Distribution of subfoveal choroidal thickness (A) and choroidal vascularity index (B) across the 
population.
Intra Rater Intra Rater
ICC (95% CI) Mean difference (95% LOA) ICC (95% CI) Mean difference (95% LOA)
TCA 0.99 (0.97 to 0.99) − 0.01 (− 0.16 to 0.13) 0.94 (0.90 to 0.97) 0 (− 0.06 to 0.07)
LA 0.96 (0.91 to 0.98) − 0.01 (− 0.11 to 0.09) 0.94 (0.89 to 0.97) 0.01 (− 0.07 to 0.10)
Table 2.  Intra- and inter-grader reliability assessment of choroidal parameters in 35 subjects. TCA, total 
sub-foveal choroidal area; LA, luminal area; ICC, intraclass correlation coefficient; CI, confidence interval; LOA, 
limits of agreement.
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Figure 3. Bland Altman plots of total choroidal area and luminal area. (A) and (B) shows intra- and 
inter- rater reliability for total choroidal area respectively. (C) and (D) shows intra- and inter- rater reliability 
for luminal area respectively. For intra-rater reliability, the difference was calculated by the 1st measurement 
minus the 2nd measurement. Pink dashed line represents regression line of difference between 1st and 2nd 
measurements. For inter-rater reliability, the difference was calculated by the grader 1 measurement minus 
the grader 2 measurement. Pink dashed line represents regression line of difference between the two graders 
measurements.
Univariate Multivariate*
Unstandardized β Standardized β P-value Unstandardized β Standardized β P-value
Ocular factors
 Axial length, mm − 15.348 − 0.155 0.005 − 10.508 − 0.105 0.002
 IOP, mmHg 3.160 0.092 0.087 3.619 0.105 0.002
 OPP, mm Hg − 0.354 -0.031 0.572 – – –
 LA, mm2 523.214 0.814 < 0.001 459.729 0.714 < 0.001
 SA, mm2 1132.841 0.787 < 0.001 68.271 0.047 0.669
Systemic factors
 Age, yrs − 3.986 − 0.360 < 0.001 − 0.856 − 0.077 0.041
 Gender, female − 22.274 − 0.114 0.034 − 13.171 − 0.068 0.068
 Body mass index, kg/m2 − 1.173 − 0.062 0.252 – – –
 Systolic blood pressure, mmHg − 0.499 − 0106 0.050 − 0.328 − 0.071 0.043
 Diastolic blood pressure mmHg 0.749 0.084 0.122 – – –
 Serum glucose, mmol/L 0.102 0.004 0.949 − − − 
 HbA1c, % 5.913 0.077 0.157 − − − 
 Total cholesterol, mmol/L 8.092 0.106 0.052 − 0.525 − 0.007 0.836
 Triglycerides, mmol/L 3.456 0.049 0.366 – – –
 Blood creatinine, mmol/L -0.050 -0.017 0.754 – – –
 Current smoking, (yes vs no) 28.392 0.116 0.031 − 11.737 − 0.049 0.187
 Alcohol consumption, (yes vs no) − 19.833 0.024 0.651 – – –
Table 3.  Linear regression analyses of ocular and systemic factors associated with sub-foveal choroidal 
thickness. *Adjusted for variables with a p-value < 0.10 in the univariate analysis. β , regression coefficient.
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we may use CVI to determine increase in vascularity of the choroid in posterior uveitis or central serous chori-
oretinopathy. CVI can also be used as a follow up tool for treatment response and resolution of diseases.
The strengths of our study include a large sample size with a single common ethnicity. Hence, our findings 
were unlikely to be confounded by ethnic heterogeneity. Standardized clinical examination protocols, as well as 
reliable differentiation and quantifications of choroidal morphometric parameters and OCT parameters were 
used in our study. Nevertheless, this study has few limitations. First, binarization of choroidal images was per-
formed only in the right eye of each study subject. There may exist inter-eye differences, yet such differences 
should be small. Second, the CT measurements in our study were not performed at the same time of the day; each 
participant underwent the OCT examination in a randomized manner with respect to when the readings were 
obtained. It seems unlikely that circadian changes may have influenced the results of our investigation. Third, 
although our images were binarized at standard threshold, there is a possibility of over or underestimation of 
both SA and LA.
In conclusion, in this population-based study, we introduced a novel OCT based marker termed “CVI” to 
assess vascularity of the subfoveal choroid. Our result showed that on a single cross sectional EDI-OCT image, 
two-third (~66%) of the subfoveal choroid is vascular in healthy eyes. This index should provide a new means 
of studying the pathophysiology of human choroid in greater detail. However, larger studies for different disease 
models are warranted to further validate the application of this index in clinical practice. Whether CVI is a com-
plimentary or substitute tool to CT can only be answered based on the proposed studies in choroidal diseases.
Univariate Multivariate*
Unstandardized β Standardized β P-value Unstandardized β Standardized β P-value
Ocular factors
 Axial length, mm − 0.274 − 0.113 0.039 − 0.106 − 0.004 0.375
 IOP, mmHg − 0.014 − 0.018 0.745 – – –
 OPP, mmHg 0.022 0.080 0.136 – – –
 SFCT, μ m 0.012 0.519 < 0.001 0.012 0.484 < 0.001
Systemic factors
 Age, yrs − 0.057 − 0.215 < 0.001 − 0.001 − 0.003 0.950
 Gender, female − 0.706 − 0.151 0.005 − 0.183 − 0.039 0.482
 Body mass index, kg/m2 − 0.026 − 0.058 0.283 – – –
 Systolic blood pressure, mmHg − 0.001 − 0.012 0.818 – – –
 Diastolic blood pressure mmHg 0.031 0.145 0.007 0.019 0.089 0.072
 Serum glucose, mmol/L 0.025 0.036 0.511 – – –
 HbA1c, % 0.034 0.018 0.736 – – –
 Total cholesterol, mmol/L 0.115 0.062 0.256 – – –
 Triglycerides, mmol/L 0.130 0.077 0.158 – – –
 Blood creatinine, mmol/L 0.003 0.035 0.516 – – –
 Current smoking, (yes vs no) 1.098 0.187 < 0.001 0.535 0.092 0.088
 Alcohol consumption, (yes vs no) 1.004 0.051 0.341 – – –
Table 4.  Linear regression analyses of ocular and systemic factors associated with choroidal vascularity 
index. *Adjusted for variables with a p-value < 0.10 in the univariate analysis. β , regression coefficient.
Sonoda et al. (2014)30 Sonoda et al. (2015)31 Current study
Study sample size 15 eyes of 15 subjects 180 eyes of 180 subjects 345 eyes of 345 subjects
Choroidal area measured 1.5 mm 7.5 mm 1.5 mm
Location of measurement Centered on fovea , 1500 um Entire raster scan, 7500 um
Centered on fovea (1500 um) due to the segmental 
nature of choroidal blood supply as described by 
Hayreh et al.37
Pre-selection of vessels
3 choroidal vessels with lumens > 100 mm were randomly 
selected and the average reflectivity of these areas was 
determined by the software
Used autolocal threshold techniques to allow 
binarization of smaller choroidal vessels or 
choriocapillaris.
Brightness adjustment Average brightness was set as the minimum value
Brightness was not adjusted as it would reduce the 
contrast between luminal and stromal areas and 
possibly affect the autolocal threshold.
Order of binarization Region of interest selected prior to image binarization
To get a clear view of the choroid-scleral interface, 
image binarization was performed prior to area 
selection.
Image segmentation time ~5 minutes per image ~1 minute per image
Table 5.  Image binarization protocol in Sonoda et al. vs current study.
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http://dx.doi.Relationship Between Peripapillary Choroid and
Retinal Nerve Fiber Layer Thickness in a
Population-Based Sample of Nonglaucomatous
EyesPREETI GUPTA, CAROL Y. CHEUNG, MANI BASKARAN, JING TIAN, PINA MARZILIANO,
ECOSSE L. LAMOUREUX, CHUI MING GEMMY CHEUNG, TIN AUNG, TIEN YIN WONG, AND
CHING-YU CHENG PURPOSE: To describe the relationship between peripa-
pillary choroidal thickness and retinal nerve fiber layer
(RNFL) thickness in a population-based sample of
nonglaucomatous eyes.
 DESIGN: Population-based, cross-sectional study.
 METHODS: A total of 478 nonglaucomatous subjects
aged over 40 years were recruited from the Singapore Ma-
lay Eye Study (SiMES-2). All participants underwent a
detailed ophthalmic examination, including Cirrus and
Spectralis optical coherence tomography (OCT) for the
measurements of RNFL thickness and peripapillary
choroidal thickness, respectively. Associations between
peripapillary choroidal thickness and RNFL thickness
were assessed using linear regression models with gener-
alized estimating equations.
 RESULTS: Of the 424 included subjects (843 nonglau-
comatous eyes), 60.9% were women, and the mean
(SD) age was 66.74 (10.44) years. The mean peripapil-
lary choroidal thickness was 135.59 ± 56.74 mm and
the mean RNFL thickness was 92.92 ± 11.41 mm. In
terms of distribution profile, peripapillary choroid was
thickest (150.04 ± 59.72 mm) at the superior and thin-
nest (110.71 ± 51.61 mm) at the inferior quadrant,
whereas RNFL was thickest (118.60 ± 19.83 mm) at
the inferior and thinnest (67.36 ± 11.36 mm) at the tem-
poral quadrant. We found that thinner peripapillary
choroidal thickness (PPCT) was independently associ-
ated with thinner RNFL thickness globally (regression
coefficient [b] [ L1.334 mm for per-SD decrease inr publication Sep 11, 2015.
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 2015 BY ELSEVIER INC.PPCT, P [ .003), and in the inferior (b [ L2.565,
P[ .001) and superior (b[L2.340, P[ .001) quad-
rants even after adjusting for potential confounders.
 CONCLUSIONS: Thinner peripapillary choroid was
independently associated with thinner RNFL globally
and in the inferior and superior regions. This structure-
structure relationship may need further exploration in
glaucomatous eyes prior to its application in clinical
settings. (Am J Ophthalmol 2015;-:-–-.  2015
by Elsevier Inc. All rights reserved.)
R
ETINAL NERVE FIBER LAYER (RNFL) THICKNESS
changes are the earliest signs of glaucoma. These
precede even optic nerve head (ONH) and visual
field changes,1,2 making the evaluation of RNFL
thickness a crucial assessment in the early diagnosis of
glaucoma.3–5 Among the various factors associated with
the development and progression of glaucoma, vascular
and hemodynamic factors have been suggested to play an
important role.6,7 Studies8,9 have now demonstrated
vascular insufficiency of the ONH to be an important
parameter in the pathogenesis of glaucomatous optic
neuropathy. Since RNFL is formed by the expansion of
the fibers of the optic nerve, any insufficient blood supply
to the ONH could lead to thinner RNFL causing
glaucomatous optic neuropathy.
Because of the common source of blood supply to the
ONH and peripapillary choroid via the short posterior
ciliary arteries,10–13 it is likely that a relationship exists
between peripapillary choroid and RNFL thickness.
However, to date, no studies have explored the
quantitative relationship between these parameters in
normal subjects, particularly in the general population.
Evaluation of the association between peripapillary
choroidal thickness and RNFL thickness may help better
elucidate the relationship between the structural
parameters that may be useful clinically for assessment of
ONH damage in glaucoma.
With the recent advancement in imaging technology us-
ing spectral-domain optical coherence tomography (SD
OCT), in particular the enhanced depth imaging (EDI)1ALL RIGHTS RESERVED.
technique of SD OCT, objective and quantitative assess-
ment of the peripapillary choroidal thickness is now
possible. The purpose of this population-based, cross-
sectional study was to evaluate the relationship between
peripapillary choroidal thickness and RNFL thickness as
measured by SD OCT in a large population sample of
nonglaucomatous subjects. We further report the distribu-
tion profile of peripapillary choroidal thickness obtained
using our automated choroidal segmentation software14
and RNFL thickness in our population.METHODS
 STUDYPOPULATIONANDDESIGN: Subjects of this study
were enrolled from the Singapore Malay Eye Study
(SiMES), a population-based cohort study of eye diseases
in a Malay population aged 40–80 years in Singapore.
The baseline examination was conducted between 2004
and 2006 and a follow-up examination of the SiMES par-
ticipants was conducted between January 2011 and
December 2013.15 For this study, we consecutively
recruited 478 subjects from SiMES participants who
attended the follow-up examination from February 2012
to July 2013. Written informed consent was obtained
from all participants after explanation of the nature and
possible consequences of the study. The study adhered to
the tenets of the Declaration of Helsinki, and ethics
approval was obtained from the Singapore Eye Research
Institute Institutional Review Board.
 OCULAREXAMINATIONS: Each study participant under-
went a standard ophthalmic examination including mea-
surement of refraction and visual acuity, slit-lamp
biomicroscopy, tonometry, pachymetry, perimetry, ocular
biometry, fundus examination, and SD OCT imaging.
Refraction and corneal curvature were measured using an
autokeratorefractometer (Canon RK 5 Auto Ref-
Keratometer; Canon Inc Ltd, Tochigiken, Japan). Spher-
ical equivalent (SE) was calculated as the sum of the spher-
ical power and half of the cylinder power. Best-corrected
visual acuity (BCVA) was measured monocularly using a
logarithm of the minimal angle of resolution (logMAR)
chart (Lighthouse International, New York, New York,
USA) at a distance of 4 m. Central corneal thickness was
measured using an ultrasound pachymeter (Advent;
Mentor O&O Inc, Norwell, Massachusetts, USA). Ocular
biometry, including axial length (AL), was measured using
noncontact partial coherence interferometry (IOL Master
V3.01; Carl Zeiss Meditec AG, Jena, Germany). Intraoc-
ular pressure (IOP) was measured using Goldmann appla-
nation tonometry (Haag-Streit, Bern, Switzerland) before
pupil dilation. Standardized visual field testing was
performed with static automated white-on-white threshold
perimetry (SITA Fast 24-2, Humphrey Field Analyzer II;2 AMERICAN JOURNAL OFCarl Zeiss Meditec, Inc, Oberkochen, Germany). Slit-
lamp biomicroscopy (Haag-Streit model BQ-900; Haag-
Streit) was performed by the study ophthalmologists to
examine the anterior chamber and lens after pupil dilation
with tropicamide 1% and phenylephrine hydrochloride
2.5%.
Glaucoma was defined using the International Society of
Geographic and Epidemiological Ophthalmology
scheme,16 based on findings from gonioscopy, optic disc
characteristics, and visual fields results (as described
below).
 VISUAL FIELD EXAMINATION: Standardized visual field
testing was performed with static automated perimetry
(Swedish Interactive Threshold Algorithm standard 24-2,
Humphery Field Analyzer II; Carl Zeiss Meditec, Dublin,
California, USA). A visual field was defined as reliable
when fixation losses were less than 20%, and false-
positive and false-negative rates were less than 33%. A
glaucomatous visual field defect was defined as the presence
of 3 or more significant (P < .05) nonedge continuous
points with at least 1 at the P < .01 level on the same
side of the horizontal meridian in the pattern deviation
plot, and classified as ‘‘outside normal limits’’ on the Glau-
coma Hemifield Test, confirmed on 2 consecutive visual
field examinations.
SiMES is part of the Singapore Epidemiology Eye Dis-
eases (SEED) study.17 For the purpose of conformity be-
tween other studies in SEED, we have used Cirrus HD-
OCT for RNFL thickness measurements and Spectralis
SD OCT with EDI for choroidal measurements. In addi-
tion, we believe that the use of 2 SD OCT machines has
its own advantages, as systematic measurement error in 1
machine, if existing, could lead to a biased association be-
tween peripapillary choroidal thickness and RNFL thick-
ness, whereas this could be taken care of by the use of 2
machines.
 RETINAL NERVE FIBER LAYER IMAGING ANDMEASURE-
MENT: Cirrus HD-OCT (software version 6.0; Carl Zeiss
Meditec, Inc, Dublin, California, USA) was used to mea-
sure peripapillary RNFL. After pupil dilation, RNFL scan
acquisitions were performed for each participant using an
optic disc cube 200 3 200 scan protocol, which generates
a cube of data in a 6 mm3 6 mm grid with 2003 200 axial
measurements. In brief, the subject’s pupil was first
centered and focused in an iris viewing camera on the ac-
quire screen, and the line scanning ophthalmoscope
(LSO) with ‘‘auto focus’’ mode was then used to optimize
the view of the retina. The ‘‘center’’ and ‘‘enhance’’ modes
were used to optimize the Z-offset and scan polarization,
respectively, for the OCT scan to maximize the OCT
signal. Rescanning was performed if a motion artifact or
saccades through the calculation circle (3.46 mm diameter
around the ONH) were detected. The OCT scans were
excluded if there was the presence of RNFL or ONH--- 2015OPHTHALMOLOGY
algorithm segmentation failure. All the OCT scans
included in the study had signal strength of at least 6, which
is considered as acceptable quality. RNFL thicknesses
(average, clock hours, and quadrants) were derived auto-
matically from a single scan using the in-built automated
software for segmentation and parameter measurements
without manual operator adjustment.
 PERIPAPILLARY CHOROIDAL THICKNESS IMAGING AND
MEASUREMENT: Peripapillary choroid was imaged using
the EDI mode of the Spectralis SD OCT. EDI is a method
that improves resolution of choroidal details as the zero-
delay line with the highest sensitivity is closer to the
choroid, and more accurate image acquisition is possible
in comparison with those of standard retinal SD OCT
methods.18 Following the Spectralis user manual guide-
lines, subjects’ keratometry readings and the refraction
data were entered into the machine to estimate optical
magnification and, therefore, to allow for more accurate
comparisons across individuals. The peripapillary region
was scanned using a 360 degree, 3.4-mm-diameter circle
that was centered on the optic disc, each comprising 100
averaged scans (using the proprietary automatic averaging
and eye tracking features of the device). Scans were
centered using an internal fixation and centering was
confirmed by a scanning laser ophthalmoscope integrated
into the instrument.
In our study, the Bruch membrane and choroidal-scleral
interface were delineated with the automatic segmentation
algorithm developed by Tian and associates.14 This algo-
rithm demonstrated good consistency with the manual
measurements of choroidal thickness (the average of the
Dice coefficients over 45 tested images was 90.5% with
standard deviation of 3%).14 The peripapillary choroidal
thickness in the optic disc region was automatically
measured as the perpendicular distance between the outer
portion of the hyperreflective line corresponding to the
RPE and the hyporeflective line or margin corresponding
to the choroidal-scleral interface at the 12 discrete loca-
tions (30 degrees apart) and the 4 quadrants. In our
recently published paper19 using automated choroidal seg-
mentation software we have demonstrated excellent intra-
session repeatability (intraclass correlation coefficient
ranging from 0.9998 to 0.999) of peripapillary choroidal
thickness measurement at all 4 quadrants.
 EXCLUSION CRITERIA: For our analyses, we excluded
subjects based on the following criteria: best-corrected
logMAR visual acuity >0.30, SE greater than 6 diopter,
and clinical features compatible with a diagnosis of glau-
coma. The quality of the SD OCT image was assessed prior
to the analysis, and images that had motion artifacts or
were of insufficient quality (signal strength of<6 for Cirrus
OCT and a quality index of <25 decibels for Spectralis
OCT, as suggested by the manufacturer, for the image qual-
ity assurance) for a reliable determination of RNFL thick-VOL. -, NO. - RELATIONSHIP BETWEEN PERIPAPILLARYness and peripapillary choroidal thickness were excluded.
Of the 478 total subjects (947 eyes) examined, 104 eyes
were excluded (5 eyes with best-corrected logMAR visual
acuity >0.30, 14 eyes with SE greater than -6 diopter, 42
eyes with a diagnosis of glaucoma, and 43 eyes with poor
OCT image quality), leaving 843 nonglaucomatous eyes
for final analysis.
 STATISTICAL ANALYSIS: Mean and standard deviation
(SD) of both peripapillary choroidal thickness and RNFL
thickness was calculated in all subjects for clock hours
and 4 quadrants. Associations of peripapillary choroidal
thickness (independent variable of interest) with RNFL
thicknesses (dependent variable) were assessed using linear
regression. Generalized estimating equations (exchange-
able correlation matrix) were used to account for the corre-
lation between pairs of eyes for each individual. Factors
such as age, sex, AL, IOP, diabetic retinopathy, and age-
related macular degeneration were included in the multi-
variate model to adjust for potential confounding. Statisti-
cal significance was set at P < .05 unless otherwise
indicated. The data were analyzed with MedCalc version
12.3 (Medcalc Software, Ostend, Belgium) and SPSS
version 20.0 (SPSS, Inc, Chicago, Illinois, USA).RESULTS
A TOTAL OF 843 EYES FROM 424 SUBJECTSWERE INCLUDED IN
the study. Of the 424 subjects, 363 (85.6%) did not have
any eye diseases; the remaining 61 (14.4%) had eye diseases
including diabetic retinopathy (8.5%) and early (5.2%)
and late (0.6%) age-related macular degeneration. The
included participants’ mean age was 66.74 6 10.44 years
and 258 (60.9%) participants were female. The clinical
characteristics of the included and excluded eyes are shown
in Table 1. Compared to the eyes included in the analysis,
excluded eyes were more myopic and had poor BCVA.
Table 2 presents the distribution of mean peripapillary
choroidal thickness and RNFL thickness measured at 12
clock hours and 4 quadrants (superior, nasal, inferior, and
temporal). The average peripapillary choroidal thickness
was 135.59 6 56.74 mm and the average RFNL thickness
was 92.92 611.41 mm. There are variations in the topo-
graphic profile of peripapillary choroidal thickness and
RNFL thickness among clock hours and different quad-
rants. Peripapillary choroid was thickest (150.04 6
59.72 mm) at the superior quadrant and thinnest (110.71
6 51.61) at the inferior quadrant, whereas RNFL was
thickest (118.60 6 19.83 mm) at the inferior and thinnest
(67.36 6 11.36) at the temporal quadrant.
Table 3 shows the linear regression analyses of the asso-
ciations of peripapillary choroidal thickness (exposure var-
iable of interest) by locations evaluated against RNFL
thicknesses (dependent variable) from the same location3CHOROID AND RNFL THICKNESS
TABLE 2. Distribution of Peripapillary Choroid and Retinal
Nerve Fiber Layer Thickness in Nonglaucomatous Eyes at
Clock-Hour Sectors (30 Degrees Apart) and 4 Quadrants,
With 360-Degree, 3.4-mm-Diameter Peripapillary Circle





Retinal Nerve Fiber Layer
Thickness (mm)
Mean (SD) Mean (SD)
Clock hours
1 138.61 (77.01) 56.95 (11.08)
2 147.09 (70.88) 81.10 (16.00)
3 148.38 (65.03) 115.72 (23.97)
4 150.46 (62.21) 116.95 (26.79)
5 151.06 (59.39) 115.26 (24.91)
6 151.68 (61.06) 81.07 (16.87)
7 145.17 (61.97) 57.38 (11.06)
8 133.58 (58.49) 67.01 (14.72)
9 115.32 (53.67) 113.61 (30.65)
10 102.01 (51.07) 127.30 (28.03)
11 113.25 (57.11) 115.00 (30.08)
12 129.24 (68.31) 67.53 (14.04)
Quadrants
Superior 150.04 (59.72) 116.05 (18.42)
Nasal 143.12 (58.46) 69.69 (11.28)
Inferior 110.71 (51.61) 118.60 (19.83)
Temporal 138.47 (68.65) 67.36 (11.36)
Average thickness 135.59 (56.74) 92.92 (11.41)
SD ¼ standard deviation.
One o’clock corresponded to the temporal region, 4 o’clock to
the superior, 7 o’clock to the nasal, and 10 o’clock to the inferior.
TABLE 1. Comparison of Ocular Characteristics of Included
and Excluded Eyes in Evaluating the Relationship Between




(n ¼ 843 Eyes)
Excluded
(n ¼ 61 Eyes)
P
Valuea
Axial length, mm 23.56 (0.98) 24.27 (1.92) .198
Anterior chamber
depth, mm
3.14 (0.38) 3.00 (0.42) .185
Corneal curvature, mm 7.67 (0.25) 7.64 (0.24) .876
Spherical equivalent, D 0.23 (1.57) 3.19 (5.54) .002
BCVA, logMAR 0.28 (0.45) 0.55 (0.78) .028
Central corneal
thickness, mm
539.72 (32.64) 536.10 (32.16) .063
Intraocular
pressure, mm Hg
14.30 (3.17) 15.48 (4.92) .150
Average RNFL
thickness, mm
92.92 (11.41) 93.11 (11.09) .923
BCVA ¼ best-corrected visual acuity; D ¼ diopter; logMAR ¼
logarithm of theminimal angle of resolution; RNFL¼ retinal nerve
fiber layer.
Data presented are means (standard deviations).
aP value was obtained with generalized estimating equation.(Figure) to calculate regression coefficients (b). In Model
1, including age, sex, and AL, we found that thinner peri-
papillary choroidal thickness was independently associated
with thinner RNFL thickness globally (b¼1.364 mm for
per-SD decrease in peripapillary choroidal thickness,
P ¼ .002) and in the inferior (b ¼ 2.539, P ¼ .001)
and superior (b ¼ 2.492, P ¼ .001) quadrants. In Model
2, including age, sex, AL, IOP, diabetic retinopathy, and
age-related macular degeneration, thinner peripapillary
choroidal thickness was independently associated with
thinner RNFL thickness globally (b ¼ 1.329 mm for
per-SD decrease in peripapillary choroidal thickness,
P ¼ .003) and in the inferior (b ¼ 2.566, P < .001)
and superior (b ¼ 2.348, P ¼ .001) quadrants. In order
to control for potential confounding effect from OCT
signal strengths, we further included signal strength from
both Cirrus and Spectralis OCT in our regression analyses.
The results remained similar after further adjustment for
signal strength (Model 3 in Table 3). However, in all
models, the association was not present in the temporal
quadrant.
DISCUSSION
OUR STUDY PROVIDES THE POPULATION-BASED DATA ON
the quantitative relationship between peripapillary
choroidal thickness and RNFL thickness measured by SD
OCT in nonglaucomatous subjects. We found that thinner4 AMERICAN JOURNAL OFperipapillary choroidal thickness was independently associ-
ated with thinner RNFL thickness globally, in the inferior
and superior quadrants, even after adjusting for relevant
confounders. The results of this study provide evidence
that thinning of the peripapillary choroid is associated
with corresponding RNFL thinning. In terms of topo-
graphic profile, the peripapillary choroid was thickest at
the superior and thinnest at the inferior quadrants, whereas
RNFL was thickest at the inferior and thinnest at the tem-
poral quadrants. Thinnest peripapillary choroid in the infe-
rior quadrant may explain the susceptibility of the inferior
optic nerve region to glaucoma.
To date, none of the studies has thoroughly investigated
the quantitative relationship between peripapillary
choroidal thickness and RNFL thickness in normal sub-
jects, particularly in the general population. Only a few
studies,20,21 when analyzing RNFL as one of the
covariates associated with peripapillary choroidal
thickness, reported no significant correlation, a finding
contrary to our results. Similarly, Maul and associates in
a cross-sectional study of 74 suspects and glaucoma patients
reported no significant association of peripapillary
choroidal thickness with either degree of glaucoma damage--- 2015OPHTHALMOLOGY
TABLE 3. The Associations of Peripapillary Choroidal Thickness With Retinal Nerve Fiber Layer Thickness in a Population-Based
Sample of Nonglaucomatous Eyes (N ¼ 843) Using Generalized Estimating Equation
Model 1a Model 2b Model 3c
Retinal Nerve Fiber Layer Thickness Retinal Nerve Fiber Layer Thickness Retinal Nerve Fiber Layer Thickness
Beta (95% CI) P Value Beta (95% CI) P Value Beta (95% CI) P Value
Average peripapillary choroidal thickness 1.364 (0.497, 2.232) .002 1.329 (0.463, 2.196) .003 1.334 (0.464, 2.205) .003
Inferior peripapillary choroidal thickness 2.539 (1.099, 3.979) .001 2.566 (1.124, 4.009) <.001 2.565 (1.119, 4.010) .001
Superior peripapillary choroidal thickness 2.492 (1.086, 3.898) .001 2.348 (0.937, 3.760) .001 2.340 (0.923, 3.757) .001
CI ¼ confidence interval.
Average, inferior, and superior peripapillary choroidal thickness was regressed with average, inferior, and superior retinal nerve fiber layer
thickness, respectively.
Average, inferior, and superior peripapillary choroidal thicknesses were analyzed per standard deviation decrease.
aAdjusted for age, sex, and axial length.
bAdjusted for age, sex, axial length, intraocular pressure, diabetic retinopathy, and age-related macular degeneration.
cAdjusted for age, sex, axial length, intraocular pressure, diabetic retinopathy, age-related macular degeneration, and signal strength from
Cirrus and Spectralis optical coherence tomography.
FIGURE. Scatterplot showing positive correlation of (Left) average retinal nerve fiber layer (RNFL) thickness with average peripa-
pillary choroidal thickness, (Middle) inferior RNFL thickness with inferior peripapillary choroidal thickness, and (Right) superior
RNFL thickness with superior peripapillary choroidal thickness.or RNFL thickness.22 There are several reasons for this.
First, their peripapillary choroidal thickness measurements
were not automated but involved manual delineation of
the choroidal boundaries, making it not only time
consuming, but also prone to measurement errors. Second,
these studies were performed in clinic-based settings with a
potential selection bias and involved smaller sample sizes
(36 and 76 normal subjects in studies by Ho and associates
and Huang and associates, respectively).20,21 To address
these issues, we therefore developed and used a novel
technique of automated choroidal segmentation14,19 to
objectively and efficiently obtain the thickness of the
peripapillary choroid and investigate its association with
RNFL thickness in a population-based sample.
Interestingly, our results demonstrate significant positive
association between inferior, superior, and average peripa-
pillary choroidal thickness and RNFL thickness (ie,VOL. -, NO. - RELATIONSHIP BETWEEN PERIPAPILLARYthinner peripapillary choroid in these quadrants was associ-
ated with thinner RNFL). A possible reason for the positive
association between these structural features could be
because both ONH and peripapillary choroid shares the
common source of blood supply via the short posterior
ciliary arteries.10–13 Our study supports the hypothesis
that since glaucomatous neurodegeneration occurs at the
ONH,23 it is likely that concurrent choroidal changes
would also occur in the peripapillary region underlying
areas of RNFL thinning. It is also interesting to note that
although the association between peripapillary choroidal
thickness and RNFL in the temporal region was significant
in the univariate analysis, it was abolished after incorpo-
rating age, sex, and AL. We believe that the association
in the temporal region is primarily driven by AL, given
that the temporal region is most influenced by ALmeasure-
ments compared to the other regions.5CHOROID AND RNFL THICKNESS
In terms of topographic profile of peripapillary choroid
and RNFL thicknesses, our results confirmed the asym-
metric distribution of both the peripapillary choroid and
RNFL thicknesses.19,24–26 The mean peripapillary
choroidal thickness and RNFL thickness measurements
showed regional differences, peripapillary choroid being
thickest superiorly and thinnest inferiorly, whereas RNFL
was thickest inferiorly and thinnest temporally. Our
observations of the distribution of peripapillary choroidal
thickness are similar to the results of previous EDI-OCT
studies in normal eyes, which have consistently shown
the inferior region to be the thinnest, compared to other re-
gions.19–21,27,28 Although it remains unclear why the
inferior choroid demonstrates such prominent thinning,
we favor the theory that both the vascular watershed
zone and the embryonic location of the optic fissure
closure may be responsible.29 As the optic fissure is located
in the inferior aspect of the optic cup and is the last part of
the globe to close,30 this regional difference in ocular
development may contribute to the thinner choroid found
in the inferior region. Therefore, development of the ONH
and peripapillary choroid needs to be considered to explain
the spatial distribution of peripapillary choroidal thickness
at different sectors.
Despite RNFL being thickest in the inferior quadrant,
this region is most vulnerable to glaucomatous damage.
Selective and predominant inferior RNFL loss in early
glaucoma is multifactorial. One of the known reasons
for the vulnerability of the inferior region is that the lam-
ina cribrosa of the inferior pole has larger pores and
thinner connective tissue and glial support for passing
retinal ganglion cell axons.31–33 Based on our findings,
this could also possibly be because of the thinnest
peripapillary choroid in the inferior region. We
speculate that thinnest peripapillary choroid in the
inferior quadrant, which represents an area of lower
blood supply, may predispose the inferior region of the
optic nerve to glaucomatous ischemic damage,
suggesting a possible explanation for the observation
that glaucoma typically affects the inferior optic nerve
region first. Peripapillary choroidal thickness as a
surrogate to vascular supply12,13 found a mild to
moderate association, more so with inferior RNFL
thickness, in our study of nonglaucomatous eyes. The
magnitude of association is weak, thus again suggesting
involvement of multiple factors related to inferior RNFL
susceptibility in glaucoma pathogenesis. Further
examination in glaucoma patients would be needed to
confirm this association and to see whether such
association is stronger in glaucomatous eyes.6 AMERICAN JOURNAL OFThe strengths of this study include its population-based
design and a relatively large sample size with a single com-
mon ethnicity. Hence, our findings were unlikely to be
confounded by ethnic heterogeneity. Unlike other studies,
which involvedmanual delineation of choroidal boundaries,
we used an automated choroidal segmentation technique to
objectively obtain the thickness of the peripapillary choroid.
Therefore, our measurements of peripapillary choroidal
thickness are less prone tomeasurement errors. The relation-
ship between peripapillary choroidal thickness and RNFL
was confirmed after adjusting for potential clinical factors.
Nevertheless, this study has a few limitations. First, recent
studies have reported diurnal fluctuations in choroidal thick-
ness in the macular region.34–36 To the best of our
knowledge, there are no data on the association between
diurnal variation and choroidal thickness in the
peripapillary region. Our subjects were examined only at a
single time point, and thus we are not able to take account
of any diurnal variation of peripapillary choroidal
thickness. However, the peripapillary choroidal thickness
measurements in our study were not performed at the same
time of the day; each participant underwent the OCT
examination in a randomized manner with respect to
when the readings were obtained. It seems unlikely that
circadian changes may have influenced the results of our
investigation. Second, owing to the cross-sectional nature
of our study we could identify a structural relationship
between peripapillary choroidal thickness and RNFL thick-
ness, but cannot address the temporal relationship between
these structures.More longitudinal data are needed to clarify
this relationship. Last, our investigation included consecu-
tive participating subjects from a population-based study
and thus some of them had eye diseases. Therefore, the dis-
tribution of peripapillary choroidal thickness and RNFL
thickness determined in this study may represent the thick-
ness not in healthy eyes but in the general adult and elderly
populations. However, this would not affect the observed as-
sociations, because in the multiple regression analysis
models we have adjusted for the potential ocular diseases
in elderly people that might influence peripapillary
choroidal thickness.
In conclusion, the current study demonstrates significant
positive associations between peripapillary choroid and
RNFL thicknesses and examines this structure-structure
relationship. Understanding of the relationship between
these structural parameters may be useful clinically for
assessment of ONH damage in glaucoma. However, this
relationship needs to be explored further in glaucomatous
eyes of varying severity before it is applied in clinical set-
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ABSTRACT.
Purpose: To determine the distribution of choroidal thickness (CT) and ocular
factors associated with CT in high myopic eyes in comparison with emmetropic
eyes of young healthy adults.
Methods: A case–control study of 648 young, male subjects, including 520 high
myopes and 128 emmetropes. Choroidal imaging was performed using enhanced
depth imaging spectral domain optical coherence tomography. Images were
postprocessed using adaptive compensation for quality enhancement. CT was
measured at nine locations, including subfovea and 1.5 and 3 mm nasal,
temporal, superior and inferior to fovea.
Results: TheCTat the subfoveawas signiﬁcantly thinner (mean  standard error:
225.87  5.51 lm)forhighmyopes compared toemmetropes (375.15  6.58 lm,
p < 0.001). Likewise, CT in high myopic group was signiﬁcantly thinner than
emmetropic control group at all locations (p for trend <0.001 for all locations).
Distribution of CT showed a markedly diﬀerent pattern in high myopic eyes
(thickest superiorly at 3 mm, 265.97  5.97 lm) and emmetropic eyes (thickest
subfoveally, 375.15  6.58 lm). Choroid was thinnest at nasal 3 mm location in
both themyopic (108.85  3.97 lm)andemmetropic (238.25  6.72 lm)groups.
Among the ocular factors studied, axial length, posterior staphyloma and chorio-
retinal atrophy were the signiﬁcant predictors of CT.
Conclusions: Highly myopic eyes have signiﬁcantly thinner choroid and showed
diﬀerent distribution pattern, compared to emmetropes. Axial length, posterior
staphyloma and chorio-retinal atrophy are the strongest determinants of CT.
Key words: case-control study – choroidal thickness – EDI SD-OCT – high myopia
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Introduction
Pathological myopia or high myopia is
one of the leading causes of visual
impairment in the world (Fredrick
2002; Hayashi et al. 2010). Although
the prevalence of high myopia (deﬁned
as 6.0 dioptres or more) varies with
ethnic groups and countries, high myo-
pia is more common in Asian popula-
tions with rates of 9–21%, (Wong et al.
2000; Lin et al. 2004) compared with 2–
4% inwhite people (Hofman et al. 1991;
Wang et al. 1994; Attebo et al. 1999).
In pathological myopia, excessive
axial elongation of globe can cause
biomechanical stretching and thinning
of choroid and retinal pigmented epi-
thelium layers, leading to increased risk
of chorioretinal complications such as
choroidal neovascularization, posterior
staphyloma, lacquer cracks in Bruch’s
membrane and myopic foveoschisis,
which may lead to visual loss (Curtin
& Karlin 1971; Curtin 1982; Noble &
Carr 1982; Avila et al. 1984; Ohno-
Matsui & Tokoro 1996; Wu et al. 2001;
Vongphanit et al. 2002; Hsiang et al.
2008; Cheung et al. 2013; Jonas et al.
2014).
As some of the earliest changes in
pathological myopia begin in the
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choroid, choroidal thickness (CT)
could be an important parameter to
study the pathogenesis of macular
vision loss in high myopia. The thick-
ness of the choroid can be measured by
enhanced depth imaging (EDI) spectral
domain optical coherence tomography
(SD-OCT) (Spaide et al. 2008) in a
variety of ocular diseases (Kim et al.
2013; Hashizume et al. 2014; Tan et al.
2014; Zhou et al. 2014). Using this
method, studies have now shown that
myopic eyes have thinner CT (ranging
from: 93.2  62.5 to 156.07 
86.39 lm) (Fujiwara et al. 2009; Ikuno
& Tano 2009; Flores-Moreno et al.
2013; Ho et al. 2013) compared to
emmetropes (normal range of subfo-
veal CT: 191  74.2 to 354  111 lm)
(Margolis & Spaide 2009; Ikuno et al.
2010; Fujiwara et al. 2012; Wei et al.
2013). However, these studies were
either conducted on small sample pop-
ulations (Fujiwara et al. 2009; Ikuno &
Tano 2009) or were mainly limited in
their assessment of CT to horizontal
locations only (Flores-Moreno et al.
2013; Ho et al. 2013). To the best of
our knowledge, there are no studies
which investigated CT by severity of
myopia and the distribution of CT and
assessed ocular factors associated with
CT in Asian eyes. Knowledge of such
factors is crucial before drawing infer-
ences on how CT inﬂuences the devel-
opment of pathological myopia.
The aim of our study was to com-
pare the distribution of CT in diﬀerent
myopic groups based on the degree of
myopia and to assess ocular determi-
nants of macular CT measured by EDI
SD-OCT. We used a case–control
study approach of young, highly myo-




A total of 28 908 male adults were
screened for myopia (mean age  SD:
19.8  1.2 years; range: 17–29 years)
from 2009 to 2010 as part of a
mandatory medical eye review for
employment purposes. Measured using
non-cycloplegic autorefraction (Huvitz
MRK-3100P), 2584 persons were iden-
tiﬁed to have myopia with spherical
equivalent (SE) of 6.0 dioptres (D) or
worse. Of these 2584 persons, 719 were
selected on the basis of a refractive
error-stratiﬁed random sampling strat-
egy and underwent a further compre-
hensive ophthalmologic examination at
Singapore Eye Research Institute from
December 2011 to June 2012. Their SE
was further conﬁrmed by subjective
refraction, and those with SE >6.0 D
(n = 96) were excluded, leaving 623
subjects with high myopia (251 with
SE between 6.0 and 8.0 D; 207 with
SE between 8.0 and 10.0 D; 165
with SE 10.0 D or worse). In addi-
tion, 151 emmetropes who had
SE < 0.5 D in both eyes measured
using autorefraction were recruited as
controls and went through a similar
ophthalmologic examination. Subjects
were further excluded if they did not
give consent to take part in this medical
review, had any previous ocular trauma
or surgery, and those with other clini-
cally signiﬁcant ocular comorbidity.
Written informed consent was taken
from the subjects and their parents/
guardians (if they were 21 years old
and below). Ethics approval was
obtained from the Institutional Review
Board of DSO National Laboratories,
Singapore. The study was conducted in
accordance with the tenets of the
World Medical Association’s Declara-
tion of Helsinki.
Ophthalmic examination and measure-
ments
Each subject underwent a standardized
questionnaire and a complete ophthal-
mologic examination. The subjects
were asked a series of questions, such
as previous ocular trauma or surgery,
history of ocular diseases.
Their refractive error screened with
autorefraction (Canon Autorefractor
RK-F1; Canon Inc. Ltd., Tochigiken,
Japan) and conﬁrmed with manifest
refraction in which the best corrected
visual acuity, which was measured
monocularly using a logarithm of the
minimum angle of resolution (Log-
MAR) chart (Lighthouse Interna-
tional, New York, NY, USA) at a
distance of 4 m, was performed. Con-
trast sensitivity (CS) was measured
using the Rabin super vision test
(Davies et al. 2004), with and without
a night vision goggle ﬁlter (SVT-NVG)
and low and high luminance log CS
were taken for this test. The NVG ﬁlter
used was a dark green, low-luminance
ﬁlter which slides in place in front of
the illuminated chart, reducing chart
luminance (from 100 to 4 cd/m2) to
simulate the low luminance (i.e. wear-
ing NVG). To minimize memorization
of optotypes, two diﬀerent sequences
were displayed for right and left eyes
and measurement of CS was recorded
by counting the number of letters
correctly read by the subjects using
the Conversion Table.
Biometry measurements, that is axial
length (AL), anterior chamber depth,
and K-readings, were obtained from
the non-contact Zeiss IOL Master
(V3.01; Carl Zeiss Meditec AG, Jena,
Germany). Intraocular pressure (IOP)
was measured using non-contact to-
nometry (Auto Non-Contact Tonome-
ter, NT-3000; Nidek, Gamagori, Aichi,
Japan), and if IOP was found to be
21 mmHg or more, a further IOP
measurement using Goldmann appla-
nation tonometry (Haag-Streit, Bern,
Switzerland) was performed by study
ophthalmologists.
Subjects underwent slit-lamp exami-
nation. Binocular indirect ophthalmos-
copy was performed approximately
30 min after topical instillation of three
drops of tropicamide and 2.5% phen-
ylephrine, given 5 min apart. Dilated
fundus examination was carried out
by ophthalmologists. The presence
and type of peripheral retinal degen-
erations and vitreous degenerations
were systematically documented. Fun-
dus photography was performed using
non-mydriatic retinal camera (Canon
CR-DGi with a 10-DSLR back,
Tokyo, Japan).
OCT imaging
The retina, optic disc and choroidal
architectural parameters were deter-
mined using SD-OCT (Spectralis,
Wavelength: 870 nm; Heidelberg Engi-
neering, Heidelberg, Germany). Cho-
roid was imaged with EDI modality
after pupil dilation. EDI is a method
that improves resolution of choroidal
detail by automatically setting the
choroid closer to the zero-delay line
and thus theoretically provides better
visualization of the choroid scleral
interface (CSI) than in standard retinal
SD-OCT images. Radial scan consist-
ing of six sections, each comprising 100
averaged scans (using the automatic
averaging and eye tracking features of
the proprietary device), was obtained
in an angle of 30° centred onto the
fovea (30° angles between the lines).
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The horizontal and vertical sections
passing through the centre of the fovea
were selected for analysis. Following
Spectralis user manual guidelines, sub-
jects’ keratometry readings and refrac-
tion were entered into the Spectralis’
software before imaging choroid to
estimate optical magniﬁcation, thus
allowing for more accurate compari-
sons across individuals. However,
Spectralis OCT does not allow AL
to be input; our methods may still
have residual errors (2–7%) (Garway-
Heath et al. 1998) due to ocular
magniﬁcation from methods that
additionally uses AL. For each sub-
ject, only right eye was chosen for
subsequent analysis.
Measurement of choroidal thickness
As an accurate evaluation of the CT
with EDI-OCT relies mainly on the
visibility of CSI, which anatomically
represents the junction between the
choroid and the sclera and is a princi-
pal landmark for quantitative measure-
ments of choroid. Therefore, in our
study, To accurately determine CT,
CSI was enhanced using our novel
technique of adaptive compensation
described in detail elsewhere (Girard
et al. 2011; Mari et al. 2013; Gupta
et al. 2014). Our method has shown
higher intra- and intergrader reliability
of CT measurements compared to
conventional method (Gupta et al.
2014).
The CT in the enhanced images was
measured as the perpendicular distance
between the outer portion of the hyper-
reﬂective line corresponding to the
RPE (automatically detected by the
instrument) to the now clear hypore-
ﬂective line or margin corresponding to
the CSI (manually drawn by an expe-
rienced grader, who was masked to
subject characteristics and clinical diag-
nosis) at the following locations: sub-
fovea and 1.5 and 3 mm nasal,
temporal, superior and inferior to
fovea. As there was no signiﬁcant
diﬀerence between the horizontal and
vertical subfoveal CT (horizontal
SFCT = 225.87 lm, vertical SFCT =
232.09 lm, p = 0.399), only horizontal
CT was used for analysis. In addition,
we evaluated the intra-observer reli-
ability of CT measurements in both the
myopic and emmetropic group. Forty
randomly selected Spectralis images (20
from each group) were assessed again
by the same grader (grader 1 versus
grader 1) after an interval of 1 week.
Statistical analysis
Subjects were excluded from analysis if
they had any history of anterior ocular
diseases, previous ocular trauma, evi-
dence of macular or vitreoretinal dis-
eases or any form of refractive surgery
performed in their eyes. However,
conditions such as peripapillary
atrophy, lacquer crack, posterior
staphyloma or chorio-retinal atrophy
were not excluded, as they are com-
monly seen in high myopic eyes. Sta-
tistical analysis was performed using
SPSS version 17.0 (SPSS, Inc., Chicago,
IL, USA) and MEDCALC version 12.3
(MedCalc Software, Ostend, Belgium).
The demographics and ocular
parameters between myopic and con-
trol eyes were compared using inde-
pendent t-tests. The intrasession
repeatability of the CT was measured
by the absolute agreement model of the
intraclass correlation coeﬃcient (ICC)
(Fleiss & Cohen 1973). For the purpose
of analyses, myopic eyes were divided
into three groups based on SE: <6 to
8 D, <8 to 10 D and <10 D.
Generalized linear model was used to
assess the mean CT across diﬀerent
locations in eyes with varying degree of
myopia, and conditions such as poster-
ior staphyloma and chorio-retinal atro-
phy were included to adjust for
potential residual confounding.
Repeated-measures analysis of vari-
ance (ANOVA) with Bonferroni post-test
was used to compare mean thickness at
various locations within each group.
Univariate and multiple linear regres-
sion analyses were performed to deter-
mine the association of ocular factors
(independent variables) with CT mea-
surements (dependent variables). For
multiple linear regression, age and
factors which showed signiﬁcant asso-
ciation in univariate analysis (p < 0.05)
were included.
Results
Of the 623 eligible high myopes
(SE ≤ 6.0 D), we further excluded
103 subjects because either their cho-
roidal images were not successfully
attained (n = 69) or the available
images were not of optimal quality to
perform accurate measurements
(n = 31) or they did not meet the
inclusion criteria (n = 3), leaving 648
subjects (520 high myopes and 128
emmetropes) with complete data on
CT for analysis.
The mean age of included myopic
and emmetropic subjects was 21.59 
1.15 years and 22.06  0.97 years,
respectively. The mean SE was
8.68  2.05 dioptres (range, 6 to
23 D) for myopic group and
0.12  0.24 dioptres for emmetropic
group. Among the myopic group, all
our subjects had peripapillary atrophy,
35.6% had posterior staphyloma, 6.5%
had chorio-retinal atrophy and 2% had
lacquer cracks. The demographics and
ocular characteristics of the study pop-
ulation are shown in Table 1. In terms
of reliability of CT measurements, the
intra-observer reliability for myopic
(ICC: 0.95–0.98) and emmetropic
group (ICC: 0.95–0.97) was excellent
for all locations of CT (Table 2).
CT varied signiﬁcantly across the
myopic subgroups and the emmetropic
control group at all the locations (p for
trend <0.001 for all locations, Table 3).
It was signiﬁcantly thinner in the more
myopic eyes over a range of eccentric-
ities, and the pattern of distribution
was diﬀerent from emmetropes
(Fig. 1A,B). Across the three myopic
subgroups, CT was found to be thick-
est at the superior location, followed by
the temporal, subfoveal, inferior and
the nasal locations (p < 0.001 by
repeated-measures ANOVA). In compar-
ison, the choroid in emmetropic eyes
was thickest at the fovea, followed by
the superior, inferior, temporal and the
nasal locations (p < 0.001 by repeated-
measures ANOVA). However, in both the
myopia and emmetropic groups, cho-
roid was thinnest at the nasal location
being 108.85 lm and 238.25 lm in
myopic and emmetropic group, respec-
tively (Fig. 1A,B).
In the univariate analysis, SE, AL,
corneal curvature, presence of poster-
ior staphyloma and chorio-retinal atro-
phy were signiﬁcantly associated with
SFCT (all p < 0.05, Table 4 and
Fig. 2). For each mm increase in AL
and corneal curvature, SFCT on aver-
age decreased by 32.31 lm (p < 0.001)
and 84.31 lm (p < 0.001), respectively.
A decrease in mean SFCT by 13.10 lm
was observed for each myopic dioptre
increase (p < 0.001). Presence of pos-
terior staphyloma and chorio-retinal
atrophy decreased the mean SFCT by
22.69 lm and 26.91 lm respectively.
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Both AL and SE inﬂuenced CT but a
larger extent from AL. The results
remained similar after adjusting for
age (data not shown).
Because of collinearity between AL
and SE (correlation coeﬃ-
cient = 0.65), only AL was selected
and retained in the multivariate analy-
sis as it had a greater explanatory
power on CT change than did SE
(standardized b, 0.489 versus 0.348).
In the multiple linear regression analy-
sis, AL, presence of posterior staphy-
loma and chorio-retinal atrophy
remained signiﬁcantly associated with
CT (all p < 0.05), whereas the associ-
ation with corneal curvature was abol-
ished (p = 0.975). However, there was
no change in results after adjusting for
age.
In addition, SFCT correlated nega-
tively with the logMAR visual acuity
(r = 0.085, p = 0.054) and log low
luminance CS (r = 0.115, p = 0.009)
although the association was not sta-
tistically signiﬁcant in multivariate
analysis (Fig. 3).
Discussion
Although the understanding of the
characteristics of the in vivo choroid
has increased substantially in recent
years, to date, only a few studies have
examined CT in high myopia. To our
best knowledge, this study measured
CT directly with EDI SD-OCT in the
largest group of young, high myopic
Asian subjects. CT in the myopic group
was signiﬁcantly lower than that of the
emmetropic control group at any loca-
tions. We demonstrated further
decrease in CT with increase in degree
of myopic refractive error. CT distri-
bution follows a diﬀerent proﬁle in
Table 2. Intragrader reliability of choroidal thickness measurements in myopic and emmetropic










Subfoveal 0.98 (0.96–0.99) 9.9 (11.3) 0.97 (0.95–0.99) 11.5 (17.7)
Nasal, 1.5 mm 0.96 (0.93–0.98) 9.6 (14.8) 0.96 (0.93–0.98) 10.1 (20.6)
Nasal, 3 mm 0.94 (0.87–0.97) 8.0 (14.4) 0.96 (0.93–0.98) 15.0 (20.8)
Temporal, 1.5 mm 0.97 (0.93–0.98) 9.1 (14.8) 0.97 (0.94–0.98) 14.3 (19.4)
Temporal, 3 mm 0.97 (0.94–0.98) 10.8 (13.0) 0.96 (0.91–0.98) 11.1 (18.5)
Superior, 1.5 mm 0.96 (0.93–0.98) 7.5 (16.2) 0.95 (0.90–0.98) 13.2 (20.4)
Superior, 3 mm 0.95 (0.90–0.98) 9.2 (17.8) 0.97 (0.94–0.99) 14.9 (17.2)
Inferior, 1.5 mm 0.97 (0.95–0.99) 11.0 (13.5) 0.96 (0.92–0.98) 14.7 (18.0)
Inferior, 3 mm 0.96 (0.93–0.98) 8.6 (17.0) 0.97 (0.94–0.99) 13.1 (18.5)
ICC = intraclass correlation coeﬃcient; CI = conﬁdence interval; SD = standard deviation.
* Mean diﬀerence was determined from the 1st measurement minus 2nd measurement.









(D) (N = 169)
Myopia > 10










Subfoveal 375.15 (6.58) 241.54 (6.63) 223.90 (7.14) 210.60 (7.13) 225.87 (5.51) 15.74 <0.001
Nasal, 1.5 mm 324.01 (6.59) 187.01 (6.17) 165.27 (6.66) 150.70 (6.64) 168.35 (5.18) 18.60 <0.001
Nasal, 3 mm 238.25 (6.72) 121.19 (4.76) 106.90 (5.13) 97.13 (5.12) 108.85 (3.97) 12.30 <0.001
Temporal, 1.5 mm 359.27 (6.51) 249.52 (6.38) 235.82 (6.87) 223.47 (6.85) 236.64 (5.27) 13.10 <0.001
Temporal, 3 mm 328.41 (6.04) 251.51 (6.02) 243.83 (6.49) 235.77 (6.47) 243.88 (4.94) 07.84 <0.001
Superior, 1.5 mm 365.01 (5.66) 263.84 (7.05) 250.70 (7.59) 238.81 (7.57) 251.47 (5.81) 12.59 <0.001
Superior, 3 mm 358.03 (5.74) 278.23 (7.25) 263.61 (7.81) 254.64 (7.79) 265.97 (5.97) 12.14 <0.001
Inferior, 1.5 mm 358.93 (6.14) 243.27 (6.32) 219.94 (6.81) 202.87 (6.79) 222.74 (5.32) 20.59 <0.001
Inferior, 3 mm 339.41 (6.30) 232.76 (6.25) 214.86 (6.74) 199.84 (6.72) 216.32 (5.21) 16.63 <0.001
p < 0.001* p < 0.001* p < 0.001* p < 0.001* p < 0.001*
Data are mean (standard error) in lm, adjusted for presence of posterior staphyloma and chorio-retinal atrophy.
† Adjusted for presence of posterior staphyloma and chorio-retinal atrophy.
* Repeated-measures ANOVA, comparing the distribution of choroidal thickness across fovea, nasal (3 mm), temporal (3 mm), superior (3 mm) and
inferior (3 mm) locations.
Table 1. Baseline characteristics of study subjects.
Myopes (n = 520) Emmetropes (n = 128) p-value
Age, years 21.59 (1.15) 22.06 (0.97) <0.001
Axial length, mm 27.32 (1.16) 23.69 (0.62) <0.001
Anterior chamber depth, mm 3.74 (0.25) 3.46 (0.27) <0.001
Corneal curvature, mm 7.76 (0.25) 7.85 (0.41) 0.137
Spherical equivalent, D 8.68 (2.05) 0.12 (0.24) <0.001
Best corrected visual acuity Log MAR 0.01 (0.08) 0.09 (0.06) <0.001
Log low luminance contrast sensitivity 0.36 (0.28) 0.50 (0.20) <0.001
Log high luminance contrast sensitivity 0.66 (0.33) 0.88 (0.21) <0.001
Intraocular pressure, mmHg 16.12 (2.94) 15.26 (2.74) 0.002
Data are mean (SD).
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high myopia (thickest CT superiorly),
compared to emmetropia (thickest CT
subfoveally). Among the range of
ocular factors studied, AL, presence
of posterior staphyloma and chorio-
retinal atrophy were the signiﬁcant
predictors of CT.
Our study provided new data on CT
and severity of myopia. There were
signiﬁcant diﬀerences in the mean CT
among myopic subgroups and the em-
metropic group at various eccentricities
(p for trend <0.001 for all locations).
Myopes had signiﬁcantly thinner cho-
roid compared to emmetropes at all
eccentricities. Our ﬁndings are consis-
tent with previous experimental animal
studies (Wallman et al. 1995; Shaikh
et al. 1999; Troilo et al. 2000) which
have shown that chicks developing
experimentally induced myopia show
profound thinning of choroid (Troilo
et al. 2000). The mean SFCT in myopic
group was 225.87  5.51 lm, which is
much thicker than those reported in
previous studies that showed a mean
CT of 93.2 (Fujiwara et al. 2009) to
115.5 (Flores-Moreno et al. 2013) lm
(Table 5). In Table 5, on performing a
metaregression on various studies to
quantify the change in mean CT with
SE adjusting for age, we found no
signiﬁcant association between SE and
mean CT (b = 0.429, p = 0.952) indi-
cating AL to be a more important
predictor of CT than SE. The mean
SFCT in emmetropes was 375.15 lm
which is also thicker than previous
studies that reported a mean thickness
of 272–354 lm (Spaide et al. 2008;
Margolis & Spaide 2009; Esmaeelpour
et al. 2010; Manjunath et al. 2010).
The diﬀerences in CT in our study
compared to other studies could be
because of diﬀerences in participants’
characteristics, such as age, refractive
error and ethnicity. Our study partici-
pants are twice as young, mean age
21.63 years compared to other studies
(Fujiwara et al. 2009; Ikuno & Tano
2009; Margolis & Spaide 2009; Es-
maeelpour et al. 2010; Manjunath
et al. 2010; Flores-Moreno et al.
2013). In addition, there were varia-
tions in OCT device characteristics
such as wavelength, eye tracking
method and averaging software among
studies. In our results, CT decreased
with increase in severity of myopic
refractive error. The ﬁndings suggest
that thinning or abnormalities of cho-
roid play a role in the pathogenesis of
myopic degeneration and thus visual
impairment.
We found that CT in highly myopic
eyes was thickest superiorly and thin-
nest nasally. In comparison, the cho-
roid in normal eyes was thickest at the
fovea and thinnest nasally. The
observed pattern of CT distribution in
our study is similar to the previous
studies, in both myopes (Ikuno & Tano
Emmetrope, –0.5 to 1D 
Myopia, <–6 to –8D
Myopia, <–8 to –10D
Myopia, <–10D
Locations on horizontal axis Locations on vertical axis
(A) (B)
Fig. 1. Graph showing the diﬀerences in macular choroidal thickness (CT) in the high myopic groups and emmetropic group along the horizontal axis
(A) and vertical axis (B). Mean thickness at each of the nasal, temporal, superior and inferior locations measured at 1.5 and 3 mm intervals eccentric
to the subfoveal area. Error bars indicate standard error. SFCT is subfoveal CT.
Table 4. Association of ocular factors with subfoveal choroidal thickness in all myopes (n = 520).










Spherical equivalent, D 13.109 0.348 <0.001 – – –
Axial length, mm 32.319 0.489 <0.001 24.232 0.370 <0.001
Corneal curvature, mm 84.318 0.279 <0.001 0.397 0.001 0.975
Anterior chamber depth, mm 8.200 0.027 0.541 – – –
Intraocular pressure, mmHg 0.714 0.027 0.535 – – –
Posterior Staphyloma 22.698 0.443 <0.001 15.642 0.306 <0.001
Chorio-retinal atrophy 26.910 0.289 <0.001 10.585 0.114 0.003
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2009; Goldenberg et al. 2012) and
emmetropes (Margolis & Spaide
2009). Fujiwara et al. (2009) measured
CT in high myopes only in the hori-
zontal meridian and reported CT to be
thickest temporal to the fovea (Hsiang
et al. 2008). Two possible reasons for
the relative choroidal thinning nasally
and inferiorly in normal eyes are the
choroidal watershed and the fetal cho-
roidal ﬁssure, which closes inferiorly at
7 weeks (Sadler 2006). In summary, the
current thickness data agreed with the
previous studies.
We found a signiﬁcant negative
association of SFCT with AL. In high
myopia because of axial elongation,
both the retina and choroid are
stretched (Yanoﬀ & Fine 1989; Lim
et al. 2005; Lam et al. 2007) leading to
thinning (Fujiwara et al. 2009; Ikuno
& Tano 2009; Margolis & Spaide
2009). However, thinner choroid is still
adequate to nourish proportionally
thin retina which is consistent with
fairly normal visual functions in ado-
lescents and young adults with high
myopia than their aged counterparts
which undergoes further age-related
reduction in choroid (Fujiwara et al.
2009). In contrast, in non-myopic
elderly eyes, thinner choroid may not
be adequate to supply the relatively
thick retina which might in turn inﬂu-
ence visual function. We therefore
speculate that the relatively thin cho-
roid in young myopes may be physio-
logically suﬃcient, although the same
CT may be considered pathologic in
older eyes without myopia.
In contrast to Nishida’s study (Nish-
ida et al. 2012) that demonstrated CT
to be an important predictor of visual
acuity in high myopes, we did not ﬁnd
a signiﬁcant correlation between SFCT
and visual acuity. They speculated that
a thin choroid may deliver decreased
amounts of oxygen and nutrients to the
retina, thus potentially aﬀecting signal
generation from the photoreceptors or
cause loss of the overlying photorecep-
tors as a consequence (Nishida et al.
2012). The discrepancy may be due to
diﬀerences in age groups and CT
between our study and Nishida’s study.
The mean age of the participants in
Nishida et al. study was 57 years, and
with the advancing age, the choroid
may undergo further age-related atten-
uation (Fujiwara et al. 2009; Margolis
(C)(A) (B)
Fig. 2. (A) Scatterplot showing negative correlation between subfoveal choroidal thickness (CT) and axial length in all myopes. (B) Scatterplot
showing positive correlation between subfoveal CT and spherical equivalent in all myopes. (C) Scatterplot showing negative correlation between
subfoveal CT and corneal curvature in all myopes.
(A)
(B)
Fig. 3. (A) Scatterplot showing negative correlation between LogMAR visual acuity and
subfoveal choroidal thickness (CT) in all myopes. (B) Scatterplot showing negative correlation
between Log contrast sensitivity and subfoveal CT in all myopes.
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& Spaide 2009). A substantially thinner
choroid (113.3 lm) observed in Nish-
ida’s study suggests that the magnitude
of thinning is likely the reason for the
observed relationshipwith visual acuity,
that is there is a threshold level of
choroidal thinning, beyond which reti-
nal function becomes compromised.
Thus, available supply from choroid
may not be suﬃcient to support outer
retina, the RPE and even the choroid
itself, whichmay explain why vision was
aﬀected. In contrast, our young partic-
ipants with thicker choroid (225.87 lm)
retained their retinal function and there-
fore enjoyed better vision. In addition,
their results may be confounded by
other ocular comorbidities due to age-
ing, while our study involved younger
subjects with few ocular comorbidities,
and thus, the results are less complicated
by confounding factors.
Presence of posterior staphyloma, a
hallmark of high myopia, was signiﬁ-
cantly associated with choroidal thin-
ning. Similar results were reported in
the previous studies which demon-
strated posterior staphyloma forma-
tion as a key factor in choroidal
thinning in highly myopic eyes (Fujiw-
ara et al. 2009; Ikuno & Tano 2009).
This association is probably because in
myopic eyes with posterior staphylo-
ma, choroidal circulation is altered
with marked attenuation and reduction
in number of large choroidal vessels
(Quaranta et al. 1996). In addition,
there is a shift in the entry site of the
posterior ciliary arteries towards the
staphyloma’s border leading to scarce
choroidal arterial network in the area
occupied by staphyloma (Moriyama
et al. 2007). Thus, all these changes
lead to choroidal thinning in eyes with
staphyloma.
The study has several strengths. Our
study has a relatively large sample size,
and EDI SD-OCT images were
enhanced using adaptive compensation
(Wang et al. 1994) to improve CSI
visibility. Therefore, the CT measure-
ments obtained in our study are likely
more reliable and accurate. Unlike
other studies, our study included an
emmetropic group, and therefore, we
could examine the diﬀerences between
highly myopic eyes and non-myopic
eyes in our case–control study. The
study also has some limitations. First,
due to our cross-sectional study design,
we were unable to determine the causal
relationships between the various risk
factors and CT. Second, all of our
study subjects were males, and thus,
some of our ﬁndings may not be
generalized to females. Previous studies
have shown higher CT in men than in
women adjusting for age and AL (Li
et al. 2011). Third, by not taking into
account AL to correct for ocular mag-
niﬁcation, there may still be some
residual error. Lastly, only horizontal
and vertical scan lines were used to
determine the CT proﬁle. A denser
scanning protocol is likely to provide
further insights regarding the thickness
proﬁle across the posterior pole. While
denser scanning protocols may not be
feasible with manual segmentation and
large subject numbers, the development
of automated choroidal segmentation
methods opens the door for potential
future studies to use denser scanning
protocols to determine the topograph-
ical thickness proﬁle of the choroid,
which will likely provide additional
insights into the changes in the choroid
associated with myopia.
Conclusion
Our study shows that CT is signiﬁ-
cantly lower in high myopic eyes.
Macular CT distribution follows a
diﬀerent proﬁle in high myopia
compared to emmetropes. AL, pres-
ence of posterior staphyloma and cho-
rio-retinal atrophy are the signiﬁcant
predictors of CT in high myopia and
must be taken into account when
interpreting the data on CT. Given
the large number of people with myo-
pia in the world, these ﬁndings seem to
have widespread implications.
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PURPOSE. To describe the topography and predictors of peripapillary choroidal thickness
(PPCT) in highly myopic eyes of young, healthy, Asian subjects.
METHODS. A total of 870 young male subjects aged 21.63 6 1.15 years were recruited from the
Singapore military. Choroidal imaging was performed using enhanced depth imaging (EDI)
spectral-domain optical coherence tomography (SD-OCT). Peripapillary choroidal thickness
was manually measured at eight locations around the optic disc.
RESULTS. We analyzed 448 subjects with high myopia (defined as spherical equivalent [SE]
worse than 6.0 diopters [D]) and 116 with emmetropia (SE > 0.5 and < 0.5 D). The mean
SE was 8.52 6 1.20 D for the high-myopic group, and 0.11 6 0.24 D for the emmetropic
group. The mean peripapillary choroid was significantly thinner (142.62 6 43.84 lm) in high
myopes compared with emmetropes (181.90 6 46.43 lm, P < 0.001). Likewise, PPCT
showed further decrease with increase in degree of myopic refractive error. Distribution of
PPCT showed a markedly different pattern in high-myopic eyes (thickest superiorly) and
emmetropic eyes (thickest temporally). However, peripapillary choroid in both the groups
was thinnest at the inferior location. Among the ocular factors studied, axial length, IOP,
presence of posterior staphyloma, and chorioretinal atrophy were the factors significantly
associated with PPCT.
CONCLUSIONS. Highly myopic eyes have significantly thinner peripapillary choroid and showed
different distribution of thickness, compared with emmetropes. Axial length, IOP, and
presence of posterior staphyloma and chorioretinal atrophy significantly influence PPCT and
should be taken into consideration during clinical interpretation of PPCT measurement.
Keywords: myopia, peripapillary choroidal thickness, spectral-domain optical coherence
tomography
The choroid contributes blood supply not only to the outerretina1 including retinal pigmented epithelium (RPE) and
photoreceptors, but also to the prelaminar portion of the optic
nerve.2 Given the role of the choroidal vasculature in the blood
supply of the anterior optic nerve head, a variety of ocular
pathologies including glaucoma3,4 and high myopia5 occur in
the peripapillary choroidal region. High myopia itself is also
associated with a high prevalence of retinal complications such
as posterior staphyloma,6,7 lacquer cracks,8 chorioretinal
atrophy as well as optic disc changes, such as oval configura-
tion, larger area of peripapillary atrophy, and disc tilt and
rotation,9 which may potentially affect the thickness and
distribution profile of peripapillary choroid. Quantitative
analysis of peripapillary choroidal thickness (PPCT) may help
elucidate the mechanisms through which the peripapillary
choroid affects these diseases. With the advancement in
imaging technology, optical coherence tomography–based
enhanced depth imaging (EDI-OCT)10 provides an easy and
noninvasive way to measure PPCT.
Several studies have previously compared choroidal thick-
ness in the macula area between myopes versus healthy
eyes.11–15 However, none of the studies have explored the
distribution of choroidal thickness around the optic disc in high
myopes. Although a few studies have also reported on the
characteristics of PPCT in healthy eyes,16–19 most were
performed retrospectively in relatively small clinic-based
samples, and thus generalization of findings may be limited.
The aim of our study was to quantify and compare the pattern
of distribution of PPCT based on the degree of myopia and to
determine the ocular determinants of PPCT measured by EDI
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spectral-domain (SD)-OCT in an Asian sample. We used a case-
control study approach of young, highly myopic, and
emmetropic healthy male adults selected from a large
population from the Singapore military. Accurate and reliable
measurements of PPCT and knowledge of its normal distribu-
tion is of clinical importance in the diagnosis and management
of diseases where choroid is implicated in the pathophysiology.
MATERIALS AND METHODS
Study Population and Design
A total of 28,908 male adults were screened for myopia (mean
age 6 SD: 19.8 6 1.2 years; range, 17–29 years) from 2009 to
2010 as part of a mandatory medical eye review for
employment purposes. Measured using noncycloplegic autor-
efraction (Huvitz MRK-3100P; Huvitz Co., Ltd., Geumjeong-
dong, Gunpo-si Gyeonggi-do, South Korea), 2584 persons were
identified to have myopia with spherical equivalent (SE) of
6.0 diopters (D) or worse. Of these 2584 persons, 719 were
selected on the basis of a refractive error–stratified random
sampling strategy and underwent a further comprehensive
ophthalmologic examination at Singapore Eye Research
Institute from December 2011 to June 2012. Their SE was
further confirmed by subjective refraction, and those with SE
less than6.0 D (n¼ 96) were excluded, leaving 623 subjects
with high myopia (251 with SE between 6.0 D and 8.0 D;
207 with SE between8.0 D and10.0 D; 165 with SE10.0 D
or worse). In addition, 151 emmetropes who had SE between
60.5 D in both eyes measured using autorefraction were
recruited as controls and went through a similar ophthalmo-
logic examination. Subjects were further excluded if they did
not give consent to take part in this medical review, had any
previous ocular trauma or surgery, and those with other
clinically significant ocular comorbidity.
Written informed consent were taken from the subjects and
their parents/guardians (if they were 21 years old and
younger). Ethics approval was obtained from the institutional
review board of Singapore Eye Research Institute, Singapore.
The study was conducted in accordance with the tenets of the
World Medical Association’s Declaration of Helsinki.
Ophthalmic Examination and Measurements
Objective refraction was measured using Canon Autorefractor
RK-F1 (Tokyo, Japan). Spherical equivalent was calculated as
the sum of the spherical power and one-half of the cylinder
power. Best-corrected visual acuity (BCVA), in which refraction
was corrected, was measured monocularly using a logarithm of
the minimum angle of resolution (logMAR) chart (Lighthouse
International, New York, NY, USA) at a distance of 4 m.
Biometry measurements (i.e., axial length [AL], anterior
chamber depth [ACD], and keratometry readings) were
obtained from the noncontact Zeiss IOL Master (V3.01; Carl
Zeiss Meditec AG, Jena, Germany). Intraocular pressure was
measured using Nidek noncontact tonometry (Auto Non-
Contact Tonometer, NT-3000; Nidek, Gamagori, Aichi, Japan)
and if IOP was found to be 21 mm Hg or more, Goldmann
applanation tonometry (Haag-Streit, Bern, Switzerland) was
performed by study ophthalmologists.
Subjects underwent slit-lamp examination. Binocular indi-
rect ophthalmoscopy was performed approximately 30 min-
utes after topical instillation of three drops of tropicamide and
2.5% phenylephrine, given 5 minutes apart. Dilated fundus
examination was carried out by the study ophthalmologist. The
presence and type of peripheral retinal degenerations and
vitreous degenerations were systematically documented. Fun-
dus photography was performed using nonmydriatic retinal
camera (Canon CR-DGi with a 10D/20D/40D SLR back; Canon,
Tokyo, Japan).
OCT Imaging
The peripapillary choroidal parameters were determined using
SD-OCT (Spectralis, Wavelength: 870 nm; Heidelberg Engi-
neering, Heidelberg, Germany). Peripapillary choroid was
imaged with EDI modality after pupil dilation. Enhanced-depth
imaging is a method that improves resolution of choroidal
detail by automatically setting the choroid closer to the zero-
delay line, and thus provides better visualization of the choroid
scleral interface than in standard retinal SD-OCT images. The
peripapillary region was scanned using a 3608, 3.5-mm
diameter circle centered on the optic disc (Fig. 1), each
comprising 100 averaged scans (using the proprietary auto-
matic averaging and eye tracking features of the SD-OCT
FIGURE 1. Enhanced-depth imaging OCT image demonstrating peripapillary region scanned using a 3608, 3.5-mm diameter circle centered on the
optic disc. The peripapillary choroidal thickness was measured as the perpendicular distance between Bruch’s membrane and the choroid–scleral
interface at the following locations: T, temporal; ST, superotemporal; S, superior; SN, superonasal; N, nasal; IN, inferonasal; I, inferior; IT,
inferotemporal.
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device). Following Spectralis user manual guidelines, subjects’
keratometry readings and refraction were entered into the
Spectralis’ software before the choroid was imaged to estimate
optical magnification, thus allowing for more accurate
comparisons across individuals. However, Spectralis OCT does
not allow AL to be input, our methods may still have residual
errors (2%–7%)20 due to ocular magnification from methods
that additionally uses AL. Only the right eye of each study
participant was included for analysis.
Measurement of Peripapillary Choroidal
Thickness
The PPCT was measured manually using the Heidelberg Eye
Explorer software (version 1.5.12.0; Heidelberg Engineering)
as the perpendicular distance between the outer portion of the
hyperreflective line corresponding to the RPE (automatically
detected by the instrument) to the hyporeflective line or
margin corresponding to the sclerochoroidal interface (manu-
ally drawn by an experienced grader, who was masked to
subject characteristics and clinical diagnosis) at the following
locations around the optic disc: temporal, superotemporal,
superior, superonasal, nasal, inferonasal, inferior, and infero-
temporal. In addition, the intraobserver reliability of PPCT
measurements was evaluated in both the myopic and
emmetropic group. Forty randomly selected Spectralis images
(20 from each group) were assessed again by the same grader
after an interval of 1 week.
Statistical Analysis
Subjects were excluded from analysis if they had any history of
anterior ocular diseases, previous ocular trauma, evidence of
macular or vitreoretinal diseases or any form of refractive
surgery done in their eyes. However, conditions such as,
peripapillary atrophy, lacquer crack, posterior staphyloma,
chorioretinal atrophy, or tilted discs were not excluded, as they
are commonly seen in high-myopic eyes. Statistical analysis was
performed using SPSS version 17.0 (SPSS, Inc., Chicago, IL,
USA) and MedCalc version 12.3 (Medcalc Software, Ostend,
Belgium). The intrasession repeatability of the PPCT was
measured by the absolute agreement model of the intraclass
correlation coefficient (ICC).21
The demographics and ocular parameters between myopic
and control eyes were compared using independent t-tests. For
the purpose of analyses, myopic eyes were divided into three
groups based on SE: less than6.0 to8.0 D, less than8.0 to
10.0 D, and worse than 10.0 D. Subgroup analysis of
choroidal thickness across different locations in eyes with
varying degree of myopia was performed. Repeated measures
ANOVA with Bonferroni posttest was used to compare mean
thicknesses at various locations within each group. Univariate
and multiple linear regression analyses were performed to
determine the association of ocular factors (independent
variables) with PPCT measurements (dependent variables).
For multiple linear regression, age, and factors, which showed
significant association in univariate analysis (P < 0.05) were
included.
RESULTS
Of the 623 eligible high myopes (SE  6.0 D), we further
excluded 175 subjects because their choroidal images were not
successfully attained due to unstable fixation (n ¼ 62), the
available images were not of optimal quality (a quality index of
< 25 dB as suggested by the manufacturer for the image quality
assurance, n ¼ 39), those where the choroid–scleral interface
was not clearly delineated (n ¼ 21) to perform accurate
measurements, subjects whose peripapillary atrophy involved
the OCT scanning ring (n ¼ 30), or they did not meet the
inclusion criteria (n ¼ 23), leaving 448 high myopes with
complete data on PPCT for analysis. Of the 151 emmetropes
recruited, 35 were found to have SE greater than 6 0.5 D on
subjective refraction and were excluded, leaving 116 emme-
tropes for analysis.
The mean age of included myopic and emmetropic subjects
was 21.63 6 1.15 years and 22.03 6 0.96 years (P < 0.001),
respectively. The mean SE was 8.52 6 1.80 D (range, 6 to
18.25 D) for myopic group, and 0.11 6 0.24 D for
emmetropic group. Among the myopic group, nearly all our
subjects (97.3%) had peripapillary atrophy, 41.3% had poste-
rior staphyloma, 6.3% had chorioretinal atrophy, 0.4% had
lacquer cracks, and 22.5% had tilted disc. The demographics
and ocular characteristics of the study population are shown in
Table 1. In terms of reliability of PPCT measurements, the
intraobserver reliability for myopic (ICC: 0.96–0.98) and
emmetropic (ICC: 0.95–0.98) group was excellent for all
locations of PPCT (Table 2).
Peripapillary choroidal thickness varied significantly across
the myopic subgroups and the emmetropic group at all the
locations (P for trend < 0.001 for all locations, Table 3).
Peripapillary choroidal thickness was significantly thinner in
the more myopic eyes over a range of eccentricities and their
pattern of distribution was different from emmetropes (Fig. 2).
Across the three myopic subgroups, peripapillary choroid was
thickest (163.41 6 50.43 lm) at the superior location, whereas
in emmetropes it was thickest (207 6 58.01 lm) at the
temporal location. Peripapillary choroid was thinnest in both
myopes (109.98 6 37.30 lm) and control eyes (137.90 6
44.53 lm) at the inferior location.
In the univariate analysis, SE, AL, corneal curvature, IOP,
average retinal nerve fiber layer (RNFL) thickness, and







Age, y 21.63 (1.15) 22.03 (0.96) <0.001
AL, mm 27.23 (1.07) 23.70 (0.61) <0.001
ACD, mm 3.74 (0.25) 3.46 (0.27) <0.001
Corneal curvature, mm 7.76 (0.25) 7.81 (0.41) 0.123
SE, D 8.52 (1.80) 0.11 (0.24) <0.001
BCVA, logMAR 0.01 (0.07) 0.09 (0.06) <0.001
IOP, mm Hg 16.11 (2.95) 15.22 (2.64) 0.003
RNFL thickness, lm 87.21 (8.94) 103.76 (9.99) <0.001
Data presented are means (SD).
* Based on independent sample t-test.
TABLE 2. Intragrader Reliability of Peripapillary Choroidal Thickness








Temporal, 3608 0.97 (0.92–0.98) 0.96 (0.90–0.98)
Superotemporal, 458 0.97 (0.94–0.99) 0.98 (0.95–0.99)
Superior, 908 0.98 (0.96–0.99) 0.96 (0.90–0.98)
Superionasal, 1358 0.98 (0.96–0.99) 0.97 (0.92–0.98)
Nasal, 1808 0.97 (0.93–0.99) 0.96 (0.90–0.98)
Inferonasal, 2258 0.96 (0.92–0.98) 0.96 (0.91–0.98)
Inferior, 2708 0.96 (0.91–0.98) 0.95 (0.88–0.98)
Inferotemporal, 3158 0.96 (0.90–0.98) 0.96 (0.90–0.98)
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presence of posterior staphyloma and chorioretinal atrophy
were significantly associated with PPCT (all P < 0.05, Table 4).
For each millimeter increase in AL and corneal curvature, PPCT
on average decreased by 13.02 (P < 0.001) and 36.72 lm (P <
0.001), respectively. A decrease in mean PPCT by 5.39 lm was
observed for each myopic diopter increase (P < 0.001). Each
millimeter of mercury increase in IOP increased the PPCT by
1.40 lm, whereas for each micrometer increase in average







SE < 6 to 8 D,
n ¼ 211
SE < 8 to 10 D,
n ¼ 143




Temporal, 3608 207.00 (58.01) 138.47 (58.57) 151.30 (62.21) 132.45 (51.00) 118.85 (54.41) <0.001
Superotemporal, 458 201.89 (53.13) 150.32 (54.10) 160.10 (57.14) 144.51 (49.02) 137.23 (50.82) <0.001
Superior, 908 188.18 (50.17) 163.41 (50.43) 170.60 (52.08) 160.88 (47.30) 151.14 (49.03) <0.001
Superionasal, 1358 189.15 (52.85) 162.21 (50.50) 169.58 (52.26) 159.19 (47.63) 150.24 (48.45) <0.001
Nasal, 1808 189.24 (53.17) 161.97 (51.82) 170.66 (55.30) 157.36 (47.22) 149.51 (47.30) <0.001
Inferonasal, 2258 168.68 (50.38) 137.82 (46.16) 146.83 (50.15) 132.62 (41.11) 125.53 (40.04) <0.001
Inferior, 2708 137.90 (44.53) 109.98 (37.30) 117.01 (39.41) 106.91 (33.54) 98.88 (34.80) <0.001
Inferotemporal, 3158 173.17 (52.10) 116.81 (49.12) 128.19 (54.12) 110.73 (41.25) 100.52 (42.05) <0.001
Average 181.90 (46.43) 142.62 (43.84) 151.78 (46.79) 138.08 (38.53) 128.99 (40.20) <0.001
P < 0.001† P < 0.001† P < 0.001† P < 0.001† P < 0.001†
Data presented are mean (SD) in micrometers.
* Peripapillary choroidal thickness varied significantly across the myopic subgroups and the emmetropic group at all the locations (P for trend <
0.001 for all locations).
† Repeated measures ANOVA, comparing the distribution of peripapillary choroidal thickness at various locations within each group.
FIGURE 2. Graph showing the distribution of mean peripapillary choroidal thickness (lm) in high-myopic and emmetropic groups at different
locations around the optic disc. The x-axis represents the locations of the measurements of peripapillary choroidal thickness around the optic disc.
Error bars indicate standard error.
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RNFL thickness, PPCT increased by 0.74 lm. Presence of
posterior staphyloma and chorioretinal atrophy decreased the
PPCT by 15.29 and 14.76 lm, respectively (both P < 0.001).
The results remained similar after adjusting for age (data not
shown).
Because of collinearity between AL and SE (correlation
coefficient¼0.574), only AL was selected and retained in the
multivariate analysis as it had a greater explanatory power on
PPCT change than did SE (standardized b, 0.319 vs. 0.222).
There was no collinearity between posterior staphyloma and
chorioretinal atrophy as variance inflation factor (VIF) was
close to 1. In the multiple linear regression analysis, AL (P ¼
0.001), IOP (P¼0.006), presence of posterior staphyloma (P <
0.001), and chorioretinal atrophy (P ¼ 0.032), remained
significantly associated with PPCT, whereas the association
with corneal curvature (P ¼ 0.062) and RNFL thickness was
abolished (P ¼ 0.156). The results remained similar after
adjusting for age. However, on performing a linear regression
analysis between IOP and average PPCT in the emmetropic
group we found no significant association (P ¼ 0.964;
regression coefficient ¼0.075; 95% confidence interval [CI],
3.334 to 3.183).
DISCUSSION
To our knowledge, this is the first study to measure PPCT
directly with EDI SD-OCT in a large group of young, highly
myopic Asian subjects. Peripapillary choroid in myopic group
was significantly thinner than emmetropic control group at any
locations. We demonstrated further decrease in PPCT with
increase in degree of myopic refractive error. Peripapillary
choroidal thickness distribution follows a different profile in
high myopia (thickest superiorly), compared with emmetropia
(thickest temporally). However in both the groups peripapil-
lary choroid was thinnest at inferior location. Among the range
of ocular factors studied, AL, IOP, and presence of posterior
staphyloma and chorioretinal atrophy were the significant
factors associated with PPCT.
None of previous studies so far have explored the profile of
peripapillary choroid in high myopia and only a limited
number of studies have reported the distribution of peripap-
illary choroid in emmetropic eyes. The mean PPCT in
emmetropes was 181.90 6 46.43 lm, which is in concurrence
with former studies showing a mean thickness of 165.0318 to
191.6219 lm (Table 5).
In terms of distribution of PPCT, in both myopic and
emmetropic eyes, peripapillary choroid was thinnest inferiorly.
Studies done so far have consistently shown inferior region to
be the thinnest among other regions of the posterior pole.16–19
As optic fissure is located in the inferior aspect of the optic cup
and is the last part of the globe to close,22 this regional
difference in ocular development may contribute to the
thinner choroid found in inferior region. Thinner choroid
would lead to decreased blood flow in choriocapillaris, which
nourishes the prelaminar portion of the optic disk, making it
more susceptible to hypoxia or to elevated IOP. This is
supported by a very common observation that glaucoma
typically affects the inferior optic disc region first.16,23 The
possible role of thinner choroid in glaucoma development is
further supported by the findings of Usui et al.24 and Hirooka
et al.23 who reported significant choroidal thinning in myopic
normal-tension glaucoma–damage eyes as compared with
myopic controls. Likewise, a substantial reduction in PPCT in
patients with glaucoma who have sclerotic optic disc was
demonstrated by Robert et al.4 Tanabe et al.16 showed thinner
choroid in the inferior region of optic disks of healthy eyes.
While some investigations25–27 have reported finding that the
PPCT did not seem to differ between healthy and glaucoma
patients.
TABLE 4. Association of Ocular Factors With Average Peripapillary Choroidal Thickness in All Myopes (n¼ 448)














Age, y 0.412 0.011 0.818 - - -
SE, D 5.396 0.222 <0.001 - - -
AL, mm 13.029 0.319 <0.001 7.090 0.175 0.001
Corneal curvature, mm 36.720 0.216 <0.001 4.456 0.026 0.602
ACD, mm 3.989 0.023 0.631 - - -
IOP, mm Hg 1.407 0.095 0.045 1.628 0.111 0.006
Average RNFL thickness, lm 0.745 0.152 0.001 0.287 0.059 0.156
Posterior staphyloma 15.296 0.519 <0.001 12.160 0.433 <0.001
Chorioretinal atrophy 14.768 0.247 <0.001 0.533 0.089 0.032
Tilted disc 2.814 0.081 0.088 - - -
For multivariate analysis after adjusting for age there was no change in the result. Bold values indicate statistical significance.
TABLE 5. Summary of Peripapillary Choroidal Thickness and Other Variables in Various Studies in Healthy Eyes
Study No. of Eyes Mean Age, y AL, mm SE, D OCT Machine EDI (Yes/No) Mean PPCT,* lm
Current study (myopes) 448 21.63 (1.15) 27.23 (1.07) 8.52 (1.80) Spectralis SD-OCT Yes 142.62 (43.84)
Current study (emmetropes) 116 22.03 (0.96) 23.70 (0.61) 0.11 (0.24) Spectralis SD-OCT Yes 181.90 (46.43)
Huang et al.13 76 56.95 (12.99) 23.20 0.31 (1.12) Spectralis SD-OCT Yes 165.03 (40.37)
Oh et al.14 40 41.2 (20.6) - 0.4 (1.1) Topcon 3D-OCT No 191.2 (62)
Tanabe et al.11 28 54.1 (20.0) - 3.6 (4.1) Spectralis SD-OCT Yes -
Ho et al.12 36 48 (16) - - Cirrus SD-OCT No -
* Data presented are means (SD).
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We found peripapillary choroid in highly myopic eyes was
thickest superiorly, whereas in emmetropic eyes was thickest
temporally. This variation in the refractive error differences in
choroidal thickness profile could be attributed to the presence
of posterior staphyloma in highly myopic eyes. Although
staphylomas may have various morphologic features, the most
common types involve the macular and optic nerve regions.28
Similar to our observation in emmetropes, Oh et al.19 also
reported peripapillary choroid to be thickest temporally.
However, the observed pattern of PPCT distribution in
emmetropes in our study differs from most of the previous
studies in healthy eyes, which reported choroid to be thickest
superiorly.4,16–18,23,26 Although, the magnitude of the differ-
ence in thickness of the thickest point is not clinically
significant (range, 15–20 lm). The differences in PPCT profile
in our study compared with other studies could be because of
the differences in age of our study participants. Our study
participants are twice as young, mean age 22 years compared
with other studies.4,16–18,23,26 Thus, the exact reason for the
variations in topographic profile of PPCT is not clear and
further studies on a wide range of age group are needed.
Peripapillary choroidal thickness was significantly thinner
in eyes with longer AL. The possible reason might be the
anatomic differences in eyes of different refractive status with
more stretched and therefore thinner peripapillary choroid in
longer eyes. Therefore, AL deserves consideration in a
normative database of PPCT measurement and should be
taken into account while interpreting the results.
Interestingly, we found a positive association between PPCT
and IOP in high myopes. Our results are in concordance with
previous studies,29 which using the pressure–volume relation-
ship of the eye,30 estimated that to produce an IOP increase of
5 mm Hg from the average IOP of 15 mm Hg, the choroid
would need to expand uniformly by approximately 10 lm. Our
subjects had a mean choroidal thickness increase of 2.38 lm
for every millimeter of mercury increase in IOP supporting the
conclusion that the IOP increase resulted from choroidal
thickness increase.
In addition, we found that presence of posterior staphyloma
was significantly associated with choroidal thinning in high
myopes. Similar results were observed in the previous studies,
which reported posterior staphyloma formation as a key factor
in choroidal thinning in highly myopic eyes.5,31 This associa-
tion is probably because in myopic eyes with posterior
staphyloma, choroidal circulation is altered with marked
attenuation and reduction in number of large choroidal
vessels.32 In addition, there is a shift in the entry site of the
posterior ciliary arteries toward the staphyloma’s border
leading to scarce choroidal arterial network in the area
occupied by staphyloma.33 Thus, all these changes contribute
to choroidal thinning in eyes with staphyloma.
Strength and Limitations
The present study is one of the most large-scale, prospective
studies conducted to investigate the topography and predictors
of PPCT in myopic subjects. Unlike other studies, our study
included a control group and therefore we could examine the
differences between highly myopic eyes and nonmyopic eyes
in our cohort. It involved a group of young, healthy, male,
Asian subjects of uniform age and was thus free of confounding
factors. However, these features may limit the application of
these data to females and subjects of other groups or
ethnicities. Further studies in other ethnic populations are
warranted to confirm the results. Another limitation is that the
cause–effect relationship cannot be ascertained due to the
cross-sectional nature of our study. Recently, diurnal fluctua-
tion of choroidal thickness was reported34 and this could have
impacted our results, though any impact of diurnal variation
should be randomly distributed among myopic and emmetrop-
ic eyes.
CONCLUSIONS
There are regional differences in terms of distribution of PPCT.
Peripapillary choroid was significantly thinner in the more
myopic eyes over a range of eccentricities and follows a
different profile compared with emmetropes. Axial length, IOP,
presence of posterior staphyloma, and chorioretinal atrophy
are the significant factors associated with PPCT in high-myopia
eyes and must be taken into consideration when interpreting
these data. Knowledge of normal PPCT and its profile in young,
high myopes and emmetropes may aid in the understanding of
physiological and pathological changes of peripapillary cho-
rioretinal conditions.
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ABSTRACT.
Purpose: To investigate the influence of choroidal thickness (CT) on visual
acuity (VA) in young persons with extremely high myopia.
Methods: We conducted a case–control study of young men with extremely high
myopia and controls with emmetropia recruited from a mandatory medical eye
review for employment purposes. Retinal and choroidal imaging was performed
using enhanced depth imaging (EDI) spectral-domain optical coherence tomog-
raphy (SD-OCT).
Results: We included 105 extremely high myopic subjects with spherical
equivalent (SE) -10 dioptre (D) or worse and 50 emmetropic subjects with SE
less than 0.5 D. The mean SE was 11.56  2.04 D (range, 10 to 23 D) for
myopic group and 0.14  0.25 D for emmetropic group. The mean age of
included myopic and emmetropic subjects was 21.51  1.22 years and
21.96  0.89 years, respectively. In the univariate analysis, subfoveal CT was
significantly associated with best-corrected visual acuity (BCVA) (b = 0.039,
p = 0.015). However, in the multiple linear regression analysis, after adjusting
for SE and presence of any pathological myopia lesions such as posterior
staphyloma, lacquer cracks or chorioretinal atrophy, subfoveal CT was not
independently associated with BCVA (p = 0.937).
Conclusion: Extremely high myopic eyes had thinner choroid, but CT was not an
independent predictor of VA. Other factors related to myopia are likely
responsible for the diminished VA in young extremely high myopic eyes.
Key words: choroidal thickness – enhanced depth imaging optical coherence tomography – high
myopes – visual acuity
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Introduction
Although myopia is one of the major
causes of visual impairment in the world
(Klaver et al. 1998; Liu et al. 2001;
Iwano et al. 2004), it is more common
in Asian populations (Wong et al. 2000,
2014; Wu et al. 2001; Morgan et al.
2012). In young Asian adults (age range
between 18 and 24 years), the preva-
lence of myopia [spherical equivalent
refraction (SE) less than -0.50 dioptres
(D)] and high myopia (SE less than
6.00 D) are 81.6–96.5% and 6.8–
21.6%, respectively (Lee et al. 2011,
2013a,b; Koh et al. 2014). High myopia
is characterized by excessive and pro-
gressive elongation of the globe, causing
biomechanical stretching and thinning
of not only the retina (Lim et al. 2005;
Lam et al. 2007) but also the choroid
(Fujiwara et al. 2009; Ikuno & Tano
2009; Spaide 2009). This excessive elon-
gation of the globe results in a variety of
pathological changes known as myopic
macular degeneration (Neelam et al.
2012; Wong et al. 2014; Ohno-Matsui
et al. 2015) and include lacquer cracks in
the Bruch’s membrane (Jonas et al.
2014), choroidal neovascularization
(Cheung et al. 2013) and chorioretinal
atrophy leading to vision loss.
The changes in the choroid are sig-
niﬁcant but not well studied. Histolog-
ical studies showed both vessel density
and diameters to be reduced in chorio-
capillaris of highly myopic eyes (Gross-
niklaus & Green 1992; Hirata & Negi
1998). In a recent study by Zaben et al.
(2015), signiﬁcant correlation between
retinal sensitivity and choroidal thick-
ness (CT) in highly myopic eyes was
presented. As the choroid provides the
major blood supply to the outer retina
and supports the metabolic demands of
the retinal pigment epithelium (RPE)
and photoreceptors (Nickla &Wallman
1
Acta Ophthalmologica 2016
2010), compromised choroidal circula-
tion and morphology may account, in
part, for outer retinal dysfunction and
vision loss in high myopia. Thus, some
researchers have hypothesized a rela-
tionship between CT in high myopes
and visual acuity (VA) (Nishida et al.
2012; Flores-Moreno et al. 2013b; Ho
et al. 2013).
Enhanced depth imaging spectral-
domain optical coherence tomography
(EDI SD-OCT) (Spaide et al. 2008) has
now allowed investigators to measure
CT in high myopes. Using this method,
studies have shown that myopic eyes
have thinner CT ranging from 90 to
160 lm (Fujiwara et al. 2009; Ikuno &
Tano 2009; Flores-Moreno et al. 2013a;
Ho et al. 2013;Wang et al. 2015). There
is now evidence from recent studies that
suggest CT to be a predictor of VA and
thinner choroid to be associated with
poorer VA (Nishida et al. 2012; Flores-
Moreno et al. 2013b; Ho et al. 2013;
Shao et al. 2014). However, these stud-
ies included only older participants
mostly above 40 years, and their results
may be confounded by other ocular
comorbidities due to ageing. In addi-
tion, in some studies (Flores-Moreno
et al. 2013b; Ho et al. 2013), the asso-
ciation was tested using univariate anal-
ysis only; thus, it remained unclear
whether the observed association
between VA and CT was a primary
relationship or was due to confounding
eﬀects from other myopia-related
changes, such as elongated axial length
(AL). Finally, these studies were per-
formed in myopic eyes free of myopic
macular degeneration. It is unclear
whether CT inﬂuences VA in the pres-
ence of myopic macular degeneration.
The purpose of this study was to
examine the potential inﬂuence of CT
on VA in young, extremely high
myopic persons with and without
myopic macular degeneration changes.
We conceived that if there exists an
association between CT and VA, it
would be more apparent in this group
of subjects. We therefore conducted a
case–control study of young, extremely
high myopic and emmetropic healthy
male adults in Singapore.
Subjects and Methods
Study population
A total of 28 908 young male subjects
(mean age  SD: 19.8  1.2 years;
range: 17–9 years) were screened for
myopia from 2009 to 2010 as part of a
mandatory medical eye review for
employment purposes. Measured using
non-cycloplegic autorefraction (Huvitz
MRK-3100P), 2584 persons were iden-
tiﬁed to have myopia with SE of6.0 D
or worse. Of these 2584 persons, 719
were selected on the basis of a refractive
error-stratiﬁed random sampling strat-
egy and underwent a further compre-
hensive ophthalmologic examination at
Singapore Eye Research Institute from
December 2011 to June 2012. Their SE
was further conﬁrmed by subjective
refraction, leaving 520 subjects with
high myopia (SE greater than 6D).
Of these 520 subjects, we selected 118
subjects with SE 10.0 D or worse in
both eyes (mean SE in the right and left
eyes was 11.56  2.04 D and
11.26  2.30 D, respectively) as cases
for the current analysis.We also selected
55 emmetropic male subjects with SE
less than 0.5 D in both eyes (mean SE
in the right and left eyeswas 0.14  0.25
D and 0.16  0.26 D, respectively) as
controls who underwent a similar oph-
thalmologic examination. Subjects were
further excluded if they did not give
consent to take part in this medical
review, had any previous ocular trauma
or surgery and those with other clini-
cally signiﬁcant ocular co-morbidity.
Written informed consent was taken
from the subjects and their parents/
guardians (if they were 21 years old
and below). Ethics approval was
obtained from the Institutional Review
Board of DSO National Laboratories,
Singapore. The study was conducted in
accordance with the tenets of the




Each subject underwent a standardized
questionnaire and a complete ophthal-
mologic examination. The subjects
were asked a series of questions, such
as previous ocular trauma or surgery,
history of ocular diseases. Their refrac-
tive error screened with autorefraction
(Canon Autorefractor RK-F1; Canon
Inc. Ltd., Tochigiken, Japan) and con-
ﬁrmed with manifest refraction in
which the best-corrected visual acuity
(BCVA) was measured monocularly
using a logarithm of the minimum
angle of resolution (LogMAR) chart
(Lighthouse International, New York,
USA) at a distance of 4 m was per-
formed. Biometry measurements, that
is AL, anterior chamber depth (ACD),
and keratometry readings were
obtained from the non-contact Zeiss
IOL Master (V3.01, Carl Zeiss Meditec
AG, Jena, Germany). Intra-ocular
pressure (IOP) was measured using
non-contact tonometry (Auto Non-
Contact Tonometer, NT-3000, Nidek,
Gamagori, Aichi, Japan), and if IOP
was found to be 21 mmHg or more, a
further IOP measurement using Gold-
mann applanation tonometry (Haag-
Streit, Bern, Switzerland) was
performed by study ophthalmologists.
Subjects underwent slit-lamp exam-
ination. Binocular indirect ophthalmo-
scopy was performed approximately
30 min after topical instillation of
three drops of tropicamide and 2.5%
phenylephrine, given 5 min apart.
Dilated fundus examination was car-
ried out by ophthalmologists. The
presence and type of peripheral retinal
degenerations and vitreous degenera-
tions were systematically documented.
Fundus photography was performed
using retinal camera (Canon CR-DGi
with a 10-DSLR back, Tokyo, Japan).
OCT imaging
The retina, optic disc and choroidal
architectural parameters were deter-
mined using SD-OCT (Spectralis,
Wavelength: 870 nm; Heidelberg Engi-
neering, Heidelberg, Germany) after
pupil dilation. Retinal thickness was
obtained using non-EDI mode,
whereas choroid was imaged with
EDI modality after pupil dilation.
EDI is a method that improves resolu-
tion of choroidal detail by automati-
cally setting the choroid closer to the
zero-delay line and thus theoretically
provides better visualization of the
choroid scleral interface (CSI) than in
standard retinal SD-OCT images.
Radial scan consisting of six sec-
tions, each comprising 100 averaged
scans (using the automatic averaging
and eye tracking features of the pro-
prietary device), were obtained in an
angle of 30° centred onto the fovea (30°
angles between the lines). The horizon-
tal and vertical section passing through
the centre of the fovea was selected for
analysis. Following Spectralis user
manual guidelines, subjects’ keratome-
try readings and refraction were
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entered into the Spectralis’ software
before imaging choroid to estimate
optical magniﬁcation, thus allowing
for more accurate comparisons across
individuals. However, Spectralis OCT
does not allow AL to be input, and our
methods may still have residual errors
(2–7%) (Garway-Heath et al. 1998)
due to ocular magniﬁcation from meth-
ods that additionally uses AL. For each
subject, only right eye was chosen for
subsequent analysis.
Measurement of choroidal and retinal
thicknesses
The CT in the enhanced images was
measured as the perpendicular distance
between the outer portion of the hyper-
reﬂective line corresponding to the
RPE (automatically detected by the
instrument) to hyporeﬂective line or
margin corresponding to the CSI (man-
ually drawn by an experienced grader,
who was masked to subject character-
istics and clinical diagnosis) at the
following locations: subfovea and 1.5
and 3 mm nasal, temporal, superior
and inferior to fovea. We found signif-
icant correlation (r = 0.95, p < 0.001)
in the horizontal and vertical subfoveal
CT (mean horizontal subfoveal
CT = 194.8  57.7 lm and mean
vertical subfoveal CT = 198.4 
61.7 lm); thus, only horizontal sub-
foveal CT was used in the analysis.
Figure 1 shows an EDI-OCT scan
comparing CT between a young emme-
trope and a young myope. Retinal
thickness was measured as the perpen-
dicular distance between internal limit-
ing membrane and RPE (both detected
automatically by the instrument), at
subfovea and 1.5 and 3 mm nasal,
temporal, superior and inferior to
fovea. We have previously demon-
strated excellent intra-observer reliabil-
ity of CT measurement in emmetropes
and myopes (ICC ranging from 0.94 to
0.98) at various locations in posterior
pole (Gupta et al. 2015).
Assessment of myopic macular
degeneration
The colour fundus photographs were
graded similar to previously established
grading techniques by a single trained
grader masked to the participant
characteristics (Vongphanit et al.
2002). Adjudication was performed by
an experienced medical retina specialist
from an accredited fundus photograph
grading centre. The main ﬁndings
which were graded included myopia-
related macular pathology, including
staphyloma, lacquer crack and peri-
papillary atrophy (PPA). The presence
of lacquer crack, its location and num-
ber were evaluated. Curtin and Karlin
classiﬁcation was used to determine the
subtype and position of PPA (Curtin &
Karlin 1970). Staphyloma was deter-
mined by visualizing the border of the
ectasia; then, its location and type were
documented based on the Curtin clas-
siﬁcation (Curtin 1977).
Intergrader reliability in grading for
the aforementioned features was
assessed with additional grading of
100 randomly selected eyes by trained
graders, and reliability was found to be
good (all intraclass correlation coeﬃ-
cient above 0.75). To conﬁrm the
presence of posterior staphyloma, the
cross-sectional images from SD-OCT
were graded by a medical retinal spe-
cialist. Figure 2 shows the presence of
posterior staphyloma on horizontal
scan of the macular central on the
fovea (20°) obtained using SD-OCT.
The presence of posterior staphyloma
was deﬁned as curvature of the RPE
layer, with a foveal depth of ≥ 500 lm
relative to the 3 mm periphery of the
OCT B-scan. This allows posterior
staphyloma with more gentle and sub-
tle sloping edges to be detected.
Statistical analysis
For this analysis, we did not exclude
subjects with presence of PPA, lacquer
crack, posterior staphyloma or chori-
oretinal atrophy, as such changes are
commonly seen in high myopic eyes.
The diﬀerences between high myopic
and control eyes were compared using
independent t-tests. Repeated-mea-
sures analysis of variance (ANOVA) with
Bonferroni posttest was used to com-
pare mean CT at various locations
within each group. Multiple linear
regression analyses were performed to
determine the independent association
of subfoveal CT (independent variable)
with logMAR BCVA (dependent vari-
able), adjusting for factors which
showed association in univariate anal-
ysis (p < 0.05). The data were analysed




Fig. 1. Comparison of spectral-domain optical coherence tomography (EDI-OCT) scans of
choroidal thickness between emmetrope and myope. (A) A 22-year-old male with no refractive
error axial length (AL = 23.61 mm) and an average choroidal thickness of 325 lm. (B) A 23-year-
old male with spherical equivalent (SE) of 12.25D (AL = 29.35 mm) and an average choroidal




Of the 118 subjects who had SE 10.0
D or worse, 13 subjects were excluded
as their choroidal images were not
successfully attained (n = 8) due to
unstable ﬁxation, those where the CSI
was not clearly delineated (n = 4) to
perform accurate measurements or
they did not meet the study inclusion
criteria (n = 1), leaving 105 highly
myopic subjects with complete data
on CT for analysis.
The mean age of included myopic
and emmetropic subjects was
21.51  1.22 years and 21.96  0.89
years, respectively. The mean SE was
11.56  2.04 D (range, 10 to 23
D) for myopic group and 0.14  0.25
D for emmetropic group (Table 1).
Among the high myopic group, nearly
all the subjects (99%) had PPA, 66.7%
had posterior staphyloma, 22.9% had
chorioretinal atrophy, and 4.8% had
lacquer cracks.
Table 2 shows the distribution pro-
ﬁle of choroidal and retinal thicknesses
at diﬀerent locations in both high
myopic and emmetropic groups. In
the highly myopic group, the mean
CT was 194.81  57.78 lm and the
mean retinal thickness was
287.39  31.75 lm. Choroid was sig-
niﬁcantly thinner in the highly myopic
eyes over a range of eccentricities, and
the pattern of distribution was diﬀerent
from emmetropes (Fig. 3A). Among
the high myopes, choroid was found
to be thickest at the superior location,
followed by the temporal, subfoveal,
inferior and the nasal locations
(p < 0.001 by repeated-measures
ANOVA). In comparison, the choroid in
emmetropic eyes was thickest at the
fovea, followed by the superior, infe-
rior, temporal and the nasal locations
(p < 0.001 by repeated-measures
ANOVA). However, in both the highly
myopic and emmetropic groups, chor-
oid was thinnest at the 3 mm nasal
location being 87.34 and 237.10 lm,
respectively (Fig. 3A). Retinal thick-
ness in both myopes and emmetropes
showed similar distribution pattern,
being thickest in the nasal location
and thinnest subfoveally (Fig. 3B).
Both AL and SE inﬂuenced BCVA
but a larger extent from SE (standard-
ized b, 0.505 versus 0.214), and thus,
only SE was selected and retained in
the multivariate analysis due to
collinearity between AL and SE
(r = 0.638).
Table 3 shows the linear regression
analyses of the associations of sub-
foveal CT (exposure variable of inter-
est) evaluated against BCVA
(dependent variable) to calculate
regression coeﬃcients (b). In model 1
(univariate analysis), subfoveal CT was
signiﬁcantly associated with BCVA
(b = 0.039, p = 0.015). However,
after adjusting for SE (model 2), sub-
foveal CT was no more signiﬁcantly
associated with BCVA (p = 0.761). In
model 3, including both SE and pres-
ence of any pathological myopia
lesions such as posterior staphyloma,
lacquer cracks or chorioretinal atro-
phy, we found that subfoveal CT was
not independently associated with
BCVA (p = 0.937). There was no sig-
niﬁcant interactions between subfoveal
CT and SE or subfoveal CT and
pathological myopia lesions on BCVA
(both p interaction >0.05).
Furthermore, the association
between BCVA and subfoveal CT in a
group of 33 highly myopic subjects
without any pathological myopic
lesions (except PPA) was found to be
insigniﬁcant (b = 0.012, p = 0.776).
It is speculated that if there exist
any association between CT and VA,
it would most likely be subfoveal CT
due to maximum number of photore-
ceptors at subfovea. To conﬁrm
whether the distribution pattern of
CT has inﬂuence on BCVA, we anal-
ysed the association of CT at diﬀerent
locations (nasal, temporal, superior
Fig. 2. shows the presence of posterior staphyloma on horizontal scan of the macular central on the fovea (20°) obtained using spectral-domain
optical coherence tomography (SD-OCT).
Table 1. Baseline characteristics of study subjects.
Myopes (n = 105) Emmetropes (n = 55) p-value*
Age, years 21.51 (1.22) 21.96 (0.89) 0.033
Axial length, mm 28.46 (1.23) 23.65 (0.58) <0.001
Anterior chamber depth, mm 3.74 (0.22) 3.47 (0.29) <0.001
Corneal curvature, mm 7.76 (0.24) 7.79 (0.44) 0.686
Spherical equivalent, Dioptre 11.56 (2.04) 0.14 (0.25) <0.001
Best-corrected visual acuity, LogMAR 0.07 (0.09) 0.10 (0.05) <0.001
Intra-ocular pressure, mmHg 16.42 (3.04) 15.28 (2.78) 0.035
Data presented are means (standard deviations).
LogMAR, logarithm of the minimum angle of resolution.
*p-value was obtained with independent sample t-test.
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and inferior) with BCVA. However,
we found no signiﬁcant associations
(all p > 0.05) between CT at diﬀerent
locations and BCVA (data not
shown).
Discussion
Our results suggest that CT alone is not
an independent indicator of VA in these
young, highly myopic eyes, and factors
such as SE still remains to be more
important predictors of BCVA. Chor-
oid was signiﬁcantly thinner in the
highly myopic eyes (mean CT 188.85 
55.78 lm verus 388.11  59.69 lm in
emmetropes) over a range of eccentric-
ities, and the pattern of distribution was
diﬀerent from emmetropes.However, in
terms of retinal thickness, both myopes
and emmetropes showed similar distri-
bution pattern.
Our ﬁnding of no independent asso-
ciation between subfoveal CT and VA
is in contrast to most of the previous
hospital-based investigations (Nishida
et al. 2012; Flores-Moreno et al.
2013b; Ho et al. 2013). Nishida and
colleagues in 145 myopic eyes (≥6 D)
with no other retinal or optic nerve
pathology demonstrated CT to be an
important predictor of VA. The dis-
crepancy may be due to diﬀerences in
age groups between our study and
Nishida’s study. Our study participants
are much younger with mean age of
22 years compared to Nishida’s study
(mean age 57 years). With the advanc-
ing age, the choroid may undergo
further age-related attenuation (Fuji-
wara et al. 2009; Spaide 2009). There-
fore, in Nishida’s study, choroidal
thinning is attributed to dual factors:
myopic refractive error and older age.
In addition, with advancing age, other
myopic maculopathy and severity
develop progressively (Chang et al.
2013), which may lead to reduced VA.
In contrast, our young subjects with
relatively thicker choroid retained their
visual function and therefore enjoyed
better vision.
In the Beijing Eye Study (Shao et al.
2014), better BCVA was found to be
Table 2. Distribution of choroidal and retinal thicknesses at diﬀerent locations across the myopic and control groups.
Choroidal thickness Retinal thickness
Locations Myopes (n = 105) Emmetropes (n = 55) p-value* Myopes (n = 105) Emmetropes (n = 55) p-value*
Subfoveal 194.81 (57.78) 377.98 (77.61) <0.001 237.19 (22.24) 224.36 (19.31) <0.001
Nasal, 1.5 mm 136.69 (54.650 325.67 (71.93) <0.001 338.51 (24.22) 361.70 (21.19) <0.001
Nasal, 3 mm 87.34 (39.39) 237.10 (69.49) <0.001 291.00 (31.56) 312.90 (22.05) <0.001
Temporal, 1.5 mm 210.48 (60.17) 358.60 (73.62) <0.001 315.84 (19.11) 337.94 (13.72) <0.001
Temporal, 3 mm 225.30 (62.57) 316.69 (68.28) <0.001 250.47 (27.89) 273.67 (14.73) <0.001
Superior, 1.5 mm 225.67 (76.06) 370.58 (67.58) <0.001 327.36 (19.89) 349.70 (23.92) <0.001
Superior, 3 mm 242.82 (84.77) 355.63 (72.81) <0.001 273.15 (20.14) 288.10 (13.14) <0.001
Inferior, 1.5 mm 188.21 (60.68) 362.23 (67.49) <0.001 316.29 (19.13) 344.52 (16.90) <0.001
Inferior, 3 mm 188.50 (69.05) 338.50 (81.60) <0.001 259.16 (18.46) 274.43 (13.99) <0.001
Average 188.85 (55.78) 338.11 (59.69) <0.001 287.39 (31.75) 307.48 (18.87) <0.001
Data presented are means (standard deviations) in lm. For both choroidal and retinal thicknesses repeated-measures ANOVA showed signiﬁcant
diﬀerence between the mean location measures within myopes and emmetropes.











































Emmetrope, <± 0.5 D
Myope, <–10D
Fig. 3. Distribution proﬁle of choroidal and retinal thicknesses at diﬀerent locations in high
myopic and emmetropic groups. Mean thickness at each of the nasal, temporal, superior and
inferior locations was measured at 1.5 and 3 mm intervals eccentric to the subfoveal area. Error
bars indicate standard error. SFCT, subfoveal choroidal thickness; SFRT, subfoveal retinal
thickness; N, nasal; T, temporal; S, superior; I, inferior.
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associated with thicker subfoveal CT
after adjusting for age, AL and other
parameters. However, Beijing Eye
Study is a population-based study with
a mean age of participant’s being
64.3 years and a mean refractive error
(SE) of 0.18 D. The observed associ-
ation between subfoveal CT and VA
could be due to residual confounding
eﬀects of AL which was taken as a
binary variable (>26 mm versus
≤26 mm).
Flores-Moreno and colleagues
(2013b) examined 60 eyes of 46 highly
myopic subjects (SE ≥6 D; mean age
45.9 years) without macular diseases
and found that in univariate analysis,
BCVA (logMAR) was signiﬁcantly
correlated with thinner subfoveal CT
(r = 0.36; p = 0.004). Similarly, Ho
and co-workers (2013) evaluated 56
myopic subjects (SE ≥6 D; mean age
50.4 years) and found that in univari-
ate analysis subfoveal CT was corre-
lated with logMAR VA (r2 = 0.295,
p = 0.008). In both studies, the associ-
ation between BCVA and subfoveal
CT was tested in univariate analysis
only, without taking into account other
potential confounders, such as SE, AL
and other ocular comorbidities due to
ageing. By contrast, our study involved
younger subjects with few ocular
comorbidities, and thus, the results
are less complicated by confounding
factors.
The results of our study are in
concordance with the results of a recent
study by Pang et al. (2015) who
reported no signiﬁcant reduction in
VA (mean VA = 20/30) in highly myo-
pic eyes (mean AL = 30.7 mm) with
extreme choroidal thinning (mean sub-
foveal CT = 14  6 lm), suggesting
CT alone is not a reliable indicator of
visual function. However, their study
involved relatively small sample size
(36 eyes of 20 myopic subjects) and
older subjects (mean age of 71 years)
with ocular comorbidities, and thus,
their results may be complicated by
confounding factors. In addition, use
of manual callipers to measure very
small CT might have introduced some
measurement errors.
It is interesting that although previ-
ous studies (Nishida et al. 2012; Flores-
Moreno et al. 2013b; Ho et al. 2013;
Shao et al. 2014) have concluded sub-
foveal CT to be inversely correlated to
VA, this study has shown that there are
clear exceptions to these observations.
We did not ﬁnd any signiﬁcant associ-
ation between decreased VA and thin-
ner choroid in our young, extremely
high myopic subjects with or without
myopic maculopathy. Although retinal
thickness was reduced in myopic eyes
(average thickness 287 lm) than in a
comparable group of control eyes (av-
erage thickness 307 lm), thinning of
20 lmmay not be clinically meaningful
and photoreceptor layer might not
have been disrupted maintaining a
fairly normal visual functions in ado-
lescents and young adults with high
myopia than their aged counterparts in
which both severity of myopia and
other myopic maculopathy increases
with advancing age leading to reduced
VA.
To satisfy the normal metabolic
demands of the outer retina, choroidal
blood ﬂow is highest of any tissue in
the body. It has been shown to be
decreased in myopia (Akyol et al.
1996) although a recent study by
Sogawa et al. (2012) demonstrated no
signiﬁcant correlation between sub-
foveal CT and total choroidal blood
ﬂow or subfoveal choroidal blood ﬂow,
and therefore, the relationship between
choroidal perfusion and CT remains
unclear. In myopic eyes with choroidal
thinning, the good VA in face of
thinner choroid may be explained by
intact choroidal perfusion from larger
patent choroidal vessels, which are
typically in Haller’s layer and located
eccentric to the subfoveal area (Nickla
& Wallman 2010). However, this study
lacks choroidal blood ﬂow measure-
ments, and future studies of choroidal
circulation will be useful to correlate
CT with perfusion in normal eyes and
in high myopes with choroidal
thinning.
The strength of this study includes a
relatively large sample size of highly
myopic young Asian adults who
prospectively underwent standardized
examinations and highly detailed col-
our fundus photographs grading.
Unlike other studies, our study
included an emmetropic group and
therefore we could examine the diﬀer-
ences between highly myopic eyes and
non-myopic eyes in our case–control
study. The limitations of our study
include the following: First, due to our
cross-sectional study design, we were
unable to determine the causal rela-
tionships between the various risk fac-
tors and BCVA. Second, all of our
study subjects were males, and thus,
some of our ﬁndings may not be
generalized to females. Third, by not
taking into account axial length to
correct for ocular magniﬁcation, there
may still be some residual error.
In conclusion, we report that high
myopic eyes had thinner choroid, but
CT was not an independent predictor
of VA. Other factors related to myopia
are likely responsible for the dimin-
ished VA in young highly myopic eyes.
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